<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>GNews Health</title><link>https://news.google.com/</link><description></description><generator>rfeed v1.1.1</generator><docs>https://github.com/svpino/rfeed/blob/master/README.md</docs><item><title>斯诺霍米什县麻疹疫情增加，最新病例与Mukilteo教堂有关- komonews.com</title><link>https://komonews.com/news/local/new-measles-cases-in-snohomish-county-new-exposure-site-measles-outbreak-washington-state-slavic-christian-church-awakening-vaccines-testing-positive</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;h2 class="StoryPage_headline__AP3j8"&gt;&lt;p&gt;Snohomish County measles outbreak grows, latest case linked to Mukilteo church&lt;/p&gt;&lt;/h2&gt;&lt;div class="ByLineContainer_storyBylineContainer__0JNT7" id="js-Story-Byline-0"&gt;&lt;div&gt;&lt;p class="ByLine_storyByLineText__cze7l"&gt;by KOMO News Staff&lt;/p&gt;&lt;span class="ByLineContainer_storyDatelineText__yS9e8"&gt;Wed, January 28, 2026 at 6:03 PM&lt;/span&gt;&lt;p class="ByLineContainer_storyDatelineText__yS9e8"&gt;&lt;span class="ByLineContainer_updatedText__0D6FY"&gt;Updated &lt;/span&gt;Wed, January 28, 2026 at 6:11 PM&lt;/p&gt;&lt;/div&gt;&lt;button class="UserWayButton_userWayButton__h8S9a ByLineContainer_userWayButton___vCFL"&gt;&lt;img alt="UserWay icon for accessibility widget" src="/resources/defaults/news_3.0/icons/accessibility/userway-transparent.svg"&gt;&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>komonews.com</author><pubDate>Thu, 29 Jan 2026 02:05:57 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgJBVV95cUxNbHFWLWhSWHFITFA5ZERfa3h5LThHR1dKQUNZa1RqUFdnN0pjTEpvdkFNSmxWYjNkalNuWjh2QnVNT09xVW16TGROMi0zQm5ySmlzVTNGdVg5YTAyR29DX21nMWl4X1dvWGZFM2djLVVOaDhnQnNWTGRrUk5WWDVPbk9QX21lQ1hCRWx4bUdQdnNqY0ZlRjNmcWh3NnF3bGdrdTUtdmxGcUVwbnliazhsakJSMzhvSkdUeHRWeHpDMGk0b1pVODlZbEdJZk5xQWVBVjJBMjZRaTZOdWVZd3Rqd21Md2ZaU3U3b1p3V000RVloRW5vcVU5bFFvWEdrVThselBGOXh5TjZiNjA5SFE</guid></item><item><title>主要研究将夜猫子与更高的心脏病发作和中风风险联系起来- ScienceAlert</title><link>https://www.sciencealert.com/major-study-links-being-a-night-owl-to-higher-heart-attack-and-stroke-risk</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;WASHINGTON (AP) – &lt;span&gt;Being a night owl can be bad for your heart.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;That may sound surprising, but a large study found people who are more active late at night – when most of the population is winding down &lt;a href="https://apnews.com/article/sleep-cycles-women-rem-d2ca54492c20ae222c6e089e23f5939b"&gt;or already asleep&lt;/a&gt; – have poorer overall heart health than the average person.&lt;/p&gt;&lt;p&gt;"It is not like, that, night owls are doomed," said research fellow Sina Kianersi of Brigham and Women's Hospital and Harvard Medical School, who led the study.&lt;/p&gt;&lt;p&gt;"The challenge is the mismatch between your internal clock and &lt;a href="https://apnews.com/article/daylight-saving-time-health-effects-body-b67f3f0c00774851514c7fc80913c7c4"&gt;typical daily schedules&lt;/a&gt; " that makes it harder to follow heart-healthy behaviors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/night-owls-face-higher-depression-risk-a-new-study-explains-the-link"&gt;Night Owls Face Higher Depression Risk. A New Study Explains The Link.&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;And that's fixable, added Kianersi, who describes himself as "sort of a night owl" who feels a boost in "my analytical thinking" after about 7 or 8 at night.&lt;/p&gt;&lt;figure id="attachment_190496" aria-describedby="caption-attachment-190496" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch.jpg" alt="graph of alertness level over time for six different chronotypes" class="wp-image-190496 size-full" srcset="https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch.jpg 1440w, https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch-642x440.jpg 642w, https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch-986x675.jpg 986w, https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch-768x526.jpg 768w, https://www.sciencealert.com/images/2026/01/SixDifferentChronotypesIdentifiedByResearch-600x411.jpg 600w" sizes="(max-width: 1440px) 100vw, 1440px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-190496" class="wp-caption-text"&gt;Some research has identified six distinct chronotypes. (&lt;a href="https://www.sciencealert.com/scientists-say-there-are-6-human-chronotypes-not-just-morning-people-and-night-owls"&gt;RUDN University&lt;/a&gt;)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Heart disease is the leading cause of death in the US.&lt;/p&gt;&lt;p&gt;The American Heart Association has a &lt;a href="https://www.heart.org/en/healthy-living/my-life-check"&gt;list of eight key factors&lt;/a&gt; that everyone should heed for better heart health: &lt;a href="https://apnews.com/article/walking-exercise-10000-steps-227efc71844611ce21bc50ed6babbcc4"&gt;being more physically active&lt;/a&gt;; avoiding tobacco; getting enough sleep and a healthy diet; and &lt;a href="https://apnews.com/article/stroke-risk-death-nutrition-exercise-ozempic-mounjaro-5fee3375b627377b6a39565ce2a647c5"&gt;controlling blood pressure&lt;/a&gt;, cholesterol, blood sugar, and weight.&lt;/p&gt;&lt;p&gt;Where does being a night owl come in?&lt;/p&gt;&lt;p&gt;That has to do with the body's circadian rhythm, our master biological clock. It follows a roughly 24-hour schedule that regulates not just when we become sleepy and when we're more awake but also keeps organ systems in sync, influencing things like heart rate, blood pressure, stress hormones, and metabolism.&lt;/p&gt;&lt;p&gt;Everybody's circadian rhythm is a little different. Prior research had suggested night owls might have more health problems, as well as risk factors like higher rates of smoking and less physical activity, than people with more typical bedtimes, Kianersi said.&lt;/p&gt;&lt;p&gt;To learn more, Kianersi's team tracked more than 300,000 middle-aged and older adults in the UK Biobank, a huge health database that includes information about people's sleep-wake preferences.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.sciencealert.com/castingcall?utm_source=SA_website&amp;amp;utm_medium=article&amp;amp;utm_campaign=casting_call"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-642x272.jpg" alt="Audition now for ScienceAlert's Casting Call" class="alignnone wp-image-189354 size-medium" srcset="https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-642x272.jpg 642w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-1200x509.jpg 1200w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-768x326.jpg 768w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-600x255.jpg 600w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1.jpg 1266w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;About 8 percent of those people classified themselves as night owls, more active physically and mentally in the late afternoon or evening, and up past most people's bedtime.&lt;/p&gt;&lt;p&gt;About a quarter were early-birds, most productive in the daylight hours, and likewise early to bed. The rest were average, somewhere in the middle.&lt;/p&gt;&lt;p&gt;Over 14 years, the night owls had a 16 percent higher risk of a first heart attack or stroke compared to the average population, the researchers found.&lt;/p&gt;&lt;p&gt;The night owls, especially women, also had overall worse cardiovascular health based on meeting the heart association's eight key factors, the researchers &lt;a href="https://doi.org/10.1161/JAHA.125.044189"&gt;reported Wednesday in the &lt;em&gt;Journal of the American Heart Association&lt;/em&gt;&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Unhealthy behaviors – smoking, insufficient sleep, and poor diet – appear to be the main reasons.&lt;/p&gt;&lt;p&gt;"It comes down to the problem of a night owl trying to live in a morning person's world. They're getting up early for work because that's when their job starts, but it may not align with their internal rhythm," said Kristen Knutson of Northwestern University, who led recent heart association guidance on circadian rhythms but wasn't involved in the new study.&lt;/p&gt;&lt;p&gt;That affects more than sleep.&lt;/p&gt;&lt;p&gt;For example, metabolism fluctuates throughout the day as the body produces insulin to turn food into energy. That means it might be harder for a night owl to handle a high-calorie breakfast eaten very early in the day, during what normally would still be their biological night, Knutson said. And if they're out late at night, it can be harder to find healthy food choices.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/a-single-nights-sleep-could-predict-your-risk-for-more-than-100-diseases"&gt;A Single Night's Sleep Could Predict Your Risk For More Than 100 Diseases&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;As for sleep, even if you can't meet the ideal of at least seven hours, sticking to a regular bedtime and wake time also may help, she and Kianersi said.&lt;/p&gt;&lt;p&gt;The study couldn't examine what night owls do when the rest of the world is asleep. But Kianersi said one of the best steps to protect heart health – for night owls and anyone – is to quit smoking.&lt;/p&gt;&lt;p&gt;"Focus on the basics, not perfection," he said, again, advice that's good for everyone.&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Thu, 29 Jan 2026 01:41:33 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipgFBVV95cUxQYU8wMTc5aC02TlJqcC1CVWtrTTA4RHdLdnZLR1ZzRk5NWUpaVVNZaHI2ZjlYeXB3SUNsM2Nyek1ldlhWZ3Q3VGI4RW1IdXFib0FmNVVLQjhRbEhLQ1Vwd1Frem1UbUNjSXNQSVpNa3VTYkROWWIyQzBuVWNPOVdLT1pVakllRDdnTlBXVGFpalEyZnROd1hWaDZaa1RyZ2FlNHotZ0RB</guid></item><item><title>官员警告旧金山高中结核病爆发后的“中等”风险- SFGATE</title><link>https://www.sfgate.com/bayarea/article/san-francisco-tuberculosis-school-21320252.php</link><description>&lt;body id="readabilityBody"&gt;
    
        
&lt;/body&gt;
</description><author>SFGATE</author><pubDate>Thu, 29 Jan 2026 00:05:30 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgFBVV95cUxQR1BNUElYR1ZaWWpRWWZXLV9OMGM2VDJJdElTNFNkYXQ0dUhGSW8yQzlHY1BsTGR3VHVjekN1R3AzWVNGMEQwY0tkTEFEY3VTZ3ZjTHY1cmFCUlpPZjlUOTJYQ056YXlaQjQ2eDBpREtfc0ZhUmRsM2x1Q2RGM2h0aVl4ZlpqalZMMjA4UlhB</guid></item><item><title>新的研究发现，到2035年，肥胖症将增加1900万，影响1.26亿美国成年人- ABC新闻</title><link>https://abcnews.go.com/US/obesity-rise-19-million-affect-126-million-american/story?id=129652323</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;The number of Americans living with obesity is expected to rise by 19 million and affect nearly 126 million people by 2035, according to a new study published in the Journal of the American Medical Association on Wednesday.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Researchers found that the number of American adults living with obesity has more than doubled over the past 30 years, increasing from 34.7 million in 1990 to an estimated 107 million American adults in 2022. New findings suggest that this upward trend is expected to continue.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;“Our projections indicate that almost half of US adults will be living with obesity by 2035,” Dr. Catherine O. Johnson, lead research scientist at the Institute for Health Metrics and Evaluation at the University of Washington and co-author of the study, told ABC News.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;In the study, researchers reviewed the body mass index of over 11 million Americans across all states. They then broke down the numbers by state, age, sex, and race.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The findings showed that women were more affected than men overall and that Southern states had a higher number of people living with obesity.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Adults ages 45 to 64 had the highest rates of obesity, while younger women under 35 experienced the fastest rise in numbers in recent years. The shift seen in women “means that this population will also likely experience younger onset of obesity-related health concerns, including diabetes and cardiovascular disease,” Johnson said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Black women had the highest rates of obesity in 2022, the study found, followed by Hispanic women.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The disparities among different races and ethnicities point to how factors like income, access to healthcare, food availability and exercise opportunities may be driving them, experts say.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"Obesity is due to multifactorial set of causes including, but not limited to, access to healthy food, aspects of the built environment, and physical inactivity,” Johnson said. &lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The findings of the research also highlight that obesity affects Americans nationwide and will continue to impact more families each year.  &lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;“Obesity is currently a major public health threat and that this is likely to continue,” Johnson said. "Public health strategies that deliver real results, as well as increased and equitable access to clinical interventions, are urgently needed to make a difference.”&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Additionally, clinicians play an important role, Johnson noted, “both in treatment for persons currently living with obesity and in helping patients maintain a healthy weight early in life, starting in childhood.”&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;However, the increasing trends in obesity may place further pressure on health care systems, given that obesity is linked to various poor health outcomes.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;“Estimates are that health care costs associated with obesity were almost 200 billion dollars in 2019 [and] this is only expected to increase,” Johnson said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The study did not primarily look at GLP-1 weight loss drugs, which have surged in popularity in recent years. Prior &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fabcnews.go.com%2FGMA%2FWellness%2Fus-obesity-rates-drop-1st-time-decade-weight%2Fstory%3Fid%3D116736017&amp;amp;data=05%7C02%7CLeah.Sarnoff%40abc.com%7C2fca7b331fbc45cad47508de5ebd3a50%7C56b731a8a2ac4c32bf6b616810e913c6%7C1%7C0%7C639052363974972789%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=wIjm1aZqPmvK83Jev5tk1gHWNVmRm6qbk0SORGYLkyQ%3D&amp;amp;reserved=0" target="_blank" dir="ltr"&gt;research&lt;/a&gt; has shown that the drug may have led to a slight downturn in obesity rates in 2024.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC eTIW sUzSN "&gt;&lt;em class=" "&gt;Camille Charles, DO, is a pediatric resident and member of the ABC News Medical Unit.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ABC News</author><pubDate>Wed, 28 Jan 2026 23:52:53 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinAFBVV95cUxNamkxb0w5b2JTYmFCTk4zZkR0Qzh3WUZvSkhUYTZFby1VdTBJTDUtemNKQzlnUVdwVnZrdXlqUHdVSE12WGI1eFFtNEo5dk1Ec1cyM084SFZzY0M5QW41dHU2dDNYOU8tLWc1UjJxNUlUdVhDbkFRNWkzLWwxWDBRbnFTU1ZsNU5yN1UyVUs3OVkzMjRzLW9KSTl1ZE3SAaIBQVVfeXFMTzlpLWZjY2xWYjkzTHN0ZlVfMkUxcWJKejBJYUlQdG9lS3ZxRlVYY3FDRVdoZVQ5WURtZFJMZlBHLVphV3ZhMzhIdThzNExQVkhhS29PZUV4VE9OSVFlUFBqdXR1eXdhR1EzdnBDOWJ0RkZQSHU5WmdOcU0ybmpkbFg0SmRCMGtKeXZmMTl0Q0pRSl9uenlmYlpnMnlCeXMwZFZ3</guid></item><item><title>Boardman Southwoods是第一家提供水刀切除术前列腺手术的当地医院- wkbn.com</title><link>https://www.wkbn.com/news/local-news/boardman-news/boardman-southwoods-is-first-local-hospital-to-offer-aquablation-prostate-surgery/</link><description>&lt;body id="readabilityBody"&gt;
    
    
    &lt;noscript&gt;
      
    &lt;/noscript&gt;
  &lt;/body&gt;
</description><author>wkbn.com</author><pubDate>Wed, 28 Jan 2026 23:34:40 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>新研究表明，吃这种早餐主食可以在短短2天内降低胆固醇- EatingWell</title><link>https://www.eatingwell.com/oatmeal-lower-your-cholesterol-study-11894705</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="mntl-sc-page_1-0" class="comp mntl-sc-page mntl-block structured-content" data-sc-sticky-offset="90" data-sc-ad-label-height="24" data-sc-ad-track-spacing="100" data-sc-min-track-height="250" data-sc-max-track-height="600" data-sc-breakpoint="50em" data-sc-load-immediate="4" data-sc-content-positions="[1, 1250, 1550, 1950, 2350, 2750, 3150, 3550, 3950]" data-bind-scroll-on-start="true"&gt;&lt;div id="mntl-sc-block_1-0" class="comp mntl-sc-block eatingwell-sc-block-callout--summary mntl-sc-block-universal-callout--tips mntl-sc-block-universal-callout theme-summary callout--bordered" data-text="Key Points" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;
&lt;div class="mntl-sc-block-universal-callout__body"&gt;&lt;ul&gt;&lt;li&gt;Eating oatmeal may help lower cholesterol in people with metabolic syndrome.&lt;/li&gt;&lt;li&gt;The study suggests that your gut microbiome may help create the benefit.&lt;/li&gt;&lt;li&gt;Adding oatmeal to your diet can be a practical strategy to support heart health.&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p id="mntl-sc-block_2-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If your doctor has mentioned that your cholesterol numbers could use some work, you’re not alone. Nearly 10% U.S. adults have total cholesterol levels above the recommended range, and many are looking for dietary changes that can make a real difference.&lt;span data-cite="1" class="inline-citation-node"&gt;&lt;/span&gt; You have likely heard that oatmeal is good for your heart, but new research suggests its benefits go beyond what we previously understood—and your gut bacteria may deserve some of the credit.
&lt;/p&gt;
&lt;p id="mntl-sc-block_3-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_4-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A new study published in &lt;em&gt;Nature Communications&lt;/em&gt; found that eating oatmeal can significantly reduce &lt;a href="https://www.eatingwell.com/hdl-vs-ldl-cholesterol-whats-the-difference-11678853" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;LDL ("bad") cholesterol&lt;/a&gt; levels in as little as two days, with reductions of about 10% in people with &lt;a href="https://www.eatingwell.com/sneaky-signs-you-have-metabolic-syndrome-8694742" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;metabolic syndrome&lt;/a&gt;. Even more surprising, the researchers discovered that much of this benefit comes from compounds produced when your &lt;a href="https://www.eatingwell.com/article/2059033/best-and-worst-foods-to-eat-for-gut-health/" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="3"&gt;gut microbiome&lt;/a&gt; breaks down the oats you eat.
&lt;/p&gt;
&lt;p id="mntl-sc-block_5-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_6-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you have been wondering whether adding more oatmeal to your routine is worth it—or how much you would need to eat to see results—this study offers some compelling answers. Here’s what the researchers found and how you can put it into practice.&lt;span data-cite="2" class="inline-citation-node"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_7-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-how-was-this-study-conducted"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_8-0" class="comp mntl-sc-block eatingwell-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; How Was This Study Conducted? &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_9-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Researchers from the University of Bonn in Germany conducted two randomized controlled dietary interventions involving a total of 68 adults with metabolic syndrome—a cluster of conditions that includes central obesity, high blood pressure, elevated blood sugar and abnormal cholesterol levels. All participants were between 45 and 70 years old.
&lt;/p&gt;
&lt;p id="mntl-sc-block_10-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_11-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In the first study, 32 participants were randomly assigned to either a short-term, high-dose oat diet or a control diet for two days. Those in the oat group ate three oat meals daily, each containing about 100 grams (roughly 1 cup) of rolled oat flakes—totaling 300 grams per day. The control group ate macronutrient-matched meals without oats. The oat group was followed for six additional weeks as they returned to their normal diet.
&lt;/p&gt;
&lt;p id="mntl-sc-block_12-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_13-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In the second study, 34 participants were assigned to either replace one meal daily with an oat meal (80 grams of oat flakes) or continue their usual &lt;a href="https://www.eatingwell.com/constipation-diet-study-11860943" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Western diet&lt;/a&gt; for six weeks. The researchers collected blood and stool samples to analyze cholesterol levels, gut bacteria composition and metabolomic profiles—essentially measuring what metabolites were circulating in participants' bodies.
&lt;/p&gt;
&lt;p id="mntl-sc-block_14-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_16-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_18-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-what-did-the-study-find"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_19-0" class="comp mntl-sc-block eatingwell-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; What Did the Study Find? &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_20-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The results were particularly striking for the short-term, high-dose oat diet. After just two days, participants in the oat group experienced significant reductions in both &lt;a href="https://www.eatingwell.com/hdl-vs-ldl-cholesterol-whats-the-difference-11678853" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;LDL ("bad") cholesterol&lt;/a&gt; (about 10%) and total cholesterol (about 8%) compared to the control group. Perhaps even more interesting, cholesterol levels tended to stay below baseline during the six-week follow-up period, even after participants returned to their regular diets.
&lt;/p&gt;
&lt;p id="mntl-sc-block_21-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_22-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Both oat interventions led to increased levels of &lt;a href="https://www.eatingwell.com/this-whole-grain-may-lower-dementia-risk-11813120" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;ferulic acid&lt;/a&gt;, a phenolic compound found in oats, in participants' blood. The high-dose oat diet also increased dihydroferulic acid, a metabolite produced when gut bacteria break down ferulic acid. This is significant because the researchers found strong associations between these microbially produced phenolic compounds and the reduction in cholesterol levels.
&lt;/p&gt;
&lt;p id="mntl-sc-block_23-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_24-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The six-week moderate oat diet showed milder effects. While it increased some phenolic metabolites and appeared to stabilize cholesterol levels, it did not produce the same dramatic cholesterol reductions as the short-term, high-dose approach. The researchers suggest this may be because individual differences in gut bacteria composition and dietary habits play a larger role when oat consumption is more moderate.
&lt;/p&gt;
&lt;p id="mntl-sc-block_25-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_26-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; It's worth noting that this study had a relatively small sample size, which means the results should be confirmed in larger studies. The participants were primarily Caucasian adults from Germany, so the findings may not apply to all populations. Additionally, some dietary information was self-reported, which always leaves room for error.
&lt;/p&gt;
&lt;p id="mntl-sc-block_27-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-how-does-this-apply-to-real-life"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_28-0" class="comp mntl-sc-block eatingwell-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; How Does This Apply to Real Life? &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_29-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you are looking to support your &lt;a href="https://www.eatingwell.com/heart-healthy-lunch-a-cardiologist-recommends-11885239" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;heart health&lt;/a&gt;, these findings suggest that oatmeal may be an even more powerful tool than we realized—particularly when consumed in larger amounts. While eating 300 grams of oat flakes daily (the amount used in the high-dose study) is not practical for most people long term, the study suggests that periodic oat-focused days could be a useful strategy for people looking to improve their cholesterol levels.
&lt;/p&gt;
&lt;p id="mntl-sc-block_30-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_31-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Here are some practical ways to incorporate more oats into your routine:
&lt;/p&gt;
&lt;p id="mntl-sc-block_32-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_33-0" class="comp mntl-sc-block mntl-sc-block-html"&gt;
&lt;li&gt;&lt;strong&gt;Start your day with oatmeal.&lt;/strong&gt; A bowl of oatmeal for breakfast is one of the easiest ways to increase your oat intake. Try topping it with berries, nuts or a drizzle of honey for added flavor and nutrition.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Add oats to smoothies.&lt;/strong&gt; Blending ¼ cup of rolled oats into your morning smoothie adds fiber and helps keep you full longer.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Use oat flour in baking.&lt;/strong&gt; Swap out some all-purpose flour for oat flour in muffins, pancakes or homemade bread.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Try overnight oats.&lt;/strong&gt; If you are short on time in the morning, prepare overnight oats the night before for a grab-and-go breakfast.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Consider periodic high-oat days.&lt;/strong&gt; Based on this study, eating several oat-based meals in a single day occasionally may offer a cholesterol-lowering boost—you could try an oaty fruit smoothie in the morning, then opt for savory oats, like our &lt;a href="https://www.eatingwell.com/recipe/270489/sriracha-egg-avocado-overnight-oats/" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Sriracha, Egg &amp;amp; Avocado Overnight Oats&lt;/a&gt;, for lunch.&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_34-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_35-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; This study also highlights the importance of gut health for heart health. The phenolic compounds that helped lower cholesterol were largely produced by gut bacteria, so nurturing a healthy &lt;a href="https://www.eatingwell.com/article/2059033/best-and-worst-foods-to-eat-for-gut-health/" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;gut microbiome&lt;/a&gt; may amplify the benefits of eating oats. To support your gut bacteria, focus on eating a variety of fiber-rich foods and &lt;a href="https://www.eatingwell.com/article/281916/must-eat-fermented-foods-for-a-healthy-gut/" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;fermented foods like yogurt&lt;/a&gt; while limiting &lt;a href="https://www.eatingwell.com/processed-and-ultra-processed-foods-dietitian-approved-11770154" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="3"&gt;ultra-processed foods&lt;/a&gt;.
&lt;/p&gt;
&lt;p id="mntl-sc-block_36-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-our-expert-take"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_37-0" class="comp mntl-sc-block eatingwell-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; Our Expert Take &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_38-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A new study published in &lt;em&gt;Nature Communications&lt;/em&gt; found that eating oatmeal may help lower cholesterol levels, and the benefits appear to be driven in part by phenolic compounds that your gut bacteria produce when breaking down oats. A short-term, high-dose oat diet reduced LDL cholesterol by about 10% in people with metabolic syndrome, while a moderate daily oat intake helped maintain stable metabolic markers over six weeks. These findings add to the evidence that &lt;a href="https://www.eatingwell.com/oatmeal-cholesterol-benefits-11891148" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;oatmeal is a heart-healthy food choice&lt;/a&gt; and suggest that your gut microbiome plays an important role in how your body benefits from oats. Adding oatmeal to your diet is an easy way to support your &lt;a href="https://www.eatingwell.com/small-habits-for-heart-health-11796620" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;cardiovascular health&lt;/a&gt;.
&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>EatingWell</author><pubDate>Wed, 28 Jan 2026 23:18:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifEFVX3lxTE51WWpLeWN4bENBV3VOMUtYbERJWkt0MFpIR1NUQldlVWpWZnRBbGJzNWN4V0tsV1hiY1NfZXBTRzBBVEI2MzRmN3J2dDBzY0NVMUZoZmZjbVM1YkM4R0pLV1dwQjRoM2JQbXZMZHZvTDN6UDJKOHVXbFJPRTM</guid></item><item><title>亚利桑那州ICE设施确认的麻疹病例- CNN</title><link>https://www.cnn.com/2026/01/28/health/ice-facility-measles-arizona</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" data-editable="content" itemprop="articleBody" data-reorderable="content"&gt;
                
    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyibxuj000x26ov6tpv9zp9@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The US Department of Homeland Security says a person in detention at an Arizona Immigration and Customs Enforcement facility has measles, a highly contagious virus that can cause high fevers and a distinctive rash.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar00063b6psidmmbnj@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Earlier this month, “the Arizona Public Health Department confirmed an active measles infection of a Mexican national detainee housed at the Florence Detention Center,” a DHS spokesperson said in an email Wednesday.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar00073b6povpa03lb@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “ICE Health Services Corp immediately took steps to quarantine and control further spread and infection, ceasing all movement within the facility and quarantining all individuals suspected of making contact with the infected,” the email said.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar00083b6p3vbqlc50@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The Florence Detention Center is located in Pinal County, Arizona, and since that initial case, two additional measles cases have been identified in the county.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar00093b6p47farir3@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “At this time, Pinal County Public Health Services District has confirmed three measles cases in the county,” spokesperson Jassmin Castro said in an email Wednesday. “PCPHSD continues to follow standard public health protocols for confirmed measles cases, in coordination with state public health partners. At this time, the overall risk to the general community remains low.”
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000c3b6pti4ruloe@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The Florence Detention Center in Arizona is operated by the private company CoreCivic, which provides detainees with health care services including screening, prevention, health education, diagnosis and treatment, company spokesperson Brian Todd said in an email Wednesday.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000d3b6pc0wpmh3k@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “The health and safety of those entrusted to our care is the top priority for CoreCivic. This commitment is shared by our government partners at ICE, and we work closely with them to ensure the well-being of everyone in our care,” Todd said in the email.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000e3b6pwfzazbfr@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “All detainees have daily access to sign up for medical care and mental health services. For those medical needs requiring specialized care, the facility works closely with local hospitals and providers to meet those needs. Emergency care is available 24 hours a day, seven days per week.”
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyibzfq00003b6p02cioluu@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            In 2016, a measles outbreak at an ICE detention center in &lt;a href="https://academic.oup.com/cid/article/68/12/2018/5106985" target="_blank"&gt;Pinal County&lt;/a&gt; resulted in more than 30 cases of measles among detainees and nine staff members, according to a &lt;a href="https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6620a5.pdf" target="_blank"&gt;report&lt;/a&gt; published by the US Centers for Disease Control and Prevention.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000a3b6pf4dxpf7u@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Since the start of this year, 25 measles cases have been reported across the state of Arizona.
    &lt;/p&gt;



    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000f3b6pw47taxiv@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Nationwide, the United States last year recorded 2,242 measles infections, significantly more than there have been in any year since measles was declared eliminated in the US in 2000.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000b3b6pd4rsgng9@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “Per our most recent data, three of those cases are from Pinal, 17 related to the Mohave outbreak that we know has been ongoing since last year, three in Maricopa and one in Pima County,” Dr. Joel Terriquez, medical director for the state’s Bureau of Infectious Diseases and the Bureau of Immunizations, said on a news call Tuesday.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph_elevate" data-uri="cms.cnn.com/_components/paragraph/instances/cmkyid9ar000g3b6py5j23ksd@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Before 2025, there were an average of about 180 measles cases reported each year since elimination, according to CDC data. But so far this year, there already have been at least 416 confirmed measles cases reported in the US.
    &lt;/p&gt;

              &lt;/div&gt;
                  &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CNN</author><pubDate>Wed, 28 Jan 2026 22:35:04 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMidEFVX3lxTE16N2x0T2xqUXB5Z2VZMmxVQlZVUmdqWGkxMk95aVFDd0o3TWNQSE9xbjZzMVc0Z05ybko0cFVyTThobGRpbVJKSGVCX1djVHcyN1l1TXpLS3k0ZGppXzdrNjJwaGN6Y0NyYmFkUklSRUF0NlY3</guid></item><item><title>印度表示，随着一些亚洲国家加强健康检查，它已遏制了尼帕病毒的爆发- NBC新闻</title><link>https://www.nbcnews.com/health/health-news/india-says-contained-nipah-virus-outbreak-asian-countries-ramp-health-rcna256385</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body__content"&gt;&lt;p id="anchor-325d1c" class="body-graf"&gt;NEW DELHI — Indian authorities said they had contained a &lt;a href="https://www.nbcnews.com/health/health-news/what-nipah-virus-n876476" target="_blank"&gt;Nipah virus outbreak&lt;/a&gt; after confirming two cases in the eastern state of West Bengal, as several Asian countries tightened health screenings and airport surveillance for travelers arriving from India.&lt;/p&gt;&lt;p id="anchor-d26521" class="body-graf"&gt;India’s Health Ministry said Tuesday that two Nipah cases had been detected since December and that all identified contacts had been quarantined and tested. The ministry did not release details about the patients but said 196 contacts had been traced and all tested negative.&lt;/p&gt;&lt;p id="taboolaReadMoreBelow"&gt;&lt;/p&gt;&lt;p id="anchor-f6899b" class="body-graf"&gt;“The situation is under constant monitoring, and all necessary public health measures are in place,” the ministry said.&lt;/p&gt;&lt;p id="anchor-b1b5dd" class="body-graf"&gt;Nipah, a zoonotic virus first identified during a 1990s outbreak in Malaysia, spreads through fruit bats, pigs and human-to-human contact. There is no vaccine for the virus, which can cause raging fevers, convulsions and vomiting. The only treatment is supportive care to control complications and keep patients comfortable.&lt;/p&gt;&lt;p id="anchor-28f5b3" class="body-graf"&gt;The virus has an estimated fatality rate of between 40% and 75%, &lt;a href="https://www.who.int/news-room/fact-sheets/detail/nipah-virus" target="_blank"&gt;according to the WHO&lt;/a&gt;, making it far more deadly than the coronavirus.&lt;/p&gt;&lt;p id="anchor-ca34b3" class="body-graf"&gt;There were no reported cases of the virus outside India, but several Asian countries introduced or reinforced screening measures at airports as a precaution. The safety measures were put in place after early media reports from India suggested a surge in cases, but health authorities said those figures were “speculative and incorrect.”&lt;/p&gt;&lt;figure class="styles_inlineImage__FvnTh styles_medium__MEKii" id="anchor-24e692"&gt;&lt;picture class="styles_image__i32F7" data-testid="picture" data-flavor="fit" data-original-height="1666" data-original-width="2500"&gt;&lt;source media="(min-width: 1000px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_avif,q_auto:eco,dpr_2/rockcms/2026-01/260128-nipah-virus-thailand-vsb-1638-969898.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_auto,q_auto:best/rockcms/2026-01/260128-nipah-virus-thailand-vsb-1638-969898.jpg 1x"&gt;&lt;/source&gt;&lt;source media="(min-width: 320px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_avif,q_auto:eco,dpr_2/rockcms/2026-01/260128-nipah-virus-thailand-vsb-1638-969898.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2026-01/260128-nipah-virus-thailand-vsb-1638-969898.jpg 1x"&gt;&lt;/source&gt;&lt;img loading="lazy" src="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2026-01/260128-nipah-virus-thailand-vsb-1638-969898.jpg" alt="Quarantine doctors watch thermal scanning at the Suvarnabhumi International Airport in Samut Prakarn, Thailand."&gt;&lt;/picture&gt;&lt;figcaption class="caption styles_caption__TCewG" data-testid="caption"&gt;&lt;span class="caption__container" data-testid="caption__container"&gt;Doctors screen travelers from West Bengal, India at the Suvarnabhumi International Airport in Samut Prakarn, Thailand, on Sunday.&lt;/span&gt;&lt;span class="caption__source" data-testid="caption__source"&gt;Suvarnabhumi International Airport via AP&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="anchor-99133c" class="body-graf"&gt;Indonesia and Thailand increased screening at major airports, with health declarations, temperature checks and visual monitoring for arriving passengers. Thailand’s Department of Disease Control said thermal scanners had been installed at arrival gates for direct flights from West Bengal at Bangkok’s Suvarnabhumi Airport.&lt;/p&gt;&lt;p id="anchor-ee2385" class="body-graf"&gt;Myanmar’s Health Ministry advised against nonessential travel to West Bengal and urged travelers to seek immediate medical care if symptoms develop within 14 days of travel. It said fever surveillance introduced during the Covid pandemic at airports has been intensified for passengers arriving from India, with laboratory testing capacity and medical supplies readied.&lt;/p&gt;&lt;p class="recommended-intersection-ref" data-activity-map="recommended-article-body-recommended" data-testid="recommended-wrapper"&gt;&lt;/p&gt;&lt;p class="recommended-intersection-ref" data-activity-map="recommended-article-body-recommended" data-testid="recommended-wrapper"&gt;&lt;/p&gt;&lt;p id="anchor-669428" class="body-graf"&gt;Vietnam’s Health Ministry on Tuesday urged strict food safety practices and directed local authorities to increase monitoring at border crossings, health facilities and communities, according to state media.&lt;/p&gt;&lt;p id="anchor-09dd70" class="body-graf"&gt;China said it was strengthening disease prevention measures in border areas. State media reported that health authorities had begun risk assessments and enhanced training for medical staff, while increasing monitoring and testing capabilities.&lt;/p&gt;&lt;p id="anchor-a39e74" class="endmark body-graf"&gt;Earlier Nipah outbreaks were reported in West Bengal in 2001 and 2007, while recent cases have largely been detected in &lt;a href="https://www.nbcnews.com/news/world/700-people-tested-nipah-virus-two-deaths-india-rcna105008" target="_blank"&gt;southern Kerala state&lt;/a&gt;. A major outbreak in 2018 killed at least 17 people in Kerala.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NBC News</author><pubDate>Wed, 28 Jan 2026 21:54:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwAFBVV95cUxQeFJqcC1Kalc0VlA3VW8zaTgxQmpZSE92eDdQdFZKaE9hS1pxRVVTOUtvYWU1S0NpME15OGNQOTQ5TW4zR2hmei1Sdm82YkppcWxtQ09aQjZWTnJsLUlLUWlCbWZSUTZodFRhcU5DRmJfS3BYNk1wTDE2RzVfakdZRkpzQTFUaEE0VkJZbHN5QURhM1dtUE5FR0VBb2FHaXM1ZU5aUlI3a2dmb2dZQW9zRHFiVWlGam5XNWUtRi1JMWY</guid></item><item><title>华盛顿州首例儿科流感死亡凸显全州新增病例- komonews.com</title><link>https://komonews.com/news/local/snohomish-county-teen-flu-season-death-health-department-vaccine-washington-state-department-of-health-covid-rsv-hospital-flu-cases-across-western-washington</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p&gt;&lt;span class="dateline"&gt;SNOHOMISH COUNTY, Wash.  — &lt;/span&gt;&lt;a href="https://www.snohd.org/m/newsflash/home/detail/909" target="_blank"&gt;A school-age teenager has died after becoming ill from influenza last week&lt;/a&gt;, marking the first pediatric influenza death in the state this season, according to the Washington State Department of Health. &lt;/p&gt;&lt;p&gt;&lt;strong&gt;SEE ALSO |&lt;a href="https://komonews.com/news/local/thurston-county-influenza-related-death-washington-state-death-flu-related-symptoms-phss-washington-state-department-of-health-statewide-illness" target="_blank"&gt; Thurston County reports first flu-related death as state sees sharp rise in cases &lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;A total of 10 deaths have been reported in Snohomish County this season from complications related to influenza, while 222 people have been hospitalized, according to the Snohomish County health department. &lt;/p&gt;&lt;p&gt;Across the state, as of Jan. 17, there have been 59 confirmed flu-related deaths, health officials said. &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;“Our hearts go out to the family and friends of this youth,” said Health Officer Dr. James Lewis. “It’s a sad reminder of the danger that influenza and other vaccine-preventable diseases pose to our community.”&lt;/p&gt;&lt;p&gt;Other respiratory viruses, such as flu, COVID-19, and RSV (Respiratory Syncytial Virus), can result in severe illness, especially for young children, older adults, and others at higher risk, health officials said. &lt;/p&gt;&lt;p&gt;The flu season typically runs from October through April, but peaks about now. &lt;/p&gt;&lt;p&gt; “It’s never too late to get vaccinated for the flu,” Dr. Lewis said. “Even if you still catch it, the vaccine generally reduces the number of sick days you’ll take from work or school and reduces the severity of symptoms, keeping you out of the hospital.” &lt;/p&gt;&lt;p&gt;The annual flu vaccine is recommended for everyone ages six months and older, the Snohomish County health department said. &lt;/p&gt;&lt;p&gt;In Washington state, children under age 19 can be vaccinated for free, and most insurance plans, including Medicare Part B, cover the cost for adults. &lt;/p&gt;&lt;p&gt;During last year’s influenza season, Snohomish County reported 53 flu-related deaths, the most in more than a decade, while 859 flu-related hospitalizations were reported, according to health officials.  &lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>komonews.com</author><pubDate>Wed, 28 Jan 2026 21:03:44 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimAJBVV95cUxOUnRnWG1HeEJRSEY5bS1SUl9oRnZONENJaFl5bTZPbF9WQkM5QmE2VGpDWG02X1pKUS1mYlBlSTM4ZWtBQlhuNXhSNDBGZnpQQjljdW9CM0pGdVZEZzhULXhZaWRSdDhBdi0tUXd0RXVrVmRiVDIwei1QdG9paEpBWTJHLXI4NzllS3pZeENJTktaQ280ZVREN3FtcEY5OW1KVmg4cUl3REYtRWpjNm0yWVRqcHRVZ3NOWmFNaHNxOENoQzZFR2tkbHlVQXZGMFdCRlV4cmVmbGp5bk5VRUpPR0poMFlQTXRQN1k1ZGlpRmRkMkFTRGVQTFI0dzFpcHlRcmMxOVl1Y0t4M3VmaVJ4Y2QybGs3VjhT</guid></item><item><title>犹他州卫生部门报告了54例最近的麻疹病例，疫情仍在继续- KSL.com</title><link>https://www.ksl.com/article/51439696/utah-health-department-reports-54-recent-measles-cases-as-outbreak-continues</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="articleContainer"&gt;&lt;p&gt;SALT LAKE CITY — Utah is already reporting 42 measles cases this year, for a total of 237 cases during the current outbreak.&lt;/p&gt;&lt;p&gt;The Utah Department of Health and Human Services updated its measles statistics on Tuesday. The report shows 54 newly identified cases in the last three weeks.&lt;/p&gt;&lt;p&gt;The number of new cases each week has been decreasing since the final week of 2025, when there were 30 new cases — but the department could still add cases that are identified later to those counts.&lt;/p&gt;&lt;p&gt;In the last two weeks, Salt Lake County reported 12 new cases and 11 new cases were reported in both the southwest Utah health district and the Utah County Health District.&lt;/p&gt;&lt;p&gt;The most recent samples of wastewater detected measles in Salt Lake, Utah, Weber and Morgan counties, as well as in the southwest Utah health district. No recent measles detections were found in wastewater samples in Tooele County, Davis County, Summit County and the TriCounty health district.&lt;/p&gt;&lt;p&gt;Exposure locations in the last two weeks include Instacare locations in Spanish Fork, West Valley, Draper, and Riverton; two events at the Potter's House Christian Center and the emergency department at Intermountain Medical Center. Each exposure has specific dates and times listed on the department's &lt;a href="https://epi.utah.gov/measles-response/" rel="nofollow" target="_blank"&gt;website&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The health department invites anyone who was at one of the exposure locations during the exposure period to take an anonymous survey, available in English and Spanish, to learn about their risk and recommended next steps.&lt;/p&gt;&lt;p&gt;The department said that although it is rare for vaccinated people to get measles, it is still reasonable for those who were at an exposure location to watch for symptoms. However, a breakthrough infection typically causes mild illness that is less likely to spread.&lt;/p&gt;&lt;p&gt;Close to 89% of Utah's cases were people who were not vaccinated, where an additional 3% were from people with an unknown vaccination status.&lt;/p&gt;&lt;p&gt;The health department said it strongly encourages parents to talk to their health care provider about getting a measles vaccine, the MMR vaccine, for their children, even if they have not been exposed. This includes possible extra early doses for infants between 6 and 12 months, especially those traveling or going to areas where there is active spread, and an early second dose for children under 4.&lt;/p&gt;&lt;p&gt;Typically, measles vaccinations are administered at 12-15 months and again at 4-6 years.&lt;/p&gt;&lt;p&gt;About 61% of the cases in Utah's current outbreak were children under 18. Just under 9% of the 237 total cases have resulted in admission to a hospital.&lt;/p&gt;&lt;p&gt;The Utah Department of Health and Human Services encouraged people who think they or their child may have measles to stay home and away from others, call a clinic or provider ahead of time to prevent exposure in the waiting area.&lt;/p&gt;&lt;p&gt;It said people with measles symptoms should seek medical care if they have a hard time breathing or a fever that won't come down.&lt;/p&gt;&lt;/div&gt;&lt;p class="kt_disclaimer"&gt;
                                    The Key Takeaways for this article were generated with the assistance of large language models and reviewed by our editorial team. The article, itself, is solely human-written.
                                &lt;/p&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KSL.com</author><pubDate>Wed, 28 Jan 2026 20:31:53 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiswFBVV95cUxQWHpnSThEanQ3ZER0b3F3TU9rMHRGUDR4N2VieVBDa2haQmcwTlNJTXhSMi1DakJhMVQ0dnpyVEVFVEE5Rk43RkpseFhPbGJtVXh4Q2J6UlRuZGJidS1faGJ6ZTh2TUY0bTBuNTNXMWVpdXgzLTBtUl9FLWhhVFF5LWhWZkJaaXdtSmNmVURiY3V6TDczNTMwQ3Zoa18wNU5HRFUxVlg4Qm1KRG44YWg2a0ttWQ</guid></item><item><title>环境驱动的免疫印记可防止过敏-自然</title><link>https://www.nature.com/articles/s41586-025-10001-5</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec8-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec9"&gt;Mice&lt;/h3&gt;&lt;p&gt;Pet shop mice were purchased from Komodo Reptile. Mice of the following strains were purchased from The Jackson Laboratory: 129S1/SvImJ (strain 002448), A/J (000646), BALB/cJ (000651), CAST/EiJ (000928), C3H/HeJ (000659), C57BL/6J (000664), DBA/1J (000670), FVB/NJ (001800), PERC/EiJ (001307), PWK/PhJ (003715) SJL/J (000686) and WSB/EiJ (001145). C57BL/6J or BALB/cJ mice were used in SPF experiments as indicated. Except where noted, all mice were kept on standard chow diet (Envigo/Inotiv 2018S). In experiments using soy-free diet (Envigo/Inotiv 2020SX), breeder pairs were placed onto soy-free diet and progeny to be used for experiments were weaned onto, and maintained, on a soy-free diet. For experiments using casein diet, breeder pairs and progeny were maintained on a custom 18% casein protein diet (Envigo/Inotiv TD170404). Mice were 8–12 weeks of age at the initiation of experimental procedures except where noted. Experimental cohorts bred in house comprised female and male mice; female mice were used in all other experiments. Cages of mice were randomized across conditions and sample sizes were not determined a priori. Workers were not blinded to treatment conditions. All protocols were reviewed, approved, and conducted under the institutional regulation of Yale University’s Institutional Animal Care and Use Committee.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec10"&gt;Pathogen testing and cytokine measurement&lt;/h3&gt;&lt;p&gt;Oral swabs, fur swabs and faecal samples were submitted to IDEXX BioAnalytics and screened by PCR for the presence of common mouse pathogens. Serum cytokine measurement was performed by Eve Technologies.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;16s rRNA sequencing and analysis&lt;/h3&gt;&lt;p&gt;Immediately upon arrival at our facilities, pet shop faecal samples were collected in sterile Eppendorf tubes. DNA was isolated (Qiagen 12855) followed by amplification of the 16S rRNA gene V4 region by PCR using a dual index multiplexing strategy as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Palm, N. W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000–1010 (2014)." href="/articles/s41586-025-10001-5#ref-CR57" id="ref-link-section-d49059602e1619"&gt;57&lt;/a&gt;&lt;/sup&gt;. Successful amplification was confirmed by gel electrophoresis; amplicons were then pooled and gel-extracted. Library quantification was conducted on gel-extracted fraction (KAPA Biosystems KK4835; Applied Biosystems QuantStudio 6 Flex instrument). Paired-end sequencing (2 × 250) was performed on an Illumina Miseq using a 500-cycle V2 reagent kit (Illumina MS-102-2003).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Co-housing and fostering&lt;/h3&gt;&lt;p&gt;To establish a colony of inbred mice bearing pathogens, adults were co-housed with pet shop mice for two weeks, then separated into breeding cages. Progeny from these breeding pairs were used as experimental animals. For studies on baseline antibody reactivities and T cell memory, adult inbred SPF mice were co-housed with pet shop mice for 60 days and directly tested. For foster experiments, P1 neonatal inbred mice from SPF breeders were fostered onto pet shop dams and remained with the dam until weaning.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Allergic sensitization and anaphylaxis measurement&lt;/h3&gt;&lt;p&gt;For subcutaneous (skin) sensitization, 5 µg of low-endotoxin cOVA (Biovendor 321001) adsorbed to ~500 µg (50 µl) aluminium hydroxide gel (alum) (Invivogen vac-alu-250) with PBS to a final volume of 100 µl was injected subcutaneously in the flank near the inguinal lymph node using an insulin syringe (BD 329410). In some experiments, KLH (Sigma H7017) was used as antigen. For intranasal (lung) sensitization, 20 µg of low-endotoxin cOVA and 20 µg of papain (ThermoFisher Scientific 416760100) with PBS to a final volume of 40 µl was administered into the nasal passage of anaesthetized mice. For intragastric (intestinal) sensitization, 50 mg of cOVA grade V (Sigma A5503) and 10 µg of cholera toxin (Sigma 227036) in 200 µl bicarbonate buffer was administered by gavage. Injections or administrations were repeated seven days later, and serum was collected after an additional five days. Two days after serum collection, mice were challenged intraperitoneally with 75 µg cOVA grade V (Sigma A5503) in PBS to a final volume of 200 µl and core body temperature was measured every 15 min using a rectal thermometer (Physitemp TH-5) over the course of 75 min. Perinatal sensitizations were performed with 5 µg cOVA adsorbed to ~250 µg alum in PBS to a final volume of 50 µl injected subcutaneously in the flank.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Pre and post-sensitization CFA immunization&lt;/h3&gt;&lt;p&gt;Mice received subcutaneous flank injections of 100 µl containing 5 µg antigen emulsified in a 1:1 mixture of PBS and CFA (Sigma F5881). In CFA pre-treatment experiments, mice were immunized with CFA plus antigen 21 days prior to standard cOVA sensitization. For CFA post-sensitization experiments, mice were immunized with CFA plus antigen 21 days after a single 5 µg dose of cOVA in alum. All CFA plus antigen injections were administered on the contralateral flank from the cOVA plus alum injection site.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Legume extract preparation and legume sensitization&lt;/h3&gt;&lt;p&gt;Legume extracts were obtained by dissolving purified proteins from pea (Greer F167), peanut (Greer F171) or soybean (Greer F209) in PBS and incubated overnight at 4 °C with rotation and centrifuged at 3,214&lt;i&gt;g&lt;/i&gt; for 30 min at 4 °C to remove insoluble matter. The resulting supernatant was filtered through 40-µm mesh filters (Fisher Scientific 22-363-547). Protein content of the resulting extracts was measured by BCA (Pierce 23225).&lt;/p&gt;&lt;p&gt;Mice received subcutaneous flank injections of 10 µg legume extract adsorbed to 500 µg alum with PBS to a final volume of 100 µl. Injections were repeated one week later. Serum was collected after an additional five days. Two days after serum collection, mice were challenged intraperitoneally with 250 µg legume extract in PBS to a final volume of 200 µl and monitored for core body temperature every 15 min over the course of 75 min.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;OVA purification and recombinant expression&lt;/h3&gt;&lt;p&gt;Egg whites were obtained from fresh eggs purchased from local grocery stores. Egg whites were fractionated using aqueous biphasic separation procedures according to a published protocol&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Pereira, M. M. et al. Single-step purification of ovalbumin from egg white using aqueous biphasic systems. Process Biochem. 51, 781–791 (2016)." href="/articles/s41586-025-10001-5#ref-CR58" id="ref-link-section-d49059602e1670"&gt;58&lt;/a&gt;&lt;/sup&gt;. The top phase was collected, diluted 1:5 with ice-cold PBS and incubated overnight at 4 °C. The following day, samples were centrifuged at 20,000&lt;i&gt;g&lt;/i&gt; for 30 min at 4 °C, and the supernatant collected for analysis. For btOVA, no eggs were readily available for OVA purification. The coding sequence of btOVA including a C-terminal His tag was synthesized (Twist Biosciences) and expressed in Expi293F cells (ThermoFisher Scientific A14527) following the manufacturer’s specifications. The cell line was not further authenticated nor tested for mycoplasma contamination. btOVA was purified using Ni-NTA agarose beads (Qiagen 30210) and buffer exchanged into PBS on 3K protein concentrators (ThermoFisher Scientific 88512). OVA purity was assessed by gel densitometry using Mini-PROTEAN TGX stain-free gels (Bio-Rad 4568086) on a Bio-Rad Chemidoc MP imaging system.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Passive systemic anaphylaxis&lt;/h3&gt;&lt;p&gt;Mice received intraperitoneal injections of 20 µg of anti-DNP IgE (Sigma D8406) in PBS to a volume of 200 µl. One day later, mice received intravenous injections of 200 µg DNP–HSA (Biosearch Technologies D-5059) in PBS to a volume of 200 µl and monitored for core body temperature every 15 min over the course of 75 min.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Anaphylaxis with compound 48/80, histamine and platelet activating factor&lt;/h3&gt;&lt;p&gt;Mice received intraperitoneal injections of 4 mg kg&lt;sup&gt;−1&lt;/sup&gt; Compound 48/80 (Sigma 2313), 20 µmol histamine dihydrochloride (Sigma) or 100 µg kg&lt;sup&gt;−1&lt;/sup&gt; platelet activating factor-16 (Sigma) all in PBS in final injection volumes of 200 µl. Core body temperature was measured every 15 min over the course of 75 min.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Oral tolerance model&lt;/h3&gt;&lt;p&gt;Oral tolerance was established similar to a published protocol&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Mucida, D. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923–1933 (2005)." href="/articles/s41586-025-10001-5#ref-CR48" id="ref-link-section-d49059602e1706"&gt;48&lt;/a&gt;&lt;/sup&gt;. Mice were provided control Milli-Q water or Milli-Q water with 1% w/v cOVA grade III (Sigma A5378) ad libitum for 5 days with water replaced every other day. Mice were returned to facility water for two days, then sensitized as described.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Listeria infection&lt;/h3&gt;&lt;p&gt;Mice were infected intravenously with 5 × 10&lt;sup&gt;4&lt;/sup&gt; colony-forming units of &lt;i&gt;L. monocytogenes&lt;/i&gt; strain 10403s or &lt;i&gt;L. monocytogenes&lt;/i&gt; transgenically expressing cOVA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Pope, C. et al. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166, 3402–3409 (2001)." href="/articles/s41586-025-10001-5#ref-CR59" id="ref-link-section-d49059602e1726"&gt;59&lt;/a&gt;&lt;/sup&gt;. Three weeks later, mice were subjected to a standard sensitization protocol followed by intraperitoneal cOVA challenge and measurement of anaphylaxis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;ELISA&lt;/h3&gt;&lt;p&gt;Nunc Maxisorp plates (ThermoFisher Scientific 442404) were coated with 100 µl per well of antigen or capture antibodies in coating buffer (Sigma C3041) either for 1 h at room temperature or overnight at 4 °C. Plates were washed three times with PBS/0.05% Tween-20 (PBS-T). Plates were blocked with 200 µl per well of blocking buffer (PBS-T + 1% w/v non-fat milk powder) for 1 h at room temperature or overnight at 4 °C. Standards and samples were diluted in blocking buffer and 100 µl per well was added in duplicates, followed by an incubation of 1 h at room temperature. Plates were washed six times with PBS-T, and 100 µl per well of blocking buffer with detection antibodies was added and incubated for 1 h at room temperature. Plates were again washed six times with PBS-T and developed using TMB (BD and reactions stopped by 0.18 M H&lt;sub&gt;2&lt;/sub&gt;SO&lt;sub&gt;4&lt;/sub&gt;). Absorbance was read on a Spectramax plate reader (Molecular Devices SpectraMax M5). Antibodies used for capture, detection and standards are listed in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10001-5#MOESM1"&gt;4&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Blocking ELISA and antibody preference index&lt;/h3&gt;&lt;p&gt;Sera were normalized to 10 ng ml&lt;sup&gt;−1&lt;/sup&gt; for anti-cOVA IgG1 or IgG2, respectively, by dilution in ELISA blocking buffer, and 50 µl per well was added to antigen-coated Nunc Maxisorp plates pre-loaded with 50 µl per well of ELISA blocking buffer with or without 200 µg ml&lt;sup&gt;−1&lt;/sup&gt; soluble antigen. From this point, plates were treated as described above. Antibody preference index was calculated by taking the percentage of OD&lt;sub&gt;450 nm&lt;/sub&gt; signal retained in cOVA-coated plates blocked with qOVA minus the percentage of OD&lt;sub&gt;450 nm&lt;/sub&gt; signal retained in qOVA-coated plates blocked with cOVA. A maximum value of 1 indicated complete preference for cOVA, and a minimum value of −1 indicated complete preference for qOVA.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;ELISpot&lt;/h3&gt;&lt;p&gt;ELISpot plates (Millipore) were coated with 100 µl per well anti-IFNγ or anti-IL-4 (BD 551881,551878) at a concentration of 5 µg ml&lt;sup&gt;−1&lt;/sup&gt; in sterile PBS overnight at 4 °C. The following day, plates were washed three times with 200 µl PBS (5-min incubations) and twice with PBS-T. Plates were blocked with 100 µl complete RPMI medium (+10% fetal calf serum, 25 mM HEPES, 2mM &lt;span class="u-small-caps"&gt;l&lt;/span&gt;-glutamine, 1× MEM non-essential amino acids, 1× penicillin/streptomycin, 1 mM sodium pyruvate) for 2 h at 37 °C. Prior to cell addition, medium was removed and 50 µl of complete RPMI + antigen (160 µg ml&lt;sup&gt;−1&lt;/sup&gt;) was added. Spleens were minced and dissociated in RPMI + 0.1 mg ml&lt;sup&gt;−1&lt;/sup&gt; DNAse I (Sigma DN25) + 0.25 mg ml&lt;sup&gt;−1&lt;/sup&gt; Liberase TL (Roche 05401020001) for 30 min at 37 °C with agitation. Following dissociation, cells were passed through 40-µm filters, spun at 800&lt;i&gt;g&lt;/i&gt; for 5 min at 4 °C and resuspended in red blood cell lysis buffer (Biolegend 420302) according to the manufacturer’s recommended protocol. Following red blood cell lysis, 45 ml of ice-cold PBS was added, and cells were spun at 800&lt;i&gt;g&lt;/i&gt; for 5 min and resuspended in 5 ml ice-cold complete RPMI. Cells were quantified on a haemocytometer and adjusted with complete RPMI to a concentration of 1 × 10&lt;sup&gt;7&lt;/sup&gt; cells per ml. From this, 50 µl of cells were added to ELISpot plates already containing complete RPMI with or without antigen. Plates were incubated ~18 h at 37 °C with 90% humidity and 5% CO&lt;sub&gt;2&lt;/sub&gt;. Following incubation, cells were tapped out of plates and wells were rinsed twice with 200 µl deionized H&lt;sub&gt;2&lt;/sub&gt;O. Biotinylated anti-IFNγ and anti-IL-4 (BD 551881,551878) were added at a concentration of 2 µg ml&lt;sup&gt;−1&lt;/sup&gt; in PBS at a volume of 100 µl per well. Plates were incubated for 2 h at room temperature, then washed three times with PBS-T. One hundred microlitres per well of Streptavidin–HRP (BD 557630) in PBS was added and plates were incubated for 1 h at room temperature. Spots were developed using AEC (Sigma AEC101), and the reactions were stopped by thoroughly rinsing plates with deionized H&lt;sub&gt;2&lt;/sub&gt;O. Spots were counted using an ELISpot reader (Autoimmun Diagnostika).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Flow cytometry&lt;/h3&gt;&lt;p&gt;Identification of antigen-reactive CD4&lt;sup&gt;+&lt;/sup&gt; T cells was performed as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Bacher, P. et al. Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire. J. Immunol. 190, 3967–3976 (2013)." href="/articles/s41586-025-10001-5#ref-CR33" id="ref-link-section-d49059602e1808"&gt;33&lt;/a&gt;&lt;/sup&gt;. Splenic single cell suspensions prepared as described above were incubated at 1 × 10&lt;sup&gt;7&lt;/sup&gt; cells per ml in 24-well plates (Falcon 353047) with complete RPMI with or without 100 µg ml&lt;sup&gt;−1&lt;/sup&gt; antigen in incubators kept at 37 °C with 5% CO&lt;sub&gt;2&lt;/sub&gt; and 95% relative humidity. After 6 h of incubation, Brefeldin A (Sigma B7651) was added to wells followed by a further 12 h of incubation. Cells were removed from wells and incubated with aCD16/CD32 (Biolegend 101320). Surface staining was performed simultaneously with Zombie UV (Biolegend). After surface staining, cells were washed and fixed (BD 554714) according to the manufacturer’s specifications and stained for intracellular antigens. Cells were analysed on a BD Symphony flow cytometer. Data were analysed using FlowJo (Tree Star). All antibodies are listed in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10001-5#MOESM1"&gt;5&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;For bacterial flow cytometry, samples were prepared as described for peptide enrichment. Following incubation with serum or monoclonal antibody, samples were stained with FITC-conjugated polyclonal goat anti-mouse IgG (Southern Biotech 103302) in PBS-T and analysed on a BD Symphony or BD LSRII flow cytometer.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;Bacterial peptide display cloning&lt;/h3&gt;&lt;p&gt;The pB33eCPX plasmid&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Rice, J. J. &amp;amp; Daugherty, P. S. Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides. Protein Eng. Des. Sel. 21, 435–442 (2008)." href="/articles/s41586-025-10001-5#ref-CR27" id="ref-link-section-d49059602e1834"&gt;27&lt;/a&gt;&lt;/sup&gt; (Addgene) was modified first by inserting an AfeI restriction site after the signal sequence embedded in a longer Gly-Ser linker. AfeI was chosen because the sequence encodes Ser-Ala, allowing for flexible display of the intervening peptide of interest. Separately, fluorescent proteins under the control of the constitutive Anderson promoter Bba_J23100 (&lt;a href="http://parts.igem.org/"&gt;http://parts.igem.org/&lt;/a&gt;) were inserted in a SalI-digested plasmid in antisense orientation relative to the peptide scaffold. Oligonucleotide pools (Integrated DNA Technologies) containing &lt;i&gt;Escherichia coli&lt;/i&gt; sequence-optimized 36 bp segments of reverse translated antigen proteins plus 10 bp plasmid overhangs were amplified for a final 25 bp of plasmid homology on either side. Amplified fragments were HiFi-assembled (New England Biolabs) into AfeI-digested plasmid en masse and transformed into NEB 5-alpha chemically competent &lt;i&gt;E. coli&lt;/i&gt;. Transformants were bulk cultured in lysogeny broth (LB) containing 25 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol. A depiction of the eCPX protein with peptide (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10001-5#Fig10"&gt;5b&lt;/a&gt;) is based on a crystal structure of OmpX&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Vogt, J. &amp;amp; Schulz, G. E. The structure of the outer membrane protein OmpX from Escherichia coli reveals possible mechanisms of virulence. Structure 7, 1301–1309 (1999)." href="/articles/s41586-025-10001-5#ref-CR60" id="ref-link-section-d49059602e1857"&gt;60&lt;/a&gt;&lt;/sup&gt; (Protein Data Bank: &lt;a href="https://doi.org/10.2210/pdb1QJ8/pdb"&gt;1QJ8&lt;/a&gt;) and was produced in part using PyMol (v.2.5, Schrödinger).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Peptide display enrichment&lt;/h3&gt;&lt;p&gt;Peptide display enrichment was performed as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Kamath, K. et al. Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology. Sci Rep. 10, 5294 (2020)." href="/articles/s41586-025-10001-5#ref-CR29" id="ref-link-section-d49059602e1876"&gt;29&lt;/a&gt;&lt;/sup&gt; with several modifications. Bacteria containing peptide libraries were grown overnight (37 °C, 250 rpm) and diluted the following day using fresh pre-warmed LB + chloramphenicol 1:6. Upon reaching an OD of 0.6, cultures were induced for scaffold/peptide expression with 0.4% w/v &lt;span class="u-small-caps"&gt;l&lt;/span&gt;-arabinose. Induced cultures were grown for 1 h (37 °C, 250 rpm), pelleted and resuspended in PBS-T.&lt;/p&gt;&lt;p&gt;Serum samples were heat inactivated (56 °C, 15 min) and blocked with bacteria expressing empty eCPX scaffold in PBS-T for 1 h (4 °C, 800 rpm) in deep well plates on a Thermomixer C (Eppendorf 5382000023). Blocking bacteria were pelleted at 3,900&lt;i&gt;g&lt;/i&gt; for 10 min, and supernatant was collected into a fresh deep-well plate. Pooled bacterial peptide libraries were added to wells and incubated for 1 h (4 °C, 800 rpm). Samples were washed 5 times with 1 ml PBS-T, then resuspended in 500 µl PBS containing 10 µl per well magnetic Protein G beads (NEB S1430S). Samples were incubated for 1 h (4 °C, 800 rpm), washed 5 times with 1 ml PBS between bead pull-down on a magnetic plate (Alpaqua A000400). Following final wash, bacteria were resuspend in 1 ml fresh LB + chloramphenicol + 0.2%w/v &lt;span class="u-small-caps"&gt;L&lt;/span&gt;-glucose. Bacteria were grown overnight in deep well plates (37 °C, 800 rpm). For monoclonal antibody enrichments, mouse anti-cOVA IgG1 (mAb1) (Chondrex 7094) and mouse anti-cOVA IgG2b (mAb2) (Chondrex 7096), each with defined linear epitopes on cOVA, were used. Universal peptide epitope screening and analysis were performed using mAb1 by Serimmune.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Next generation sequencing&lt;/h3&gt;&lt;p&gt;Plasmids from overnight cultures were isolated (Qiagen 27291) on a vacuum manifold (Qiagen 19504) and used as a template for PCR. First, amplicons containing peptide coding sequence were generated with primers F (5′-TCGTCGGCAGCGT CAGATGTGTATAAGAGACAGBHH VBCTTCCGTAGCTGGCCAGTCT-3′) and R (5′-GTCTCGTGGGCTCGGA GATGTGTATAAGAGACAGTGC CCAGACTGCCCTCC-3′). Ambiguous bases BHHVB were included in the F primer as the first five to be read during sequencing in order to avoid miscalling of clusters. Amplicons were purified with Sera-Mag SpeedBead carboxylate-modified magnetic particles (Cytiva 45152105050250) in crowding buffer as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Rohland, N. &amp;amp; Reich, D. Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Genome Res. 22, 939–946 (2012)." href="/articles/s41586-025-10001-5#ref-CR61" id="ref-link-section-d49059602e1900"&gt;61&lt;/a&gt;&lt;/sup&gt;. Purified products were further amplified using indexing primers containing 8-nt indices allowing for 96 unique index pairs, purified, and quantified on a Nanodrop 8000 and with Qubit high-sensitivity assay (Invitrogen Q32851). Samples were pooled and PhiX (Illumina FC-110-3001) was added to comprise 30% of the total DNA content. Pooled samples were single-end sequenced in an Illumina P1 100 cycle cartridge (Illumina 20074933) on an Illumina Nextseq2000. De-multiplexed reads were trimmed&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Bolger, A. M., Lohse, M. &amp;amp; Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014)." href="/articles/s41586-025-10001-5#ref-CR62" id="ref-link-section-d49059602e1904"&gt;62&lt;/a&gt;&lt;/sup&gt; and analysed using the Phippery suite of tools&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Galloway, J. G. et al. phippery: a software suite for PhIP-Seq data analysis. Bioinformatics 39, btad583 (2023)." href="/articles/s41586-025-10001-5#ref-CR63" id="ref-link-section-d49059602e1908"&gt;63&lt;/a&gt;&lt;/sup&gt;. Enrichment data are displayed as log FC versus serum-free controls. Negative log FC values were set to zero for visualization. Peptides for which any bead control had zero reads were excluded from analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec28"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;All statistical analyses were conducted using GraphPad Prism 9.0 (GraphPad Software).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10001-5#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 20:26:15 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5sZW02dk9ybkZLUGFtUWt2THNlWFVId0xfWXBHa2Y4emJEaXNsYWlwOTh1TGdGYVFBdXlQdnQ1dTFCUGNpMXV0UXdPUTdfV240ZkdBcjlsVWxIVjNtOFJZ</guid></item><item><title>肠巨噬细胞沿肠-脑轴调节突触核病变-自然</title><link>https://www.nature.com/articles/s41586-025-09984-y</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec7-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec8"&gt;Mice&lt;/h3&gt;&lt;p&gt;All experiments were performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and following local ethical advice. Experimental procedures were approved by the UK Home Office and ethical approval was granted through consultation with veterinary staff at University College London (UCL). For all experiments, mice were obtained from the following sources and subsequently bred side by side in cages: C57BL/6J (WT) mice were obtained from Charles River UK, C57BL/6-Tg(Thy1-SNCA*E35K*E46K*E61K)3798Nuber/J (3KL) were obtained from The Jackson Laboratory. VHD (B6.tg(HD2)) mice were obtained from V. Cerovic (Institute of Molecular Medicine, RWTH Aachen). Sncatm1.1Kluk/J (&lt;i&gt;Snca&lt;/i&gt;&lt;sup&gt;WT/GFP&lt;/sup&gt;) were obtained from K. Luk (Perelman School of Medicine, University of Philadelphia). &lt;i&gt;Cx3cr1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;CreERT2&lt;/i&gt;&lt;/sup&gt;&lt;i&gt;.Tgfb1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;LoxP&lt;/i&gt;&lt;/sup&gt; animals were obtained from M. Greter (University of Zurich). Different strains were bred in the same location to harmonize environmental factors. All animals were housed under temperature-controlled (temperature, 23.1 °C; humidity, 30–60%) and pathogen-free conditions with 12 h light–12 h dark cycle with an ad libitum supply of food and water. Both male and female age-matched mice were used in this study: WT, VHD, &lt;i&gt;Snca&lt;/i&gt;&lt;sup&gt;WT/GFP&lt;/sup&gt;. Both male and female 3KL mice were used. Animals of 3–4 months were used for ME injection experiments.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec9"&gt;Human tissue samples&lt;/h3&gt;&lt;p&gt;All tissue samples were donated with the full, informed consent. Accompanying clinical and demographic data of all cases used in this study were stored electronically in compliance with the 1998 Data Protection Act. Ethical approval for the study was obtained from the NHS Research Ethics Committee and in accordance with the Human Tissue Authority’s code of practice and standards under licence number 12198, with an approved material transfer agreement. Consent has been obtained for sharing of individual-level data. Use of Translational Pathology Core Laboratory-derived human tissues was approved by the University of California Los Angeles Institutional Review Board, which waived the informed consent requirement for specimens acquired from the Translational Pathology and Core Laboratory (TPCL) (IRB 11-002504). Specimens were deidentified and age was provided as a 5-year age range.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec10"&gt;Tamoxifen treatment&lt;/h3&gt;&lt;p&gt;&lt;i&gt;Cx3cr1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;CreERT2&lt;/i&gt;&lt;/sup&gt;&lt;i&gt;.Tgfb1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;LoxP&lt;/i&gt;&lt;/sup&gt; and littermate control mice were orally gavaged 3 times (every other day) with 5 mg of tamoxifen (Sigma-Aldrich T5648) dissolved in corn oil at around 6 weeks of age.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;Tissue isolation for histology&lt;/h3&gt;&lt;p&gt;Mice were deeply anaesthetized using pentobarbital and were transcardially perfused with 15 ml of ice-cold filtered PBS (Gibco) followed by 15 ml of ice-cold 4% paraformaldehyde (PFA) (ThermoFisher). To obtain tissue from the ME, the small intestine was isolated, stored in ice-cold PBS and cut open longitudinally. Ice-cold PBS was used to clean the tissue from luminal debris. The tissue was stretched on a Sylgard plate, and the ME was carefully peeled off using surgical tools. Isolated ME was further fixed in ice-cold 4% PFA for 20 min and preserved at −20 °C in cryoprotectant solution (10% sucrose, ethylene glycol) until stained. From the lamina propria (cross-sections), 2-cm long pieces of small intestine were isolated and luminal contents were gently flushed with ice-cold PBS using a syringe. The tissue was further fixed in 4% PFA at 4 °C overnight and excess PFA was washed with 3 × 10 min in ice-cold PBS. The tissue was dehydrated using 30% sucrose solution in PBS and frozen vertically in embedding moulds (Epredia) with optimal cutting temperature medium (Sakura) before cryo-sectioning. Sections of 20–25 μm were mounted on microscopy slides (Epredia) until staining. The brain was isolated from the skull and was further fixed, frozen and sectioned as described for cross-sections above. Sections were preserved at −20 °C in cryoprotectant solution until stained. To obtain whole mounts of dura mater, the skull cap containing the dura mater was removed from the mouse skull and stored fixed in ice-cold 4% PFA at 4 °C for 2 h. After fixation, the dura mater was carefully removed.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Tissue isolation for FACS and cell sorting&lt;/h3&gt;&lt;p&gt;Mice were anaesthetized using pentobarbital and were transcardially perfused with 15 ml of ice-cold filtered PBS. Collected tissues were stored in ice-cold Roswell Park Memorial Institute medium 1640 (RPMI-1640) (Gibco) completed with 5% FBS (Gibco) and 20 mM HEPES (Gibco). To obtain single-cell suspensions from the ME, peeled ME was cut in 1–2-mm pieces and digested with 2 mg ml&lt;sup&gt;−1&lt;/sup&gt; Collagenase type IV and 0.8 mg ml&lt;sup&gt;−1&lt;/sup&gt; dispase in RPMI (Gibco) supplemented with 2% HEPES (Gibco), 2% FBS (Gibco) and 50 μg ml&lt;sup&gt;−1&lt;/sup&gt; DNase for 1 h at 37 °C with continuous agitation. The single-cell suspensions were then homogenized with a potter grinder and strained through 70-μm cell strainers (BD Falcon). From the lamina propria, the remaining tissue following isolation of the ME, containing the lamina propria and submucosa layers, was washed with ice-cold Hank’s buffered saline solution (Gibco) supplemented with 1 mM dithiothreitol (Sigma-Aldrich), 1 mM EDTA (Invitrogen) and 20 mM HEPES for 8 min. Single-cell suspensions of lamina propria were prepared by digestion with 0.85 mg ml&lt;sup&gt;−1&lt;/sup&gt; Collagenase Type V (Sigma-Aldrich) in MEMα (Lonza) supplemented with 2% HEPES, β-mercaptoethanol (Gibco) and DNase for 30 min at 37 °C with continuous agitation. For the brain and dura, brains were quickly isolated from the skull, and brainstem was dissected from the rest of the brain tissue on ice using chilled instruments. The dorsal part of the skull was carefully removed, and meningeal dura mater was peeled off of the skull cap. The tissues were finely chopped using chilled razorblades and transferred to tubes containing ice-cold RPMI-1640 supplemented with 10% FBS and 20 mM HEPES medium. Single-cell suspensions from brainstem were prepared using the Dissociation kit (Miltenyi Biotech) according to the manufacturer’s instructions. Tissue chunks were pelleted by centrifugation at 300&lt;i&gt;g&lt;/i&gt; for 2 min at 4 °C followed by medium removal and resuspension in a mix of buffer Z with enzymes A, P and Y. For digestion of meningeal dura mater, chopped tissue was resuspended in 0.5 mg ml&lt;sup&gt;−1&lt;/sup&gt; Collagenase P, 0.8 mg ml&lt;sup&gt;−1&lt;/sup&gt; Dispase II and 250 U ml&lt;sup&gt;−1&lt;/sup&gt; DNase1 and digested for 30 min. Single-cell suspensions from all tissues were then blocked with rat anti-mouse CD16/CD32 antibodies (BD Biosciences) used at the recommended dilution for 12 min before incubation with primary antibodies diluted at recommended dilutions (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM5"&gt;3&lt;/a&gt;) in FACS buffer (PBS, 2% FBS, 0.78 mM EDTA) containing Fc block for 20 min at 4 °C. Dead cells were excluded using Live/Dead near-infrared dye staining (Invitrogen) diluted in PBS or 4,6-diamidino-2-phenylindole (DAPI). Precision Count Beads (BioLegend) were used for absolute cell counting and analysed using the following formula: absolute cell count (cells per μm) = cell count/beads count × bead concentration. Flow cytometry data were analysed using FACSDiva software (v.4.0) and FlowJo software (Treestar).&lt;/p&gt;&lt;p&gt;Cell sorting was performed on a BD Aria III (BD Biosciences). For scRNA-seq (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig4"&gt;4&lt;/a&gt;) and proteomics (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig1"&gt;1&lt;/a&gt;), live CX3CR1&lt;sup&gt;hi&lt;/sup&gt;CD11b&lt;sup&gt;+&lt;/sup&gt;CD11c&lt;sup&gt;−&lt;/sup&gt; ME-Macs and CD3&lt;sup&gt;+&lt;/sup&gt; cells (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig11"&gt;6a&lt;/a&gt;) were sorted in DMEM supplemented with 30% FBS and resuspended in PBS with 0.04% BSA.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Immunofluorescence&lt;/h3&gt;&lt;p&gt;For free-floating sections, fixed ME or brain sections were permeabilized with 0.5% (ME) or 0.3% (brain) Triton X-100 at room temperature for 1 h followed by blocking with blocking buffer (5% donkey or goat serum (Abcam) and 0.5% or 0.3% Triton X-100 (ThermoFisher Scientific)) at room temperature for 1 h. Primary antibodies diluted at their recommended concentrations (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM5"&gt;3&lt;/a&gt;) in blocking buffer were added and the tissue was incubated at 4 °C overnight. Following 4 15-min PBS washes, the tissue was incubated with secondary antibodies diluted in blocking buffer for 2 h at room temperature and was washed again with PBS. Secondary antibody aliquots were centrifuged at 15,000&lt;i&gt;g&lt;/i&gt; for 15 min before dilution in blocking buffer. Tissue was incubated for 5 min with DAPI (Roche) before being mounted on Prolong Gold Antifade Mounting Medium (ThermoFisher Scientific). For on-slide staining, for the gut cross-sections, slides were washed in PBS to remove excess optimal cutting temperature medium before permeabilizing with 0.3% Triton and blocking with 5% goat or donkey serum for 15 min. For dura mater whole-mount images, sections were washed 2 times with PBS and blocked for 1.5 h at room temperature with 10% normal donkey serum (Sigma-Aldrich) in PBS containing 0.3% Triton (Sigma-Aldrich) (PBS-T). Subsequently, the sections were stained with primary antibodies in 3% normal donkey serum/PBS-T (overnight, 4 °C). The following day, the samples were washed three times with PBS-T and once with PBS. The tissues were then stained with DAPI (Sigma-Aldrich)/PBS solution for 30 min at room temperature and washed twice with PBS. Finally, the sections were mounted using Mowiol 4-88 (Polysciences Inc.) mounting solution (prepared according to the manufacturer’s instructions) and stored at 4 °C. Dura mater whole mounts were imaged using a Phenoimager (Akoya Biosciences), or Nikon SoRa Spinning Disk Confocal using a ×10/×20 objective for large overview images and ×40/×60 objective for zoom-ins, all other tissues were analysed using a LSM800 (Zeiss), a LSM980 or Leica Stellaris STED microscope using a ×100 1.4 numerical aperture (NA) oil immersion Plan-Apochromat objective. All images were processed and analysed with Fiji (National Institutes of Health, NIH) and QuPath&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017)." href="/articles/s41586-025-09984-y#ref-CR51" id="ref-link-section-d48957798e3300"&gt;51&lt;/a&gt;&lt;/sup&gt;. For T cell quantification (Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig3"&gt;3&lt;/a&gt;–&lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig5"&gt;5&lt;/a&gt;), we analysed 1–2 regions of interest (ROIs) (159.72 µm × 159.72 µm) per 4–5 adjacent ganglia in the duodenum, with data represented per ROI. Glial fibrillary acidic protein-positive myenteric glial cells were 3D-reconstructed using Imaris software (Bitplane), and their volume was calculated following background subtraction. For each mouse, four ROIs were analysed per ganglion. HuC/D&lt;sup&gt;+&lt;/sup&gt; neurons were quantified in two adjacent ganglia within the duodenum, with a ganglion defined as a cohesive aggregate of HuC/D-positive cells. Extraganglionic cells were excluded from the analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Single molecule fluorescence in situ hybridization (smFISH) (RNAscope) and smFISH combined with IHC&lt;/h3&gt;&lt;p&gt;To detect single RNA molecules, the RNA probe for &lt;i&gt;Tgfb1&lt;/i&gt; (407751) as well as the RNAscope Multiplex Fluorescent Detection Reagents v2 (323110) kit were purchased from ACD BioTechne. ME tissue was cryosectioned at 20 μm and was collected on Superfrost Plus Gold Slides (ThermoFisher K5800AMNZ72) and dried at room temperature overnight. The assay was performed according to the manufacturer’s instructions, and the standard IHC protocol as described above was used.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Brain IHC&lt;/h3&gt;&lt;p&gt;Free-floating 15-μm or 25-μm (for brainstem and dorsal motor nucleus of the vagus) or 30-μm (SNpc) serial coronal sections were cut with a Leica CM1860 cryostat. The tissue was then treated with 0.3% H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; for 30 min. For staining with mouse anti-s129p antibodies, the samples were then incubated in M.O.M. blocking solution from mouse-on-mouse Elite Peroxidase Kit (Vector laboratories, PK-2200) prepared according to the manufacturer’s instruction for 1.5 h. The tissue was then blocked for another 5 min in M.O.M. diluent from the kit. Then, the sections were incubated with primary antibodies against s129p αS (1:10 000; BioLegend, clone P-syn/81A, 825701) for 12 h at 4 °C. The following day, the sections were treated with M.O.M. Biotinylated Anti-Mouse IgG Reagent from M.O.M. Elite Peroxidase Kit (PK-2200) prepared according to the manufacturer’s instructions for 1 h at room temperature, and subsequently transferred into ABC solution (Vectastain Elite ABC Kit, Vector Laboratories) for 10 min at room temperature, and visualized with 3,3′-diaminobenzidine (DAB) (DAB Substrate Kit, Vector Laboratories). Sections were then transferred onto the glass slides, air dried, sequentially dehydrated in PBS, 70%, 100% ethanol and 100% xylene, and mounted. The images were taken on an Axioscope 5 microscope (Zeiss). For staining with rabbit anti-s129p antibodies, the free-floating sections were treated with 0.3% triton for 30 min, 0.3% H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; for 30 min and blocked in 20% normal goat serum, 1% BSA, 0.3% triton for 1 h at room temperature. The samples were then incubated with primary antibodies against s129p αS (1:20 000; Abcam, EP1536Y) for 12 h at 4 °C. After washing with PBS, the sections were incubated with the biotinylated secondary antibodies (1:200, Vector, Goat Anti-Rabbit IgG Antibody (H+L), Biotinylated, BA-1000-1.5) for 1 h at room temperature, subsequently transferred into ABC solution (Vectastain Elite ABC Kit, Vector Laboratories, PK-6100) for 45 min at room temperature and visualized with DAB (DAB Substrate Kit, Vector Laboratories).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;s129p αS analysis&lt;/h3&gt;&lt;p&gt;Fiji (NIH) was used to measure the total area of s129p αS signal in the total myenteric plexus and brainstem.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec17"&gt;Myenteric plexus&lt;/h4&gt;&lt;p&gt;Individual channels were first &lt;i&gt;Z&lt;/i&gt;-projected and background-subtracted (10-pixel rolling ball radius). Next, threshold channels were empirically determined and then consistently applied to each channel for all subjects. For quantifying s129p, the Analyze Particles tool in ImageJ was used to quantify the total area of s129p (per myenteric ganglia or calculated per mm&lt;sup&gt;2&lt;/sup&gt;). For the brainstem (for immunofluorescence), &lt;i&gt;Z&lt;/i&gt;-stacks were taken of the entire tissue thickness within the dorsal motor nucleus of the vagus at 1-μm &lt;i&gt;Z&lt;/i&gt;-step increments. Images were analysed in Fiji (NIH), in which individual channels were first &lt;i&gt;Z&lt;/i&gt;-projected and thresholded empirically and a median filter of 0.5 pixels was applied to determine only punctate staining of total and s129p αS. This was consistently applied to each channel for all subjects. ROIs were drawn around choline acetyltransferase-positive cells with the freehand selections tool. The Analyze Particles tool in Fiji was used to quantify the total number of puncta and the percentage of punctate staining within each choline acetyltransferase-positive cell by applying ROIs to the corresponding total and s129p αS channels. For the brainstem (for DAB), first, colour deconvolution with H DAB vectors was used. Then, the background was subtracted with a rolling ball radius of 50 pixels from the images, followed by adjusting the threshold to measure the fibrillar inclusions of s129p αS. Total signal area was measured for each image, and the data were normalized to the average of the control group in each staining batch. Alternatively, the optical density of the DAB signal was measured in Fiji by first calibrating the software according to the ImageJ User guide. The optical density of individual cell bodies was then measured and the background optical density was subtracted. Mean values for each mouse were then calculated.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec18"&gt;SNpc&lt;/h4&gt;&lt;p&gt;&lt;i&gt;Z&lt;/i&gt;-stacks were taken of the entire tissue thickness within the SNpc at 1-μm &lt;i&gt;Z&lt;/i&gt;-step increments. Images were analysed in Fiji (NIH), where channels were split, the tyrosine hydroxylase (TH) channel was &lt;i&gt;Z&lt;/i&gt;-projected and ROIs were drawn around TH&lt;sup&gt;+&lt;/sup&gt; cells as well as at least one ROI to measure background fluorescence. These ROIs were applied to the total and s129p αS channels and area, mean fluorescence and integrated density were measured for each cell at each plane of the &lt;i&gt;Z&lt;/i&gt;-stack. Corrected total cell fluorescence (CTCF) for each TH&lt;sup&gt;+&lt;/sup&gt; cell was determined with the following equation: CTCF = integrated density − (area of selected cell × mean fluorescence of background readings). For SNpc s129p αS analysis, data were normalized to total αS and all data were then normalized to the mean of the NHC-αS group value.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;TH and Nissl IHC&lt;/h3&gt;&lt;p&gt;For TH IHC, brains were sagittally hemisected at the midline following removal of the hindbrain. The left hemisects were embedded in 10% sucrose, 0.5% glutaraldehyde in chicken egg yolk. The sample was allowed to polymerize for 5 min before being stored at −80 °C until sectioning. Embedded brains were sectioned into 30-μm slices using a Leica CM1860 cryostat and stored in cryoprotection solution at −20 °C until used for staining. All staining was performed in free-floating baskets (made in-house). Free-floating sections were washed once in PBS pH 7.5 for 5 min at room temperature on a horizontal rocker. Sections were then blocked in 5% BSA + 0.3% Triton X-100 in PBS for 1 h at room temperature. Following 3 × 5 min wash in PBS, sections were incubated in anti-TH antibody (Immunostar 22941) diluted 1:1,000 in 2% BSA + 0.1% Triton X-100 in PBS for roughly 16 h at 4 °C. Following 3 × 5-min washes in PBS, sections were incubated in biotinylated anti-mouse secondary antibody for 2 h at room temperature. Avidin-biotin complex elite kit (ABC, Vector labs PK-6100) (1:50 in PBS) was prepared 30 min before use according to the manufacturer’s instructions. Sections were then washed 3× for 5 min in PBS and incubated for 1 h at room temperature in ABC. Following a final 3 × 5-min wash in PBS, sections were incubated for 10 min in DAB solution (1 tablet Sigma D4418-50 set, 15 ml of PBS + 4.5 μl of H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;). Sections were then washed once in PBS (5 min) and once in dH&lt;sub&gt;2&lt;/sub&gt;O before being mounted onto slides and dried for roughly 30 min at 37 °C, and then covered with a glass coverslip with a polyvinyl alcohol-based mounting media (made in-house). All counting was performed blinded for treatment type and images were taken using a ×20 objective on a Leica Mica microscope acquiring &lt;i&gt;z-&lt;/i&gt;stacks with a 0.7 μm &lt;i&gt;z&lt;/i&gt;-step size. Stacked image tiles were loaded into StereoInvestigator desktop (MBF Bioscience). Stereological quantification was performed using the optical fractionator method from StereoInvestigator, analysing every sixth 30-μm coronal section serially for the SNpc and VTA ROIs. Using a counting frame of 50 × 50 μm snapped to 1-μm increments and a systematic random sampling grid size of 100 × 100 μm, TH&lt;sup&gt;+&lt;/sup&gt; cells were quantified unbiasedly&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Aron, L. et al. Pro-survival role for Parkinson’s associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. PLoS Biol. 8, e1000349 (2010)." href="/articles/s41586-025-09984-y#ref-CR52" id="ref-link-section-d48957798e3416"&gt;52&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Meka, D. P. et al. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest. 125, 1873–1885 (2015)." href="/articles/s41586-025-09984-y#ref-CR53" id="ref-link-section-d48957798e3419"&gt;53&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;For Nissl staining, mounted sections containing SNpc and VTA used in the TH&lt;sup&gt;+&lt;/sup&gt; cell body quantifications were Nissl stained on top using a cresyl violet acetate-based solution to stain Nissl bodies (nucleoli and rough ER) purple. Slides were washed for 5 min in dH&lt;sub&gt;2&lt;/sub&gt;O and then submerged in Nissl staining solution (4.5 g cresyl violet acetate, 45 ml of 100% ethanol, 450 ml of distilled water) for 8 min before destaining for 10 s in 2% acetic acid in ethanol, 30 s in 100% ethanol and 1 min in 100% ethanol. Sections were cleared in xylene for 10–15 min, before mounting with DPX mounting media (Cellpath SEA-1304-00A) and glass coverslips. TH&lt;sup&gt;+&lt;/sup&gt; neurons and Nissl&lt;sup&gt;+&lt;/sup&gt; neurons only (not glial cells) were quantified by unbiased stereology using the same parameters as the TH&lt;sup&gt;+&lt;/sup&gt; cell body quantifications&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Meka, D. P. et al. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest. 125, 1873–1885 (2015)." href="/articles/s41586-025-09984-y#ref-CR53" id="ref-link-section-d48957798e3437"&gt;53&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Kramer, E. R. et al. Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol. 5, 0616–0628 (2007)." href="/articles/s41586-025-09984-y#ref-CR54" id="ref-link-section-d48957798e3440"&gt;54&lt;/a&gt;&lt;/sup&gt;. The Nissl stain is most intense in nucleoli and in the rough endoplasmic reticulum of neurons and less in glia cells, enabling differentiation on the basis of staining patterns.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Nanostring DSP&lt;/h3&gt;&lt;p&gt;Here, 5-μm-thick formalin-fixed paraffin-embedded sections of the myenteric plexus were deparaffinized and incubated with antibodies against bIII-tubulin to select myenteric ganglia as segmented ROI, according to the manufacturer’s instructions and ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586–599 (2020)." href="/articles/s41586-025-09984-y#ref-CR55" id="ref-link-section-d48957798e3453"&gt;55&lt;/a&gt;&lt;/sup&gt;. Cell nuclei were stained with DAPI. Each ROI was manually drawn around myenteric ganglia in the myenteric plexus (geometric segments), encompassing both neurons and glial cells, resulting in a total of 2–3 analysed ROIs per slide. Each slide was incubated with an antibody panel conjugated to a unique UV-photocleavable oligonucleotide tag. Selected ROIs were individually illuminated with UV light using NanoString’s GeoMx Digital Spatial Profiler System (NanoString Technologies). Cleaved oligonucleotides were collected in 96-well plates and optical barcodes were analysed using the NanoString nCounter system. Obtained digital counts were normalized for signal-to-noise ratio using Rat IgG2b and Rabbit IgG. Internal housekeeping proteins included Histone H3, S6 and GAPDH.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;TCR sequencing and analysis&lt;/h3&gt;&lt;p&gt;RNA extracted was extracted from tissue samples and the TCR α and β genes were sequenced using an established quantitative sequencing pipeline, which uses unique molecular barcodes to correct for PCR bias, and sequencing errors&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Uddin, I. et al. Quantitative analysis of the T cell receptor repertoire. Methods Enzymol. 629, 465–492 (2019)." href="/articles/s41586-025-09984-y#ref-CR56" id="ref-link-section-d48957798e3465"&gt;56&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Oakes, T. et al. Quantitative characterization of the T cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which is robust, economical, and versatile. Front. Immunol. 8, 1267 (2017)." href="/articles/s41586-025-09984-y#ref-CR57" id="ref-link-section-d48957798e3468"&gt;57&lt;/a&gt;&lt;/sup&gt;. The fastq files were processed and annotated using the in-house open-source computational pipeline Decombinator V5 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Peacock, T., Heather, J. M., Ronel, T. &amp;amp; Chain, B. Decombinator V4: An improved AIRR compliant-software package for T-cell receptor sequence annotation? Bioinformatics 37, 876–878 (2021)." href="/articles/s41586-025-09984-y#ref-CR58" id="ref-link-section-d48957798e3472"&gt;58&lt;/a&gt;&lt;/sup&gt;). Plots were prepared using Python v.3.12.4, Plotly and Scipy. The NHC-αS- and PD-αS-injected groups were compared using a Bonferroni-adjusted unpaired &lt;i&gt;t&lt;/i&gt;-test with Welch’s correction. The Jaccard index is defined as&lt;/p&gt;&lt;div id="Equ1" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$J=\frac{|A\cap B|}{|A\cup B|}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (1)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;A&lt;/i&gt; and &lt;i&gt;B&lt;/i&gt; are each a set of clonotypes in a tissue. To compute the expanded index, let &lt;i&gt;c&lt;/i&gt;(&lt;i&gt;σ&lt;/i&gt;) be the count of clonotype &lt;i&gt;σ&lt;/i&gt; transcripts in the sample it is found in, and &lt;i&gt;E&lt;/i&gt;&lt;sub&gt;&lt;i&gt;A&lt;/i&gt;&lt;/sub&gt; be the expanded subset of &lt;i&gt;A&lt;/i&gt; such that&lt;/p&gt;&lt;div id="Equ2" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${E}_{A}=\{c|c(\sigma ) &amp;gt; 1\,{\rm{\forall }}\sigma \in A\}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (2)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;Then the expanded index is computed by&lt;/p&gt;&lt;div id="Equ3" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\varepsilon =\frac{|{E}_{A}\cap B|}{|{E}_{A}|}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (3)
                &lt;/p&gt;&lt;/div&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Mass spectrometry on sorted ME-Macs&lt;/h3&gt;&lt;p&gt;Protein lysates from sorted duodenal ME-Macs were digested using the single-pot, solid-phase-enhanced sample-preparation method&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68–85 (2018)." href="/articles/s41586-025-09984-y#ref-CR59" id="ref-link-section-d48957798e3751"&gt;59&lt;/a&gt;&lt;/sup&gt;. Samples were processed in accordance with the published methodology. Briefly, samples were reduced and alkylated using tris(2-carboxyethyl)phosphine and iodoacetamide, respectively. Alkylated proteins were then bound to the Sera-Mag SpeedBeads (ThermoFisher Scientific) by raising the organic solvent content of the buffer to above 70%. Proteins could then be washed using ethanol and acetonitrile before digestion within the same sample tube to reduce protein loss. Proteins were digested through the addition of 100 ng of Trypsin/Lys-C mix (Pierce) in 50 mM ammonium bicarbonate and leaving it at 37 °C at 300&lt;i&gt;g&lt;/i&gt; overnight. Digested peptides were cleaned by binding them to the beads by means of increasing the organic solvent content of the buffer to above 95%. Samples were washed using 100% acetonitrile before being eluted from the beads using 2% DMSO. Peptide samples were then acidified to a final concentration of 0.1% Formic acid before injection onto the mass spectrometer. Acidified peptide samples were analysed on a Bruker TIMS-TOF Pro 2 using an EvoSep One. Samples were prepared onto an EvoTip in accordance with the manufacturer’s instructions. Samples were loaded onto the mass spectrometer using the ‘20 samples per day’ HPLC method provided by EvoSep using 100% water as a buffer A and 100% Acetonitrile as buffer B. The samples were acquired in data-independent acquisition mode with trapped ion mobility spectrometry on. Resultant data files were searched using DIA-NN v.1.8 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. &amp;amp; Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41–44 (2019)." href="/articles/s41586-025-09984-y#ref-CR60" id="ref-link-section-d48957798e3758"&gt;60&lt;/a&gt;&lt;/sup&gt;). Search was performed against the UniProt SwissProt Mouse database in direct search mode. The double-pass neural network classifier was used and protein inference was using the protein IDs from the FASTA file. Precursor ion generation for the library used the default settings with a precursor false discovery rate at 1%. Mass accuracy and MS1 accuracy were set at 10 ppm each and the match between runs setting was enabled. Differential analysis data were analysed and visualized using CURTAIN v.2.0 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Phung, T. K. et al. CURTAIN—a unique web-based tool for exploration and sharing of MS-based proteomics data. Proc. Natl Acad. Sci. USA 121, e2312676121 (2024)." href="/articles/s41586-025-09984-y#ref-CR61" id="ref-link-section-d48957798e3762"&gt;61&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Whole gastrointestinal transit function&lt;/h3&gt;&lt;p&gt;An amount of 6% carmine red dye containing 1% methylcellulose was administered by oral gavage in 3-month-old 3KL mice or at 1 month and 3 months post-ME injection to determine the total gastrointestinal transit time. This parameter represents the time required for the mice to expel faeces containing the carmine red dye, starting from the moment of oral gavage.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Directed depletion of ME-Macs&lt;/h3&gt;&lt;p&gt;Depletion of ME-Macs was carried out using a published protocol adapted to our purpose&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Muller, P. A. et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 158, 300–313 (2014)." href="/articles/s41586-025-09984-y#ref-CR9" id="ref-link-section-d48957798e3782"&gt;9&lt;/a&gt;&lt;/sup&gt;. Mice were injected with 15 µg g&lt;sup&gt;−1&lt;/sup&gt; αCSF1R (clone AFS98, Bio XCell) versus IgG2a control (clone 2A3, Bio XCell) into the ME, 24 h before injection with NHC-αS versus PD-αS. Mice were orally gavaged with 15 µg αCCR2 (MC21, kindly provided by M. Mack, Universität Regensburg) daily for 7 days after AFS98 treatment to restrain ME-Mac replenishment.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;Fingolimod treatment&lt;/h3&gt;&lt;p&gt;T cell egression was targeted by oral administration of fingolimod (FTY720, Cambridge Biosciences) at a dose of 0.5 mg kg&lt;sup&gt;−1&lt;/sup&gt; through gavage on days 1, 3, 5 and 7 following PD-αS treatment. Fingolimod was dissolved in ethanol (2 mg ml&lt;sup&gt;−1&lt;/sup&gt;) and saline. Saline containing 2 mg ml&lt;sup&gt;−1&lt;/sup&gt; ethanol was used as vehicle control.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Quantification of s129p αS engulfment&lt;/h3&gt;&lt;p&gt;Engulfment analysis was performed as previously described but adapted to ME&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Schafer, D. P., Lehrman, E. K., Heller, C. T. &amp;amp; Stevens, B. An engulfment assay: a protocol to assess interactions between CNS phagocytes and neurons. J. Vis. Exp. 88, e51482 (2014)." href="/articles/s41586-025-09984-y#ref-CR62" id="ref-link-section-d48957798e3811"&gt;62&lt;/a&gt;&lt;/sup&gt;. Mouse ME was immunostained with MHCII, LAMP1 and s129p αS, and human ME was immunostained with CD209 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Bujko, A. et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J. Exp. Med. 215, 441–458 (2017)." href="/articles/s41586-025-09984-y#ref-CR63" id="ref-link-section-d48957798e3815"&gt;63&lt;/a&gt;&lt;/sup&gt;), LAMP1 and 2F12. Two regions and 3–6 ROIs were acquired for each mouse and human sample, respectively, on a ×63 1.4 NA objective Zeiss 800 microscope. For mouse, 60–80 &lt;i&gt;z&lt;/i&gt;-stack planes were taken with 0.27-μm spacing and raw images were processed in Imaris (Bitplane) for analysis, after background subtractions. A mask was applied in MHCII&lt;sup&gt;+&lt;/sup&gt; LAMP1&lt;sup&gt;+&lt;/sup&gt; reconstructed lysosomes for s129p αS, and the percentage engulfment of s129p αS within lysosomes was calculated using the following formula: volume of engulfed material (s129p or 2F12 within LAMP1)/total ME-Mac volume × 100.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Sequential extraction of insoluble fraction from human brain&lt;/h3&gt;&lt;p&gt;Sequential extraction from human brain was performed according to ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Peng, C. et al. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies. Nature 557, 558–563 (2018)." href="/articles/s41586-025-09984-y#ref-CR24" id="ref-link-section-d48957798e3834"&gt;24&lt;/a&gt;&lt;/sup&gt;. Briefly, 0.5 mg of brain tissue was homogenized in high salt (HI) buffer (50 mM Tris-HCl, 750 mM NaCl, 5 mM EDTA, 10 mM NaF, pH 7.40) containing protease inhibitors. After ultracentrifugation at 100,000&lt;i&gt;g&lt;/i&gt; for 30 min at 4 °C, supernatant was removed and fresh HI buffer added. The same steps were subsequently repeated with HI buffer containing 1% Triton, HI buffer with 1% Triton and 30% sucrose, HI buffer with 1% sarkosyl and finally in PBS to resuspend the sarkosyl-insoluble fraction of the brain homogenate enriched in aggregated αS. In the absence of pathology, the sample is expected to contain minimal random contaminants, with samples showing comparable total αS levels between disease and NHC groups&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="de Boni, L. et al. Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations. Acta Neuropathol. 143, 453–469 (2022)." href="/articles/s41586-025-09984-y#ref-CR64" id="ref-link-section-d48957798e3841"&gt;64&lt;/a&gt;&lt;/sup&gt;. Postmortem brain samples used in this study are summarized in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM3"&gt;1b&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec28"&gt;αS SAA&lt;/h3&gt;&lt;p&gt;Flash-frozen PD brain tissue (500 µg, frontal cortex, Braak VI, absent copathology) was homogenized and subjected to serial extraction as described earlier. For the SAA reaction to amplify and monitor αS aggregates, 10 μl of brain-derived seed was incubated with recombinant monomeric αS at 42 °C in a BMG FLUOstar Omega plate reader to amplify amyloid αS by incorporating monomeric αS into the growing aggregate&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Concha-Marambio, L., Pritzkow, S., Shahnawaz, M., Farris, C. M. &amp;amp; Soto, C. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat. Protoc. 18, 1179–1196 (2023)." href="/articles/s41586-025-09984-y#ref-CR22" id="ref-link-section-d48957798e3856"&gt;22&lt;/a&gt;&lt;/sup&gt;. Before each SAA experiment, lyophilized monomeric protein was dissolved in 40 mM phosphate buffer (pH 8), filtered using a 0.22-mm filter and the concentration of recombinant protein was measured by use of absorbance at 280 nm using a Nanodrop One spectrophotometer. Brain-derived insoluble protein was tip-sonicated for 30 s (1 s off, 1 s on) at 30% of amplitude and added to a 96-well plate with 230 mM NaCl, 0.4 mg ml&lt;sup&gt;−1&lt;/sup&gt; αS and a 3-mm glass bead (Millipore Sigma, no. 1040150500). Repeated shaking (1 min incubation, 1 min double-orbital shaking at 400 rpm) disrupts the aggregates to produce an expanded population of converting units. The amyloid dye thioflavin T was used in adjacent wells to monitor the increase in fibrillar content through fluorescence readings at 480 nm every 30 min until the signal plateaued towards the end of the amplification interval of 4 days. The lag time of each sample was defined as the time at which the average, background corrected thioflavin T fluorescence of the sample reached 5% of its own maximum fluorescence. For SAA on isolated ME-Macs and neurons, single-cell suspensions were isolated from the ME using the magnetic-activated cell sorting method (Miltenyi Biotec, 130-097-142). ME tissues were first homogenized as described earlier and centrifuged at 400&lt;i&gt;g&lt;/i&gt; for 7 min. The resulting cell suspension was incubated with a CD11b antibody (Miltenyi Biotec) for 30 min at 4 °C to label CD11b&lt;sup&gt;+&lt;/sup&gt; cells. The suspension was then passed through a magnetic-activated cell sorting magnetic column, and the flow-through containing CD11b&lt;sup&gt;−&lt;/sup&gt; cells was collected for subsequent neuronal isolation. For the isolation of enteric neurons, CD11b&lt;sup&gt;−&lt;/sup&gt; cells were processed using the Adult Neuron Isolation Kit (Miltenyi Biotec, catalogue no. 130-126-602). Briefly, cells were incubated with the Adult Non-Neuronal Cell Biotin-Antibody for 30 min, followed by centrifugation at 400&lt;i&gt;g&lt;/i&gt; for 7 min. The pellet was incubated with anti-biotin microbeads for 10 min and subsequently applied to a magnetic-activated cell sorting magnetic column. The flow-through from this step represented the enriched enteric neuronal fraction. Isolated ME-Macs and enteric neurons were then lysed to obtain protein extracts. Tip sonication was performed for 30 s (1 s off, 1 s on) at 30% amplitude to ensure efficient lysis. Lysed cells were subjected to SAA as described above.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;Recombinant αS expression and purification&lt;/h3&gt;&lt;p&gt;Briefly, plasmid pET21a-SNCA was expressed in BL21(DE3) &lt;i&gt;Escherichia coli&lt;/i&gt;. After cell lysis, αS was purified by use of ion exchange chromatography (5 ml HiTrap Q HP columns, GE Life Sciences, 17516301) and size exclusion chromatography (13 ml of HiPrep 26/60 Sephacryl S-200 HR, GE Life Sciences) using the ÄKTAprime plus fast protein liquid chromatography system and subsequently lyophilized in protein low binding tubes (Eppendorf)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Sanderson, J. B. et al. Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Commun. 2, fcaa010 (2020)." href="/articles/s41586-025-09984-y#ref-CR65" id="ref-link-section-d48957798e3886"&gt;65&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec30"&gt;αS ELISA&lt;/h3&gt;&lt;p&gt;Samples were processed and analysed as described before using 2F12 (MABN1817, Merck) as a capture, SOY1 (Merck, MABN1818) as a sulfo-tagged detection antibody on an MSD enzyme-linked immunosorbent assay (ELISA) platform&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Sanderson, J. B. et al. Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Commun. 2, fcaa010 (2020)." href="/articles/s41586-025-09984-y#ref-CR65" id="ref-link-section-d48957798e3898"&gt;65&lt;/a&gt;&lt;/sup&gt;. For sulfotag labelling of detection antibodies, 200 μl of SOY1 antibody (1.37 mg ml&lt;sup&gt;−1&lt;/sup&gt; in PBS) was incubated at room temperature for 2 h with 16 μl of 3 nmol μl&lt;sup&gt;−1&lt;/sup&gt; MSD NHS-Sulfotag reagent (150 nmol freshly suspended in 50 μl of PBS). Next, 250 μl of PBS was added to antibody solutions, concentrated using Amicon ultra filter tubes (10,000 molecular weight cut off), and brought up to 500 μl of PBS again. This was repeated five times to dilute out the tag reagent. Protein concentration was subsequently measured using BCA assay. For plate preparation, MSD Standard plates were coated with 30 µl of 200 ng filtered 2F12 (1 mg ml&lt;sup&gt;−1&lt;/sup&gt;) from recently filtered batches diluted in PBS and stored overnight at 4 °C. Plates were then tapped out, blocked with 150 µl per well in 5% MSD blocker A in 0.01% PBS-T, sealed and placed on an orbital shaker for 1 h at room temperature. Plates were subsequently washed 5 times with 150 µl of PBS-T per well, samples were added in 2% SDS in PBS-T with 1% MSD blocker A, as well as recombinant αS at different concentration gradients in PBS-T with 1% MSD blocker A (0.5% NP-40) (Meso Scale Diagnostics LLC) and incubated for 2 h at room temperature with orbital shaking. Plates were washed 5 times with 150 µl of 0.1% PBS-T per well before the addition of detection antibody solution: that is, 30 µl per well of 200 ng sulfo-tagged SOY1 antibody in PBS-T with 1% MSD blocker A. Plates were incubated for 1 h at room temperature with orbital shaking and protected from light. After 5 washes with PBS-T, 150 µl of 2× MSD reader buffer diluted in MilliQ water was added and the plate was read using a Meso Sector S 600.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec31"&gt;Proteinase K digest&lt;/h3&gt;&lt;p&gt;Sarkosyl-insoluble and SAA-amplified samples were treated with 1 µg ml&lt;sup&gt;−1&lt;/sup&gt; of proteinase K (Roche, 3115836001) at 37 °C for 1 h with gentle shaking. The digestion was stopped by adding NuPAGE LDS sample buffer (Invitrogen, NP0007) and boiling the sample at 95 °C for 7 min. Samples were then loaded onto a Novex 16% Tricine gels (Invitrogen) for protein separation. After electrophoresis, gels were incubated in 20% ethanol for 5 min at room temperature and blotted onto iBlot 2 Nitrocellulose Regular Stacks (Invitrogen) using the iBlot 2 Dry Blotting system (Invitrogen). The membrane was rinsed in ultrapure water and incubated in 4% PFA/PBS for 30 min at room temperature. The membranes were blocked in Odyssey blocking buffer (PBS)/PBS buffer 1:1 (LI-COR) or casein buffer 0.5% (BioRad) for 1 h at room temperature. After blocking, membranes were incubated overnight at 4 °C with anti-αS clone 42 (BD Biosciences). After three washes in PBS-T 0.1%, the membrane was incubated for 1 h at room temperature with the secondary antibody (goat anti-mouse IgG F(Ab)2 conjugated with horseradish peroxidase (HRP), Abcam) in blocking solution. Membranes were washed in PBS-T 0.1% and then the signal was detected using the Invitrogen iBright imaging system and the Luminata Crescendo Western HRP substrate (Millipore).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec32"&gt;Endotoxin analysis of insoluble fractions&lt;/h3&gt;&lt;p&gt;Lipopolysaccharide levels were measured with Pierce Chromogenic Endotoxin Quantification Kit (ThermoFisher, no. A39552). All experiments were conducted within a Laminar Flow cabinet using pyrogen (endotoxin) free pipette tips. The pH of each sample was measured using pH Strips and adjusted to within 6–8 using endotoxin-free sodium hydroxide (Merck) or hydrogen chloride (Merck). Before starting the assay all samples and kit components were left to warm to room temperature. The &lt;i&gt;E. coli&lt;/i&gt; endotoxin standard vial was reconstituted with room temperature endotoxin-free water by adding 1:10 ml of the EU amount indicated on the vial to make a 10 EU ml&lt;sup&gt;−1&lt;/sup&gt; solution, then vortexed at 1,200 rpm for 15 min. Standards were prepared according to table 2 in the manufacturer’s instructions. Samples were diluted to between 1:2 and 1:30 (10–50 µl of sample) with room temperature endotoxin-free water. Lyophilized Amoebocyte was reconstituted immediately before loading the plate with 1.7 ml of endotoxin-free water. Next, 50 µl of each standard, and samples were loaded in triplicate onto prewarmed plate (plate kept at 37 °C on a Thermoblock for the duration of the assay). Following sample and standard loading, 50 µl of reconstituted amoebocyte was added to each well. The plate was covered and left to incubate based on the manufacturer’s instructions. Before the amoebocyte incubation window closing, chemogenic substrate was reconstituted with 3.4 ml of endotoxin-free water and incubated at 37 °C for 5–10 min. When amoebocyte incubation was finished, 100 µl of warm chemogenic substrate was added to each well and plate was left to incubate at 37 °C for 6 min. Finally, 25% acetic acid was added to each well (diluted in endotoxin-free water). The plate was read at an optical density of 405 nm before analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec33"&gt;Transmission electron microscopy&lt;/h3&gt;&lt;p&gt;Transmission electron microscopy specimens were prepared on carbon-coated formvar grids (Electron Microscopy Sciences). Samples were adsorbed on the grids for 5 min and then negatively stained with 1% (w/v) aqueous uranyl acetate. Images were taken on a JEOL 1400 transmission electron microscope (JEOL USA Inc.) at an accelerating voltage of 100 kV.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec34"&gt;Microinjections of human αS extracts into ME&lt;/h3&gt;&lt;p&gt;Mice were anaesthetized with isoflurane (2–4%) and kept at constant body temperature with a conventional heat pad. Abdominal hair was removed, and an incision was made along the midline. A 10-μl 36 G Hamilton syringe (World Precision Instruments) was used to inject a total of 7 μl of human brain insoluble fraction (containing roughly 87 pg fibrillar αS by ELISA, Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig8"&gt;3a&lt;/a&gt;) into the wall of the duodenum at 4 sites. The injection sites were located 0.5–1 cm away from pyloric stomach and at least 0.3 cm from each other. Injection sites were marked with 0.2% Fast Green FCF (Sigma-Aldrich). Following the injections, animals were sutured and single housed for 5 days to allow recovery. Animals received carprofen (33.33 mg ml&lt;sup&gt;−1&lt;/sup&gt;) in their drinking water for 4 days postsurgery. Mice were euthanized at 1 month or 3 months postinjection.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec35"&gt;scRNA-seq library preparation, expression and NicheNet analysis&lt;/h3&gt;&lt;p&gt;For scRNA-seq, four biologically independent samples (duodenal ME) were used per genotype, and one sample represents pooled ME from four mice. Single-cell libraries were prepared using 10X Genomics Chromium Next GEM Single Cell 5′ kit v.3.1, according to the manufacturer’s instructions. Libraries were sequenced using an S2 flowcell on an Illumina NovaSeq S6000 instrument, with sequencing parameters recommended by 10X Genomics, aiming for 40,000 reads per cell. Raw Fastq read files were processed using cellranger count (v.6.0) for each dataset to generate count matrices that were used for subsequent analysis (filtered_feature_bc_matrix). Integrated analysis of multimodal single-cell data in R (v.4.0) were used to first examine each dataset individually using Seurat (v.4.3) and SeuratObject (v.4.1.3)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021)." href="/articles/s41586-025-09984-y#ref-CR66" id="ref-link-section-d48957798e3961"&gt;66&lt;/a&gt;&lt;/sup&gt;. Cells expressing fewer than 200 or more than 2,500 features were excluded from further analysis, as well as cells expressing more than 30% mitochondrially encoded features (‘MT’ chromosome in GRCm39). Each dataset was normalized individually using SCTtransform (v.0.4.1) and datasets were integrated together (IntegrateData) using 3,000 genes. Principle component analysis was carried using the ‘RunPCA()’ command on 100 principal components and the appropriate number of principal components evaluated using the and ElbowPlot function. Clusters of transcriptionally related cells were identified using the Louvain method and the ‘FindClusters’ command at 0.2 resolution and were visualized using uniform manifold approximation and projection for dimension reduction. Cell clusters corresponding to macrophages were identified through the expression of marker genes &lt;i&gt;Csf1r&lt;/i&gt;, &lt;i&gt;Aif1&lt;/i&gt; (&lt;i&gt;Iba1&lt;/i&gt;), &lt;i&gt;Fcgr3&lt;/i&gt; (CD16) and &lt;i&gt;H2-Eb1&lt;/i&gt; (MHCII). T cells were identified through expression of &lt;i&gt;Cd3e&lt;/i&gt; (CD3), &lt;i&gt;Cd8a&lt;/i&gt; (CD8) and &lt;i&gt;Cd4&lt;/i&gt;. Cell clusters that did not express any of these markers above were not considered for further analyses. Differentially expressed genes were computed for each cluster using the ‘FindMarkers’ command. ClusterProfiler (v.4.12.6) was used for Gene Ontology analysis considering differentially expressed genes with log&lt;sub&gt;2&lt;/sub&gt; fold change greater than 0.75 and Bonferroni-adjusted &lt;i&gt;P&lt;/i&gt; value less than 0.05. Ligand–receptor interaction networks were inferred using nichenetr (v.2.2.0) considering differentially expressed genes in the receiver population (T cells) and the top ten ligands based on the area under the precision–recall curve expressed by 3KL macrophages.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec36"&gt;Mouse multiplex cytokine array&lt;/h3&gt;&lt;p&gt;Mice were anaesthetized and perfused with ice-cold PBS. The gut was dissected, and 75 mg of duodenal tissue was collected in 300 μl (4 times wet weight) ice-cold PBS with cocktail protease inhibitors (ThermoFisher Scientific, 11814111). The tissue was homogenized at 50 Hz for 5 min using a TissueLyser LT (Qiagen) and centrifuged at 10,000&lt;i&gt;g&lt;/i&gt; for 10 min at 4 °C. The supernatant was collected and mixed well in an equal volume of RIPA lysis buffer (Thermo Scientific, 10017003), and left for 20 min on ice. The samples were then centrifuged at 10,000&lt;i&gt;g&lt;/i&gt; for 10 min at 4 °C and the supernatant was collected and sonicated (70% amplitude, 30 s on and 30 s off for 10 min) (Q800R3 Sonicator, QSONICA). A standard BCA protein assay was performed on the supernatant fraction to obtain the amount of protein (ThermoFisher Scientific, 10678484). Cytokine levels were assessed using the proteome profiler array (Mouse Cytokine Array Panel A, BioTechne, ARY006), which detects the levels of 40 mouse cytokines. The analysis was performed using the manufacturer’s instructions and 200 ng ml&lt;sup&gt;−1&lt;/sup&gt; of the samples were used. The dot blots were visualized by chemiluminescence detection using an Amersham Imager 680 (Bioke) system.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec37"&gt;ME photoconversion&lt;/h3&gt;&lt;p&gt;For photoconversion of ME T cells, VHD mice were first injected with NHC-αS versus PD-αS into ME. Five days later, mice were re-anaesthetized and small intestine was exposed to the site of injection, marked with 0.2% Fast Green FCF (Sigma-Aldrich). The rest of the body was carefully covered with aluminium foil to avoid undesired exposure. Next, the intestine was illuminated with UV light (405 nm) 1 cm distally from injection site for total of 2 min (2 intervals of 60 s each) using a BlueWave QX4 high-intensity spot-curing system (DyMax) equipped with a 3 mm diameter focusing lens. During the illuminations, the intestine was kept wet with PBS. Abdominal incisions were carefully closed with separate sutures on both peritoneal layer and skin. Animals received carprofen (33.33 mg ml&lt;sup&gt;−1&lt;/sup&gt;) in their drinking water for 4 days postsurgery. Animals were euthanized at 1 month postsurgery.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec38"&gt;Human gut tissue IHC&lt;/h3&gt;&lt;p&gt;Postmortem formalin-fixed paraffin-embedded jejunal sections (ten from patients with PD, ten from NHC participants) were obtained from the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona, USA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Beach, T. G. et al. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology 35, 354 (2015)." href="/articles/s41586-025-09984-y#ref-CR67" id="ref-link-section-d48957798e4030"&gt;67&lt;/a&gt;&lt;/sup&gt; (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM3"&gt;1a&lt;/a&gt;). The sections were incubated in a 60 °C oven overnight before staining after which they were deparaffinized in xylene and rehydrated in decreasing grades of alcohol. The sections were then stained using Leica Bond RX under standard IHC protocols within UCLA’s TPCL. Briefly, automated detection was performed based on protocol F using the Bond Polymer Refine Detection kit (Leica Biosystems). Heat-induced antigen retrieval was performed using the BOND Epitope Retrieval Solution 2 (Leica Biosystems, catalogue no. AR9640) buffer for 30 min. For chromogenic IHCs, the primary CD4 (Cell Marque, 104R-14, 1:50) was incubated for 60 min. Sections were incubated with Dakocytomation Envision System Labelled Polymer HRP anti-rabbit (Agilent Technologies, catalogue no. K4003) for 10 min followed by BOND Polymer Refine Detection DAB chromogen (Leica, catalogue no. DS9800) for 10 min. Images were acquired with a Lionheart LX Automated Microscope (Agilent Technologies). In some cases, QuPath was used to view slides scanned with an Aperio ScanScope AT (Leica) in the UCLA TPCL&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017)." href="/articles/s41586-025-09984-y#ref-CR51" id="ref-link-section-d48957798e4037"&gt;51&lt;/a&gt;&lt;/sup&gt;. For fluorescent IHC, the sections were blocked in 10% donkey serum, 1% BSA and 0.1% Tween in tris-buffered saline (TBS) for 30 min at room temperature, and then incubated with the primary antibodies overnight (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM5"&gt;3&lt;/a&gt;). The sections were washed in 0.1% Tween TBS and incubated with the secondary antibodies for 1 h at room temperature. The sections were then washed in 0.1% Tween TBS, treated with an autofluorescence quenching kit (Vector, SP-8400-15) following the manufacturer’s instructions, incubated in 1:10,000 DAPI in PBS for 10 min, washed again and mounted onto slides with ProLong Glass mounting medium. Information regarding sex is included in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM3"&gt;1a&lt;/a&gt;; however, sex was not taken into consideration when including patient samples. Findings did not apply to only one sex.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec39"&gt;Rotarod coordination test&lt;/h3&gt;&lt;p&gt;All behavioural testing was performed under a handling hood with lights off. On the first day, the mice were trained on a rotarod (Ugo Basile) with a constant speed of 8 rpm for a total of 5 min. Then, on the next three consecutive days, the animals were placed on an accelerating rotarod. The speed of rotation constantly accelerated from 4 rpm to 40 rpm in 3 min, and a trial lasted for a maximum of 5 min. The time was recorded when the animal fell off the apparatus or spun on it twice without attempts to resume running (latency to fall). On each day, the animals did 2 trials with 15–25 min break, and the results are presented as the mean of latency to fall (6 trials).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec40"&gt;Statistics&lt;/h3&gt;&lt;p&gt;All statistical analyses were performed in Prism (GraphPad Software, v.9.3.1) or R (v.4.3.2) and a complete overview is provided in Supplemental Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM6"&gt;4&lt;/a&gt;. Outliers were identified in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig1"&gt;1j&lt;/a&gt; and Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig8"&gt;3a&lt;/a&gt; and removed from the dataset using GraphPad Prism (ROUT, Q = 1%). For some datasets, bimodality was observed, probably reflecting variability introduced by different researchers performing experiments on separate days (for example, Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig1"&gt;1p&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig3"&gt;3d&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig5"&gt;5k&lt;/a&gt; and Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig7"&gt;2i&lt;/a&gt;). Normal distribution and equality of variance of the residuals were tested using the Shapiro–Wilk normality test and the &lt;i&gt;F&lt;/i&gt;-test, Spearman’s test, Bartlett’s test, Brown-Forsythe test or Levene’s test, using significance level &lt;i&gt;α&lt;/i&gt; = 0.05. To stabilize variances on heteroscedastic residuals, we performed log&lt;sub&gt;10&lt;/sub&gt; or square root transformations on the data for Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig1"&gt;1c&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig2"&gt;2d,g&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig3"&gt;3p&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig4"&gt;4f&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig5"&gt;5c,d,g,j,n&lt;/a&gt; and Extended Data Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig7"&gt;2d&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig9"&gt;4i&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig11"&gt;6h,l,n&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig12"&gt;7h,j&lt;/a&gt; (linear data were used for plotting to facilitate interpretation of the outcome). For Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig1"&gt;1p&lt;/a&gt;, to test the association between two binary variables (SAA negative versus positive), the Fisher’s exact test was used. A one-sample &lt;i&gt;t&lt;/i&gt;-test was performed to assess whether the mean αS levels in enteric neurons (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig7"&gt;2l&lt;/a&gt;) significantly differed from zero, analysed independently for each group. Two groups were compared using two-sided unpaired Student’s &lt;i&gt;t&lt;/i&gt;-test, two-sided Welch’s &lt;i&gt;t&lt;/i&gt;-test or two-sided Mann–Whitney test, depending on the data structure. For clonotype overlap (Jaccard and Expanded Index) and effective number of species between ME and dura mater, Bonferroni-adjusted unpaired &lt;i&gt;t&lt;/i&gt;-test with Welch’s correction was used (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig3"&gt;3r,t&lt;/a&gt; and Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig10"&gt;5a&lt;/a&gt;). To compare more than two groups (IgG, anti-CSF1R, anti-CCR2 or anti-CSF1R/anti-CCR2), one-way analysis of variance (ANOVA) with Bonferroni’s multiple-comparison posthoc test, Kruskal–Wallis test with Dunn’s multiple comparisons posthoc test was used, depending on the data structure. Two-way ANOVA with Bonferroni’s multiple-comparison test was used to assess the interaction of PD-αS versus NHC-αS injection with (1) anti-CSF1R/anti-CCR2 versus IgG treatment, (2) UV versus non-UV illumination, (3) &lt;i&gt;Cx3cr1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;CreERT2&lt;/i&gt;&lt;/sup&gt;&lt;i&gt;.Tgfb1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;LoxP&lt;/i&gt;&lt;/sup&gt; versus &lt;i&gt;Cx3cr1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;+/+&lt;/i&gt;&lt;/sup&gt;&lt;i&gt;.Tgfb1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;Lox&lt;/i&gt;&lt;/sup&gt; or at (4) 1 month or 3 months post-treatment. Two-way repeated measures ANOVA was used when values were matched (for example, different ME-Mac clusters or intestinal regions from the same mouse in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig4"&gt;4f&lt;/a&gt; and Extended Data Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig7"&gt;2b&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig11"&gt;6j,l&lt;/a&gt;; within variable, mouse). Multiple Mann–Whitney tests, with the Benjamini–Krieger–Yekutiel correction to control for the false discovery rate, were used to compare αS levels between cytosolic and insoluble fractions, as well as to compare cytokine levels in ME at 1 month postinjection. For brain region (SNpc versus VTA) versus treatment (NHC versus PD-extract injection) analysis in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig2"&gt;2k&lt;/a&gt; and Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig8"&gt;3f&lt;/a&gt;, we used a linear mixed-effect model with multivariate &lt;i&gt;t&lt;/i&gt;-distribution posthoc (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09984-y#Fig2"&gt;2k&lt;/a&gt;), using mouse as a nested variable to incorporate the intermouse differences across region. All data are presented as mean ± s.e.m., statistical significance was set at &lt;i&gt;α&lt;/i&gt; = 0.05. Statistical methods were not used to predetermine study sizes but were based on similar experiments previously published. Experiments were blinded to the genotype of the animal as well as the treatment of the animal. Experiments involving human sections were blinded to the demographics of the patients. Independent experiments were performed to confirm the reproducibility of the data.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec41"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09984-y#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 20:03:45 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE1BV0lzQ1hhTThuV1dDcGdSZUd1Rjdjc0wxN2VObEhIOU5nb3MwUnM3RHo1ZW5CdzdwNDRuekNvNjJzMmRGLU1vTS0ybHdvSTVLdUYyV0tXNk8yOHJfSGxV</guid></item><item><title>新的研究对食用奇亚籽的影响做出了巨大的发现- LADbible</title><link>https://www.ladbible.com/news/science/chia-seeds-impact-study-science-health-171164-20260128</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p class="text_text__nEn66"&gt;Popped on top of porridge, mixed into smoothies, or made into pudding, chia seeds are a pretty popular addition to people’s diets.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Regarded as a ‘super&lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/food-and-drink"&gt;food&lt;/a&gt;’, the little tiny things are packed with fibre, protein, omega-3 fatty acids, antioxidants, and various vitamins.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;However, some people have complained about ‘&lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/news/health/chia-seeds-expand-stuck-in-food-pipe-798076-20250609"&gt;blockages&lt;/a&gt;’ caused by the seeds or claimed that others simply aren’t consuming them in &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/lifestyle/food-and-drink/doctor-superfood-chia-seeds-dr-karan-rajan-viral-665530-20250815"&gt;the ‘correct’ way&lt;/a&gt;.&lt;/p&gt;&lt;p class="floating-video-player_container__u4D9_"&gt;&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;But there is no denying that there are &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/lifestyle/food-and-drink/chia-seeds-health-benefits-what-happens-one-week-212309-20251027"&gt;plenty of benefits&lt;/a&gt; of having chia seeds, and research published late last year made huge findings about their impact.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Brazilian &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/science"&gt;scientists&lt;/a&gt; aimed to investigate the effects of chia flour and chia oil and satiety, inflammation and antioxidant potential in the brain. In order to do this, they tested on rats who were fed a high-fat, high-fructose (HFHF) diet.&lt;/p&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;Chia seeds are a popular superfood. (Getty Stock)&lt;/cite&gt;&lt;/div&gt;&lt;p class="text_text__nEn66"&gt;Published in the journal &lt;a class="anchor_link__6t7IO" target="_blank" rel="noopener" href="https://www.sciencedirect.com/science/article/abs/pii/S0899900725003259?via%3Dihub"&gt;Nutrition&lt;/a&gt;, the researchers fed the majority of the animals this unhealthy diet, to help trigger metabolic changes and make them more like humans. They also had a control group of rats with a standard, healthy diet to help compare the impact of the chia seeds.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;For 10 weeks, there was one group fed the unhealthy diet as is, one fed it with the addition of chia oil, and the other with chia flour. Brain tissue samples were then collected from the rats for analysis.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Those fed chia oil ended up showing an increase in activity of genes relating to satiety – therefore suggesting chia can help people feel fuller after eating. This wasn’t quite the same for those fed chia flour.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;But both the versions of chia seemed to improve the brain’s response to the hormone leptin, which is associated with feelings of hunger in the body.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The chia products were generally found to restore brain functioning and reduce the urge to overeat.&lt;/p&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;Researchers found the products are 'potential modulators of satiety'. (Getty Stock)&lt;/cite&gt;&lt;/div&gt;&lt;p class="text_text__nEn66"&gt;The researchers wrote in their conclusion: “The consumption of chia flour and oil associated with a HFHF diet modulated the expression of genes involved in satiety and inflammatory response mechanisms. In addition, the modulation of the intestinal microbiota may be correlate with brain satiety signals, as well as inflammatory and oxidative responses, making it a potential strategy for controlling metabolic diseases associated with unbalanced diets.”&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Essentially, the study found that chia products can help people feel full after eating, putting an end to the desire to eat. So therefore, it can be helpful to those looking to make healthy changes to their diet in order to aid weight loss.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>LADbible</author><pubDate>Wed, 28 Jan 2026 19:32:17 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilwFBVV95cUxNXzlVQk5UTzFZVGpNZ0h1LUlSQzU1c3RndkRyRGVYdm85N3FGRndFbnhJa1BRcFh2Vl9SUTdZSEpYWjM1M2NVaVVCN1NsTy15Z3lMWkZXZUFCQ1IwWVRRWUJDWEd3X2d1U3dEUDdpNGZlX0tQel9hbEhtSjBoaVBWNk54Tlp4OVZWMktjTWVURWxCZXVrdkRn</guid></item><item><title>诺如病毒在您家中传播的意外方式- abc7.com</title><link>https://abc7.com/post/unexpected-norovirus-can-spread-household/18488345/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;Stomach bugs are pretty common this time of year, but health officials confirm California, including Los Angeles, is experiencing elevated norovirus activity.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;These types of viruses can spread in a way you might not realize. Mistakes you make with your laundry could be a source of transmission.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Wastewater reveals a new highly-contagious subvariant called GII.17 could be driving this trend.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The virus is spread through the fecal-oral route. We often blame tainted food, but doctors say your laundry could also be a source of transmission.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"If you are actively sick with diarrhea or some kind of a GI-related condition, go ahead and separate those clothes from other healthy people in the household," said Emergency Medicine specialist Dr. Ali Jamehdor with Dignity Health St. Mary's Hospital in Long Beach.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Some people let clothes sit in the hamper for weeks. He said that diarrhea-causing E. coli and salmonella can live that long in your laundry bin.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"Things are happening in the hamper. They love growing. The bacteria and viruses love growing and multiplying," he said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Staphylococcus aureus, which causes skin infections, may survive a month in a moist hamper. He recommends a short washing cycle with bleach after an especially germy load.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Experts say underwear contains the most germs, followed by children's clothing.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Jamehdor suggests everyone with kids do their laundry separately from theirs. And do you wash your hands after you load laundry?&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"You know. I don't think I do. I might occasionally but it's not something I do out of habit," said Craig Stone of Burbank.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"You need to be cognizant of washing your hands. It's like handling anything that's dirty," said Jamehdor.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Some experts also suggest drying your clothes on the highest heat cycle for at least 40 minutes.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;But, Jamehdor doesn't think any dryer reaches temperatures hot enough to kill germs.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Most importantly, clothes cannot stay damp. They need to be completely dried.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"I'm sure you've noticed when you take it out, it smells like mildew or has a weird smell to it. And that's a sign that it wasn't dried the right way, and you might need to wash your clothes again," he said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;And don't forget to sanitize your hamper or wash it if it's cloth.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC eTIW sUzSN "&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="uvrxY zOGtW "&gt;Copyright © 2026 KABC Television, LLC. All rights reserved.&lt;/p&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>abc7.com</author><pubDate>Wed, 28 Jan 2026 19:14:32 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifkFVX3lxTE1DUTV5S2JDdDF2V3JHQ29rZVBUT2p3N1JuNldTanlhN2lIa2RQOEZaYXc0dHhPOTlzaFB1NHViUXcyMzFaQkZmQUdVT2hjVkhUUWUxMko0cm5oRnFIWjZOaWNlV0xaNGY3ZzFIN0U4S0JyZUVTUWhsWFhJYkQ4Z9IBgwFBVV95cUxPaTgyYlVPaHNHQkc5OVNKMW5HR2I2enRYZUk2OHVkRmVDVV9DWDktSTV4N29FZjFlWmpHbldpS3VDbDl2UDU5X3duRTVUdWJaUDNjU1JGZ1RwdGxaeUkwVGFydWY0TDUxVS13aEhlSEZQOVdCdDR5XzhkNDlrWWxXdmo0NA</guid></item><item><title>科学家们更接近于解决“接吻病”之谜- Bloomberg.com</title><link>https://www.bloomberg.com/news/articles/2026-01-28/scientists-inch-closer-to-solving-the-kissing-disease-mystery</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="body-content"&gt;&lt;p class="ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr" data-component="paragraph"&gt;Scientists have identified 22 genes that increase the risk of conditions like lupus, stroke, and rheumatoid arthritis in patients who’ve caught the virus behind mono, an illness known as the “kissing disease.”&lt;/p&gt;&lt;p class="ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr" data-component="paragraph"&gt;The research, published Wednesday in the journal Nature, tried to unravel why some people who contract the Epstein-Barr virus go on to experience other medical conditions later in life. The hope is that by understanding who is most at risk, scientists might be able to better target treatments and turbo-charge research into vaccines for prevention. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Bloomberg.com</author><pubDate>Wed, 28 Jan 2026 17:14:30 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMisgFBVV95cUxNWXFMZk1Fa3NseXp0M041T0JrQzdzUkdlSTVyWUhCSFlhZjBBeEVHMHkwNmh6bXc3UnUzUGczQjJibmducmhNM1B4NjF0YWxidjNKaGtYR1NxQzlxQTJNUjFlQ0NPWVhROHZUN3pkQnNpN0tOQXloekFNWDliZWpUTGV5MldMVnlxejh5dDRHYWpqQlpFclY3S25meEU3NkZUbUg4cThmTE45YW81ZGZwME9B</guid></item><item><title>南卡罗来纳州麻疹： 23所学校被击中， 550多所学校因疫情爆发而被隔离- Ars Technica</title><link>https://arstechnica.com/health/2026/01/sc-measles-23-schools-hit-over-550-quarantined-as-outbreak-hits-record/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content post-content-double"&gt;
          
          
&lt;p&gt;Measles is one of the most infectious viruses we know of and can linger in the airspace of a room for up to two hours after an infected person has been present. Among unvaccinated people exposed to an infectious person, up to 90 percent will become ill. Many infections are only identified when measles’ telltale rash develops, but a person can be infectious for four days &lt;em&gt;before&lt;/em&gt; that rash develops, allowing the virus to more easily spread. People remain infectious for four days after the rash appears. In newly infected people, symptoms, which also include high fevers, typically begin 7 to 14 days after exposure, but this incubation period can be as long as 21 days, which is the length of quarantine.&lt;/p&gt;
&lt;p&gt;In its &lt;a href="https://dph.sc.gov/news/tuesday-measles-update-dph-reports-89-new-measles-cases-upstate-bringing-outbreak-total-789"&gt;latest update&lt;/a&gt;, South Carolina’s Public Health Department reported data indicating that its large case jumps will continue. In recent weeks, officials have identified 23 schools where measles has been unleashed. In 20 of the schools, unvaccinated and exposed students have been identified and quarantined, with individual schools’ quarantine totals spanning 13 to 59 students. For the remaining three schools with exposures, officials are still determining how many students need to be quarantined.&lt;/p&gt;
&lt;p&gt;State officials have also identified eight public places where measles exposures have occurred recently, including grocery stores, a US Post Office, and a skating center.&lt;/p&gt;
&lt;p&gt;For now, 557 students are quarantined, but additional susceptible people have likely been exposed.&lt;/p&gt;
&lt;p&gt;Among the 789 cases, 769 (97 percent) were unvaccinated or partially vaccinated or had an undocumented vaccination status. Two doses of the measles, mumps, and rubella vaccine are 97 percent effective against measles, and that protection is considered lifelong.&lt;/p&gt;


          
                  &lt;/div&gt;

                  
          &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Ars Technica</author><pubDate>Wed, 28 Jan 2026 17:02:48 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMirwFBVV95cUxPWWZBYndPUnpBV3E2VENWc2hXaWpER0QtVGZ0dnFMX3pJM3B3V2NZN2NFZUFUdV9uMEFNSkFpenNfTlZud3hDckw3OFpiQmltQjJHQTRleVNma2pESkt5MHYzRm1aUHZEdUlUODdvQnRoamNvdlY2Q3VHcGJ5TU5XUnJxbjFJWGFoWFZFczdaNlNZamJCNXY4Zk9hODFvTEpKdlVDQkh1b0ZsZ1VKLW9R</guid></item><item><title>美国麻疹爆发。- Tangle News</title><link>https://www.readtangle.com/measles-outbreaks-in-the-united-states/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article class="ct-post-content"&gt;
                            &lt;p&gt;&lt;em&gt;I'm Isaac Saul, and this is Tangle: an independent, nonpartisan, subscriber-supported politics newsletter that summarizes the best arguments from across the political spectrum on the news of the day — then “my take.”&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Are you new here? &lt;/em&gt;&lt;a href="https://www.readtangle.com/"&gt;&lt;em&gt;Get free emails&lt;/em&gt;&lt;/a&gt;&lt;em&gt; to your inbox daily. Would you rather listen? You can find our podcast &lt;/em&gt;&lt;a href="https://shows.acast.com/66510864c0852400122bc7be?ref=readtangle.com" rel="noreferrer"&gt;&lt;em&gt;here&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;&lt;hr&gt;&lt;h3 id="today%E2%80%99s-read-16-minutes"&gt;Today’s read: 16 minutes.&lt;/h3&gt;&lt;div class="kg-card kg-callout-card kg-callout-card-red"&gt;&lt;p class="kg-callout-emoji"&gt;💉&lt;/p&gt;&lt;p class="kg-callout-text"&gt;We examine the recent outbreaks of measles in several different states — and the continued debate over childhood vaccination.&lt;/p&gt;&lt;/div&gt;&lt;hr&gt;&lt;h3 id="we%E2%80%99re-doing-a-deep-dive"&gt;We’re doing a deep dive.&lt;/h3&gt;&lt;p&gt;One of the most frequently asked questions from readers over the last few weeks has been about the Department of Homeland Security’s (DHS) hiring and training practices. We’re putting together a story to better understand exactly what that process looks like, and the experience for agents on the ground. If you or anyone you know works for DHS, or its enforcement arms of Immigration and Customs Enforcement (ICE) and Customs and Border Patrol (CBP), we’d love to talk with you and learn more. Just drop us a line on Signal by searching our username @tanglenews.96 or clicking the link &lt;a href="https://signal.me/?ref=readtangle.com#eu/xw9Y1ATjnZue_Pe7cjTM9NrjjYuCJM9CqGGgwfwUYBMV5r_fGHNPP5Fu1VNmvMV7"&gt;&lt;u&gt;here&lt;/u&gt;&lt;/a&gt; (you’ll have to download the app to message). You can also reach out to &lt;a href="mailto:testimonials@readtangle.com"&gt;&lt;u&gt;testimonials@readtangle.com&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;&lt;hr&gt;&lt;h3 id="quick-hits"&gt;Quick hits.&lt;/h3&gt;&lt;ol&gt;&lt;li&gt;According to a government report sent to Congress, two U.S. Customs and Border Protection agents fired their weapons during the shooting of Alex Pretti in Minneapolis on Saturday. The report does not state whether Pretti’s firearm discharged at any point during the encounter. (&lt;a href="https://www.cbsnews.com/news/two-federal-agents-fired-their-weapons-during-alex-pretti-shooting-report-congress-says/?ref=readtangle.com"&gt;&lt;u&gt;The update&lt;/u&gt;&lt;/a&gt;) Separately, House Democrats said they will begin impeachment proceedings against Homeland Security Secretary Kristi Noem if President Donald Trump does not remove her. (&lt;a href="https://www.cnbc.com/2026/01/27/house-democrats-kristi-noem-impeachment-trump.html?ref=readtangle.com"&gt;&lt;u&gt;The threat&lt;/u&gt;&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;Border Patrol agents shot and wounded a man in Arizona. Officials said they were attempting to apprehend the man as a suspect in a human-trafficking investigation when he fled and began firing at agents and a Border Patrol helicopter. (&lt;a href="https://apnews.com/article/arizona-border-patrol-shooting-arivaca-5d097088d4851c86a2dcd3ba58250f2d?ref=readtangle.com"&gt;&lt;u&gt;The shooting&lt;/u&gt;&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;During a town hall, a man sprayed Rep. Ilhan Omar (D-MN) with an unknown substance. Omar said she was unharmed and continued with the town hall. (&lt;a href="https://thehill.com/homenews/house/5709698-omar-attacked-minneapolis-town-hall/?ref=readtangle.com"&gt;&lt;u&gt;The incident&lt;/u&gt;&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;The families of two Trinidadian men who were killed in a U.S. strike on a boat allegedly trafficking drugs sued the U.S. government for wrongful death and extrajudicial killing. It is the first such lawsuit filed in federal court related to the Trump administration’s boat strikes. (&lt;a href="https://www.nbcnews.com/politics/white-house/first-wrongful-death-lawsuit-filed-trump-administration-drug-boat-stri-rcna256022?ref=readtangle.com"&gt;&lt;u&gt;The suits&lt;/u&gt;&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;India and the European Union agreed to a free-trade deal that will eliminate or reduce tariffs on most goods traded between the economies. (&lt;a href="https://www.wsj.com/economy/trade/eu-and-india-reach-free-trade-deal-as-world-responds-to-trump-tariffs-bbbdb8d2?ref=readtangle.com"&gt;&lt;u&gt;The deal&lt;/u&gt;&lt;/a&gt;)&lt;/li&gt;&lt;/ol&gt;
&lt;div class="kg-card kg-cta-card kg-cta-bg-white kg-cta-minimal   kg-cta-link-accent " data-layout="minimal"&gt;
            
                
            
            &lt;div class="kg-cta-content"&gt;
                
                
                    &lt;div class="kg-cta-content-inner"&gt;
                    
                        &lt;div class="kg-cta-text"&gt;
                            &lt;p&gt;&lt;b&gt;&lt;strong&gt;16 Nearly Secret Things To Do If You Have Amazon Prime&lt;/strong&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;span&gt;If you shop on Amazon regularly, there’s a good chance you’re leaving &lt;/span&gt;&lt;a href="https://financebuzz.com/shopper-hacks-amazon?utm_source=tangle&amp;amp;utm_medium=paid-newsletter-cpf&amp;amp;utm_term=Tangle&amp;amp;utm_campaign=BM-FBZ-Tangle-shopper-hacks-amazon-CPF&amp;amp;adgroupid=BM-Tangle-shopper-hacks-amazon-CPF-01282026" rel="noreferrer" class="cta-link-color"&gt;&lt;span&gt;real money&lt;/span&gt;&lt;/a&gt;&lt;span&gt; on the table every single month. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;Many shoppers don’t realize there are simple tools, features, and settings built right into Amazon that can help you save more and even earn extra cash on purchases you’re already making.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;We’ve put together &lt;/span&gt;&lt;a href="https://financebuzz.com/shopper-hacks-amazon?utm_source=tangle&amp;amp;utm_medium=paid-newsletter-cpf&amp;amp;utm_term=Tangle&amp;amp;utm_campaign=BM-FBZ-Tangle-shopper-hacks-amazon-CPF&amp;amp;adgroupid=BM-Tangle-shopper-hacks-amazon-CPF-01282026" rel="noreferrer" class="cta-link-color"&gt;&lt;b&gt;&lt;strong&gt;16 lesser-known Amazon hacks&lt;/strong&gt;&lt;/b&gt;&lt;/a&gt;&lt;span&gt; that can unlock serious savings. These tips can help you lower prices, earn cash back, stop paying for subscriptions you don’t use, and avoid common Amazon charges most people never notice. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;And the best part? &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;You don’t need to buy anything new or change how you shop. There’s no complicated setup or learning curve here. Instead of paying full price and moving on, you can start getting more value out of purchases you’re already making.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="https://financebuzz.com/shopper-hacks-amazon?utm_source=tangle&amp;amp;utm_medium=paid-newsletter-cpf&amp;amp;utm_term=Tangle&amp;amp;utm_campaign=BM-FBZ-Tangle-shopper-hacks-amazon-CPF&amp;amp;adgroupid=BM-Tangle-shopper-hacks-amazon-CPF-01282026" rel="noreferrer" class="cta-link-color"&gt;&lt;b&gt;&lt;strong&gt;Take a few minutes to see what you could be missing&lt;/strong&gt;&lt;/b&gt;&lt;/a&gt;&lt;b&gt;&lt;strong&gt;.&lt;/strong&gt;&lt;/b&gt;&lt;/p&gt;
                        &lt;/div&gt;
                    
                    
                    &lt;/div&gt;
                
            &lt;/div&gt;
        &lt;/div&gt;
&lt;hr&gt;&lt;h3 id="today%E2%80%99s-topic"&gt;Today’s topic. &lt;/h3&gt;&lt;p&gt;The measles outbreaks. Last week, South Carolina officials reported that measles is transmitting rapidly in the state, with &lt;a href="https://dph.sc.gov/diseases-conditions/infectious-diseases/measles-rubeola/measles-dashboard?ref=readtangle.com"&gt;&lt;u&gt;789 confirmed cases&lt;/u&gt;&lt;/a&gt; so far. South Carolina is the fifth state to accumulate at least 100 measles cases since January 2025, joining Utah, New Mexico, Arizona, and Texas (where the first cases in 2025 were reported). During the current outbreaks, over 150 children have been hospitalized with measles; two children and one adult (all unvaccinated) have died from measles complications, the first such deaths in the U.S. in a decade.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Back up: &lt;/strong&gt;Measles, or rubeola, is a highly contagious airborne viral infection characterized by a high fever, cough, runny nose, and a blotchy rash. Once a common &lt;a href="https://www.mayoclinic.org/diseases-conditions/measles/symptoms-causes/syc-20374857?ref=readtangle.com"&gt;&lt;u&gt;childhood disease&lt;/u&gt;&lt;/a&gt;, scientific advancements have mitigated its incidence and severity. Most people who contract measles recover within 10 days, but severe cases can be deadly for those with weakened immune systems, including children under five.&lt;/p&gt;&lt;p&gt;In January, measles was &lt;a href="https://www.scientificamerican.com/article/what-to-know-about-measles-as-the-outbreak-in-texas-ends-and-the-school-year/?ref=readtangle.com"&gt;&lt;u&gt;reported&lt;/u&gt;&lt;/a&gt; in a largely unvaccinated Mennonite community in West Texas. The disease spread from there, with &lt;a href="https://www.dshs.texas.gov/news-alerts/texas-announces-end-west-texas-measles-outbreak?ref=readtangle.com#:~:text=As%20of%20Aug.%2018%2C%20762%20cases%20of%20measles%20have%20been%20confirmed%20in%20the%20outbreak%20since%20late%20January.%20More%20than%20two%2Dthirds%20of%20the%20cases%20were%20in%20children.%20Ninety%2Dnine%20people%20were%20hospitalized%20over%20the%20course%20of%20the%20outbreak%2C%20and%20there%20were%20two%20fatalities%20in%20school%2Daged%20children."&gt;&lt;u&gt;762 cases&lt;/u&gt;&lt;/a&gt; in Texas reported by August, growing into the largest single outbreak of measles in the United States since 2000 (when the disease was declared eliminated in the country). The Texas outbreak ended in August, but cases continued to be reported in other states. According to the U.S. Centers for Disease Control and Prevention (CDC), a total of 2,255 measles cases &lt;a href="https://www.cdc.gov/measles/data-research/index.html?ref=readtangle.com"&gt;&lt;u&gt;were confirmed&lt;/u&gt;&lt;/a&gt; in the United States in 2025, marking the worst year for measles in over two decades. So far in 2026, the CDC has confirmed 416 cases across 14 jurisdictions.&lt;/p&gt;&lt;p&gt;To maintain its elimination status, the United States must demonstrate that transmissions of the disease were not sustained across outbreaks. The World Health Organization defines elimination as 12 consecutive months without sustained transmission; the U.S. loses its elimination status, it will &lt;a href="https://www.reuters.com/business/healthcare-pharmaceuticals/european-countries-including-uk-lose-measles-elimination-status-2026-01-26/?ref=readtangle.com"&gt;&lt;u&gt;join&lt;/u&gt;&lt;/a&gt; Spain, Austria, Armenia, Azerbaijan, Uzbekistan, the United Kingdom, and Canada as nations that have lost their elimination status in the past year.&lt;/p&gt;&lt;p&gt;Leaders at the Department of Health and Human Services have downplayed the current outbreaks. “It’s just the cost of doing business with our borders being somewhat porous for global and international travel,” Ralph Abraham, principal deputy director at the CDC, &lt;a href="https://www.cbsnews.com/news/measles-elimination-rfk-jr-cdc-deputy-downplays/?ref=readtangle.com"&gt;&lt;u&gt;said&lt;/u&gt;&lt;/a&gt;. Despite the American Academy of Pediatrics &lt;a href="https://thehill.com/policy/healthcare/5706819-aap-2026-immunization-schedule/?ref=readtangle.com"&gt;&lt;u&gt;recently breaking&lt;/u&gt;&lt;/a&gt; from the CDC over its vaccination schedule, both bodies still recommend parents provide their children with the MMR (measles, mumps, and rubella) vaccine.&lt;/p&gt;&lt;p&gt;Recent outbreaks in the U.S. and across the globe have reignited debates over childhood vaccinations. According to &lt;a href="https://www.cdc.gov/measles/data-research/index.html?ref=readtangle.com"&gt;&lt;u&gt;CDC data&lt;/u&gt;&lt;/a&gt;, 93% of confirmed measles cases in 2025 occurred in individuals who did not receive the measles vaccine or whose vaccination status is unknown. Many vaccine skeptics frame the choice to forgo the vaccine as a personal decision, while proponents stress that at least 95% of the population must vaccinate to provide herd immunity to those who are medically unable to vaccinate.&lt;/p&gt;&lt;p&gt;Below, we’ll get into what the right, left, and scientific community is saying about the measles outbreak. Then, Managing Editor Ari Weitzman gives his take.&lt;/p&gt;&lt;hr&gt;&lt;h3 id="what-the-left-is-saying"&gt;What the left is saying.&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;The left worries that more outbreaks are coming — and top health leaders are not meeting the moment.&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Some argue this outcome is a result of RFK Jr.’s messaging about vaccines.&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;In The Washington Post, Leana S. Wen called the return of measles &lt;/strong&gt;&lt;a href="https://www.washingtonpost.com/opinions/2025/02/25/measles-texas-outbreak-vaccines/?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;“a public health tragedy.”&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;“Time will tell how many more people will become infected and fall seriously ill in this outbreak. What’s certain is that this outbreak will not be the last. At least 15 states have proposed legislation to loosen vaccine requirements. In Texas, lawmakers have already introduced more than 20 such bills this year,” Wen said. “Robert F. Kennedy Jr., the newly confirmed health and human services secretary, refuses to disavow the debunked theory that MMR is linked to autism. And among the several thousand Department of Health and Human Services employees terminated in Elon Musk’s purge of government agencies are those tasked with disease investigation and outbreak response.&lt;/p&gt;&lt;p&gt;“It’s been said that vaccines are a victim of their own success. Indeed, younger generations fail to appreciate the extraordinary benefit of vaccines because they have never seen the lethal illnesses that vaccines help avert,” Wen wrote. “One can only hope that parents learn this lesson before more children are infected and suffer the consequences of measles and other vaccine-preventable diseases.”&lt;/p&gt;&lt;p&gt;&lt;strong&gt;In Scientific American in April 2025, Dan Vergano criticized &lt;/strong&gt;&lt;a href="https://www.scientificamerican.com/article/measles-vaccine-denial-is-a-massive-brainwashing-campaign/?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;“the brainwashing campaign that is measles misinformation.”&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;“Why is this happening? An April poll on measles beliefs from the health policy-centered Kaiser Family Foundation tells us. One quarter of the 1,380 people surveyed believe the false notion that the measles vaccine causes autism. Some 19 percent mistakenly believe the vaccine is more dangerous than the deadly virus it prevents,” Vergano said. “This is a shameful, mass propaganda campaign, unfolding in real time, championed by our top health official… We are on the brink of an epidemic, one that could make millions of people sick with measles each year, and this is all being done for political and personal gain, with children as the collateral damage.”&lt;/p&gt;&lt;p&gt;“In 2024 Trump brought RFK, Jr. (whom he once accused of being a ‘fake’ anti-vaxxer) onto his campaign precisely for his anti-medical establishment credentials. Kennedy’s views, steadily peddled on right-wing outlets, attracted measles-vaccine-doubting voters. It was a classic case of ‘If you can’t beat ’em on lying about vaccines, give him control of the nation’s public health apparatus,’” Vergano wrote. “For the politicians and the grifters who pump out this dangerous dishonesty, these deaths don’t matter, so long as they get the votes. For everyone else, the deadly spread of measles is the dismal future they now promise our kids.”&lt;/p&gt;&lt;hr&gt;&lt;h3 id="what-the-right-is-saying"&gt;What the right is saying.&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Many on the right are also concerned about the outbreak and say public health officials are fueling vaccine skepticism.&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Some suggest the severity of the outbreak is being overstated. &lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;The Wall Street Journal editorial board wrote about &lt;/strong&gt;&lt;a href="https://www.wsj.com/opinion/measles-outbreak-vaccines-cdc-rfk-jr-ralph-abraham-8f14599c?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;“measles as a ‘cost of doing business.’”&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;“Asked by the press this week if he’s worried about this, CDC principal deputy director Ralph Abraham — recently appointed by Health and Human Services Secretary Robert F. Kennedy Jr. — shrugged. ‘Not really,’ he replied. ‘You know, it’s just the cost of doing business, with our borders being somewhat porous [and] global and international travel,’” the board said. “Not really. Fewer than 2% of U.S. cases have been imported from abroad. But outbreaks happen when vaccination rates fall below the levels needed to maintain herd immunity, which is about 95%. The kindergarten vaccination rate in South Carolina was 91% during the 2024-2025 school year.”&lt;/p&gt;&lt;p&gt;“Outbreaks have increased because childhood immunizations have declined since the pandemic… Mr. Kennedy has fueled the vaccine distrust, even saying the vaccine causes disabilities and death like the virus. It doesn’t,” the board wrote. “Like his boss, Dr. Abraham claims people should be ‘free’ not to vaccinate children… The problem with this line is that unvaccinated children can sicken infants and immuno-compromised children who can’t be inoculated, leaving some disabled or worse. In a better Administration, government leaders would explain this to parents rather than brush aside serious illness as inconsequential.”&lt;/p&gt;&lt;p&gt;&lt;strong&gt;In Hot Air, David Strom criticized &lt;/strong&gt;&lt;a href="https://hotair.com/david-strom/2025/12/16/liberals-are-bad-at-math-liars-or-both-n3809933?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;the left’s framing&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; of the measles outbreak. &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;“If you compare measles rates in the United States with those of our peer countries, including Canada, France, and Germany, we have the lowest per-capita rate, and the number of cases is so low that natural fluctuations of a few cases per year can make the shifts appear large,” Strom said. “Germany and the United States have comparable rates, with extremely few cases in any given year… As for rates of increase? Natural variations account for that, although until a trend can be established, we can’t rule out the possibility that RFK, Jr.’s skepticism might affect future cases. But certainly there is no evidence of that yet.&lt;/p&gt;&lt;p&gt;“How do I know? In 2025, Canada’s per capita rate for measles was 125 per 1,000,000, while the US’s rate was 5.6. In other words, Canada currently has a rate 25 times higher than the United States, suggesting that something other than a few months of vaccine skepticism is at work in the variation,” Strom wrote. “I prefer an actual scientific approach where all the costs and benefits of each jab is examined and weighed, the vaccine schedule as a whole is examined to determine whether there is a better and safer way to give vaccines, and above all, consent only follows complete information provided to parents and other patients.”&lt;/p&gt;&lt;hr&gt;&lt;h3 id="what-medical-experts-are-saying"&gt;What medical experts are saying.&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Some experts say the outbreak will continue to spiral without a better public health approach.&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Others suggest the challenge of containing infectious diseases is rooted in the independence of state health agencies. &lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;In The New York Times in April 2025, Dr. Michael Mina, an epidemiologist and immunologist, wrote &lt;/strong&gt;&lt;a href="https://www.nytimes.com/2025/04/02/opinion/measles-epidemic-texas.html?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;“I’m terrified we’re headed for an epidemic.”&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;“Measles is among the most contagious viruses known… Infants too young for vaccination, immune-compromised people and the elderly are all at risk. Measles isn’t just a fever and rash. It can cause pneumonia, brain inflammation, permanent disability and death,” Mina said. “The current measles outbreak, with more than 480 cases, largely in unvaccinated children, is gearing up to be the worst in years. And it’s likely just the beginning. Recent studies estimate that more than nine million American children are susceptible to measles… 3.6 million infants are too young to be vaccinated and millions of immunocompromised Americans can’t safely receive the vaccine.”&lt;/p&gt;&lt;p&gt;“For infants under 1 who aren’t yet eligible for M.M.R. vaccination and who live in areas where measles is spreading (which is a rapidly expanding list), it’s worth asking your pediatrician about getting the first dose early, as young as 6 months,” Mina wrote. “Instead of focusing on getting people measles vaccines, Mr. Kennedy is putting resources into a study into vaccine-autism links… Public health depends on public trust. When that trust is broken, when people start to see vaccines as personal choices without regard to public health — or, worse, as threats — diseases like measles come roaring back.”&lt;/p&gt;&lt;p&gt;&lt;strong&gt;In MedPage Today, Nathaniel Mamo, Dhriti Jagadish, and Arthur Caplan said &lt;/strong&gt;&lt;a href="https://www.medpagetoday.com/opinion/second-opinions/118582?ref=readtangle.com"&gt;&lt;strong&gt;&lt;u&gt;“science has been lost amidst politics and patchwork state health policy.”&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;“Also beginning in a small religious community, this year’s measles outbreak emerged in a west Texas Mennonite community with low vaccine coverage. The case rate has surpassed 2019’s and continues to rise, fueled by decreased measles vaccination rates and nationwide spread to nearly every state,” the authors wrote. “While a state may only set public health policies for its residents, the implications extend to the rest of the country. Infectious disease follows people, not borders. Naturally, it should be the federal government’s role to moderate policy differences between jurisdictions. And yet, ours does not. The explanation is not a lack of power but of authority.&lt;/p&gt;&lt;p&gt;“Despite the seemingly mighty stature of federal health agencies, they have little authority over state health departments. States operate health systems largely independent of the federal government, and sometimes directly against,” the authors said. “Increasingly, as the nation’s politics have polarized, public health has become a way of asserting political priorities, giving public health the appearance that it is a matter of ideology and not objectivity. This was on full display during the pandemic, and has come to define American public health today.”&lt;/p&gt;&lt;hr&gt;&lt;h3 id="my-take"&gt;My take.&lt;/h3&gt;&lt;p&gt;&lt;strong&gt;Reminder: “My take” is a section where we give ourselves space to share a personal opinion. If you have feedback, criticism or compliments, don't unsubscribe. Write in by replying to this email, or &lt;/strong&gt;&lt;a href="https://www.readtangle.com/measles-outbreaks-in-the-united-states/#ghost-comments-root" rel="noreferrer"&gt;&lt;strong&gt;leave a comment&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;.&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;One of the biggest contributors to vaccine skepticism is an unwillingness to discuss it.&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;When you take skeptical points one by one, the argument against the MMR vaccine fails.&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Secretary Kennedy wants to rhapsodize fear; don’t let him.&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;Managing Editor Ari Weitzman: &lt;/strong&gt;If you’ve read the above opinions (I hope you did), you’ll find a lot of consensus about the effectiveness of the MMR vaccine to prevent measles. However, you won’t find a lot of engagement with the points made by those who are skeptical or outright opposed to vaccines. So I’d like to jump straight to addressing those concerns.&lt;/p&gt;&lt;p&gt;First, imagine that you have a friend who lost a child under the age of one to an unknown cause. Imagine the pain and confusion that comes with such a tragedy and the desperate desire for answers that follows. That process looks different for everyone, but for a person scouring their own choices for blame, looking into vaccines — often the most obvious medical intervention a child receives after birth — is a natural starting point. &lt;/p&gt;&lt;p&gt;For many people in that situation, page after page of Google searches telling them they’re misguided won’t settle their concerns. Instead, comfort comes from the first believable person who says, “You’re not crazy. Vaccines &lt;em&gt;are&lt;/em&gt; dangerous, and I can prove it.”&lt;/p&gt;&lt;p&gt;Today, the most prominent person delivering that message is Robert F. Kennedy Jr. Despite rejecting the label of “anti-vaxxer,” the HHS Secretary has consistently defended the opinion to opt out of the MRR vaccine for years; now, he offers governmental authority for vaccine skeptics to justify their decision.&lt;/p&gt;&lt;p&gt;Instead of dismissing Kennedy’s argument out of hand, I want to address it directly. Using a 2019 article authored by Kennedy in &lt;a href="https://childrenshealthdefense.org/news/robert-f-kennedy-jr-s-response-to-the-message-of-measles-what-the-new-yorker-wouldnt-publish/,?ref=readtangle.com"&gt;&lt;u&gt;Children’s Health Defense&lt;/u&gt;&lt;/a&gt; — written before his run for president and still representative of his views today — I’ll respond to his individual points, in his own words, below.&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;CDC’s mortality and morbidity data suggest that measles fatalities in the pre-vaccine era were 1/500,000 population wide; 1 in 10,000 among infected individuals.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;I have found plenty of sources to corroborate this claim. Before vaccines were made available to the public, measles killed 0.2 of every 100,000 people (1/500,000), according to &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1522578/?ref=readtangle.com"&gt;&lt;u&gt;the 1962 paper cited&lt;/u&gt;&lt;/a&gt; by Kennedy’s source. But Kennedy does some sleight of hand, here, discussing the &lt;em&gt;pre-vaccine&lt;/em&gt; mortality rates among infected people and among the general population&lt;em&gt; &lt;/em&gt;while omitting the &lt;em&gt;current&lt;/em&gt; rates. The &lt;strong&gt;median&lt;/strong&gt; &lt;em&gt;general&lt;/em&gt; mortality rate of measles for each year this century is 0 — meaning that, in most years since 2000, nobody in the entire country died of measles. The &lt;strong&gt;maximum &lt;/strong&gt;general mortality rate, set in 2025, is 1:115,000,000 — a mere 320-fold improvement on the pre-vaccine benchmark (at worst). &lt;/p&gt;&lt;p&gt;Among &lt;em&gt;infected&lt;/em&gt; people, the mortality rate has been about &lt;a href="https://www.paho.org/sites/default/files/2025-03/2025-mar-24-phe-risk-assessment-measles-final.pdf?ref=readtangle.com"&gt;&lt;u&gt;1 in 10,000&lt;/u&gt;&lt;/a&gt; in the U.S. since 1962 — and roughly 1 out of every 1,000 infected children under 10 (again, according to Kennedy’s own source, Physicians for Informed Consent).&lt;/p&gt;&lt;p&gt;Here’s a chart that Physicians for Informed Consent designed to help you feel comfortable with this number (and nervous about the MMR vaccine):&lt;/p&gt;&lt;figure class="kg-card kg-image-card kg-card-hascaption"&gt;&lt;img src="https://www.readtangle.com/content/images/2026/01/data-src-image-4b864257-5e8f-4dd4-b395-9221bcae04ad.png" class="kg-image" alt="Source: Physicians for Informed Consent" loading="lazy" srcset="https://www.readtangle.com/content/images/size/w600/2026/01/data-src-image-4b864257-5e8f-4dd4-b395-9221bcae04ad.png 600w, https://www.readtangle.com/content/images/size/w1000/2026/01/data-src-image-4b864257-5e8f-4dd4-b395-9221bcae04ad.png 1000w, https://www.readtangle.com/content/images/2026/01/data-src-image-4b864257-5e8f-4dd4-b395-9221bcae04ad.png 1536w" sizes="(min-width: 720px) 720px"&gt;&lt;figcaption&gt;&lt;span&gt;Source: Physicians for Informed Consent&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;A 0.1% mortality looks really small compared to cancer’s 2%. The difference, of course, is that you can’t get inoculated at birth for cancer. But if you could, would you say, “I’m four times likelier to die in a car accident, so what’s the point?” &lt;/p&gt;&lt;p&gt;No, because the point, obviously, is that fewer kids die. To quote Alexander Langmuir, the author of the aforementioned 1962 paper, “Measles is a disease whose importance is not to be measured by total days disability or number of deaths, but rather by human values and by the fact that tools are becoming available which promise effective control and early eradication.”&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;No one can say, scientifically, that any one of the 70 vaccine doses currently recommended for American children saves more lives than it costs. That question can only be answered by studies that compare long-term health outcomes in vaccinated versus unvaccinated populations.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;When Kennedy says no one can say “scientifically” that a vaccine saves more lives than it costs, he really means no one can say it &lt;em&gt;definitively&lt;/em&gt;, with certitude. But we can’t say a lot of things with certitude. I haven’t walked on the moon, so I couldn’t say, &lt;em&gt;definitively&lt;/em&gt;, that I would feel lighter on its surface. However, a lot of findings &lt;em&gt;scientifically &lt;/em&gt;support the belief that I would feel lighter on the moon. Similarly, many studies scientifically support the belief that the MMR vaccine prevents far more harm than it causes.&lt;/p&gt;&lt;p&gt;In his demand for proof, Kennedy seems reasonable, but really he is asking for the moon. Or, to quote &lt;a href="https://www.nationalacademies.org/read/13563/chapter/2?ref=readtangle.com"&gt;&lt;u&gt;the National Academies&lt;/u&gt;&lt;/a&gt;, such a large study “would be prohibitively time-consuming and difficult.”&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;Studies support an unconscionably high injury rate from MMR. Merck’s own MMR pre-licensure studies found that 40% of children receiving the MMR [vaccine] suffered gastrointestinal illnesses within 42 days of the injection and 55% suffered respiratory illnesses — symptoms that might persuade rational consumers to choose the infections over the vaccine.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;Here, Kennedy conflates “injury” with the “symptoms” outlined by the 1978 Merck study, which &lt;a href="https://childrenshealthdefense.org/wp-content/uploads/FDA-Relied-Upon-STUDIES-LICENSING-MMR-VACCINE-FOIA.pdf$page=43?ref=readtangle.com"&gt;&lt;u&gt;found&lt;/u&gt;&lt;/a&gt; that “upper respiratory and gastrointestinal infections were reported in about 55% and 40% of vaccinees [in two reviewed groups] respectively.” It also found “a faint measles-like rash” in nine subjects and “mild transient arthralgia" in one. While this sounds scary, these are &lt;a href="https://www.drugs.com/sfx/m-m-r-ii-side-effects.html?ref=readtangle.com"&gt;&lt;u&gt;common side effects&lt;/u&gt;&lt;/a&gt; of a live vaccination (though less common today), not long-term conditions that we might think of when we hear “vaccine injury.” &lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;26% of post-pubertal females might develop arthritis and arthralgia from the MMR.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;More conflation. According to a Johns Hopkins &lt;a href="https://www.vaccinesafety.edu/do-vaccines-cause-arthralgia-or-arthritis/?ref=readtangle.com"&gt;&lt;u&gt;epidemiological review&lt;/u&gt;&lt;/a&gt;, adult women who took the MMR vaccine developed temporary arthritic and arthralgic &lt;em&gt;symptoms&lt;/em&gt;. They did not actually develop arthritis. If my hands ache for a few days after getting the flu, the flu did not give me arthritis; I just had arthritic symptoms that then went away.&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt; &lt;em&gt;A 2004 JAMA study found that an additional 1 in 640 children has seizures after MMR compared to unvaccinated children; about 5% of these will progress to epilepsy.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;Again, temporary symptoms (and febrile seizures are not uncommon in infants) are not the same as contracting a condition (here, epilepsy). Kennedy supports his claim with a &lt;a href="https://pubmed.ncbi.nlm.nih.gov/15265850/?ref=readtangle.com"&gt;&lt;u&gt;2004 JAMA study&lt;/u&gt;&lt;/a&gt;; this is how it concludes: “MMR vaccination was associated with a transient increased rate of febrile seizures but the risk difference was small even in high-risk children. The long-term rate of epilepsy was not increased in children who had febrile seizures following vaccination compared with children who had febrile seizures of a different etiology.”&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;HHS’s voluntary post-marketing surveillance program on vaccines, VAERS, reports over 89,000 adverse reactions to MMR through March 31, 2018, including 445 deaths. However, VAERS is a voluntary and notoriously ineffective system. VAERS captures “fewer than 1% of vaccine injuries” according to a 2010 HHS funded study performed by another federal agency, the Agency for Health Care Research and Quality (AHRQ). If you multiply the known adverse events from the MMR by 100, you get 44,500 deaths and 8,900,000 injuries making the measles vaccine far worse than measles.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;First, Kennedy gravely misinterprets the VAERS data. Volunteers reported deaths or injuries after vaccination; they didn’t — and really can’t — report causation. They also can’t be closely vetted. In a classic example, Dr. James R. Laidler &lt;a href="https://www.factcheck.org/2023/06/scicheck-what-vaers-can-and-cant-do-and-how-anti-vaccination-groups-habitually-misuse-its-data/?ref=readtangle.com#:~:text=In%20a%20now,could%20be%20deleted."&gt;&lt;u&gt;said&lt;/u&gt;&lt;/a&gt; he filed a VAERS report that “an influenza vaccine had turned me into The Hulk.” The report remained in the database until VAERS, after a discussion, asked if it could be deleted. So Kennedy’s initial number is invalid.&lt;/p&gt;&lt;p&gt;Second, VAERS captures about 1% of &lt;em&gt;nonserious&lt;/em&gt; events, not serious ones. To the contrary, roughly 25% of adverse reactions, like anaphylaxis and Guillain-Barré syndrome, &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11252891/?ref=readtangle.com"&gt;&lt;u&gt;are reported&lt;/u&gt;&lt;/a&gt; to VAERS. So Kennedy’s multiplication is also invalid, making his claim of 44,500 vaccine-related deaths in 2018 a pure fiction.&lt;/p&gt;&lt;hr&gt;&lt;blockquote&gt;&lt;em&gt;Most “anti-vaxxers” are individuals who believe in the traditional liberal axiom that Americans should have sovereignty over their own bodies and that the government has no right to coerce healthy Americans to submit to a risky medical procedure.&lt;/em&gt;&lt;/blockquote&gt;&lt;p&gt;Of course, everybody has a right to ask questions and make their own choices. And being nervous about vaccines is reasonable. But having bodily autonomy means having the choice, a choice to cooperate for a higher common good or let your selfish fears persuade you. Kennedy is advocating for your fears, through the language of patriotic idealism — and I can counter with an opposing and equally patriotic story.&lt;/p&gt;&lt;p&gt;After an audacious victory in Trenton in 1776, General George Washington’s ragged Continental Army had to endure a brutal winter in Valley Forge, locked in a battle against an enemy Washington &lt;a href="https://www.frauncestavernmuseum.org/george-washingtons-public-health-crisis?ref=readtangle.com"&gt;&lt;u&gt;called&lt;/u&gt;&lt;/a&gt; “ten times more dangerous than Britons, Canadians and Indians together.” That enemy was smallpox, and the weapon Washington chose to fight it was equally audacious: inoculation. Between 1777 and 1778, the forward-thinking Washington ordered a mass inoculation of continental soldiers. As a result, the Continental Army won its battle against smallpox — and, eventually, the war. &lt;/p&gt;&lt;p&gt;In 1777, urgency pushed Washington to supersede bodily autonomy for the sake of a common good — and, ultimately, the very birth of our nation. In 2025, armed with access to a vaccine and information about its benefits, our nation’s choice is not an authoritarian leader’s decision to make between mass bodily autonomy and the common good. Instead, it is an individual choice between that higher good and one's own fear. &lt;/p&gt;&lt;p&gt;You have bodily autonomy; we all do. The achievements of our predecessors granted us that right. Now, we must exercise it wisely.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Take the survey: &lt;/strong&gt;What do you think of the measles outbreaks? &lt;a href="https://interrobang.vercel.app/survey/fc7bd483-4507-4fee-8511-fc6e58bfdc83?ref=readtangle.com"&gt;&lt;u&gt;Let us know&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;&lt;em&gt;Disagree? That's okay. Our opinion is just one of many. Write in and let us know why, and we'll consider publishing your feedback.&lt;/em&gt;&lt;/p&gt;&lt;hr&gt;&lt;h3 id="your-questions-answered"&gt;Your questions, answered.&lt;/h3&gt;&lt;p&gt;&lt;em&gt;We're skipping the reader question today to give our main story some extra space. Want to have a question answered in the newsletter? You can reply to this email (it goes straight to our inbox) or &lt;/em&gt;&lt;a href="https://docs.google.com/forms/d/e/1FAIpQLScQhqBSG_6_oBhwcTQMeS570n29XYbeQ9C9Bis7rjqI31g1tA/viewform?usp=header&amp;amp;ref=readtangle.com" rel="noreferrer"&gt;&lt;em&gt;fill out this form&lt;/em&gt;&lt;/a&gt;&lt;em&gt;. &lt;/em&gt;&lt;/p&gt;&lt;hr&gt;&lt;h3 id="under-the-radar"&gt;Under the radar.&lt;/h3&gt;&lt;p&gt;This week, the first in a series of trials scrutinizing the impact of social media on young users began in Los Angeles, California. The plaintiff in the first case is a 20-year-old woman who joined several social media platforms as a child and says she became addicted to them, leading to anxiety and depression. She alleges that these social media companies purposely designed the addictive features and caused direct harm to users. In total, nine cases related to social media and addiction are expected to go to trial in Los Angeles; in another set of cases scheduled for this summer in Oakland, California, school districts and states will argue social media is a public nuisance. The social media companies argue that there is no causal link between social media use and addiction. &lt;a href="https://www.nytimes.com/2026/01/27/technology/what-to-know-about-the-social-media-addiction-trials.html?ref=readtangle.com"&gt;&lt;u&gt;The New York Times has the story&lt;/u&gt;&lt;/a&gt;. &lt;/p&gt;
&lt;div class="kg-card kg-cta-card kg-cta-bg-white kg-cta-minimal   kg-cta-link-accent " data-layout="minimal"&gt;
            
                
            
            &lt;div class="kg-cta-content"&gt;
                
                
                    &lt;div class="kg-cta-content-inner"&gt;
                    
                        &lt;div class="kg-cta-text"&gt;
                            &lt;p&gt;&lt;b&gt;&lt;strong&gt;You're Probably Overpaying on Amazon&lt;/strong&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;Most Prime members miss built-in tools that lower prices, &lt;/span&gt;&lt;a href="https://financebuzz.com/shopper-hacks-amazon?utm_source=tangle&amp;amp;utm_medium=paid-newsletter-cpf&amp;amp;utm_term=Tangle&amp;amp;utm_campaign=BM-FBZ-Tangle-shopper-hacks-amazon-CPF&amp;amp;adgroupid=BM-Tangle-shopper-hacks-amazon-CPF-01282026" rel="noreferrer" class="cta-link-color"&gt;&lt;span&gt;earn cash back&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, and cancel forgotten subscriptions automatically. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;We compiled 16 lesser-known features that unlock real savings on purchases you're already making — no new apps, no complicated setup. Just a few minutes to stop leaving money on the table.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="https://financebuzz.com/shopper-hacks-amazon?utm_source=tangle&amp;amp;utm_medium=paid-newsletter-cpf&amp;amp;utm_term=Tangle&amp;amp;utm_campaign=BM-FBZ-Tangle-shopper-hacks-amazon-CPF&amp;amp;adgroupid=BM-Tangle-shopper-hacks-amazon-CPF-01282026" rel="noreferrer" class="cta-link-color"&gt;&lt;b&gt;&lt;strong&gt;See All 16 Amazon Hacks&lt;/strong&gt;&lt;/b&gt;&lt;/a&gt;&lt;b&gt;&lt;strong&gt;.&lt;/strong&gt;&lt;/b&gt;&lt;/p&gt;
                        &lt;/div&gt;
                    
                    
                    &lt;/div&gt;
                
            &lt;/div&gt;
        &lt;/div&gt;
&lt;hr&gt;&lt;h3 id="numbers"&gt;Numbers.&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;&lt;a href="https://www.who.int/news-room/fact-sheets/detail/measles?ref=readtangle.com#:~:text=Before%20the%20introduction%20of%20measles%20vaccine%20in%201963%20and%20widespread%20vaccination%2C%20major%20epidemics%20occurred%20approximately%20every%20two%20to%20three%20years%20and%20caused%20an%20estimated%202.6%C2%A0million%20deaths%20each%20year."&gt;&lt;strong&gt;&lt;u&gt;1963.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The year the first measles vaccine was introduced. &lt;/li&gt;&lt;li&gt;&lt;a href="https://www.who.int/news-room/fact-sheets/detail/measles?ref=readtangle.com#:~:text=Before%20the%20introduction%20of%20measles%20vaccine%20in%201963%20and%20widespread%20vaccination%2C%20major%20epidemics%20occurred%20approximately%20every%20two%20to%20three%20years%20and%20caused%20an%20estimated%202.6%C2%A0million%20deaths%20each%20year."&gt;&lt;strong&gt;&lt;u&gt;2.6 million.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The estimated number of annual deaths globally caused by measles before the vaccine was introduced. &lt;/li&gt;&lt;li&gt;&lt;a href="https://www.who.int/news-room/fact-sheets/detail/measles?ref=readtangle.com#:~:text=Accelerated%20immunization%20activities%20by%20countries%2C%20WHO%2C%20the%20Measles%20%26%20Rubella%20Partnership%2C%20and%20other%20international%20partners%20successfully%20prevented%20an%20estimated%2059%20million%20deaths%20between%202000%20and%202024.%20Vaccination%20decreased%20an%20estimated%20measles%20deaths%20from%20780%20000%20in%202000%20to%2095%20000%20in%202024%C2%A0(1)."&gt;&lt;strong&gt;&lt;u&gt;59 million.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The estimated number of measles deaths prevented by the measles vaccine between 2000 and 2024. &lt;/li&gt;&lt;li&gt;&lt;a href="https://www.who.int/news-room/fact-sheets/detail/measles?ref=readtangle.com#:~:text=An%20estimated%2095%20000%20people%20died%20from%20measles%20in%202024%20%E2%80%93%20mostly%20children%20under%20the%20age%20of%20five%20years%2C%20despite%20the%20availability%20of%20a%20safe%20and%20cost%2Deffective%20vaccine."&gt;&lt;strong&gt;&lt;u&gt;95,000.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The estimated number of people globally who died from measles in 2024.  &lt;/li&gt;&lt;li&gt;&lt;a href="https://www.annenbergpublicpolicycenter.org/americans-say-benefits-of-mmr-vaccine-for-children-outweigh-risks-by-nearly-5-1/?ref=readtangle.com#:~:text=Americans%20overwhelmingly%20say%20the%20benefits%20of%20the%20MMR%20vaccine%20for%20children%20outweigh%20the%20risks%20(83%25%20to%2017%25).%5C"&gt;&lt;strong&gt;&lt;u&gt;83%.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The percentage of Americans who say the benefits of the measles, mumps, and rubella (MMR) vaccine for children outweigh the risks, according to a May 2025 Annenberg poll.&lt;/li&gt;&lt;li&gt;&lt;a href="https://www.annenbergpublicpolicycenter.org/americans-say-benefits-of-mmr-vaccine-for-children-outweigh-risks-by-nearly-5-1/?ref=readtangle.com#:~:text=Many%20more%20Americans%20(70%25)%20think%20healthy%20children%20should%20be%20required%20to%20be%20vaccinated%20to%20attend%20public%20school%20because%20of%20the%20potential%20risk%20to%20others%20who%20are%20not%20vaccinated%20than%20think%20it%20should%20be%20a%20matter%20of%20parental%20choice%20(18%25)."&gt;&lt;strong&gt;&lt;u&gt;70%.&lt;/u&gt;&lt;/strong&gt;&lt;/a&gt; The percentage of Americans who say healthy children should be required to be vaccinated to attend public school because of the potential risk to others who are not vaccinated. &lt;/li&gt;&lt;/ul&gt;&lt;hr&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;One year ago today&lt;/strong&gt; we wrote about Trump &lt;a href="https://www.readtangle.com/trump-withdraws-from-the-paris-agreement-and-who-2/"&gt;&lt;u&gt;withdrawing from the Paris Agreement and WHO&lt;/u&gt;&lt;/a&gt;.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;The most clicked link in yesterday’s newsletter&lt;/strong&gt; was our &lt;a href="https://www.readtangle.com/tracking-trump-presidency-part-one/"&gt;&lt;u&gt;Friday edition tracking the Trump presidency&lt;/u&gt;&lt;/a&gt;.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Nothing to do with politics:&lt;/strong&gt; Famed free solo climber Alex Honnold &lt;a href="https://www.youtube.com/watch?v=_e6VqBZb_9M&amp;amp;ref=readtangle.com"&gt;&lt;u&gt;describing how he manages fear&lt;/u&gt;&lt;/a&gt;.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Yesterday’s survey:&lt;/strong&gt; 2,005 readers responded to our survey on the Middle East peace deal with 34% opposing Trump’s plan and pessimistic about peace. “I don’t trust the self-dealing. Trump/Kushner will get rich and the Palestinian people will be forgotten,” one respondent said. “I wish there were an option for ‘I’m lukewarm but at least it’s something — let’s give it a go and see what happens,’” said another.&lt;/li&gt;&lt;/ul&gt;&lt;figure class="kg-card kg-image-card"&gt;&lt;img src="https://www.readtangle.com/content/images/2026/01/data-src-image-8f8072bd-485f-4e1b-88bb-0d8e5b9f93dc.png" class="kg-image" alt="" loading="lazy" srcset="https://www.readtangle.com/content/images/size/w600/2026/01/data-src-image-8f8072bd-485f-4e1b-88bb-0d8e5b9f93dc.png 600w, https://www.readtangle.com/content/images/size/w1000/2026/01/data-src-image-8f8072bd-485f-4e1b-88bb-0d8e5b9f93dc.png 1000w, https://www.readtangle.com/content/images/2026/01/data-src-image-8f8072bd-485f-4e1b-88bb-0d8e5b9f93dc.png 1600w" sizes="(min-width: 720px) 720px"&gt;&lt;/figure&gt;&lt;hr&gt;&lt;h3 id="have-a-nice-day"&gt;Have a nice day.&lt;/h3&gt;&lt;p&gt;Microplastics are one of the most omnipresent environmental pollutants, and reports about their dangers have also been omnipresent. Researchers have detected microscopic remnants in the brain, testes, placentas and arteries, prompting an explosion of research into their detrimental effects. Now, peer reviews of those studies are finding something surprising and equally as far-reaching: false positives. “Fat is known to make false-positives for polyethylene. The brain has [approximately] 60% fat,” said Dr. Dušan Materić at the Helmholtz Centre for Environmental Research in Germany, describing a methodological flaw with one paper. Scientists raised fundamental concerns with other landmark microplastic findings, as well, and &lt;a href="https://www.theguardian.com/environment/2026/jan/13/microplastics-human-body-doubt?ref=readtangle.com"&gt;&lt;u&gt;The Guardian has the story&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;
                        &lt;/article&gt;

                        

                    

                    

                         
            
                &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Tangle News</author><pubDate>Wed, 28 Jan 2026 17:02:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMidEFVX3lxTFBXYWNfZ3gtbVEydmtiNHZxWlNlWGN3NkpLei1fdmNxOG1CNnFKbVVfVlJacmRzWFZUZWF3V0pzbUYxdl9JbzJCTDBDb21lVUxway13c1lZMlZXc3plT0ZCOVpkR2N0WEdDbzBWeExPbUR0VHZj</guid></item><item><title>什么是“痴呆症面部” ？某个暴君是否表现出所有迹象？ - Queerty</title><link>https://www.queerty.com/what-is-dementia-face-is-a-certain-despot-showing-all-the-signs-20260128/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="cf-column"&gt;
            &lt;h2 data-translate="blocked_why_headline"&gt;Why have I been blocked?&lt;/h2&gt;

            &lt;p data-translate="blocked_why_detail"&gt;This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.&lt;/p&gt;
          &lt;/div&gt;

          &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Queerty</author><pubDate>Wed, 28 Jan 2026 17:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMingFBVV95cUxQdThvdnVjaHZQMURVeHJ5OVZPSEZzWlA0TmJxLUdLOVBMbXJkV0Q4S18zdlVsUEVzX2JQOTBHd3N0YjgxQ0RGODk1dTVSMEhpUFUtT1FudHNuZ1ltb2FQS25QUXJXdEplZ1JibHlkcUdZUXZBMWdnYlhLRlNHVEpKNE03U3Z4dVJvNk01TFZoRXI0VUkxcGlHWTE2NzM3UQ</guid></item><item><title>小鼠研究表明，心脏病发作的损害来自大脑信号-自然</title><link>https://www.nature.com/articles/d41586-026-00261-0</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__teaser" data-test="access-teaser"&gt; &lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-026-00261-0/d41586-026-00261-0_51985344.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-026-00261-0/d41586-026-00261-0_51985344.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="A coloured 3D CT angiogram scan of a human heart framed by the ribcage." loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-026-00261-0/d41586-026-00261-0_51985344.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span class="mr10"&gt;Heart damage caused by a myocardial infarction is exacerbated by activation of a heart–brain–immune axis.&lt;/span&gt;&lt;span&gt;Credit: Sevolod Zviryk/Science Photo Library&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;Researchers have proposed a rethink of the brain’s role in &lt;a href="https://www.nature.com/articles/d41586-024-02436-z" data-track="click" data-label="https://www.nature.com/articles/d41586-024-02436-z" data-track-category="body text link"&gt;heart attacks&lt;/a&gt;, finding that crosstalk between the heart, the brain and the immune system damages the heart after a myocardial infarction in mice. The results, published in &lt;i&gt;Cell&lt;/i&gt; on 27 January&lt;sup&gt;&lt;a href="#ref-CR1" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;1&lt;/a&gt;&lt;/sup&gt;, suggest that such events are not just diseases of the cardiovascular system.&lt;/p&gt;&lt;p&gt;In the study, scientists identify a brain–immune circuit that exacerbates cardiovascular pathology during a heart attack. They identified neurons in the vagus nerve that relay signals between the heart and the brain, which in turn &lt;a href="https://www.nature.com/articles/d41586-024-02557-5" data-track="click" data-label="https://www.nature.com/articles/d41586-024-02557-5" data-track-category="body text link"&gt;activates immune and inflammatory responses&lt;/a&gt; and causes widespread damage to the heart. Blocking this pathway improved outcomes after a heart attack in mice, which could pave the way for developing new therapies. &lt;/p&gt;&lt;p&gt;“The heart does not exist in isolation. The nervous system talks to the heart, the immune system talks to the heart,“ says study co-author Vineet Augustine, a neuroscientist at the University of California, San Diego. The current work is a “step forward into putting all of these systems together and this approach can be applied to other diseases as well”, he adds. &lt;/p&gt;&lt;p&gt;“We have known for decades that the brain and nervous systems are critical components to [heart attack] pathogenesis, management and care,” says Cameron McAlpine who studies immune function in the cardiovascular and nervous systems at the Icahn School of Medicine at Mount Sinai in New York City. “It appears that this axis plays a critical role.“&lt;/p&gt;&lt;h2&gt;Brain–heart axis&lt;/h2&gt;&lt;p&gt;Heart attacks happen when blood flow to the heart muscle is blocked. They cause damage to the heart’s muscles, and trigger cellular and molecular changes across its tissues. &lt;/p&gt;&lt;p&gt;“The heart attack is exactly like an earthquake. You have an epicentre, which is a focal point and then it spreads out,” explains Augustine. “Once it starts spreading out, this is when a large chunk of the tissue dies.” &lt;/p&gt;&lt;p&gt;Earlier research has shown that the vagus nerve — a key pathway that connects the brain to many other organs — sends signals to the brain after a heart attack. &lt;/p&gt;&lt;p&gt;“All the regular functions of the heart are controlled by the nervous system,” says Kalyanam Shivkumar, a cardiologist at the University of California, Los Angeles. &lt;/p&gt;&lt;p&gt;These post-heart attack signals from the heart to the brain result trigger the sympathetic nervous system — the body’s ‘fight or flight’ response — he explains. The increased sympathetic response then causes inflammation in the heart tissues and impairs cardiac function, which can lead to heart failure. &lt;/p&gt;&lt;p&gt;“The root cause of the problem is signals going from the heart to the brain,” says Shivkumar. But the key cells and molecular pathways that underlie these processes have remained unclear.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-024-01259-2" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-026-00261-0/d41586-026-00261-0_27046282.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;Found: the dial in the brain that controls the immune system&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;To investigate this, Augustine and his colleagues experimentally induced heart attacks in mice by permanently blocking an artery in their hearts.&lt;/p&gt;&lt;p&gt;First, they aimed to trace how nerve connections between the heart and the vagus nerve change after a heart attack. They found that a group of sensory neurons in the vagus nerve that detect harmful stimuli grew new projections around the injured part of the heart. &lt;/p&gt;&lt;p&gt;Blocking these neurons reduced the damage and inflammation in the heart’s tissues and stabilized its rate and rhythm. “Those neurons directly talk to the area of the heart where the injury is,” says Augustine. By silencing them, “you can really quickly prevent it from expanding. And so the injury becomes extremely, extremely small”. &lt;/p&gt;&lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 16:59:18 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE0wQVhRLWY3Nm4tenlZYlI0UVNCazVIcnRrd1hoc2lIN2Z2aDNZUDFReG1adk5Ob1J2anBGUjNTdjdlNlZQS0hKano0ZTVWaWUyYmw1SWpRR2J1WXBVMl9r</guid></item><item><title>多巴胺释放的胆碱能调节驱动勤奋的行为-自然</title><link>https://www.nature.com/articles/s41586-025-10046-6</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec8-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec9"&gt;Subjects&lt;/h3&gt;&lt;p&gt;Male and female mice of C57BL/6J background (Jackson Laboratories, strain 000664) were used in approximately equal numbers for all experiments. Wild-type mice were crossed with DAT:IRES–Cre mice (Jackson Laboratory, strain 006660) or ChAT:IRES–Cre mice (Jackson Laboratory, strain 006410). For slice electrophysiology experiments, ChAT:IRES–Cre mice were crossed with DAT–Flp mice (Jackson Laboratories, strain 035436). All transgenic animals used in experiments were genotyped and found to be heterozygous for Cre-recombinase or Flp-recombinase. Mice were separated by sex and group housed after weaning before surgical procedures or behavioural assays. All behavioural experiments were conducted during the dark cycle (12 h light–dark) when mice were 10–24 weeks old. Mice were housed at approximately 21 °C in 30–70% humidity, and they were food restricted to 85% of ad libitum body weight for all behavioural experiments to facilitate motivated behaviour. All procedures complied with the animal care standards set forth by the National Institutes of Health (NIH) and were approved by the Stanford University Administrative Panel on Laboratory Animal Care.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec10"&gt;Behavioural training&lt;/h3&gt;&lt;p&gt;Food restriction and behavioural training began at a minimum of 2 weeks after virus injection and fibre implantation. Before starting behavioural experiments, mice were habituated for 2 days, including handling, tethering to the patch cords and allowing exploration of the operant boxes (Med Associates) for 30 min. After habituation, mice were exposed to 1 day of a Pavlovian task in which rewards were delivered at random intervals spanning 25–35 s for 30 min. Operant chambers were equipped with a speaker for white noise and three identical nose-poke ports, each with an associated cue light and an infrared emitter sensor to measure port entry times. Rewards were delivered in conjunction with a 2-s cue comprising white noise and central port light so that mice would associate reward delivery with the light–sound cue. For sucrose rewards, 10 µl of 32% (w/v) sucrose was used, apart from one experiment in which 5% sucrose was used (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig14"&gt;9n–w&lt;/a&gt;). After 1 day of Pavlovian training, mice progressed to the operant task. Mice trained on FR1 for a minimum of five sessions. The active nose-poke port (left or right) was counterbalanced between mice; each mouse continued with the same active port for all experiments. On days 1–3, the active food port was baited with a crushed portion of fruit loop to encourage exploration of that port. After earning at least 10 rewards at FR1, with an accuracy (% active nose pokes) of more than 80%, mice progressed to FR5. Mice continued FR5 for at least five sessions and until the number of rewards earned per session remained within 20% for 3 consecutive days. Once this criterion was met, mice progressed to the sucrose effort task. We did not attempt to equalize reward consumption between mice, but rather aimed to ensure that all mice had accurate and internally consistent performance. Training for optogenetic self-stimulation was achieved in the same manner as for sucrose, except the sucrose reward was replaced with 5-s optogenetic stimulation paired with the 2-s light and white-noise cue. All behavioural tasks were coded in Med-PC V (Med Associates).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;Sucrose effort task&lt;/h3&gt;&lt;p&gt;The sucrose effort task comprised five 10-min blocks of FRs including FR46, FR21, FR10, FR5 and FR1. After mice poked in the active port for the required number of times, sucrose reward (10 µl 32% (w/v)) was delivered in a central magazine, accompanied by a 2-s light and white-noise cue. Once the cue stopped and mice entered the magazine to consume the reward, they were free to start the next trial at their own pace by poking in the active port. As in our previous work&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Eshel, N. et al. Striatal dopamine integrates cost, benefit, and motivation. Neuron 112, 500–514.e5 (2024)." href="/articles/s41586-025-10046-6#ref-CR17" id="ref-link-section-d48776736e2173"&gt;17&lt;/a&gt;&lt;/sup&gt;, the FRs were presented in descending order to prevent mice from achieving early satiety under low-cost conditions, except for one control experiment with ascending presentation of blocks (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig14"&gt;9j–m&lt;/a&gt;). Block transitions were not signalled to the mice.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Modified sucrose effort task&lt;/h3&gt;&lt;p&gt;For microinjection experiments with PBS or DHβE, due to concern that the behavioural effect of the drug was a result of the drug wearing off over the course of the session, we used a modified sucrose effort task. In the modified task, after PBS or DHβE injection, mice underwent a 30-min session in which the poking requirement was kept constant for the entire session at either FR1 or FR21. The order of the 4 experimental days (PBS versus DHβE; FR1 versus FR21) was counterbalanced between mice.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;ChRmine effort task&lt;/h3&gt;&lt;p&gt;The ChRmine effort task was structured identically to the sucrose effort task, except that mice worked for optogenetic DA stimulation. ChRmine stimulation was paired with the same 2-s light and white-noise cue in the magazine port, and upon cue cessation, the mice were free to start the next trial at their own pace.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Stereotaxic injections and viruses&lt;/h3&gt;&lt;p&gt;Mice (8–12 weeks old) were anaesthetized with isoflurane (5% induction, 1–2% maintenance). Subjects were fixed on a stereotaxic frame (Kopf Instruments), a small incision was made and burr holes were drilled in the skull over the sites of injection or fibre implantation. The following coordinates relative to bregma were used: VTA, −3.1 mm anteroposterior, ±0.4 mm mediolateral and 4.2 mm dorsoventral; NAc core, 1.5 mm anteroposterior, ±0.9 mm mediolateral and 4.1 mm dorsoventral from the skull surface. Microliter syringes (Hamilton) were lowered to the specified depth from the skull and used to inject 500 nl of virus solution at a flow rate of 0.1–0.25 ml min&lt;sup&gt;−1&lt;/sup&gt;. Borosilicate optic fibres for photometry and/or optogenetic stimulation with 200–400 µm diameter and numerical aperture 0.66 (Doric) were implanted directly above the striatal or midbrain virus injection site and secured to the skull using screws (Antrin Miniature Specialties) and light-cured dental adhesive cement (DenMat, Geristore A&amp;amp;B paste). For the cohorts with recordings in the NAc and cannula or optogenetic fibre placement in the midbrain (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig2"&gt;2&lt;/a&gt; and Extended Data Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig8"&gt;3&lt;/a&gt;–&lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig10"&gt;5&lt;/a&gt;), the VTA implant was cemented first and then the NAc fibre was implanted in the same hemisphere. For cohorts with drug microinjections and recordings, a dual optical fibre–cannula (multiple fluid injection cannula, 400 µm diameter, 0.66 numerical aperture; OmFC, Doric) was implanted in the NAc or midbrain. Cannulas for drug microinfusion were implanted 1.5 mm above the target site with the injector extending to the site. For all cohorts, the hemisphere targeted for recordings was counterbalanced between mice.&lt;/p&gt;&lt;p&gt;The adeno-associated viruses (AAVs) used for stereotaxic injections were AAV9-hSyn-GRAB&lt;sub&gt;DA&lt;/sub&gt; DA2m (DA4.4, WZ Biosciences), red-shifted AAV9-hSyn-GRAB&lt;sub&gt;DA&lt;/sub&gt; rDA2m (WZ Biosciences), AAV2/9-hSyn-gACh4m (GRAB ACh, brain VTA), AAV5-hSyn1-SIO-stGtACR2-FusionRed (Addgene), AAV9-syn-FLEX-jGCaMP8m-WPRE (Addgene), AAV-8-EF1a-DIO-rsChRmine-oScarlet-WPRE (Stanford Gene Vector and Virus Core), AAV-dj-CMV-DIO-eGFP-2A-TetTox (Stanford Gene Vector and Virus Core), AAV-dj-CMV-DIO-eGFP (Stanford Gene Vector and Virus Core), AAV-dj-Ef1a-DIO-NpHR3.0-mCherry (Stanford Gene Vector and Virus Core), AAV-dj-Ef1a-DIO-mCherry (Stanford Gene Vector and Virus Core) and AAV-dj-Ef1a-fDIO-eYFP (Stanford Gene Vector and Virus Core). AAV titres ranged from 1 × 10&lt;sup&gt;12&lt;/sup&gt; to 2 × 10&lt;sup&gt;13&lt;/sup&gt; gc ml&lt;sup&gt;−1&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Fibre photometry&lt;/h3&gt;&lt;p&gt;Mice implanted with optical implants (400 µm diameter, 0.66 numerical aperture, Doric lenses) were connected via a ceramic sleeve (Precision Fiber Products) to low-autofluorescence patch cords of matching diameter and numerical aperture (Doric). Signals passed through a fibre optic rotary joint (Doric) before filtering through a fluorescence mini cube (Doric) and reaching a femtowatt photodetector (2151, Newport). For triple recordings (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig2"&gt;2a–f&lt;/a&gt;), the signals from the VTA and NAc fibres were passed through different mini cubes to different photodetectors, thus ensuring full separation between the cell body and axon GCaMP recordings. LEDs (Doric) emitted frequency-modulated ultraviolet (405 nm) and blue (465 nm) light to stimulate control and either GRAB or GCaMP signals through the same fibre. Blue LED power was adjusted to approximately 35 µW at the fibre tip and lowered as needed if the signal saturated the photodetector. Ultraviolet LED power was adjusted to approximately 10 µW at the fibre tip. Digital signals were sampled at 1.0173 kHz, demodulated, lock-in amplified and recorded by a real-time signal processor (RZ5P, Tucker-Davis Technologies) using Synapse software (Tucker-Davis Technologies). Synchronized behavioural events from the Med Associates boxes were collected directly into the RZ5P digital input ports. To reduce any confounds from photobleaching, animals were recorded for about 5 min before behavioural testing began.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;Optogenetic manipulations&lt;/h3&gt;&lt;p&gt;Optogenetic manipulations with rsChRmine and NpHR were conducted simultaneously as fibre photometry recordings through the same optical implants. Optogenetic manipulation with stGtACR was conducted through optical implants of 200 µm with 0.66 numerical aperture without simultaneous fibre photometry recording. Optogenetic manipulation with rsChRmine or NpHR was conducted by connecting a 625-nm LED light source (Prizmatix) via a plastic fibre (1 mm diameter, NA 0.63) and a fibre optic rotary joint (Doric). rsChRmine stimulation was performed at a stimulation of 5 s, 20 Hz and 6 mW with a pulse width of 10 ms. Optogenetic inhibition with NpHR or control mCherry was conducted with a constant 4 s, approximately 6-mW light. Optogenetic manipulation with stGtACR2 was conducted with a 450-nm LED light source (Prizmatix), using 5–10 s of constant approximately 10-mW light.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Drug administration&lt;/h3&gt;&lt;p&gt;For systemic injection experiments, mice were administered intraperitoneal injections of aprepitant 10 mg kg&lt;sup&gt;−1&lt;/sup&gt; (Axon Medchem), DPCPX 2 mg kg&lt;sup&gt;−1&lt;/sup&gt; (Tocris), istradeffyline 2 mg kg&lt;sup&gt;−1&lt;/sup&gt; (Tocris) or SR 48692 5 mg kg&lt;sup&gt;−1&lt;/sup&gt; (Tocris). DPCPX and instradeffyline were dissolved in DMSO (Sigma-Aldrich) and diluted to 20% DMSO in 0.9% saline to prevent precipitation. Aprepitant and SR 48692 were dissolved in DMSO and diluted to 5% DMSO in corn oil (Sigma-Aldrich) to prevent precipitation. Mice were injected with a volume of 10 ml kg&lt;sup&gt;−1&lt;/sup&gt;. After injection, mice were placed in their home cages for 10 min, then placed in the operant chambers for 5 min of habituation before beginning the rsChRmine effort task. For these agents, systemic injection was chosen over intracranial injection due to risk of brain injury from the necessary solvents.&lt;/p&gt;&lt;p&gt;For local injection experiments, mice were administered an intra-VTA infusion of muscimol 1 mM (Tocris) or intra-NAc infusion of DHβE hydrobromide 30 µg per hemisphere (Tocris), terazosin 3 µg (Tocris), osanetant 375 ng (Axon Medchem), scopolamine 22 nmol (Tocris) or ML375 105 pmol (Axon Medchem). Osanetant was dissolved in Tween 20% until homogeneous, then diluted to 1% Tween in filtered molecular-quality PBS to prevent precipitation. All other antagonists were dissolved in filtered molecular-quality PBS only. We also infused the GABA&lt;sub&gt;A&lt;/sub&gt; antagonist bicuculline (Tocris) and the GABA&lt;sub&gt;B&lt;/sub&gt; antagonist CGP 35348 (Tocris) into the NAc, but this treatment evoked severe motor deficits, including seizures in some cases, preventing mice from performing the task. Thus, we could not collect time-locked DA recordings during these infusions.&lt;/p&gt;&lt;p&gt;Drugs were infused through an injector cannula connected to a 5-µl Hamilton syringe using a microinfusion pump (Harvard Apparatus) at a continuous rate of 150 nl per minute to a total volume of 0.3 µl unilaterally or bilaterally. For unilateral infusions with fibre photometry recording, multiple fluid injection cannulas (400 µm diameter, 0.66 numerical aperture; OmFC, Doric) were used. For bilateral infusions, bilateral infusion cannulas (P1 Technologies) were used. Injector cannulas were removed 2 min after infusions were complete. After infusion, mice were placed in the operant chambers and allowed to habituate for 5 min before beginning the sucrose or rsChRmine effort task.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Validation of VTA DA cell body inhibition&lt;/h3&gt;&lt;p&gt;To validate the effect of muscimol on VTA DA cell bodies, a cohort of DAT:IRES–Cre mice was injected with AAV9-syn-FLEX-jGCaMP8m into the VTA and implanted with multiple fluid injection cannulas (OmFC, Doric). To visualize the effect of muscimol in real time, one of these mice was prepared with a steel cross-bar for head-fixed recording during PBS or muscimol microinjection (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig9"&gt;4e–g&lt;/a&gt;). This mouse was habituated to a cylindrical enclosure and bilateral clamps were fixed to each side of the cross-bar. The pre-loaded injector was then inserted into the cannula and the recording began. After a 5-min baseline, the drug was injected and the recording continued for an additional 10 min. The injector was removed after the recording ended. Although this procedure allowed us to record photometry signals before, during and after the muscimol infusion, the head fixation prevented the animal from seeking or consuming liquid rewards in our behavioural setup. Thus, the remainder of the mice were not head fixed. Instead, they were microinjected with either muscimol or PBS immediately before a photometry recording that consisted of a 10-min baseline and then a 30-min, freely moving Pavlovian reward delivery session (the sucrose reward was delivered along with a sound or light cue every 30 s on average). Neural activity during both the baseline and Pavlovian reward task were then compared between muscimol and PBS sessions (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig9"&gt;4h–j&lt;/a&gt;). We chose the Pavlovian task because it minimized the motor requirements for these mice. Owing to the rotations elicited by muscimol, the mice could reliably enter one port (the magazine to consume sucrose), but not two (the active nose poke and the magazine), and thus they could not perform the sucrose task after muscimol infusion.&lt;/p&gt;&lt;p&gt;It was not technically possible to use fibre photometry to directly validate the effect of stGtACR on DA cell body activity because of saturation or photoswitching artefacts when this opsin is co-expressed with either green-shifted or red-shifted calcium sensors&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Taniguchi, J. et al. Comment on ‘Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation’. eLife 13, e95694 (2024)." href="/articles/s41586-025-10046-6#ref-CR14" id="ref-link-section-d48776736e2293"&gt;14&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Akerboom, J. et al. Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front. Mol. Neurosci. 6, 2 (2013)." href="#ref-CR64" id="ref-link-section-d48776736e2296"&gt;64&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Dana, H. et al. Sensitive red protein calcium indicators for imaging neural activity. eLife 5, e12727 (2016)." href="#ref-CR65" id="ref-link-section-d48776736e2296_1"&gt;65&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Wu, J. et al. Improved orange and red Ca2+ indicators and photophysical considerations for optogenetic applications. ACS Chem. Neurosci. 4, 963–972 (2013)." href="/articles/s41586-025-10046-6#ref-CR66" id="ref-link-section-d48776736e2299"&gt;66&lt;/a&gt;&lt;/sup&gt;. Instead, stGtACR was validated through GRAB DA recordings in the NAc (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig10"&gt;5e–g&lt;/a&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Slice electrophysiology&lt;/h3&gt;&lt;p&gt;Acute brain slices were prepared from adult ChAT–Cre:DAT–Flp mice between postnatal days 120–180. ChAT–Cre:DAT–Flp mice were sterotaxically injected with 500 nl of AAVdj-eF1a-fDIO-eYFP into the VTA (−3.1 mm anteroposterior, +0.4 mm mediolateral and −4.2 dorsolateral) and AAV8-Ef1a-DIO-rsChRmine-oScarlet into the NAc (+1.5 mm anteroposterior, +0.9 mm mediolateral and −4.1 mm dorsolateral) at postnatal days 90–120 and were used for electrophysiology experiments 4–8 weeks post-injection. Mice were anaesthetized with isoflurane anaesthesia and transcardially perfused before decapitation. Brains were carefully extracted and 250-µm thick coronal slices were cut using a vibratome (Leica VT1200 S) in ice-cold slice solution containing 110 mM sucrose, 62.5 mM NaCl, 2.5 mM KCl, 6 mM MgCl&lt;sub&gt;2&lt;/sub&gt;, 1.25 mM KH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;, 26 mM NaHCO&lt;sub&gt;3&lt;/sub&gt;, 0.5 mM CaCl&lt;sub&gt;2&lt;/sub&gt; and 20 mM &lt;span class="u-small-caps"&gt;d&lt;/span&gt;-glucose, pH 7.35–7.40. Slices were incubated in slice solution for 20 min at 33 °C, then transferred to a room-temperature holding chamber with artificial cerebrospinal fluid (ACSF; 125 mM NaCl, 2.5 mM KCl, 1 mM MgCl&lt;sub&gt;2&lt;/sub&gt;, 1.25 mM KH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;, 26 mM NaHCO&lt;sub&gt;3&lt;/sub&gt;, 2 mM CaCl&lt;sub&gt;2&lt;/sub&gt; and 20 mM &lt;span class="u-small-caps"&gt;d&lt;/span&gt;-glucose, pH 7.35–7.40). Brain slices were stored in room temperature ACSF and used for recording 30–300 min later. All solutions were saturated with carbogen.&lt;/p&gt;&lt;p&gt;Individual brain slices were placed in an RC-27 recording chamber (Warner Instruments) and superfused with carbogen-saturated ACSF (33–36 °C) at a flow rate of 2–3 ml min&lt;sup&gt;−1&lt;/sup&gt;. eYFP-positive cut ends of axons (blebs) originating from the VTA present at the slice surface in the NAc were visualized with a BX51WI upright microscope (Olympus) equipped with epifluorescence, IR-DIC optics, 470 nm (ET-GFP 49002, Chroma) and 596/83-nm single-band bandpass (FF01-596/83-25, Semrock) filter cubes, and a ×40 0.8 NA water immersion objective (LUMPLFLN, Olympus). Perforated-patch recordings were made using parafilm-wrapped borosilicate pipettes filled with internal solution containing 135 mM KCl, 10 mM NaCl, 2 mM MgCl&lt;sub&gt;2&lt;/sub&gt;, 10 mM HEPES, 0.5 mM EGTA and 0.1 mM CaCl&lt;sub&gt;2&lt;/sub&gt;, 280 mOsm, pH 7.4 adjusted with KOH. Recording electrodes (6–10 MΩ) were back filled with internal solution, then filled with internal containing 100 µg ml&lt;sup&gt;−1&lt;/sup&gt; gramicidin (Sigma). Pipette capacitance neutralization and bridge balance were manually adjusted before current clamp recordings. ChAT–Cre&lt;sup&gt;+&lt;/sup&gt; neurons expressing rsChRmine were optically stimulated with 10-ms transistor-transistor logic (TTL) pulses every 10 s using orange (596 nm) light ranging from 0.2 to 3 mW delivered through the microscope objective by an LED driver (Thorlabs). Baseline axonal responses to rsChRmine stimulation in ACSF were measured for 3 min, and the average response from the first 10 sweeps at baseline was compared with the average response from the final 10 sweeps during a 3-min period in the presence of 1 µM DHβE (Tocris). Acute application of DHβE was achieved via gravity-driven bath perfusion. Current clamp recordings were sampled at 20 kHz and filtered at 10 kHz using a MultiClamp 700B and Digidata 1550B and analysed using pClamp11 (Molecular Devices). Data are presented as mean ± s.e.m., where &lt;i&gt;n&lt;/i&gt; or &lt;i&gt;N&lt;/i&gt; represent the number of cells and animals, respectively.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Immunohistochemistry&lt;/h3&gt;&lt;p&gt;Mice were transcardially perfused with 4% (w/v) paraformaldehyde in PBS and brains were removed and post-fixed overnight at 4 °C. A vibratome (Leica Biosystems) was used to prepare 50-µm coronal sections. After three 10-min washes in PBS on a shaker, the slices were incubated with blocking solution (10% normal goat serum, 0.2% bovine serum albumin and 0.5% Triton X-100 in PBS) for 1 h. After one 10-min wash in PBS, slices were incubated in primary antibodies using a concentration of 1:1,000 for 12–20 h at 4 °C on a shaker. Primary antibodies included rat mCherry monoclonal antibody (M11217, Invitrogen), chicken anti-GFP (GFP-1020, Aves Labs), mouse anti-tyrosine hydroxylase (MAB318, Millipore), and, to visualize TetTox, the mouse anti-2A peptide (MABS2005, Millipore). After three washes of 10 min in PBS, secondary antibodies were added at a concentration of 1:750 and incubated for 2 h at room temperature on a shaker. Secondary antibodies included goat anti-rat Alexa Fluor 594 (A11007, Invitrogen), goat anti-chicken Alexa Fluor 488 (AB150169, Abcam) and goat anti-mouse Alexa Fluor 647 (A21235, Invitrogen). Both primary and secondary antibodies were incubated with slices in a carrier solution (1% normal goat serum, 0.2% bovine serum albumin and 0.5% Triton X-100 in PBS). After three more washes, the slices were mounted on SuperFrost Plus glass slides with DAPI Fluoromount-G mounting medium (Southern Biotech) for visualization using a Nikon A1 confocal microscope with NIS Elements AR software or a Keyence BZ-X800 microscope.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;Data analysis&lt;/h3&gt;&lt;p&gt;Subject mice were excluded (less than 5%) from the analysis if they did not reach behavioural criteria or on the basis of histology if they had (1) inaccurate implant placement, or (2) off-target or minimal transgene expression. MATLAB (MathWorks) scripts from Tucker-Davis Technologies were used for signal processing. Signals were downsampled by a factor of 10, underwent LOESS smoothing (window size of 30 ms) to reduce high-frequency noise and analysed in 15-s windows around the following timestamps: the first nose poke of each trial (excluding FR1 trials, where the first nose poke triggers reward delivery), reward delivery (which is coincident with a light–sound cue) and reward consumption (defined as when the mice first entered the magazine port after sucrose reward delivery). Entire sessions were debleached according to a previously published iterative method&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Bruno, C. A. et al. pMAT: an open-source software suite for the analysis of fiber photometry data. Pharmacol. Biochem. Behav. 201, 173093 (2021)." href="/articles/s41586-025-10046-6#ref-CR67" id="ref-link-section-d48776736e2379"&gt;67&lt;/a&gt;&lt;/sup&gt; which calculates the d&lt;i&gt;F&lt;/i&gt;/&lt;i&gt;F&lt;/i&gt; in short moving windows, centres and normalizes these windows, and then repeats these calculations for 100 temporally offset windows in the same session. &lt;i&gt;Z&lt;/i&gt;-scores were then calculated using the mean and standard deviation of the signal spanning the entire session to minimize confounds in behaviour contaminating the local baseline periods for trial-based methods of analysis. As a control, the analyses were all repeated in a different manner, using local baselines to calculate &lt;i&gt;Z&lt;/i&gt;-scores, and the results were qualitatively identical.&lt;/p&gt;&lt;p&gt;To separate the contribution of individual behavioural events that occurred close in time, we (1) fit regression models to predict photometry data based on multiple variables (see below), and (2) examined neural activity on the subset of trials with large ITIs (for example, more than 30 or 60 s), which revealed similar results (for example, Extended Data Figs. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig7"&gt;2&lt;/a&gt;, &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig14"&gt;9&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig15"&gt;10&lt;/a&gt;). All trials within a session were first combined into a single session average, and then sessions were averaged together for each mouse. All photometry figures in the article show the mean and standard error of the photometry signal across mice, which is a more conservative approach than using the trial or session average. To quantify neural activity, we used AUC — calculated using the trapezoidal numerical integration of the &lt;i&gt;Z&lt;/i&gt;-scores for the windows defined in the figure legends — or calculated the maximum value in the windows denoted in the figure legends. Windows for quantification were chosen based on visual inspection of the traces and applied consistently throughout the analysis for any direct comparison between traces. To minimize bleaching confounds, we removed the first 5 min of each recording, when the steepest bleaching was likely to occur. We also limited our interpretations to short windows of data, avoiding any analysis of longer-timescale changes, which are more likely to be confounded by bleaching or other gradual changes (for example, slight adjustments in the connection between the implant and the patch cord), and more likely to vary depending on the exact debleaching strategy used. In addition, for GRAB DA recordings, we took the approach reported by Sych et al.&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Sych, Y., Chernysheva, M., Sumanovski, L. T. &amp;amp; Helmchen, F. High-density multi-fiber photometry for studying large-scale brain circuit dynamics. Nat. Methods 16, 553–560 (2019)." href="/articles/s41586-025-10046-6#ref-CR68" id="ref-link-section-d48776736e2410"&gt;68&lt;/a&gt;&lt;/sup&gt; and examined simultaneously recorded control signals (405 nm), which we found to be flat or slightly negative traces with substantially lower amplitude than what we observed with the experimental excitation (465 nm). Although this analysis is imperfect because 405 nm is not the isosbestic point for GRAB DA, the result implies that motion artefacts, bleaching or other intrinsic, non-DA-dependent signal changes could not have made a major contribution to our results.&lt;/p&gt;&lt;p&gt;To analyse spontaneous activity in VTA DA cell bodies after muscimol versus saline (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig9"&gt;4i&lt;/a&gt;), we debleached the signal by fitting a double-exponential curve and subtracting the fit from the raw data, and then used the MATLAB function findpeaks to identify all local peaks that were at least 1.5 &lt;i&gt;Z&lt;/i&gt;-scores in prominence and 150 ms in width at half peak, as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Higginbotham, J. A. et al. Estradiol protects against pain-facilitated fentanyl use via suppression of opioid-evoked dopamine activity in males. Neuron 113, 1413–1429.e5 (2025)." href="/articles/s41586-025-10046-6#ref-CR69" id="ref-link-section-d48776736e2423"&gt;69&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Kernel regression analysis&lt;/h3&gt;&lt;p&gt;To quantify the contribution of behavioural variables to neural activity, linear mixed effects models were used as in previous work&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023)." href="/articles/s41586-025-10046-6#ref-CR13" id="ref-link-section-d48776736e2435"&gt;13&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Blanco-Pozo, M., Akam, T. &amp;amp; Walton, M. E. Dopamine-independent effect of rewards on choices through hidden-state inference. Nat. Neurosci. 27, 286–297 (2024)." href="#ref-CR70" id="ref-link-section-d48776736e2438"&gt;70&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Elum, J. E. et al. Distinct dynamics and intrinsic properties in ventral tegmental area populations mediate reward association and motivation. Cell Rep. 43, 114668 (2024)." href="#ref-CR71" id="ref-link-section-d48776736e2438_1"&gt;71&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Engelhard, B. et al. Specialized coding of sensory, motor and cognitive variables in VTA dopamine neurons. Nature 570, 509–513 (2019)." href="#ref-CR72" id="ref-link-section-d48776736e2438_2"&gt;72&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Parker, N. F. et al. Choice-selective sequences dominate in cortical relative to thalamic inputs to NAc to support reinforcement learning. Cell Rep. 39, 110756 (2022)." href="/articles/s41586-025-10046-6#ref-CR73" id="ref-link-section-d48776736e2441"&gt;73&lt;/a&gt;&lt;/sup&gt;. First, task-relevant behavioural predictors (for example, active nose poke, inactive nose poke, reward delivery, magazine entry, FR and ITI) were aligned to the photometry signal&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023)." href="/articles/s41586-025-10046-6#ref-CR13" id="ref-link-section-d48776736e2445"&gt;13&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Blanco-Pozo, M., Akam, T. &amp;amp; Walton, M. E. Dopamine-independent effect of rewards on choices through hidden-state inference. Nat. Neurosci. 27, 286–297 (2024)." href="/articles/s41586-025-10046-6#ref-CR70" id="ref-link-section-d48776736e2448"&gt;70&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Parker, N. F. et al. Reward and choice encoding in terminals of midbrain dopamine neurons depends on striatal target. Nat. Neurosci. 19, 845–854 (2016)." href="/articles/s41586-025-10046-6#ref-CR74" id="ref-link-section-d48776736e2451"&gt;74&lt;/a&gt;&lt;/sup&gt;. Behavioural events were assigned as fixed effects, represented in a predictor matrix &lt;i&gt;X&lt;/i&gt; of dimension &lt;i&gt;N&lt;/i&gt; × &lt;i&gt;p&lt;/i&gt;, where &lt;i&gt;N&lt;/i&gt; is the number of timestamps in the photometry recording and &lt;i&gt;p&lt;/i&gt; is the number of predictor variables&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023)." href="/articles/s41586-025-10046-6#ref-CR13" id="ref-link-section-d48776736e2471"&gt;13&lt;/a&gt;&lt;/sup&gt;. Variables were represented in binary form, indicating whether a behavioural event occurred at a given timestamp. The mouse from which the data were collected was treated as a random effect, stored in a sparse design matrix &lt;i&gt;Z&lt;/i&gt; of size &lt;i&gt;N&lt;/i&gt; × &lt;i&gt;m&lt;/i&gt;, where &lt;i&gt;m&lt;/i&gt; is the number of mice from which data were collected. The predictor matrix &lt;i&gt;X&lt;/i&gt; was time shifted by &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; (&lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; = 60 timeshifts per 1.5 s for sucrose; &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; = 100 timeshifts per 2.5 s for ChRmine) timestamps backwards and &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; (&lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; = 125 timeshifts per 4 s for sucrose; &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; = 400 timeshifts per 10 s for ChRmine) timestamps forwards to encapsulate effects of behavioural variables on the signal at previous and future timestamps&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023)." href="/articles/s41586-025-10046-6#ref-CR13" id="ref-link-section-d48776736e2517"&gt;13&lt;/a&gt;&lt;/sup&gt;. The new, time-shifted predictor matrix was of dimension &lt;i&gt;N&lt;/i&gt; × &lt;i&gt;p&lt;/i&gt;(2(&lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1 +&lt;/sub&gt; &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;) + 1). Data for timestamps at which no behavioural event of interest occurred, or which did not fall within the [−&lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;] timestamps of a behavioural event, were excluded. The fixed effects matrix &lt;i&gt;X&lt;/i&gt; and random effects matrix &lt;i&gt;Z&lt;/i&gt; were used to train a linear mixed effects model of the form &lt;i&gt;y&lt;/i&gt; = &lt;i&gt;X&lt;/i&gt;&lt;i&gt;β&lt;/i&gt; + &lt;i&gt;Zµ&lt;/i&gt; + &lt;i&gt;ε&lt;/i&gt;, where &lt;i&gt;y&lt;/i&gt; is the &lt;i&gt;N&lt;/i&gt; × 1 dimensional response vector consisting of the photometry signal values at each timestamp, &lt;i&gt;β&lt;/i&gt; is a &lt;i&gt;p&lt;/i&gt;(2(&lt;i&gt;T&lt;/i&gt;&lt;sub&gt;1 +&lt;/sub&gt; &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;) + 1) × 1 vector of β-coefficients for each time-shifted predictor variable, &lt;i&gt;µ&lt;/i&gt; is an &lt;i&gt;m&lt;/i&gt; × 1 vector of coefficients for each random effect, and &lt;i&gt;ε&lt;/i&gt; is an &lt;i&gt;N&lt;/i&gt; × 1 vector representing the residual variance that cannot be explained by the fixed or random effects. Response kernels were generated and plotted over the time window for each behavioural variable representing the contribution of each behavioral variable to the predicted fibre photometry signal&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023)." href="/articles/s41586-025-10046-6#ref-CR13" id="ref-link-section-d48776736e2599"&gt;13&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Blanco-Pozo, M., Akam, T. &amp;amp; Walton, M. E. Dopamine-independent effect of rewards on choices through hidden-state inference. Nat. Neurosci. 27, 286–297 (2024)." href="/articles/s41586-025-10046-6#ref-CR70" id="ref-link-section-d48776736e2602"&gt;70&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Parker, N. F. et al. Reward and choice encoding in terminals of midbrain dopamine neurons depends on striatal target. Nat. Neurosci. 19, 845–854 (2016)." href="/articles/s41586-025-10046-6#ref-CR74" id="ref-link-section-d48776736e2605"&gt;74&lt;/a&gt;&lt;/sup&gt;. The observed signal was plotted against the predicted signal to demonstrate the efficacy of the model fit. The model was trained using tenfold cross-validation; reported &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; values and plotted β-coefficients are the average across model runs for all tenfolds. The relative contribution of each behavioural variable to the total photometry signal was determined by performing a leave-one-out analysis where behavioural variables were sequentially removed from the model to observe the change in the overall predictive ability of the model as quantified by the &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; value. The relative contribution of a variable was then defined as the proportional change in &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; when that variable was removed from the model&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Elum, J. E. et al. Distinct dynamics and intrinsic properties in ventral tegmental area populations mediate reward association and motivation. Cell Rep. 43, 114668 (2024)." href="/articles/s41586-025-10046-6#ref-CR71" id="ref-link-section-d48776736e2622"&gt;71&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Single-cell RNA sequencing analysis&lt;/h3&gt;&lt;p&gt;We accessed the whole mouse brain 10X single-cell RNA sequencing datasets made publicly available by the Allen Institute&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Yao, Z. et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624, 317–332 (2023)." href="/articles/s41586-025-10046-6#ref-CR75" id="ref-link-section-d48776736e2634"&gt;75&lt;/a&gt;&lt;/sup&gt;. We analysed neurons that belong to cell classes already identified by the Allen Institute for each brain region. We restricted our analysis to the midbrain, striatal ventral region, anterior cingulate region, hippocampal region, prelimbic/infralimbic/orbital areas, thalamus and cortical subplate. Within each region outside of the NAc and midbrain, we examined cell types predicted to project to the NAc. We extracted expression levels for major cell types local to the region of interest, focusing on the following nicotinic α-subunit genes: &lt;i&gt;Chrna1&lt;/i&gt;, &lt;i&gt;Chrna2&lt;/i&gt;, &lt;i&gt;Chrna3&lt;/i&gt;, &lt;i&gt;Chrna4&lt;/i&gt;, &lt;i&gt;Chrna5&lt;/i&gt;, &lt;i&gt;Chrna6&lt;/i&gt; and &lt;i&gt;Chrna7&lt;/i&gt;. Transcript expression was quantified by calculating the log&lt;sub&gt;2&lt;/sub&gt;(CPM + 1), where CPM is counts per million. The percentage of cells expressing each transcript was also quantified. These analyses were performed in Python with custom scripts and notebooks from the Allen Institute.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Statistics and reproducibility&lt;/h3&gt;&lt;p&gt;Investigators were blinded to the manipulations that experimental subjects had undergone during the behavioural testing, recordings and data analysis. All photometry analysis and behavioural analysis was conducted in MATLAB. Quantifications of the photometry and behavioural results were graphed and analysed using GraphPad. All data were tested for normality of sample distributions using the Shapiro–Wilk normality test, and when violated, non-parametric statistical tests were used. Normally distributed data were analysed by paired, two-tailed &lt;i&gt;t&lt;/i&gt;-tests, or one-factor or two-factor repeated measures analysis of variance. Non-normally distributed data were analysed using the Wilcoxon matched-pairs signed rank test or Friedman’s test. When data were not paired, unpaired &lt;i&gt;t&lt;/i&gt;-tests or the Mann–Whitney rank test was performed for normally and non-normally distributed data, respectively. If individual data points were missing from these matched comparisons, mixed-effects models were used instead. Mixed-effects models were also used when examining the effects of multiple fixed effects (for example, FR and drug), accounting for the random effect of subject. In these cases, the significance of the fixed effects was reported in the figure legends and if there were significant fixed effects, Sidak-corrected post-hoc comparisons were reported with asterisks in the figures. Kruskal–Wallis tests were used to compare three or more unmatched groups (for example, DA responses from trials with different ITIs). Spearman correlations were used to measure the association between two independently measured observations (for example, rewards on consecutive days). Fluorescent micrographs are representative of six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig1"&gt;1a&lt;/a&gt;), eight mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig1"&gt;1l&lt;/a&gt;), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig2"&gt;2b&lt;/a&gt;), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig2"&gt;2d&lt;/a&gt;), eight mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig2"&gt;2g&lt;/a&gt;), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig3"&gt;3b&lt;/a&gt;), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig3"&gt;3h&lt;/a&gt;), three mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig3"&gt;3n&lt;/a&gt;), eight mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig4"&gt;4a&lt;/a&gt;), eight mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig4"&gt;4g&lt;/a&gt;, top), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig4"&gt;4g&lt;/a&gt;, bottom), six mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig5"&gt;5a&lt;/a&gt;), eight mice (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig5"&gt;5g&lt;/a&gt;), six mice (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig11"&gt;6a&lt;/a&gt;), nine mice (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig15"&gt;10a&lt;/a&gt;) and seven mice (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10046-6#Fig16"&gt;11a&lt;/a&gt;). For experiments involving multiple groups, subjects were randomly assigned to experimental conditions. No statistical methods were used to predetermine sample size. All statistical tests were two-sided and performed in MATLAB (Mathworks) or Prism (GraphPad). NS, not significant. *&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05, **&lt;i&gt;P &lt;/i&gt;&amp;lt; 0.01, ***&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001 and ****&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.0001. In all figures, data are shown as mean ± s.e.m.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10046-6#MOESM1"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 16:09:45 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE9jOE05cW91ZUhiU3JSWHNvdjhna2w2RFFtWlpmeXZWekxUczFCM1drdjNHanJRUk9rRmVmbGFqMGxkanRSZUcyODUxNFo1MHdmUnNld1pxYks5U2NTT0xZ</guid></item><item><title>科学家将22个基因与常见病毒的致命风险联系起来-英国《金融时报》</title><link>https://www.ft.com/content/815dd3d9-f83b-448d-af52-ca6da6c9cd03</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="o-grid-row details-section o3-type-body-base css-pmzbjb"&gt;&lt;p&gt;&lt;span&gt;&lt;span&gt;Delivery Monday - Saturday, including FT Weekend and FT Digital Edition: all the content of the FT newspaper on any device. Savings based on annual price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Financial Times</author><pubDate>Wed, 28 Jan 2026 16:07:12 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMicEFVX3lxTE1PTEE3Vmk0UWFpX0RRUzdDOFk4OVNEcTBrRUtDYkJYT1poUHo2VUp2UmZEX3Q4dkRPQy1CSzFPeEpWVGIwUk1ZYW9tbFE1ekJ3MlZLTm5qWGFncDM4eG5tdmRZcTRkOS1laFViY0YwZXY</guid></item><item><title>群体规模测序解决了持续性EBV DNA的决定因素-自然</title><link>https://www.nature.com/articles/s41586-025-10020-2</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec9-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec10"&gt;Rationale of EBV detection&lt;/h3&gt;&lt;p&gt;The 171,823-nucleotide EBV genome (&lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_007605.1"&gt;NC_007605.1&lt;/a&gt;) was first included in December 2013 (hg38 version GCA_000001405.15) as a sink for off-target reads that are often present in sequencing libraries, to account for pervasive EBV reads present from the immortalization of LCLs (as with the 1000 Genomes Project and related consortia). Importantly, WGS in the UKB and AOU consortia was performed on whole blood&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="All of Us Research Program Genomics Investigators Genomic data in the All of Us Research Program. Nature 627, 340–346 (2024)." href="/articles/s41586-025-10020-2#ref-CR18" id="ref-link-section-d49068241e2124"&gt;18&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Halldorsson, B. V. et al. The sequences of 150,119 genomes in the UK Biobank. Nature 607, 732–740 (2022)." href="/articles/s41586-025-10020-2#ref-CR60" id="ref-link-section-d49068241e2127"&gt;60&lt;/a&gt;&lt;/sup&gt;, reflecting that EBV reads detected would derive from viral DNA from past infections.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;WGS data and cohort analyses in the UKB&lt;/h3&gt;&lt;p&gt;For the UKB, we obtained per-base abundance of EBV DNA of the 490,560 WGS libraries by extracting reads aligning to chrEBV in the hg38 human genome reference that had a read mapping quality (MAPQ) ≥ 30 (q30) via the SAMtools view command&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)." href="/articles/s41586-025-10020-2#ref-CR61" id="ref-link-section-d49068241e2139"&gt;61&lt;/a&gt;&lt;/sup&gt;. To quantify EBV DNA abundance for each position, we summed the coverage of each base in the EBV genome across all libraries (per-base abundance). The resulting coverage across the viral contig was approximately flat, supporting that EBV DNA detection from WGS reads was real viral DNA, with two key exceptions (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig1"&gt;1b&lt;/a&gt;). First, a total of 27,692 positions had low to no coverage (per-base abundance ≤10) due to low mappability of the EBV contig. Second, two regions (positions 36,390–36,514 and 95,997–96,037) had orders-of-magnitude higher coverage (per-base abundance of ≥10&lt;sup&gt;3&lt;/sup&gt; at these 166 positions). On further examination, the sequences were highly repetitive. Hence, we reasoned that these two regions may confound EBV DNA quantification. To assess this, we calculated EBV DNA abundance per person before and after masking, by summing MAPQ ≥ 30 coverage either across all &lt;i&gt;J&lt;/i&gt; = 171,823 bases, or only across the remaining &lt;i&gt;J&lt;/i&gt;′ = 143,965 well-covered bases (10 &amp;lt; per-base abundance &amp;lt; 10&lt;sup&gt;3&lt;/sup&gt; for each base). The per-individual EBV sum unmasked was computed over all &lt;i&gt;J&lt;/i&gt; bases, whereas the masking was performed over &lt;i&gt;J&lt;/i&gt;′ bases.&lt;/p&gt;&lt;p&gt;We then used a two-sided Fisher’s exact test to test for association between EBV DNA presence (EBV DNA coverage &amp;gt; 0) and EBV serostatus, recorded in the UKB as ‘EBV seropositivity for Epstein–Barr Virus’ (data field 23053). Before masking, EBV DNA presence had a weak but insignificant positive association with EBV seropositivity (odds ratio = 1.2, &lt;i&gt;P&lt;/i&gt; = 0.03). Conversely, after masking these repetitive regions and recomputing donor detection status, the association between EBV DNA detection and seropositivity was much stronger (odds ratio = 14.6, &lt;i&gt;P&lt;/i&gt; = 1.7 × 10&lt;sup&gt;−26&lt;/sup&gt;) (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig1"&gt;1c&lt;/a&gt;). These analyses demonstrate that masking highly repetitive regions in the viral contig is required to perform valid inferences from whole genome sequencing data, as evidenced by statistical overlap with EBV serostatus.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Contig mappability analyses&lt;/h3&gt;&lt;p&gt;To confirm that regions of the EBV contig that were not detected were attributable to poor mapping quality of those regions, we generated synthetic reads of length 101 bases by tiling the reference EBV contig. Next, each synthetic read was aligned using bowtie2 v.2.5.1 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Langmead, B. &amp;amp; Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012)." href="/articles/s41586-025-10020-2#ref-CR62" id="ref-link-section-d49068241e2185"&gt;62&lt;/a&gt;&lt;/sup&gt;). We define mappability as the percentage of reads overlapping a position with a map quality score exceeding ten. This analysis reproduced regions depleted from the pseudobulk abundance (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig6"&gt;1a&lt;/a&gt;), indicating that low detection in these regions was due to homology in the hg38 reference rather than variable DNA presence from past infection.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;EBV DNA copy number estimation, simulation and thresholding&lt;/h3&gt;&lt;p&gt;To calculate EBV DNA abundance per person, we summed the coverage over the well-covered, non-biased bases (&lt;i&gt;J&lt;/i&gt;′). We normalized this value against the effective EBV genome size (143,965 bases) to obtain an estimate of the coverage per EBV genome. Next, we used the 30× human WGS coverage and accounted for the diploid human genome to compute an estimate of EBV DNA copy number per human cell, which resulted in approximately 1 in 1,000–10,000 cells in individuals with detectable EBV DNA (that is, our limit of detection was approximately 1 EBV genome per 10,000 cells). To contextualize these values, the upper range of EBV copy numbers in healthy individuals measured using qPCR was 10&lt;sup&gt;3&lt;/sup&gt; EBV genomes per 1 µg DNA, or 1 EBV genome per 200 cells&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Conacher, M. et al. Epstein–Barr virus can establish infection in the absence of a classical memory B-cell population. J. Virol. 79, 11128–11134 (2005)." href="/articles/s41586-025-10020-2#ref-CR23" id="ref-link-section-d49068241e2205"&gt;23&lt;/a&gt;&lt;/sup&gt;. The latter number was estimated with the assumption that 10&lt;sup&gt;5&lt;/sup&gt; cells produce 0.5 µg DNA. Although a previous study similarly used EBV reads in a cohort of ~8,000 donors, this analysis did not correct for the repetitive, biased DNA abundances that significantly skewed the resulting quantification&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Moustafa, A. et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 13, e1006292 (2017)." href="/articles/s41586-025-10020-2#ref-CR4" id="ref-link-section-d49068241e2211"&gt;4&lt;/a&gt;&lt;/sup&gt;. After quantifying per-person EBV DNA abundance, 85.7% of individuals in the UKB had no detectable EBV DNA.&lt;/p&gt;&lt;p&gt;In the UKB cohort, over 90% of individuals are seropositive, yet only 14.3% of individuals have non-zero EBV DNA levels detected. Therefore, we conducted a simulation study to better characterize the discrepancy. Using maximum likelihood estimation, we estimated values for the mean and standard deviation of a log-normal distribution to initialize the simulation and subsequently modified these values to (1) account for a mixture including 10% zeros (representing the individuals who were not infected with EBV) and (2) adjust the mean for a round, interpretable number. The final values used in the simulation (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig6"&gt;1d&lt;/a&gt;) were set to zero for 50,000 individuals, whereas the remaining 450,000 individuals were simulated via a log-normal distribution, with a mean of 0.2 EBV genome copies per 10,000 cells, a standard deviation of 0.62 and a censored value of 0.71. We emphasize that this simulation does not test an explicit statistical question but is designed primarily for illustrative purposes, to show that a single underlying component can explain many features of the empirical data (rather than requiring a second condition).&lt;/p&gt;&lt;p&gt;The extreme skew of the EBV levels distribution (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig6"&gt;1f&lt;/a&gt;) motivated our transformation of EBV DNA copy number to a binary trait, which we define as EBV DNAemia, since a quantitative trait otherwise assumes a dose-dependent relationship when testing for associations. To binarize our data for downstream analyses, we used a series of two-sided Fisher’s exact test to survey different cutoffs against association with EBV serostatus (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig1"&gt;1g&lt;/a&gt;). Our goal was to determine an optimal EBV copy number threshold. We observed the most significant positive association with a threshold of 1.2 EBV copies per 10&lt;sup&gt;4&lt;/sup&gt; human cells (odds ratio = 82.17, &lt;i&gt;P&lt;/i&gt; ≈ 0) after accounting for standard covariates used in a GWAS analysis (age, sex, age × sex, and ancestry PCs 1–15). This corresponded to having a per-person abundance of at least 302 bases covered on the EBV genome, which in turn corresponded to a full paired-end sequencing read (2 × 151 bp) with no soft-clipping. There were 47,452 people (9.67%) with EBV copy numbers greater than this threshold, which was used for all downstream analyses.&lt;/p&gt;&lt;p&gt;For the 9,607 individuals with both EBV serology and WGS available, there were 919 individuals (9.57%) that had EBV DNAemia. Only two (0.2%) of these 919 individuals were seronegative. One donor had an EBV DNA load of 1.36 EBV genomes per 10&lt;sup&gt;4&lt;/sup&gt; cells (just above our EBV DNAemia cutoff) with a high VCAp18 titre, but low titres for the other three EBV antigens. The other donor had an EBV DNA load of 3.34 EBV genomes per 10&lt;sup&gt;4&lt;/sup&gt; cells, with a positive titre for EA-D but low titres for the other antigens. In other words, among the 347 donors with no seropositivity against any antigens, none were annotated as individuals with EBV DNAemia (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig6"&gt;1b&lt;/a&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;EBV DNA detection in AOU&lt;/h3&gt;&lt;p&gt;We obtained per-base abundance of EBV DNA for 245,394 people in AOU with WGS data similarly by extracting reads that mapped to chrEBV in the hg38 human genome reference with MAPQ ≥ 30. To quantify EBV DNA abundance per base, we summed the q30 coverage of each base in the 171,823 bp EBV genome across all people. We again observed an overall uniform coverage; 23,513 positions had no coverage (per-base abundance = 0), and four regions (positions 36,389–36,516; 52,012–52,034; 95,997–96,037 and 163,596–163,617) had abnormally high coverage (per-base abundance of &amp;gt;1,000 at 214 positions; Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig7"&gt;2b&lt;/a&gt;). The effective EBV genome size was the remaining 148,096 bases (&amp;gt;0 but &amp;lt;10&lt;sup&gt;3&lt;/sup&gt; for each base). Although the largest repetitive region was the same in both the UKB and AOU, differences in the other regions with variable bias could be attributed to differences in the alignment software for either cohort, noting that all analyses used the existing mappings from either cohort.&lt;/p&gt;&lt;p&gt;We quantified the EBV copy number per person in AOU with a similar approach to the one used for the UKB. In brief, we quantified EBV DNA loads after masking and normalized them by the effective EBV genome size, then by the average genome coverage (30× human WGS) provided by AOU metadata. A total of 51,459 people (21%) had detectable EBV DNA (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig7"&gt;2c&lt;/a&gt;). The top EBV DNA load harboured was ~1 EBV copy per 1.4 cells (or 7,046 EBV copies per 10&lt;sup&gt;4&lt;/sup&gt; cells).&lt;/p&gt;&lt;p&gt;Using the same EBV DNA copy number thresholds as in the UKB, a total of 29,249 people (11.9%) had EBV copy numbers greater than the threshold of 1.2 EBV copies per 10&lt;sup&gt;4&lt;/sup&gt; human cells (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig7"&gt;2c&lt;/a&gt;). The overall higher EBV loads in AOU compared to in the UKB may be due to a difference in the recruitment criteria and demographics of the two cohorts: relative to the general population (as in AOU), the UKB shows a ‘healthy volunteer bias’ where participants were less likely to have self-reported health conditions&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Gallagher, C. S., Ginsburg, G. S. &amp;amp; Musick, A. Biobanking with genetics shapes precision medicine and global health. Nat. Rev. Genet. 26, 191–202 (2024)." href="/articles/s41586-025-10020-2#ref-CR57" id="ref-link-section-d49068241e2275"&gt;57&lt;/a&gt;&lt;/sup&gt;. In comparison, the maximum copy number described in a previous paper was a few orders of magnitude higher (2,404,531 EBV copies per 10&lt;sup&gt;5&lt;/sup&gt; human cells), potentially due to our exclusion of abnormally high coverage regions&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Moustafa, A. et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 13, e1006292 (2017)." href="/articles/s41586-025-10020-2#ref-CR4" id="ref-link-section-d49068241e2281"&gt;4&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Phenome-wide association studies&lt;/h3&gt;&lt;p&gt;We conducted PheWAS using the UKB as a discovery cohort to test for the association between EBV DNAemia and 13,290 binary phenotypes and 1,931 quantitative phenotypes amongst participants with broadly NFE as in the GWAS (refer to the following section). We used logistic regression with Firth correction, including sex and age as covariates. Using a Bonferroni correction, we defined 0.05/15,221 = 3.3 × 10&lt;sup&gt;−6&lt;/sup&gt; as our significance threshold. To ensure that the PheWAS was not confounded by immunosuppressive drugs, we ran a secondary analysis in which we included immunosuppressive drug status as an additional covariate in the regression. Because a majority of blood samples used for WGS were drawn at the time of enrollment, we identified these individuals on the basis of medication taken at the time of their initial assessment visit (UKB data field 20003). A full list of the 169 medications used for annotating immunosuppressed individuals is reported in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM3"&gt;2&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;As validation in AOU, we obtained unique RxNorm codes for 53 of the 169 drugs (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM3"&gt;2&lt;/a&gt;) and queried for individuals that had any of these drug exposures, along with the exposure start and end dates. We annotated each individual as immunosuppressed only when the biosample collection date for WGS fell between the drug exposure start and end dates (or after start dates, if no end date was recorded). We observed a positive but not significant association between immunosuppressive drug exposure at the time of WGS collection and EBV DNAemia (odds ratio = 1.03, &lt;i&gt;P&lt;/i&gt; = 0.54) (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig7"&gt;2f&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;We replicated PheWAS associations using the AOU cohort of individuals with European ancestry via Fisher’s exact tests for association between EBV DNAemia and each representative ICD-9 or ICD-10CM code in AOU. As recommended in the AOU workbench, we defined a representative ICD code as a code appearing at least twice in a person and 20 instances across all participants. The top results were predominantly being HIV positive, having immunodeficiencies, or receiving organ transplants, which we also observed in the UKB. To compare effect sizes between hits in the UKB and AOU, we matched AOU ICD-10CM codes to a corresponding UKB ICD-10 code by taking the first four characters of the ICD-10CM code, as codes &amp;gt;4 characters do not exist in the ICD-10 ontology used in UKB. For the two traits linked to EBV discussed in the main text, multiple sclerosis was queried using the ICD-10CM code ‘G35’ in AOU, and gammaherpesviral mononucleosis was queried using the ICD-10CM code ‘B27.00’. &lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;Genetic associations with EBV DNAemia in the UKB&lt;/h3&gt;&lt;p&gt;For UKB individuals of broadly NFE ancestry, array-based imputed genotypes with good genome-wide coverage in the common (&amp;gt;5%) and low-frequency (1–5%) MAF ranges were available&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018)." href="/articles/s41586-025-10020-2#ref-CR17" id="ref-link-section-d49068241e2321"&gt;17&lt;/a&gt;&lt;/sup&gt;. Genotyping arrays capture genome-wide genetic variations (SNPs and indels) within both coding and noncoding regions, allowing imputation of genotypes and tests for association between genotypes and a specified trait. To avoid confounding results due to differences in ancestral background, we stratified the cohort across six broad genetic ancestries (African, AFR; Hispanic or Latin American, AMR; Ashkenazi Jewish, ASJ; East Asian, EAS; non-Finnish European, NFE; and South Asian, SAS) before testing for associations between EBV DNAemia and UKB-imputed genotypes, which resulted in a total of 450,032 individuals with array imputed genotype data available, including 426,563 individuals of NFE ancestry. We then used REGENIE v.3.5 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021)." href="/articles/s41586-025-10020-2#ref-CR63" id="ref-link-section-d49068241e2325"&gt;63&lt;/a&gt;&lt;/sup&gt;) to examine associations between EBV DNAemia and imputed genotypes, using a logistic model with covariates and applying Firth correction: EBV DNAemia ~ age + sex + age × sex + age&lt;sup&gt;2&lt;/sup&gt; + age&lt;sup&gt;2 &lt;/sup&gt;× sex + batch + ancestry PCs 1–20, as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Burren, O. S. et al. Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences. Nat. Genet. 56, 1832–1840 (2024)." href="/articles/s41586-025-10020-2#ref-CR64" id="ref-link-section-d49068241e2333"&gt;64&lt;/a&gt;&lt;/sup&gt;. The input to REGENIE includes directly genotyped variants (MAF &amp;gt; 1%, MAC &amp;gt; 100, genotyping rate per variant &amp;gt;99%, and genotyping rate per individual &amp;gt;80%). We pruned these variant sets using PLINK2 (--indep-pairwise 1000 100 0.8) as input to REGENIE’s step1 analyses. This step produces a whole genome regression model to fit to the binary trait of EBV DNAemia and outputs a set of genomic predictions.&lt;/p&gt;&lt;p&gt;For REGENIE step2, we further filtered out SNPs that had 0.99 ‘missingness’, imputation INFO &amp;lt; 0.7, and p.HWE &amp;gt; 1 × 10&lt;sup&gt;−5&lt;/sup&gt;. This step fits a logistic model to imputed data, using the genomic predictions from step1. To estimate heritability of SNPs and genomic inflation, we performed linkage disequilibrium score regression (LDSC) by applying the ldsc package (v.1.0.1). In brief, we used munge_stats.py on the cleaned summary stats, then used ldsc.py to estimate &lt;i&gt;h&lt;/i&gt;&lt;sup&gt;&lt;i&gt;2&lt;/i&gt;&lt;/sup&gt; using the supplied 1KG Genomes linkage disequilibrium score matrices (Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM1"&gt;4&lt;/a&gt;). Identical steps were applied to conduct the EBV serology GWAS on the subset of UKB participants for whom EBV serostatus was measured&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Mentzer, A. J. et al. Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. Nat. Commun. 13, 1–12 (2022)." href="/articles/s41586-025-10020-2#ref-CR40" id="ref-link-section-d49068241e2351"&gt;40&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;To annotate variant loci, we focused on significant variants (&lt;i&gt;P&lt;/i&gt; &amp;lt; 5 × 10&lt;sup&gt;−8&lt;/sup&gt;) and created genomic intervals of ±1 Mb around each variant. As variants on chromosome 6 often exhibit linkage disequilibrium with MHC, we created a custom interval (chr6: 25,500,000 to 34,000,000) for the HLA region. We then combined overlapping intervals using the GenomicRanges reduce function and selected the most significant variant per interval as the index variant. In the case of ties, we selected the variant closest to the midpoint of the region. We applied the reduce function again to ensure we had a set of non-redundant index variants. Finally, we annotated each variant by the closest gene, using Ensembl v.111 (Jan 2024) gene annotations and selecting the gene whose midpoint was closest to the index variant. For visualization of specific loci, we used the canonical hg38 reference genome isoforms. Linkage disequilibrium was determined via LDlink&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Machiela, M. J. &amp;amp; Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557 (2015)." href="/articles/s41586-025-10020-2#ref-CR65" id="ref-link-section-d49068241e2363"&gt;65&lt;/a&gt;&lt;/sup&gt; for the regions noted (Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM1"&gt;4&lt;/a&gt;). Zoom plots were from the array-based GWAS associations in the UKB, and the linkage disequilibrium reference panel in LDLink&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Machiela, M. J. &amp;amp; Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557 (2015)." href="/articles/s41586-025-10020-2#ref-CR65" id="ref-link-section-d49068241e2370"&gt;65&lt;/a&gt;&lt;/sup&gt; used all European populations.&lt;/p&gt;&lt;p&gt;We complemented our GWAS with an exome-wide association analyses (ExWAS), leveraging the whole genome sequencing data available in the UKB. Specifically, we tested for associations between EBV DNAemia and protein-coding variants observed in at least six participants of NFE ancestry in the UKB. We applied our previously described protocol to generate variant-level statistics&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597, 527–532 (2021)." href="/articles/s41586-025-10020-2#ref-CR29" id="ref-link-section-d49068241e2377"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Spargo, T. P. et al. Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease. Cell Rep. 44, 115355 (2025)." href="/articles/s41586-025-10020-2#ref-CR66" id="ref-link-section-d49068241e2380"&gt;66&lt;/a&gt;&lt;/sup&gt;. Variants were required to pass the following quality control criteria: coverage ≥10x; ≥0.20 of reads with the alternate allele for heterozygous genotype calls; binomial test of alternate allele proportion departure from 50% in heterozygous state &lt;i&gt;P&lt;/i&gt; ≥ 1 × 10&lt;sup&gt;−6&lt;/sup&gt;; GQ ≥ 20; Fisher Strand Bias ≤ 200 for indels and ≤ 60 for SNVs; root-mean-square mapping quality (MQ) ≥ 40; QUAL ≥ 30; read position rank sum score (RPRS) ≥ −2; mapping quality rank score (MQRS) ≥ −8; DRAGEN variant status = PASS; and ≤ 10% of the cohort with missing genotypes. Additional out-of-sample quality control filters were also imposed based on the gnomAD v2.1.1 exomes (GRCh38 liftover) dataset&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020)." href="/articles/s41586-025-10020-2#ref-CR67" id="ref-link-section-d49068241e2389"&gt;67&lt;/a&gt;&lt;/sup&gt;. The sites of all variants were required to have ≥10x coverage in ≥30% of gnomAD exomes and, if present, each variant was required to have an allele count ≥50% of the raw allele count. Variants with missing values for any filter were retained unless they failed another metric. Variants failing quality control in &amp;gt;20,000 people were also removed. &lt;i&gt;P&lt;/i&gt; values were generated via Fisher’s exact two-sided test. Three distinct genetic models were studied for binary traits: allelic (A versus B allele), dominant (AA + AB versus BB), and recessive (AA versus AB + BB), where A denotes the alternative allele and B denotes the reference allele. ExWAS hits were filtered following: &lt;i&gt;P&lt;/i&gt; &amp;lt; 5 × 10&lt;sup&gt;−8&lt;/sup&gt;, nCases &amp;gt;20, and protein-altering Most Damaging Effect (‘Stop_lost’, ‘Stop_gained’, ‘Start_lost’, ‘Splice_region_variant’, ‘Splice_donor_variant’, ‘Splice acceptor variant’, ‘Missense_variant’, ‘Frameshift_variant’, ‘Disruptive_inframe_insertion’,‘Disruptive_inframe_deletion’). For functional variant annotation and interpretation, AlphaMissense&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023)." href="/articles/s41586-025-10020-2#ref-CR68" id="ref-link-section-d49068241e2402"&gt;68&lt;/a&gt;&lt;/sup&gt; was executed on all variants that were statistically significant from the ExWAS analyses using default parameters. If multiple transcripts were associated, only one is reported (the one with the highest AlphaMissense score, if available).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Replication of UKB EBV DNAemia-associated genotypes&lt;/h3&gt;&lt;p&gt;To broadly capture variants in individuals with EUR ancestry in AOU, we used the variant-level metadata for the SNP and indel variants contained in the short read WGS (srWGS) data dictionary. We filtered for variants with an alternative allele frequency (AF) of 0.01 &amp;lt; AF &amp;lt; 0.49 or 0.51 &amp;lt; AF &amp;lt; 0.99 (gvs_eur_af) and at least 100 individuals containing this variant (gvs_eur_sc ≥ 100) in the EUR subpopulation as the input SNPlists to step1 and 2 of the REGENIEv3.2.4 pipeline. This resulted in 16,566,413 variants across chromosomes 1–22. EBV DNAemia was supplied as a binary trait, along with the covariates age, sex, age × sex, and ancestry PCs 1–15. There were 133,578 such individuals that had EBV DNAemia status determined, of which 131,938 had complete covariate data and were included in the analysis, and 12,099,305 total variants had GWAS statistics results.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Genomic architecture associations&lt;/h3&gt;&lt;p&gt;To holistically evaluate genetic architecture similarities between EBV DNAemia and IMDs, we used the R package cupcake&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Burren, O. S. et al. Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases. Genome Med. 12, 106 (2020)." href="/articles/s41586-025-10020-2#ref-CR38" id="ref-link-section-d49068241e2422"&gt;38&lt;/a&gt;&lt;/sup&gt;. The package was used to define shared components of genetic architecture across 13 IMDs, applying shrinkage to adjust for linkage disequilibrium, allele frequency and differential sample size. Summary statistics of 13 large IMD GWASs were used to define a reduced dimension space using PCA, which served as a common genetic basis that enabled simultaneous comparisons between multiple diseases. The reduced dimension space included 566 driver variants and 13 PCs that were defined as orthogonal genetic risk components&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Burren, O. S. et al. Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases. Genome Med. 12, 106 (2020)." href="/articles/s41586-025-10020-2#ref-CR38" id="ref-link-section-d49068241e2426"&gt;38&lt;/a&gt;&lt;/sup&gt;. Applying this approach, we extracted summary association statistics for these 566 driver variants from our UKB NFE EBV DNAemia GWAS. After checking and adjusting the effect allele alignment, we used cupcake&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Burren, O. S. et al. Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases. Genome Med. 12, 106 (2020)." href="/articles/s41586-025-10020-2#ref-CR38" id="ref-link-section-d49068241e2430"&gt;38&lt;/a&gt;&lt;/sup&gt; to project these variants onto the 13 IMD genetic risk bases and assess the significance of association with each component. The output from this projection is a score or delta (&lt;i&gt;δ&lt;/i&gt;) for each PC that quantifies the difference between the projected genetic risk for that trait on a particular basis axis and a synthetic control (which has zero effect sizes for all SNPs). This effectively measures how strongly the trait aligns with the risk architecture represented by that component. To account for uncertainty, the variance of δ is calculated using the propagation of error from the input GWAS summary statistics, adjusted for the same shrinkage weights and allele frequency variance as applied in basis construction. With δ and its variance, a &lt;i&gt;Z&lt;/i&gt;-statistic can be formed for each component, and standard statistical inference can be used to compute a &lt;i&gt;P&lt;/i&gt; value&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Burren, O. S. et al. Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases. Genome Med. 12, 106 (2020)." href="/articles/s41586-025-10020-2#ref-CR38" id="ref-link-section-d49068241e2444"&gt;38&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Pathway and single-cell analyses&lt;/h3&gt;&lt;p&gt;To evaluate the gene expression program uncovered by our ExWAS associations, we used a high-resolution single-cell cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) dataset of PBMCs from eight distinct donors with 210,911 quality-controlled cells&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021)." href="/articles/s41586-025-10020-2#ref-CR41" id="ref-link-section-d49068241e2456"&gt;41&lt;/a&gt;&lt;/sup&gt;. The 148 ExWAS-associated genes were input alongside the preprocessed Seurat&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021)." href="/articles/s41586-025-10020-2#ref-CR41" id="ref-link-section-d49068241e2460"&gt;41&lt;/a&gt;&lt;/sup&gt; object into the AddModuleScore function with default hyperparameters. To reduce technical variation, we removed genes mapping to the HLA region as well as ribosome-associated genes from the input gene list (HLA for genetic polymorphisms; ribosome for cell quality) from the module score foreground and background. Downstream association analyses of cell type enrichment were performed using the pre-supplied labels.&lt;/p&gt;&lt;p&gt;Pathway enrichment analyses were performed using the same ExWAS gene set via the clusterProfiler R package&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Yu, G., Wang, L.-G., Han, Y. &amp;amp; He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012)." href="/articles/s41586-025-10020-2#ref-CR69" id="ref-link-section-d49068241e2467"&gt;69&lt;/a&gt;&lt;/sup&gt;. Gene set analyses were performed using the enrichGO (for biological processes) and enrichKEGG functions (for pathways) using the set of 148 genes and all ENSEMBL human genes as a background set. For analyses with HLA (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig4"&gt;4e&lt;/a&gt;) and chromosome 6 excluded (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig4"&gt;4f&lt;/a&gt;), we removed either HLA or chromosome 6 genes from both the foreground (that is, test set) and background set for statistical analyses. We used the simplify() function in clusterProfiler with a similarity cutoff of 0.7 (the default value) to reduce the number of redundant association terms. Hence, we note that the labels in panels Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig4"&gt;4d–f&lt;/a&gt; are not identical in name; this result is due to the simplify() function’s selection of a single term that is nearly identical to other related terms.&lt;/p&gt;&lt;p&gt;Enrichment analyses for non-coding enrichment in accessible chromatin used 18 fluorescent activated cell sorting (FACS)-isolated immune and hematopoietic populations that were uniformly reprocessed and aggregated using the hg19 reference genome (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig10"&gt;5a&lt;/a&gt;). To compute enrichment scores, we isolated genome-wide significant variants from the UKB NFE GWAS, lifted over the hg38 coordinates to hg19, and built a RangedSummarizedExperiment object to compute the enrichment. For accessible chromatin enrichments, we used an approach motivated by the chromVAR statistical testing framework adapted for genetic variants. Specifically, 100 background peaks (identified through the same mean and GC content of the ATAC-seq peak) were used as a null distribution, and the mean deviations at peaks variably containing genome-wide significant variants were computed via the abundance of accessible chromatin from each sorted population. The background and observed deviations were used to estimate an empirical &lt;i&gt;Z&lt;/i&gt;-statistic, which was transformed into a &lt;i&gt;P-&lt;/i&gt;value using the pnorm() R function.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;HLA haplotype and EBV peptide presentation&lt;/h3&gt;&lt;p&gt;We used the four-digit HLA imputation calls processed in the UKB Research Analysis Platform using HLA*IMP:02 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Dilthey, A. et al. Multi-population classical HLA type imputation. PLoS Comput. Biol. 9, e1002877 (2013)." href="/articles/s41586-025-10020-2#ref-CR70" id="ref-link-section-d49068241e2501"&gt;70&lt;/a&gt;&lt;/sup&gt;). Allele dosage values of &amp;gt;0.7 were used to assign donor haplotypes for a specific four-digit HLA allele. Homozygotes were determined by alleles with values of &amp;gt;1.3. For the AOU cohort, predetermined HLA genotypes were not available in the workbench. Hence, we reconstructed the HLA calls for all individuals of EUR ancestry using the T1K toolkit&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Song, L., Bai, G., Liu, X. S., Li, B. &amp;amp; Li, H. Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. Genome Res. 33, 923–931 (2023)." href="/articles/s41586-025-10020-2#ref-CR71" id="ref-link-section-d49068241e2505"&gt;71&lt;/a&gt;&lt;/sup&gt; (v.1.0.8-r237) by extracting reads aligning to the HLA region, which included canonical chr6 HLA region (chr6: 25,500,000 to 34,000,000) and all alternative HLA contigs in the hg38 reference. Using a .bed file of the HLA region coordinates, these alignments were streamed with the GATK PrintReads commands into the T1K genotyper, which was set to default parameters. Following T1K toolkit recommendations, the donor haplotypes were assigned for alleles called with a quality score of &amp;gt;0. Homozygotes were determined by donors with only a single allele and with a quality score of &amp;gt;30.&lt;/p&gt;&lt;p&gt;To determine specific HLA associations with EBV DNAemia, we used the per-person four-digit HLA alleles for both class I and II as predictors in a logistic regression, with EBV DNAemia as an outcome. Models included standard covariates used throughout the paper (age, sex, genetic PCs and so on). We performed this regression on the 208 HLA class I and 145 HLA class II alleles in UKB NFE individuals. We then repeated the same analysis for 175 class I and 132 class II alleles that were also present in the AOU EUR cohort (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM3"&gt;7&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;The amino acid sequences of all 87 unique EBV protein sequences were obtained from the peptide sequence of the nuccore &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_007605"&gt;NC_007605&lt;/a&gt;. The protein .fasta file was input to NetMHCpan, along with all observed MHC class I (HLA-A, HLA-B or HLA-C) and class II (HLA-DR, HLA-DP or HLA-DQ) alleles in the UKB NFE cohort. Sliding windows of all 8-, 9-, 10- or 11-mers of the provided protein sequences were generated for the prediction of class I allele peptide presentation; sliding windows of size 15-mers were used for class II. The binding scores of these peptides were determined for all observed UKB NFE MHC alleles that could be scored by NetMHCpan4.1 and NetMHCIIpan4.3 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Reynisson, B., Alvarez, B., Paul, S., Peters, B. &amp;amp; Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449–W454 (2020)." href="/articles/s41586-025-10020-2#ref-CR48" id="ref-link-section-d49068241e2525"&gt;48&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;p&gt;The NetMHC output reflects the predicted %rank score for each peptide and a given allele, which is a measure of the rank of the predicted affinity of the allele for the peptide compared to a set of 400,000 random natural peptides. For MHC class I, we computed the HBR score per allele by taking the harmonic mean over the two genotyped alleles for each of HLA-A, B and C. For homozygotes, the harmonic mean is equivalent to any individual observation. For individuals missing a single allele, we considered only the genotyped call, and for two missing alleles, the individual was excluded from the per-allele analysis.&lt;/p&gt;&lt;p&gt;For MHC class II analyses, all HLA-DRB alleles were directly applied as input—along with the EBV proteome .fasta file—to generate HLA-peptide presentation scores for all possible 15-mer sliding windows. As HLA-DQ and HLA-DR alleles exist in pairs of alpha and beta alleles within the predictions, we took all HLA-DQ and HLA-DP alleles imputed in the UKB NFE cohort and generated all possible combinations of HLA-DQA/HLA-DQB alleles and all possible combinations of HLA-DPA–HLA-DPB allele pairs. These alpha–beta allele combinations were then used as inputs to NetMHCIIpan, along with the EBV proteome .fasta file. Again, the output file lists each peptide, the protein from which the peptide is derived, a given class II allele (pair) and the predicted %rank_EL score, which is the percentile rank of the eluted ligand prediction score. As HLA-DRA is the only non-variable gene in the population, each individual has only two possible HLA-DR heterodimers. Each individual can form four possible alpha–beta heterodimers from HLA-DP and HLA-DQ (between alpha and beta molecules). Hence, each individual may assemble up to ten unique heterodimeric MHC class II molecules&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Marty Pyke, R. et al. Evolutionary pressure against MHC class II binding cancer mutations. Cell 175, 416–428.e13 (2018)." href="/articles/s41586-025-10020-2#ref-CR50" id="ref-link-section-d49068241e2536"&gt;50&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;The per-allele HBR was computed using the harmonic rank of the heterodimers for each allele class and rescaled by a factor of 10&lt;sup&gt;6&lt;/sup&gt; when computing the final ∆HBR score (shown in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig5"&gt;5&lt;/a&gt;). The comparisons were only between the NFE/EUR ancestry populations in either cohort. To further verify that our effect was linked to class II presentation strength, we completed regression analyses using the same set of covariates for our genetic association analyses, which verified that other forms of confounding (for example, population stratification or sex) did not explain the associations between the class II predicted presentation strength and EBV DNAemia.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;EBV viral sequence analysis&lt;/h3&gt;&lt;p&gt;Raw sequencing reads from chrEBV were merged from all participants from both cohorts. The aggregated .bam file was transformed into a per-base, per-nucleotide count using bam-readcount&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Khanna, A. et al. Bam-readcount - rapid generation of basepair-resolution sequence metrics. J. Open Source Softw. 7, 3722 (2022)." href="/articles/s41586-025-10020-2#ref-CR72" id="ref-link-section-d49068241e2556"&gt;72&lt;/a&gt;&lt;/sup&gt;. For the type 1 and 2 strain analyses, we sought to quantify the abundance directly from the aligned reads to the chrEBV reference (a type 1 EBV strain). Here we performed a multiple-sequence alignment of the EBNA-2 gene (the major difference between strains) for nuccore IDs &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/K03333"&gt;K03333&lt;/a&gt; (type 1) and &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/K03332"&gt;K03332&lt;/a&gt; (type 2) and mapped the MSA coordinates back to the chrEBV reference to identify putative regions that would reflect single nucleotide variation, which, in turn, would reflect strain-level differences. We identified nine variants on chrEBV: 36209C&amp;gt;T, 36226T&amp;gt;A, 36251A&amp;gt;G, 36252A&amp;gt;T, 36258C&amp;gt;A, 36275G&amp;gt;T, 36302A&amp;gt;C, 36312T&amp;gt;A and 36320C&amp;gt;T, where the reference allele was type 1-derived and the alternate was type 2-derived. These variants were selected on the basis of: (1) the combined allele frequency being greater than 99% for the reference and alternate alleles and (2) no overlap with the repetitive regions (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig1"&gt;1b&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;Next, we analysed a set of 31 protein-altering mutations in EBV (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig12"&gt;7c&lt;/a&gt;), which was curated from a recent global-scale analyses of EBV genomes&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Briercheck, E. L. et al. Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses. Blood Adv. 8, 3731–3744 (2024)." href="/articles/s41586-025-10020-2#ref-CR55" id="ref-link-section-d49068241e2583"&gt;55&lt;/a&gt;&lt;/sup&gt; derived from individuals with EBV&lt;sup&gt;+&lt;/sup&gt; nasopharyngeal carcinomas. Of these 31 EBV VUS, there were four VUS that were detected at less than 5% pseudobulk in both cohorts. To assess whether these four VUS were potentially involved in immune evasion, we assembled all possible peptides for presentation on both classes I and II, and then scored these peptides with all of the NFE/EUR observed HLA alleles to compute a NetMHC rank score for both the wild-type and mutated forms of the peptides. As both the wild-type and mutated peptides generally had similar values, and few were near the IEDB-validated thresholds (blue dotted lines; Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10020-2#Fig12"&gt;7d,e&lt;/a&gt;), we suggest that these VUS—if there is an effect—are probably not mediated via immune evasion but instead via altered function of the viral protein.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10020-2#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 16:06:41 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFBQbjJHMGNXLVl1cjkwY2h3ZWhxZi1nNzA3aWNZVFpFTDdmZ3dDeXk1RUYxcHpiVXBJdUpraUwweG5hLTVPc09BQ213MlhIMlZ5dVhQOGxNT0x5c056SzFF</guid></item><item><title>气候变化对非洲疟疾的预计影响-自然</title><link>https://www.nature.com/articles/s41586-025-10015-z</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec7-content"&gt;&lt;p&gt;Our analysis framework comprised nine main stages, summarized in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig4"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec8"&gt;Preparation of consistent geotemporal climatologies, 2000–2050&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec9"&gt;Historical climate data&lt;/h4&gt;&lt;p&gt;Climate data were obtained from the Climate Hazards Centre&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Funk, C. et al. The climate hazards infrared precipitation with stations—a new environmental record for monitoring extremes. Sci. Data 2, 150066 (2015)." href="/articles/s41586-025-10015-z#ref-CR36" id="ref-link-section-d70647809e1546"&gt;36&lt;/a&gt;&lt;/sup&gt; and Climate Research Unit gridded Time Series&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Harris, I., Osborn, T. J., Jones, P. &amp;amp; Lister, D. Version 4 of the CRU TS monthly high-resolution gridded multivariate climate dataset. Sci. Data 7, 109 (2020)." href="/articles/s41586-025-10015-z#ref-CR37" id="ref-link-section-d70647809e1550"&gt;37&lt;/a&gt;&lt;/sup&gt;, downscaled by Worldclim&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Fick, S. E. &amp;amp; Hijmans, R. J. WorldClim 2: new 1km spatial resolution climate surfaces for global land areas. Int. J. Climatol. 37, 4302–4315 (2017)." href="/articles/s41586-025-10015-z#ref-CR38" id="ref-link-section-d70647809e1554"&gt;38&lt;/a&gt;&lt;/sup&gt;. Data were gap-filled&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Weiss, D. J. et al. An effective approach for gap-filling continental scale remotely sensed time-series. ISPRS J. Photogramm. Remote Sens. 98, 106–118 (2014)." href="/articles/s41586-025-10015-z#ref-CR53" id="ref-link-section-d70647809e1558"&gt;53&lt;/a&gt;&lt;/sup&gt;, aligned to a standard 5 × 5 km reference grid and aggregated to monthly time-steps. Details of all historical climate data used in this study are provided in Supplementary Information Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec10"&gt;CMIP6 projections&lt;/h4&gt;&lt;p&gt;Projections of future climate under SSP 2-4.5 were obtained from the NASA Earth Exchange Global Daily Downscaled Projections (NEX-GDDP-CMIP6)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Thrasher, B. et al. NASA global daily downscaled projections, CMIP6. Sci. Data 9, 262 (2022)." href="/articles/s41586-025-10015-z#ref-CR35" id="ref-link-section-d70647809e1573"&gt;35&lt;/a&gt;&lt;/sup&gt;. These data consist of downscaled and bias-corrected daily CMIP6 multi-model ensemble outputs for historical (2000–2014) and future projection (2015–2050) eras. Data were aggregated to monthly resolution before applying the delta method&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="WorldClim Database. WorldClim 
                https://www.worldclim.org/data/downscaling.html
                
               (2025)." href="/articles/s41586-025-10015-z#ref-CR54" id="ref-link-section-d70647809e1577"&gt;54&lt;/a&gt;&lt;/sup&gt; to provide a final calibration to historical climate data described above. To account for between-model uncertainty, 14 models were processed and used for projection of ecologically driven climate impacts (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;2&lt;/a&gt;), whereas a thinned subset of three models (ACCESS-CM2, EC-Earth3-Veg-LR and MPI-ESM1-2-LR) was used for the additional analysis of disruptive climate impacts.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;Modelling of historical and projected climate suitability indices&lt;/h3&gt;&lt;p&gt;The assembled climate data were used in two mathematical models to develop two geotemporal suitability indices: (1) a temperature suitability index (TSI) tracking relative vectorial capacity and (2) a larval habitat suitability index (HSI) measuring relative availability and potential productivity of mosquito larval breeding sites.&lt;/p&gt;&lt;p&gt;Temperature provides both an upper and lower constraint on malaria transmission, reflecting the ectothermic nature of mosquito and parasite lifecycles. Mathematical models linking temperature to relative vectorial capacity are well established and described elsewhere&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Shapiro, L. L. M., Whitehead, S. A. &amp;amp; Thomas, M. B. Quantifying the effects of temperature on mosquito and parasite traits that determine the transmission potential of human malaria. PLoS Biol. 16, e2003489 (2017)." href="/articles/s41586-025-10015-z#ref-CR55" id="ref-link-section-d70647809e1596"&gt;55&lt;/a&gt;&lt;/sup&gt;. Here we updated a degree-day-based framework&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Gething, P. W. et al. Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasites Vectors 4, 92 (2011)." href="/articles/s41586-025-10015-z#ref-CR56" id="ref-link-section-d70647809e1600"&gt;56&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Weiss, D. J. et al. Air temperature suitability for Plasmodium falciparum malaria transmission in Africa 2000–2012: a high-resolution spatiotemporal prediction. Malar. J. 13, 171 (2014)." href="/articles/s41586-025-10015-z#ref-CR57" id="ref-link-section-d70647809e1603"&gt;57&lt;/a&gt;&lt;/sup&gt; to include recently published data on the &lt;i&gt;A. gambiae&lt;/i&gt; complex&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Suh, E. et al. Estimating the effects of temperature on transmission of the human malaria parasite, Plasmodium falciparum. Nat. Commun. 15, 3230 (2024)." href="/articles/s41586-025-10015-z#ref-CR14" id="ref-link-section-d70647809e1610"&gt;14&lt;/a&gt;&lt;/sup&gt;. The resulting temperature suitability curve is nonlinear, peaking at 26.4 °C.&lt;/p&gt;&lt;p&gt;To describe the relationship between local rainfall, temperature and humidity and the resulting availability of habitat for oviposition and larval development we discretized a Clausius–Clapeyron-based model of habitat availability used in an established mechanistic model of malaria&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Eckhoff, P. A. A malaria transmission-directed model of mosquito life cycle and ecology. Malar. J. 10, 303 (2011)." href="/articles/s41586-025-10015-z#ref-CR58" id="ref-link-section-d70647809e1617"&gt;58&lt;/a&gt;&lt;/sup&gt; as follows: let &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;&lt;i&gt;t&lt;/i&gt;&lt;/sub&gt; denote rainfall volume at time &lt;i&gt;t&lt;/i&gt;, so that transient larval habitat is given by the recursion:&lt;/p&gt;&lt;div id="Equ1" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{Habitat}}(t)={R}_{t}+\frac{1}{{\delta }_{t}}{\rm{Habitat}}(t-1),$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;δ&lt;/i&gt;&lt;sub&gt;&lt;i&gt;t&lt;/i&gt;&lt;/sub&gt; is the time-dependent temperature and humidity-dependent evaporation rate, which is a function of temperature &lt;i&gt;T&lt;/i&gt;&lt;sub&gt;&lt;i&gt;t&lt;/i&gt;&lt;/sub&gt;, humidity &lt;i&gt;H&lt;/i&gt;&lt;sub&gt;&lt;i&gt;t&lt;/i&gt;&lt;/sub&gt; and a physical constant &lt;i&gt;C&lt;/i&gt;:&lt;/p&gt;&lt;div id="Equ2" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\delta }_{t}=C\exp \left\{-\frac{1}{{T}_{t}+273.15}\right\}\sqrt{\frac{1}{{T}_{t}+273.15}}(1-{H}_{t}).$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;Then the expected duration of habitat at time &lt;i&gt;t&lt;/i&gt; is:&lt;/p&gt;&lt;div id="Equ3" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\mathrm{dur}}_{t}=\frac{1}{{\log }_{2}}\frac{1}{{\delta }_{t}},$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;and we may approximate Habitat(&lt;i&gt;t&lt;/i&gt;) as HSI(&lt;i&gt;m&lt;/i&gt;) for a month &lt;i&gt;m&lt;/i&gt; of length |&lt;i&gt;m&lt;/i&gt;|:&lt;/p&gt;&lt;div id="Equ4" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\begin{array}{l}{\rm{HSI}}(m)=\sum _{d\in m}\frac{{R}_{d}}{|m|}\,\min ({{\rm{dur}}}_{m},|m|-d)\\ \,\,\,+\sum _{d\in m-1}\frac{{R}_{d}}{|m-1|}\,\max (0,{{\rm{dur}}}_{m}-|m|+d){\mathbb{I}}({{\rm{dur}}}_{m-1} &amp;gt; |m-1|-d)\end{array}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;span class="mathjax-tex"&gt;\({\mathbb{I}}\)&lt;/span&gt; denotes an indicator variable equal to 1 when the condition is true and 0 otherwise. We augmented this transient larval habitat suitability with a ‘permanent larval habitat’ layer derived from Tasselled Cap Wetness&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Weiss, D. J. et al. An effective approach for gap-filling continental scale remotely sensed time-series. ISPRS J. Photogramm. Remote Sens. 98, 106–118 (2014)." href="/articles/s41586-025-10015-z#ref-CR53" id="ref-link-section-d70647809e2216"&gt;53&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Lobser, S. E. &amp;amp; Cohen, W. B. MODIS tasselled cap: land cover characteristics expressed through transformed MODIS data. Int. J. Remote Sens. 28, 5079–5101 (2007)." href="/articles/s41586-025-10015-z#ref-CR59" id="ref-link-section-d70647809e2219"&gt;59&lt;/a&gt;&lt;/sup&gt; observations adjusted for local rainfall.&lt;/p&gt;&lt;p&gt;To visually examine the empirical signal of these two climatic suitability indices, we binned &lt;i&gt;Pf&lt;/i&gt;PR observations into deciles by TSI and HSI (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig10"&gt;7&lt;/a&gt;). Subsetting observations to those in rural settings, and then further to areas of low insecticidal bednet (ITN) coverage, the variation in &lt;i&gt;Pf&lt;/i&gt;PR associated with changing TSI and HIS becomes more pronounced.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Preparation of historical geotemporal housing, intervention and contextual data&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec13"&gt;Malaria control&lt;/h4&gt;&lt;p&gt;The scale up of malaria control is responsible for most of the decline in burden in sub-Saharan Africa since 2000 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207–211 (2015)." href="/articles/s41586-025-10015-z#ref-CR28" id="ref-link-section-d70647809e2247"&gt;28&lt;/a&gt;&lt;/sup&gt;). Geotemporal estimates of historic ITN, indoor residual spray (IRS), SMC and antimalarial treatment coverage were obtained from the Malaria Atlas Project. To account for the nonlinearity in the ITN–&lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt; relationship, ITN coverage was transformed using a pre-defined parametric interaction with estimated pre-intervention-era parasite rate&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207–211 (2015)." href="/articles/s41586-025-10015-z#ref-CR28" id="ref-link-section-d70647809e2256"&gt;28&lt;/a&gt;&lt;/sup&gt;. The resulting functional form of the ITN–&lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–&lt;/sub&gt;&lt;sub&gt;10&lt;/sub&gt; relationship was consistent with biological understanding as encoded in mechanistic malaria models&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Griffin, J. T. et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med. 7, e1000324 (2010)." href="/articles/s41586-025-10015-z#ref-CR60" id="ref-link-section-d70647809e2267"&gt;60&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Smith, D. L. et al. Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol. 25, 511–516 (2009)." href="/articles/s41586-025-10015-z#ref-CR61" id="ref-link-section-d70647809e2270"&gt;61&lt;/a&gt;&lt;/sup&gt;. This study did not seek to model possible future trends in intervention coverage. Instead we defined a baseline intervention coverage reflecting present-day levels, and this was used for all future scenarios (with or without disruption due to extreme weather events). To account for the campaign-based nature of ITN distribution we took a 4-year average across 2019–2022 as baseline. For treatment coverage, delivered horizontally, 2022 was taken as baseline for future projections.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec14"&gt;Relative abundance of vector species&lt;/h4&gt;&lt;p&gt;Malaria ecology varies by mosquito species, with the relationship between the environment and transmission expected to vary between settings with different dominant vectors, even after controlling for interventions and socioeconomic factors. To account for this, we fit species-specific terms in the model, with predictions based on relative abundance of the three dominant vectors in sub-Saharan Africa: &lt;i&gt;A. gambiae&lt;/i&gt; (s.s. and &lt;i&gt;coluzzi&lt;/i&gt;), &lt;i&gt;Anopheles funestus&lt;/i&gt; and &lt;i&gt;Anopheles arabiensis&lt;/i&gt;. Estimates of relative abundance of each species were obtained from ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Sinka, M. E. et al. Modelling the relative abundance of the primary African vectors of malaria before and after the implementation of indoor, insecticide-based vector control. Malar. J. 15, 142 (2016)." href="/articles/s41586-025-10015-z#ref-CR39" id="ref-link-section-d70647809e2294"&gt;39&lt;/a&gt;&lt;/sup&gt;, providing for each 5 × 5 km grid cell a three-way weighting of malaria vector species. We omit explicit modelling of the invasive &lt;i&gt;Anopheles stephensi&lt;/i&gt; vector but acknowledge this mosquito represents a substantial emerging threat.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec15"&gt;Socioeconomics&lt;/h4&gt;&lt;p&gt;Improved housing has been shown to reduce risk of malaria infection&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Tusting, L. S. et al. Housing improvements and malaria risk in sub-Saharan Africa: a multi-country analysis of survey data. PLoS Med. 14, e1002234 (2017)." href="/articles/s41586-025-10015-z#ref-CR62" id="ref-link-section-d70647809e2310"&gt;62&lt;/a&gt;&lt;/sup&gt; and is a key mechanism by which socioeconomic development impacts malaria independently of direct malaria investment. We updated existing estimates of the prevalence of improved housing&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Tusting, L. S. et al. Mapping changes in housing in sub-Saharan Africa from 2000 to 2015. Nature 568, 391–394 (2019)." href="/articles/s41586-025-10015-z#ref-CR42" id="ref-link-section-d70647809e2314"&gt;42&lt;/a&gt;&lt;/sup&gt; using data on characteristics of 1,083,386 households across Africa&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="The Demographic and Health Survey Program. The DHS Program 
                http://www.dhsprogram.com
                
               (2024)." href="/articles/s41586-025-10015-z#ref-CR63" id="ref-link-section-d70647809e2318"&gt;63&lt;/a&gt;&lt;/sup&gt; and predictors that include gridded data on population density&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Wang, X., Meng, X. &amp;amp; Long, Y. Projecting 1 km-grid population distributions from 2020 to 2100 globally under shared socioeconomic pathways. Sci. Data 9, 563 (2022)." href="/articles/s41586-025-10015-z#ref-CR49" id="ref-link-section-d70647809e2322"&gt;49&lt;/a&gt;&lt;/sup&gt;, gross domestic product&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Wang, T. &amp;amp; Sun, F. Global gridded GDP data set consistent with the shared socioeconomic pathways. Sci. Data 9, 221 (2022)." href="/articles/s41586-025-10015-z#ref-CR64" id="ref-link-section-d70647809e2326"&gt;64&lt;/a&gt;&lt;/sup&gt;, land cover&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Friedl, M. &amp;amp; Sulla-Menashe, D. MODIS/Terra+Aqua Land Cover Type Yearly L3 Global 500m SIN Grid V061. NASA EOSDIS Land Processes Distributed Active Archive Center 
                https://doi.org/10.5067/MODIS/MCD12Q1.061
                
               (2022)." href="/articles/s41586-025-10015-z#ref-CR65" id="ref-link-section-d70647809e2331"&gt;65&lt;/a&gt;&lt;/sup&gt; and travel time&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Weiss, D. J. et al. A global map of travel time to cities to assess inequalities in accessibility in 2015. Nature 553, 333–336 (2018)." href="/articles/s41586-025-10015-z#ref-CR66" id="ref-link-section-d70647809e2335"&gt;66&lt;/a&gt;&lt;/sup&gt;. To account for the lifespan of buildings, a monotonicity constraint (increasing) was applied. We did not seek to model future trends in improved housing, and 2022 was used as the present-day baseline for projections.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;Preparation of historical malaria response data&lt;/h3&gt;&lt;p&gt;A total of 49,994 geo-located observations of &lt;i&gt;Pf&lt;/i&gt;PR were collated from Demographic and Health Surveys (DHS) Program and other nationally representative surveys&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="The Demographic and Health Survey Program. The DHS Program 
                http://www.dhsprogram.com
                
               (2024)." href="/articles/s41586-025-10015-z#ref-CR63" id="ref-link-section-d70647809e2352"&gt;63&lt;/a&gt;&lt;/sup&gt; and systematic literature review&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Malaria Atlas Project. map 
                https://data.malariaatlas.org
                
               (2025)." href="/articles/s41586-025-10015-z#ref-CR41" id="ref-link-section-d70647809e2356"&gt;41&lt;/a&gt;&lt;/sup&gt;, representing 2.54 million people tested between 1995 and 2021 across 41 African countries. These data were standardized for age (to 2–10 years) and diagnostic type (to light microscopy), consistent with established approaches to modelling these data&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Weiss, D. J. et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. Lancet 394, 322–331 (2019)." href="/articles/s41586-025-10015-z#ref-CR67" id="ref-link-section-d70647809e2360"&gt;67&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Characterizing historical climate, housing, intervention and other contextual effects on malaria&lt;/h3&gt;&lt;p&gt;We used stacked generalization&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Bhatt, S. et al. Improved prediction accuracy for disease risk mapping using Gaussian process stacked generalization. J. R. Soc. Interface 14, 20170520 (2017)." href="/articles/s41586-025-10015-z#ref-CR68" id="ref-link-section-d70647809e2372"&gt;68&lt;/a&gt;&lt;/sup&gt; to regress the predictor variables onto &lt;i&gt;Pf&lt;/i&gt;PR observations. This method, which ensembles out-of-sample predictions from several ‘level 0’ models as predictors in a final geostatistical generalizer, has been shown to outperform standard model-based geostatistics when applied to &lt;i&gt;Pf&lt;/i&gt;PR data&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Bhatt, S. et al. Improved prediction accuracy for disease risk mapping using Gaussian process stacked generalization. J. R. Soc. Interface 14, 20170520 (2017)." href="/articles/s41586-025-10015-z#ref-CR68" id="ref-link-section-d70647809e2382"&gt;68&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;Three ‘level 0’ models were used in this analysis:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(1)&lt;/span&gt;
                  
                    &lt;p&gt;Linear model: for observed &lt;i&gt;Pf&lt;/i&gt;PR &lt;i&gt;y&lt;/i&gt;,&lt;/p&gt;&lt;div id="Equ5" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\begin{array}{c}\mathrm{elogit}\,{y}_{s,t} \sim \mathrm{Normal}({{\rm{\mu }}}_{s,t},{\sigma }_{{\epsilon }}^{2})\\ {{\rm{\mu }}}_{s,t}={U}_{c[s]}+\tilde{\beta {\prime} }{X}_{s,t}^{\mathrm{climate}}+\tilde{\gamma {\prime} }{X}_{s,t}^{\mathrm{contextual}}\end{array}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;U&lt;/i&gt;&lt;sub&gt;&lt;i&gt;c&lt;/i&gt;[&lt;i&gt;s&lt;/i&gt;]&lt;/sub&gt; was a country-specific intercept, &lt;span class="mathjax-tex"&gt;\({X}_{s,t}^{{\rm{climate}}}\)&lt;/span&gt; was a matrix with columns (i) standardized as inh-transformed HSI, cumulative across 2- and 3-month lags; (ii) standardized TSI at 1-month lag, (iii) their multiplicative interaction; (iv) and (v) &lt;i&gt;A. arabiensis&lt;/i&gt; relative abundance weighted versions of (i) and (ii); and finally (vi), (vii) &lt;i&gt;A. funestus&lt;/i&gt; relative abundance weighted versions of (i) and (ii) (&lt;i&gt;A. gambiae&lt;/i&gt; (s.s. and &lt;i&gt;coluzzi&lt;/i&gt;) was taken as our reference species for terms (i) and (ii)). &lt;span class="mathjax-tex"&gt;\({X}_{s,{t}}^{{\rm{contextual}}}\)&lt;/span&gt; was a five-column matrix consisting of prevalence of improved housing, the ITN interaction term, IRS coverage, access to effective treatment with an antimalarial and SMC coverage. &lt;span class="mathjax-tex"&gt;\({\sigma }_{{\epsilon }}^{2}\)&lt;/span&gt; denotes variance of the Gaussian noise term. &lt;span class="mathjax-tex"&gt;\({\rm{elogit}}\)&lt;/span&gt; denotes the empirical logit.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(2)&lt;/span&gt;
                  
                    &lt;p&gt;Generalized additive model: model formula as for meta-model (1), with &lt;i&gt;A. funestus&lt;/i&gt; as reference species, and the linear terms for &lt;i&gt;A. gambiae&lt;/i&gt; relative abundance weighted HSI, housing, IRS and SMC replaced with penalized cubic splines.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(3)&lt;/span&gt;
                  
                    &lt;p&gt;Generalized boosted regression: model formula as for meta-model (1), with interaction term removed and replaced with species-specific terms. Monotonicity constraints were placed on the model terms to prevent spurious results. A total of 1,000 trees were fit, with an interaction depth of four.&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;p&gt;These three models were fit to the &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt; dataset described above, avoiding overfitting by using fivefold cross-validation to generate out-of-sample predictions to be used as fixed effects when training the level 1 generalizer model. For tractability, we modified the stacked generalization approach by, for each level 0 model, generating these hold-out predictions with interventions set to zero. That is, each of the level 0 models provided an (out-of-sample) predictor representing estimated risk in the absence of interventions.&lt;/p&gt;&lt;p&gt;Each intervention class was then included in the geostatistical primary model as a fixed effect. For location &lt;i&gt;s&lt;/i&gt; and time &lt;i&gt;t&lt;/i&gt; the generalizer model can be expressed, for &lt;i&gt;Pf&lt;/i&gt;PR &lt;i&gt;y&lt;/i&gt;&lt;sub&gt;&lt;i&gt;s,t&lt;/i&gt;&lt;/sub&gt;, as:&lt;/p&gt;&lt;div id="Equ6" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\begin{array}{c}\mathrm{elogit}\,{y}_{s,t} \sim \mathrm{Normal}({\eta }_{s,t},{\sigma }_{{\epsilon }}^{2})\\ {\eta }_{s,t}=\mathop{\sum }\limits_{i=1}^{3}{\beta }_{i}^{{\prime} }{X}_{i,s,t}+\mathop{\sum }\limits_{j=1}^{4}{\gamma }_{j}^{{\prime} }{I}_{j,s,t}+{Z}_{s,t}\\ {Z}_{s,t} \sim {\mathcal{G}}{\mathcal{P}}\,(0,{\Sigma }_{\mathrm{space}}\otimes {\Sigma }_{\mathrm{time}})\\ {\Sigma }_{\mathrm{space}} \sim \mathrm{Mat}{\rm{ \acute{{\rm{e}}} }}\mathrm{rn}(5/2),\mathrm{PC}\,\mathrm{prior}\,:P\left(\mathrm{range} &amp;lt; \frac{7{\rm{\pi }}}{180}\right)=0.1,\\ P({{\sigma }}_{\mathrm{space}} &amp;gt; \,\log (1.1))=0.01\\ {\Sigma }_{\mathrm{time}} \sim \mathrm{AR}(1)(\rho ),\mathrm{PC}\,\mathrm{prior}\,:P(\rho  &amp;gt; 0.7)=0.99,\\ P({{\sigma }}_{\mathrm{time}} &amp;gt; 0.05)=0.01\\ {\beta }_{i}^{{\prime} } \sim N(0,1)\\ {\gamma }_{1}^{{\prime} } \sim N(4,0.1)\\ {\gamma }_{2}^{{\prime} } \sim N(0.5,0.1)\\ {\gamma }_{j}^{{\prime} } \sim N(0.5,1),j=3,4\end{array}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;X&lt;/i&gt;&lt;sub&gt;&lt;i&gt;s,t&lt;/i&gt;&lt;/sub&gt; are the out-of-sample zero-intervention predictions forming the level 0 stack, &lt;i&gt;I&lt;/i&gt;&lt;sub&gt;&lt;i&gt;s,t&lt;/i&gt;&lt;/sub&gt; is the vector of malaria control coverage (interacted with pre-intervention-era &lt;i&gt;Pf&lt;/i&gt;PR, in the case of ITNs) at pixel &lt;i&gt;s&lt;/i&gt; at time &lt;i&gt;t&lt;/i&gt;, &lt;i&gt;Z&lt;/i&gt; is spatio-temporal random field with separable Matérn-5/2 spatial and AR(1) temporal kernel. The meta-learner slopes &lt;i&gt;β&lt;/i&gt;′ were non-negative—a sufficient condition for stacked generalization&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Bhatt, S. et al. Improved prediction accuracy for disease risk mapping using Gaussian process stacked generalization. J. R. Soc. Interface 14, 20170520 (2017)." href="/articles/s41586-025-10015-z#ref-CR68" id="ref-link-section-d70647809e3470"&gt;68&lt;/a&gt;&lt;/sup&gt;. Following previous approaches to modelling &lt;i&gt;Pf&lt;/i&gt;PR, we used a Gaussian likelihood and empirical logit transform to ensure well-specified posterior distributions&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Haldane, J. B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet. 20, 309–311 (1956)." href="/articles/s41586-025-10015-z#ref-CR69" id="ref-link-section-d70647809e3477"&gt;69&lt;/a&gt;&lt;/sup&gt;. The geostatistical model was fit in R 4.2.0 using INLA v.22.12.16 (refs. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Rue, H., Martino, S. &amp;amp; Chopin, R. Approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations (with discussion). J. R. Stat. Soc. B. 71, 319–392 (2009)." href="/articles/s41586-025-10015-z#ref-CR70" id="ref-link-section-d70647809e3481"&gt;70&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Lingren, F. An explicit link between Gaussian fields and Gaussian Markov random fields: the SPDE approach (with discussion). J. R. Stat. Soc. B. 73, 423–498 (2011)." href="/articles/s41586-025-10015-z#ref-CR71" id="ref-link-section-d70647809e3484"&gt;71&lt;/a&gt;&lt;/sup&gt;). Fitted parameters for both the level 0 models and geostatistical generalizer model are given in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;Supplementary Information&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;This modelling approach estimates the empirical associations between each predictor and &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;. Counterfactual predictions may then be constructed by modifying covariates of interest, holding other variables constant, and using the fitted parameters to generate predictions of &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;, which can then be differenced from a baseline prediction in which all variables were held constant. By repeating the procedure for each predictor and combination of predictors, we estimate the change in response attributed to change in covariates, conditioned on the model structure and observed data.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec18"&gt;Validation&lt;/h4&gt;&lt;p&gt;In-sample observed versus fitted correlation was 0.86 and mean absolute error was 8.5% at cluster and 1.1% at DHS survey aggregate. Verification of out-of-sample predictive ability using fivefold cross-validation yielded out-of-sample correlation of 0.83, mean absolute error of 9.5% (2.5% DHS survey out-of-sample aggregate). Further validation details are provided in Supplementary Information section &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;5.2&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Generation of future scenarios of extreme weather events&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec20"&gt;Scenario-based projections of flood events&lt;/h4&gt;&lt;p&gt;Random Forest models were developed to predict flood occurrence, extent and duration. The training set consisted of historic flood events extracted at 230-m spatial resolution from Floodbase&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Tellman, B. et al. Satellite imaging reveals increased proportion of population exposed to floods. Nature 596, 80–86 (2021)." href="/articles/s41586-025-10015-z#ref-CR43" id="ref-link-section-d70647809e3529"&gt;43&lt;/a&gt;&lt;/sup&gt;, aggregated to Pfafstetter level 4 basin and over-sampled to reduce bias arising from data imbalance. A binary classifier was trained on historic level 4 basin flood occurrence using predictors that included rainfall and Atlantic and Indian Oceans sea-surface temperatures (see Supplementary Information Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;7&lt;/a&gt; for a full description of 27 predictors).&lt;/p&gt;&lt;p&gt;Flood extent (in square kilometres) and duration were modelled probabilistically with similar predictors (see Supplementary Tables &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;8&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM1"&gt;9&lt;/a&gt; for full description).&lt;/p&gt;&lt;p&gt;The performance of the three flood models was assessed using a 30% test set. The frequency model correctly classified 82% of occurrences and 85% of non-occurrences (area under the curve 0.84), whereas the duration and extent models had &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; values of 0.83 and 0.81, respectively.&lt;/p&gt;&lt;p&gt;We calculated GCM-specific future projections of flood occurrence, duration and extent by level 4 basin for 2024–2049. For each GCM, the simulated period 2024–2026 was resampled to generate future counterfactual scenarios representing present-day climate flood frequency and extents. To downscale the predicted level 4 basin-level extents, high-resolution occurrence data of historic floods&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Tellman, B. et al. Satellite imaging reveals increased proportion of population exposed to floods. Nature 596, 80–86 (2021)." href="/articles/s41586-025-10015-z#ref-CR43" id="ref-link-section-d70647809e3555"&gt;43&lt;/a&gt;&lt;/sup&gt; were combined with a hydrological model&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Wing, O. E. J. et al. A 30 m global flood inundation model for any climate scenario. Water Resour. Res. 60, e2023WR036460 (2024)." href="/articles/s41586-025-10015-z#ref-CR72" id="ref-link-section-d70647809e3559"&gt;72&lt;/a&gt;&lt;/sup&gt; to obtain, for each grid cell, flood propensity scores. For each flood event, grid-cells were then flooded from highest to lowest flood propensity until the predicted extent was reached. Projections were ceteris paribus, with land use variables held constant.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec21"&gt;Scenario-based projections of cyclones&lt;/h4&gt;&lt;p&gt;Historical Indian Ocean cyclone data (track morphology, start and end date, wind speeds) were obtained from IBTrACS&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Knapp, K. et al. The International Best Track Archive for Climate Stewardship (IBTrACS): unifying tropical cyclone best track data. Bull. Am. Meteorol. Soc. 91, 363–376 (2010)." href="/articles/s41586-025-10015-z#ref-CR44" id="ref-link-section-d70647809e3571"&gt;44&lt;/a&gt;&lt;/sup&gt;. Storms in the IBTrACS database coming within 50 km of the coast of Africa were included, yielding a training set of 192 tropical depressions, storms and cyclones since 1980. Future scenarios of cyclone genesis and trajectories were generated using the Imperial College Storm Model (IRIS) dataset&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Sparks, N. &amp;amp; Toumi, R. The Imperial College storm model (IRIS) dataset. Sci. Data 11, 424 (2024)." href="/articles/s41586-025-10015-z#ref-CR45" id="ref-link-section-d70647809e3575"&gt;45&lt;/a&gt;&lt;/sup&gt;—a 10,000-year synthetic dataset of statistical characteristics of cyclones, adjusted with climate data from the downscaled and bias-corrected CMIP6 models. Following the IRIS method, we modelled cyclone generation events (commencing from the point of lifetime maximum intensity (LMI)), with probability of occurrence at each location in the southern Indian Ocean modelled as Poisson distributed with spatial variation learned using coordinates of historic LMI locations. From these LMIs, synthetic tracks were generated by perturbing historical tracks using forecast cone uncertainty.&lt;/p&gt;&lt;p&gt;The maximum sustained wind speeds at LMI were calculated using climate data and thermodynamic constraints, including potential intensity. After LMI, the model simulated intensity decay separately for ocean and land. Track steering and wind speed calculations used decay rates based on observed data and projected climate variables. Cyclone size was calculated dynamically, starting from LMI using a radial wind profile evolving along the track, capturing intensity-dependent size changes. Minimum pressure during the decay phase was modelled using a unified pressure-wind relationship, influenced by storm size and latitude. These components together generated synthetic cyclone datasets that replicated key physical and statistical characteristics of observed cyclones.&lt;/p&gt;&lt;p&gt;Only category 1 or greater cyclones making landfall in Africa were included in our final scenarios. Cyclones were assumed to begin at LMI, and tracks were terminated when modelled wind speed fell below tropical storm threshold (63 km h&lt;sup&gt;−1&lt;/sup&gt;). A counterfactual future scenario of cyclones reflecting present-day climate conditions was generated by resampling past cyclones, with Poisson rates of each category given by their frequency since 1980. Impact footprints were calculated based on &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;18&lt;/sub&gt;—the radius of damaging winds.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Parameterizing impact of extreme weather events on housing and interventions&lt;/h3&gt;&lt;p&gt;Extreme weather events were modelled as disrupting access to three key suppressants of malaria transmission: (1) improved housing, (2) indoor vector control tools and (3) access to antimalarial treatment. The magnitude and duration of disruption was parameterized for each event class and severity on the basis of a mixed-methods approach: a literature review extracted 22 studies from the peer-reviewed and grey literature documenting the impact of extreme weather events (Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-10015-z#Tab2"&gt;2&lt;/a&gt;). This process was augmented with 34 expert interviews. Parameters derived from this exercise were used to define recovery curves to be applied within footprints of extreme events, shown schematically in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig5"&gt;2&lt;/a&gt;, with parameters described in Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-10015-z#Tab3"&gt;3&lt;/a&gt;. Acute and persisting impacts were differentiated, with the latter parameterized sigmoidally by time to 50% and 99% recovery. Uncertainty in the magnitude of disruption was then represented using a 50–150% scaling around the consensus central values.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Projecting impact of extreme weather events on housing and interventions&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec24"&gt;Disruptions to healthcare accessibility&lt;/h4&gt;&lt;p&gt;Present-day access to effective treatment (EFT) for clinical malaria at location &lt;i&gt;s&lt;/i&gt; was estimated using a composite of three surfaces generated by the Malaria Atlas Project&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Malaria Atlas Project. map 
                https://data.malariaatlas.org
                
               (2025)." href="/articles/s41586-025-10015-z#ref-CR41" id="ref-link-section-d70647809e3624"&gt;41&lt;/a&gt;&lt;/sup&gt;: probability of care-seeking c&lt;sub&gt;&lt;i&gt;s&lt;/i&gt;&lt;/sub&gt;, use of antimalarial drugs &lt;span class="mathjax-tex"&gt;\({p}_{s}^{{\rm{drug}}}\)&lt;/span&gt;, and drug- and location-specific therapeutic efficacy &lt;span class="mathjax-tex"&gt;\({E}_{s}^{{\rm{drug}}}\)&lt;/span&gt;:&lt;/p&gt;&lt;div id="Equ7" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\rm{EFT}}}_{s}={c}_{s}{\sum }_{{\rm{drug}}}{p}_{s}^{{\rm{drug}}}{E}_{s}^{{\rm{drug}}},$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where ‘drug’ is one of artemisinin combination therapy (the first-line treatment for &lt;i&gt;falciparum&lt;/i&gt; malaria in Africa), amodiaquine, sulfadoxine-pyrimethamine, chloroquine or quinine.&lt;/p&gt;&lt;p&gt;Using a database of health facility geolocations&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Weiss, D. J. et al. Global maps of travel time to healthcare facilities. Nat. Med. 26, 1835–1838 (2020)." href="/articles/s41586-025-10015-z#ref-CR73" id="ref-link-section-d70647809e3793"&gt;73&lt;/a&gt;&lt;/sup&gt;, a transport network model for Africa&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="OpenStreetMap contributors. Planet OSM 
                https://planet.openstreetmap.org
                
               (2015)." href="/articles/s41586-025-10015-z#ref-CR74" id="ref-link-section-d70647809e3797"&gt;74&lt;/a&gt;&lt;/sup&gt; and a least-cost-path journey time algorithm&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Weiss, D. J. et al. A global map of travel time to cities to assess inequalities in accessibility in 2015. Nature 553, 333–336 (2018)." href="/articles/s41586-025-10015-z#ref-CR66" id="ref-link-section-d70647809e3801"&gt;66&lt;/a&gt;&lt;/sup&gt;, we determined present-day (disruption free) travel time to health facilities for each grid cell. A bi-exponential relationship between these travel times &lt;span class="mathjax-tex"&gt;\({{\mathcal{T}}}_{s}\)&lt;/span&gt; and 104,516 geo-located observations of propensity to seek care for fever was fitted, resulting in the function:&lt;/p&gt;&lt;div id="Equ8" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{t}}\_{\rm{decay}}({{\mathcal{T}}}_{s})=0.1451\,\exp (-0.0798{{\mathcal{T}}}_{s})+0.5396\,\exp (-0.0008\,{{\mathcal{T}}}_{s}).$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;Health facilities located within the footprint of extreme weather extents were considered non-functional during acute impacts, with the proportion of facilities in each 5 × 5 km grid cell remaining non-functional in the post-acute period sampled from a binomial distribution, with probability of closure given by intersecting the appropriate recovery curve with a time-since-last-event surface. Given these dynamic functional facility geolocations, we recalculated travel time to health facilities for each scenario, by month, to 2050. In addition to facility closures, damage to road infrastructure was parameterized as travel time penalties derived from the recovery curves and time-since-event surfaces overlaid on the OpenStreetMap road network&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="OpenStreetMap contributors. Planet OSM 
                https://planet.openstreetmap.org
                
               (2015)." href="/articles/s41586-025-10015-z#ref-CR74" id="ref-link-section-d70647809e3962"&gt;74&lt;/a&gt;&lt;/sup&gt;. Off-road travel time was recalculated by perturbing a friction surface&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Weiss, D. J. et al. Global maps of travel time to healthcare facilities. Nat. Med. 26, 1835–1838 (2020)." href="/articles/s41586-025-10015-z#ref-CR73" id="ref-link-section-d70647809e3966"&gt;73&lt;/a&gt;&lt;/sup&gt; in the same way. The result was scenario-specific travel time to healthcare &lt;span class="mathjax-tex"&gt;\({{\mathcal{T}}}_{s}^{{\rm{scenario}}}\)&lt;/span&gt;. We then calculated care-seeking penalties relative to undisrupted conditions, so that at location &lt;i&gt;s&lt;/i&gt; and time &lt;i&gt;t&lt;/i&gt;:&lt;/p&gt;&lt;div id="Equ9" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\rm{EFT}}}_{s,t}^{{\rm{scenario}}}=\frac{{\rm{t}}\_{\rm{decay}}({{\mathcal{T}}}_{s,\,t}^{{\rm{scenario}}})}{{\rm{t}}\_{\rm{decay}}({{\mathcal{T}}}_{s}^{{\rm{no}}\,{\rm{disruption}}})}{c}_{s}{\sum }_{{\rm{drug}}}{p}_{s}^{{\rm{drug}}}{E}_{s}^{{\rm{drug}}}.$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;Antimalarial efficacy, proportional usage of different antimalarials and secular variation in care-seeking behaviour were held constant, as was the undisrupted transport network.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec25"&gt;Disruptions to ITN coverage and access to improved housing&lt;/h4&gt;&lt;p&gt;ITN campaigns were simulated every three years on 1 January, commencing in 2025. As we aimed to model unmitigated impacts of extreme weather events, disrupted ITN coverage did not return to normal until the next simulated campaign. ITN access was assumed to be lost if access to housing was acutely disrupted. Access to improved housing was directly perturbed using the derived recovery curve.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Projecting ecological and disruptive effects of climate change&lt;/h3&gt;&lt;p&gt;A set of scenarios was defined to derive the ecological, disruptive and combined impacts of climate change by the 2040s; these are described in Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-10015-z#Tab1"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;To model ecologically driven impacts of climate change we generated estimates of monthly &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt; from 2019 to 2049 for each of the 14 ensemble members. A climate-change-free scenario (&lt;i&gt;E&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt;) was defined as the ensemble mean of median &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;, 2019–2022, and corresponding scenario of future changes in ecological suitability (&lt;i&gt;E&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;) as ensemble mean of median &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;, 2040–2049. The ecological impact of climate change was thus estimated by the difference &lt;i&gt;E&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; −&lt;i&gt; E&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig1"&gt;1a&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;We derived counterfactual and SSP 2-4.5 extreme weather event scenarios for a tractable subset of three GCMs: ACCESS-CM2, EC-Earth3-Veg-LR and MPI-ESM1-2-LR. For each ensemble member, two time-series of spatial &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt; projections were calculated. Scenario &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; was defined as the (three-GCM) ensemble mean of median &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;, 2040–2049, generated with present-day TSI and HSI as in &lt;i&gt;E&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; and with extreme events simulated as occurring at present-day frequency. Still holding TSI and HSI at present-day levels, SSP 2-4.5 projections of changing extreme weather event frequency were imposed to derive scenario &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, so that the difference &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; − &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; isolated the impact of disruptive events due to climate change (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig2"&gt;2a&lt;/a&gt; and Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-10015-z#Tab1"&gt;1&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;Ecological and disruptive impacts were combined by defining &lt;i&gt;C&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; equal to &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; (that is, present-day climate suitability and extreme event frequency). SSP 2-4.5 projections of changing climate suitability indices (as in &lt;i&gt;E&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;) and changing extreme weather frequency (as in &lt;i&gt;D&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;) were combined to generate &lt;i&gt;C&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, the (three-GCM) ensemble mean of median &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt;, 2040–2049. The combined ecological and disruptive impacts were then calculated as &lt;i&gt;C&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; − &lt;i&gt;C&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-10015-z#Fig2"&gt;2b&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;Projected &lt;i&gt;Pf&lt;/i&gt;PR&lt;sub&gt;2–10&lt;/sub&gt; for each scenario was converted to clinical case incidence using an established natural history model&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Cameron, E. et al. Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria. Nat. Commun. 6, 8170 (2015)." href="/articles/s41586-025-10015-z#ref-CR48" id="ref-link-section-d70647809e4361"&gt;48&lt;/a&gt;&lt;/sup&gt;. Gridded population projections consistent with SSP 2-4.5 were used to generate estimates of absolute cases&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Wang, X., Meng, X. &amp;amp; Long, Y. Projecting 1 km-grid population distributions from 2020 to 2100 globally under shared socioeconomic pathways. Sci. Data 9, 563 (2022)." href="/articles/s41586-025-10015-z#ref-CR49" id="ref-link-section-d70647809e4365"&gt;49&lt;/a&gt;&lt;/sup&gt;. Projected time-series of clinical cases and mortality were scaled to align with 2022 official World Health Organization estimates, as reported in World Malaria Report 2023 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="World Malaria Report 2023 (World Health Organization, 2023)." href="/articles/s41586-025-10015-z#ref-CR50" id="ref-link-section-d70647809e4369"&gt;50&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-10015-z#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 16:05:48 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE9YUUtzQXlaaUNkbUV0NmkxQ3NRUGFURGVrdVZ5OFpxRFJKWWl6YUF1UU9xQmoycG1BdDB0SkszWHk1NGF2TU9rVmtYS3c1b1dHRUl4cmVtXzcwY1N4QklR</guid></item><item><title>借助AlphaGenome ，研究人员正在使用人工智能来解码人类蓝图-《纽约时报》</title><link>https://www.nytimes.com/2026/01/28/science/alphagenome-ai-deepmind-genetics.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 28 Jan 2026 16:00:26 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMihwFBVV95cUxNMFlvQXpxNkhTVUM1VXZSMUpPQW1US3lqTG9aUGFQaTlyY3VNaWtjTHc4bzRPRExVWkNGT0E0VnZPeW5RcDRQMXZQQXRWcWFWZDY2V1RmUDF2c1ZxY1Q0NXRLRU9qaWluQXRVd2tMRG4zRUVUd0ktcEtoU1hMMTN5V3l4Zm51VXM</guid></item><item><title>印度表示，随着一些亚洲国家加强健康筛查，它已遏制了尼帕病毒的爆发- ABC新闻</title><link>https://abcnews.go.com/International/wireStory/india-contained-nipah-virus-outbreak-asian-countries-ramp-129625736</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;&lt;span class="oyrPY qlwaB AGxeB  "&gt;NEW DELHI -- &lt;/span&gt;Indian authorities said they had contained a Nipah virus outbreak after confirming two cases in the eastern state of West Bengal, as several Asian countries tightened health screenings and airport surveillance for travelers arriving from India.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;India’s Health Ministry said Tuesday that two Nipah cases had been detected since December and that all identified contacts had been quarantined and tested. The ministry did not release details about the patients but said 196 contacts had been traced and all tested negative.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;“The situation is under constant monitoring, and all necessary public health measures are in place,” the ministry said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Nipah, a zoonotic virus first identified during a 1990s outbreak in Malaysia, spreads through fruit bats, pigs and human-to-human contact. There is no vaccine for the virus, which can cause raging fevers, convulsions and vomiting. The only treatment is supportive care to control complications and keep patients comfortable.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The virus has an estimated fatality rate of between 40% and 75%, according to the WHO, making it far more deadly than the coronavirus.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;There were no reported cases of the virus outside India, but several Asian countries introduced or reinforced screening measures at airports as a precaution.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Indonesia and Thailand increased screening at major airports, with health declarations, temperature checks and visual monitoring for arriving passengers. Thailand’s Department of Disease Control said thermal scanners had been installed at arrival gates for direct flights from West Bengal at Bangkok’s Suvarnabhumi Airport.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Myanmar’s Health Ministry advised against nonessential travel to West Bengal and urged travelers to seek immediate medical care if symptoms develop within 14 days of travel. It said fever surveillance introduced during the COVID-19 pandemic at airports has been intensified for passengers arriving from India, with laboratory testing capacity and medical supplies readied.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Vietnam’s Health Ministry on Tuesday urged strict food safety practices and directed local authorities to increase monitoring at border crossings, health facilities and communities, according to state media.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;China said it was strengthening disease prevention measures in border areas. State media reported that health authorities had begun risk assessments and enhanced training for medical staff, while increasing monitoring and testing capabilities.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Earlier Nipah outbreaks were reported in West Bengal in 2001 and 2007, while recent cases have largely been detected in southern Kerala state. A major outbreak in 2018 killed at least 17 people in Kerala.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;——&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC eTIW sUzSN "&gt;Associated Press journalists across Asia contributed to this report.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ABC News</author><pubDate>Wed, 28 Jan 2026 15:51:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>印度尼帕病毒爆发引发亚洲机场安检-雅虎加拿大新闻</title><link>https://ca.news.yahoo.com/nipah-virus-outbreak-india-triggers-080220469.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="" data-article-body="true"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;An outbreak of the deadly Nipah virus in India's West Bengal state has sparked concern in parts of Asia, with some tightening screening measures at airports.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Thailand has started screening passengers at three airports that receive flights from West Bengal. Nepal has also begun screening arrivals at Kathmandu airport and other land border points with India.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Two cases have been confirmed in West Bengal since December, reportedly in healthcare workers. Some 196 people who were in contact with them have been traced and tested negative for the virus, India's health ministry says.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The virus can spread from animals to humans. It has a high death range – ranging from 40% to 75% – as there is no vaccine or medicine to treat it.&lt;/p&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl"&gt;What is the Nipah virus and what are its symptoms?&lt;/h2&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The Nipah virus can be transmitted from animals, like pigs and fruit bats, to humans. It can also spread person-to-person through contaminated food.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The World Health Organization has described Nipah in its top ten priority diseases, along with pathogens like Covid-19 and Zika, because of its potential to trigger an epidemic.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The incubation period ranges from four to 14 days.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;People who contract the virus show a wide range of symptoms, or sometimes, none at all.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Initial symptoms may include fever, headaches, muscle pain, vomiting and sore throat. In some people, these may be followed by drowsiness, altered consciousness, and pneumonia.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Encephalitis, a sometimes-fatal condition that causes inflammation of the brain, may occur in severe cases.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;To date, no drugs of vaccines have been approved to treat the disease.&lt;/p&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;[BBC]&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl"&gt;Where were the past outbreaks?&lt;/h2&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The first recognised Nipah outbreak was in 1998 among pig farmers in Malaysia and later spread to neighbouring Singapore. The virus got its name from the village where it was first discovered.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;More than 100 people died and a million pigs culled in an effort to contain the virus. It also resulted in significant economic losses for farmers and those in the livestock trade.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Bangladesh has borne the brunt in recent years, with more than 100 people dying of Nipah since 2001.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The virus has also been detected in India. Outbreaks were reported in West Bengal in 2001 and 2007.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;More recently, the southern state of Kerala has been a Nipah hotspot. In 2018, 19 cases were reported of which 17 were fatal; and in 2023, two out of six confirmed cases later died.&lt;/p&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl"&gt;What is happening now?&lt;/h2&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;India's health ministry said that following confirmation of the cases in West Bengal, contacts of the infected individuals were "identified, traced, monitored, and tested" - and had been found to be asymptomatic.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;"The situation is under constant monitoring, and all necessary public health measures are in place," the ministry said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;No cases have yet been reported outside India, but several countries are stepping up precautions.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;On Sunday, Thailand started screening passengers at three international airports in Bangkok and Phuket that receive flights from West Bengal. Passengers from these flights have been asked to make health declarations.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The parks and wildlife department has also implemented stricter screenings in natural tourist attractions.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Jurai Wongswasdi, a spokeswoman for the Department for Disease Control, told BBC Thai authorities are "fairly confident" about guarding against an outbreak in Thailand.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Nepal, too, has begun screening people arriving through the airport in Kathmandu and other land border points with India.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Meanwhile, health authorities in Taiwan have proposed to list the Nipah virus as a "Category 5 disease". Under the island's system, diseases classified as Category 5 are emerging or rare infections with major public health risks, that require immediate reporting and special control measures.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;em&gt;Correction: An earlier version of this story said that at least five people had been infected in West Bengal but India's health ministry later released a statement saying only two cases had been confirmed in the state since December.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Yahoo News Canada</author><pubDate>Wed, 28 Jan 2026 15:49:21 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxOUUpJdmZ6b2Q2SjZoQ2NMMXRNbDRYRWNNQV85YWtBZllvUUhUMHNOa1NIVTNVSHRjWi1fNVh4aEU1cnYxQlZudzlXS3NNOFlSb2xmMkhHRUs0Y2VjdzV5Wl9fTW9JeTdhX3lvSWVYOFN6YU0zYTYwUGdINzBsaHc0YmJB</guid></item><item><title>服用维生素D以最大限度吸收的最佳时间-健康：值得信赖和富有同理心的健康和保健信息</title><link>https://www.health.com/best-time-to-take-vitamin-d-for-maximum-absorption-11893374</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="mntl-sc-page_1-0" class="comp mntl-sc-page mntl-block structured-content" data-sc-sticky-offset="90" data-sc-ad-label-height="24" data-sc-ad-track-spacing="100" data-sc-min-track-height="250" data-sc-max-track-height="600" data-sc-breakpoint="50em" data-sc-load-immediate="4" data-sc-content-positions="[1, 1250, 1550, 1950, 2350, 2750, 3150, 3550, 3950]" data-bind-scroll-on-start="true"&gt;
&lt;p id="mntl-sc-block_2-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Vitamin D offers crucial benefits, such as supporting strong, healthy bones and enabling calcium absorption—but many people don’t get enough of it.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt; Supplements can help fill the gap, but is there a best time to take vitamin D for optimal absorption? According to experts, what you pair vitamin D with matters more than timing.
&lt;/p&gt;
&lt;p id="mntl-sc-block_3-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-the-best-time-to-take-vitamin-d-for-absorption"&gt;&lt;/span&gt;
&lt;p id="mntl-sc-block_5-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; There’s no evidence that vitamin D is absorbed better at certain times of the day, according to &lt;a href="https://www.drvictoriamaizes.com/" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1" rel="nofollow"&gt;Victoria Maizes, MD&lt;/a&gt;, founding executive director of the Andrew Weil Center for Integrative Medicine at the University of Arizona. 
&lt;/p&gt;
&lt;p id="mntl-sc-block_6-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_7-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Rather than timing, what’s more important is taking vitamin D with a meal that contains fat, she said. That’s because vitamin D is a fat-soluble vitamin, meaning it needs fat to dissolve and be stored in tissue.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt; 
&lt;/p&gt;
&lt;p id="mntl-sc-block_8-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_9-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; While taking vitamin D with the largest meal of the day—the one likely to contain the most fat—is a good idea, pairing it with any amount of fat can help with absorption, said &lt;a href="https://bodytosoulhealth.com/about/" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1" rel="nofollow"&gt;Jen Bianchini, MS, RD, IFNCP&lt;/a&gt;, functional nutritionist and founder at Body to Soul Health. 
&lt;/p&gt;
&lt;p id="mntl-sc-block_10-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_11-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The &lt;a href="https://www.health.com/saturated-vs-unsaturated-fat-8633405" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;type of fat&lt;/a&gt; you pair the supplement with doesn’t appear to matter—one study found no difference in vitamin D absorption when supplements were taken with both monounsaturated and polyunsaturated fats.&lt;span class="ql-inline-citation" data-cite="2"&gt;&lt;/span&gt; Foods such as nuts, avocados, fish, or olive oil could all be good choices.
&lt;/p&gt;
&lt;p id="mntl-sc-block_12-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-other-factors-to-consider"&gt;&lt;/span&gt;
&lt;p id="mntl-sc-block_14-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In addition to taking vitamin D with certain foods, dosage also plays a role in effectiveness. Not surprisingly, larger doses lead to greater absorption, Maizes said. 
&lt;/p&gt;
&lt;p id="mntl-sc-block_15-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_16-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; That said, it is possible to take too much vitamin D. Though rare, high doses taken over long periods can cause &lt;a class="recommendation-inline-link" href="https://www.health.com/side-effects-too-much-vitamin-d-11867499" link-destination-recommendation="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;vitamin D toxicity&lt;/a&gt;, which can lead to symptoms like nausea, vomiting, frequent urination, bone pain, low appetite, and fatigue.&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt; To avoid this, Maizes recommends not exceeding 4,000 International Units (IU) per day unless advised by a doctor. 
&lt;/p&gt;
&lt;p id="mntl-sc-block_17-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_18-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Choosing the right form of the vitamin is another major consideration. “Vitamin D3 requires less conversion than D2 and is more effective at raising blood levels, so Vitamin D3 is usually recommended,” said Bianchini. In fact, according to 2022 research, vitamin D3 injections were twice as effective as D2 when used alone and three times more effective when combined with an oral tablet.&lt;span class="ql-inline-citation" data-cite="4"&gt;&lt;/span&gt; 
&lt;/p&gt;
&lt;p id="mntl-sc-block_19-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-who-can-benefit-most-from-taking-vitamin-d"&gt;&lt;/span&gt;
&lt;p id="mntl-sc-block_21-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The Recommended Dietary Allowance (RDA) for vitamin D is 600 IU per day for adults under 70, which increases to 800 IU for those over 70.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt; Many people have difficulty reaching these targets because vitamin D is found in only a &lt;a href="https://www.health.com/foods-high-in-vitamin-d-11884949" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;limited number of foods&lt;/a&gt;, such as oily fish and eggs, and often in small amounts. You can also get vitamin D through ultraviolet rays, but you need about 10 to 20 minutes of direct sunlight (without sunscreen) per day to get the required amount, Bianchini said.
&lt;/p&gt;
&lt;p id="mntl-sc-block_22-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_23-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Because it can be challenging to obtain sufficient vitamin D, Bianchini believes many people may benefit from supplementation. Certain groups—such as those who live at northern latitudes, have darker skin pigmentation, or spend little time in the sun—may be particularly good candidates, according to Maizes. Weight status is another risk factor for &lt;a class="recommendation-inline-link" href="https://www.health.com/causes-of-vitamin-d-deficiency-11862028" link-destination-recommendation="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;low vitamin D levels&lt;/a&gt;. “Obese adults are less able to produce vitamin D through sun exposure,” Maizes explained.
&lt;/p&gt;
&lt;p id="mntl-sc-block_24-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_26-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_27-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you’re deficient in vitamin D, you may experience symptoms like muscle pain or weakness, bone pain, and tingling in the hands and feet.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt; However, a blood test is the best way to know if you’re lacking the nutrient. With regular testing, your healthcare team can help you determine whether a supplement is right for you.
&lt;/p&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Health: Trusted and Empathetic Health and Wellness Information</author><pubDate>Wed, 28 Jan 2026 15:28:35 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiigFBVV95cUxPNlJLT3d3YTdYUEYzSjRoUWMtdFdrQlZNeXVvcFhfN3hiTEh5NGphbnRvdXNjVE5DcmZPbDhOa1BsT3ZxTVhKekZZSENwcUJSdHJNc2d0dEx4djlFNHlsLUgwYnJoalczb3UxY3RlclRVUk9IenlOSjN2ZkI4dEl3SWxXekFVRmN3N3c</guid></item><item><title>14种可能有助于支持低能量水平的补充剂- Verywell Health</title><link>https://www.verywellhealth.com/supplements-for-energy-11887807</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="health-sc-page_1-0" class="comp health-sc-page mntl-sc-page mntl-block structured-content article-content expert-content right-rail__offset lock-journey" data-sc-sticky-offset="60" data-sc-ad-label-height="24" data-sc-ad-track-spacing="100" data-sc-min-track-height="250" data-sc-max-track-height="600" data-sc-breakpoint="50em" data-sc-load-immediate="4" data-sc-content-positions="[400, 1400, 1400, 1700, 2000, 2200, 2400, 2600, 2800]" data-bind-scroll-on-start="true"&gt;&lt;div id="health-sc-block-callout--key-takeaway_1-0" class="comp health-sc-block-callout--key-takeaway health-sc-block-callout-base mntl-sc-block-callout mntl-block theme-key-takeaway theme-key-takeaway" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;&lt;h3 id="mntl-sc-block-callout-heading_1-0" class="comp mntl-sc-block-callout-heading mntl-text-block"&gt;Key Takeaways&lt;/h3&gt;
&lt;div id="mntl-sc-block-callout-body_1-0" class="comp mntl-sc-block-callout-body mntl-text-block expert-content"&gt;&lt;ul&gt;&lt;li&gt;Low iron levels can cause fatigue, and supplements may help, but you should check with a healthcare provider first.&lt;/li&gt;&lt;li&gt;Vitamin B12 is important for energy, but only people with low levels need supplements. &lt;/li&gt;&lt;li&gt;Creatine may help with short bursts of high-intensity exercise and symptoms of mental fatigue, but more research is needed.&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p id="mntl-sc-block_2-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Persistent fatigue or lack of energy affects as many as 45% of people in the United States, making energy supplements a popular source for relief. Studies show that 30% of people who use supplements do so to boost energy, but the effects depend on several factors.&lt;span class="ql-inline-citation" data-cite="4"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_3-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-1-iron"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_4-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 1. Iron &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_5-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Around 1% of U.S. males and 11% of U.S. females have low iron levels. A &lt;a href="https://www.verywellhealth.com/iron-deficiency-signs-and-symptoms-2507719" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;deficiency of iron&lt;/a&gt; can cause symptoms such as the following:&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_6-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_7-0" class="comp mntl-sc-block mntl-sc-block-html"&gt;
&lt;li&gt;Fatigue&lt;/li&gt;
&lt;li&gt;Low endurance&lt;/li&gt;
&lt;li&gt;Restless legs&lt;/li&gt;
&lt;li&gt;&lt;a href="https://www.verywellhealth.com/facts-about-anemia-6503636" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Anemia&lt;/a&gt; (a reduction in hemoglobin, a component of red blood cells)&lt;span class="ql-inline-citation" data-cite="23"&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_8-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_9-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Iron is crucial for the transport of oxygen throughout the body. In &lt;a href="https://www.verywellhealth.com/iron-deficiency-anemia-4083289" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;iron-deficiency anemia&lt;/a&gt;, the muscles don't get as much oxygen as they need. This lowers exercise endurance:&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_10-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_11-0" class="comp mntl-sc-block mntl-sc-block-html"&gt;
&lt;li&gt;Most people can maintain iron levels through &lt;a class="recommendation-inline-link" href="https://www.verywellhealth.com/foods-high-iron-5216344" link-destination-recommendation="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;iron-rich foods&lt;/a&gt; like red meat.&lt;/li&gt;
&lt;li&gt;Those with anemia may need &lt;a href="https://www.verywellhealth.com/iron-supplements-benefits-4178814" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;iron supplements&lt;/a&gt;, either over-the-counter (OTC) or through an IV in a healthcare setting.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li&gt;It's unclear whether iron supplements benefit people who are low in iron but don't have anemia. A review of 18 trials concluded that iron improved feelings of fatigue in adults without anemia but didn't impact any physical markers of exercise ability.&lt;span class="ql-inline-citation" data-cite="23"&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_12-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_13-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Iron's main side effects involve the gastrointestinal system, including &lt;a href="https://www.verywellhealth.com/nausea-5082995" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;nausea&lt;/a&gt;, &lt;a href="https://www.verywellhealth.com/diarrhea-7152315" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;diarrhea&lt;/a&gt;, or &lt;a href="https://www.verywellhealth.com/constipation-8685701" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="3"&gt;constipation&lt;/a&gt;.&lt;span class="ql-inline-citation" data-cite="23"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_14-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_16-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-2-protein"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_17-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 2. Protein &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_18-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/what-is-a-protein-5076292" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Protein&lt;/a&gt; supports muscles, bones, and the &lt;a href="https://www.verywellhealth.com/nervous-system-1298170" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;nervous system&lt;/a&gt;. It's also vital for physical performance as you age:&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_19-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_20-0" class="comp mntl-sc-block mntl-sc-block-html"&gt;
&lt;li&gt;The average person needs around 0.8 grams (g) of protein per kilogram (g) of body weight (g/kg) daily. Typically, this is obtained through the food you eat.&lt;/li&gt;
&lt;li&gt;Athletes may need almost twice this amount (up to 1.5 g/kg body weight) in order to meet their &lt;a href="https://www.verywellhealth.com/does-protein-give-you-energy-11797021" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;energy needs&lt;/a&gt;.&lt;span class="ql-inline-citation" data-cite="9"&gt;&lt;/span&gt;&lt;br&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_21-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_22-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A small study of 60 healthy adults showed that protein supplementation for 90 days reduced low-energy periods by 25% compared to a placebo.&lt;span class="ql-inline-citation" data-cite="25"&gt;&lt;/span&gt; Participants also noted improved exercise performance.
&lt;/p&gt;
&lt;p id="mntl-sc-block_23-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_24-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Still, there's not much data on long-term protein supplementation, and it's not warranted for most people. Generally, getting protein from your diet is better than from nutritional supplements when possible.&lt;span class="ql-inline-citation" data-cite="24"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_25-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_26-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Protein powders are known to cause &lt;a href="https://www.verywellhealth.com/dehydration-symptoms-8662174" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;dehydration&lt;/a&gt; and stomach problems like nausea and constipation.&lt;span class="ql-inline-citation" data-cite="25"&gt;&lt;/span&gt; More serious side effects of protein, especially at high doses, include:&lt;span class="ql-inline-citation" data-cite="5"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_27-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_29-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_30-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; People with kidney conditions should speak to their healthcare provider before changing their protein intake.
&lt;/p&gt;
&lt;p id="mntl-sc-block_31-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-3-vitamin-b12"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_32-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 3. Vitamin B12 &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_33-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/benefits-of-vitamin-b12-8644483" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Vitamin B12&lt;/a&gt; (&lt;span data-tts="true"&gt;cobalamin&lt;/span&gt;) is essential for DNA production and cell energy. It's also crucial for oxygen transport.&lt;span class="ql-inline-citation" data-cite="12"&gt;&lt;/span&gt; 
&lt;/p&gt;
&lt;p id="mntl-sc-block_34-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_35-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Low levels of B12 are associated with symptoms like the following:&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_36-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_38-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_39-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Supplementation is needed for people with low levels of B12. However, there's not enough evidence to recommend it for the general population who get adequate B12 through the diet.
&lt;/p&gt;
&lt;p id="mntl-sc-block_40-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_41-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Also, high levels of B12 may be associated with an increased risk of &lt;a href="https://www.verywellhealth.com/how-dangerous-is-a-broken-hip-when-youre-older-2223520" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;hip fractures&lt;/a&gt; and &lt;a href="https://www.verywellhealth.com/lung-cancer-7368778" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;lung cancer&lt;/a&gt;.&lt;span class="ql-inline-citation" data-cite="11"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_42-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_44-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-4-other-b-vitamins"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_45-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 4. Other B Vitamins &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_46-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Along with vitamin B12, most other B vitamins are important for energy production in your body's cells.
&lt;/p&gt;
&lt;p id="mntl-sc-block_47-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_48-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; B vitamins that may help combat fatigue include the following:&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_49-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_51-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_52-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Low levels of these vitamins can cause conditions like the following:
&lt;/p&gt;
&lt;p id="mntl-sc-block_53-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_55-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_56-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; These conditions are each characterized by weakness and fatigue.&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_57-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_58-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A review of seven clinical trials found that supplementing with high doses of B vitamins was associated with improvements in the following:
&lt;/p&gt;
&lt;p id="mntl-sc-block_59-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_60-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;li&gt;Self-reported energy levels&lt;/li&gt;&lt;li&gt;Stamina&lt;/li&gt;&lt;li&gt;Mental health&lt;span class="ql-inline-citation" data-cite="26"&gt;&lt;/span&gt;&lt;br&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_61-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-5-creatine"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_62-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 5. Creatine &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_63-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Creatine is a popular supplement used by athletes to build muscle and enhance exercise performance.&lt;span class="ql-inline-citation" data-cite="15"&gt;&lt;/span&gt; Creatine provides energy to cells in the muscles.
&lt;/p&gt;
&lt;p id="mntl-sc-block_64-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_65-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; It is made in the body, and levels can be boosted through the diet (for instance, with &lt;a href="https://www.verywellhealth.com/foods-high-in-creatine-11798561" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;red meat and fish&lt;/a&gt;) or by taking supplements.&lt;span class="ql-inline-citation" data-cite="13"&gt;&lt;/span&gt; Most people need between 2 and 3 g of creatine a day.&lt;span class="ql-inline-citation" data-cite="15"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_66-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_67-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Creatine is likely beneficial for:
&lt;/p&gt;
&lt;p id="mntl-sc-block_68-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_69-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;li&gt; Short bursts of high-intensity exercise&lt;span class="ql-inline-citation" data-cite="13"&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;Improving symptoms of mental fatigue and enhancing memory and cognition&lt;span class="ql-inline-citation" data-cite="15"&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_70-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_71-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Research suggests it might help those with chronic fatigue syndrome or &lt;a href="https://www.verywellhealth.com/covid-long-haulers-5101640" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;long COVID&lt;/a&gt;, but more studies are needed.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_72-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-6-tyrosine"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_73-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 6. Tyrosine &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_74-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/everything-you-need-to-know-about-l-tyrosine-7567409" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Tyrosine&lt;/a&gt; is an amino acid converted into chemical messengers like &lt;a href="https://www.verywellhealth.com/dopamine-5086831" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;dopamine&lt;/a&gt; and &lt;a href="https://www.verywellhealth.com/norepinephrine-what-does-or-doesnt-it-do-for-you-3967568" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="3"&gt;norepinephrine&lt;/a&gt; in your body. These may help fight fatigue.
&lt;/p&gt;
&lt;p id="mntl-sc-block_75-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_76-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Tyrosine is available as a dietary supplement. It's also found in lots of foods, including the following:&lt;span class="ql-inline-citation" data-cite="17"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_77-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_78-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;li&gt;Cheese&lt;/li&gt;&lt;li&gt;Beans&lt;/li&gt;&lt;li&gt;Meat&lt;/li&gt;&lt;li&gt;Nuts&lt;/li&gt;&lt;li&gt;Dairy products&lt;/li&gt;&lt;li&gt;Whole grains&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_79-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_80-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Tyrosine did not appear to improve physical performance, according to a review. However, the authors suggested it may benefit mental performance during high-stress situations.&lt;span class="ql-inline-citation" data-cite="10"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_81-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_82-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In a human study, a single dose of tyrosine improved cognitive function in the short term.&lt;span class="ql-inline-citation" data-cite="17"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_83-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-7-selenium"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_84-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 7. Selenium &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_85-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/selenium-8689983" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Selenium&lt;/a&gt; is a micronutrient found in foods like meats and fish. It's also available as a dietary supplement, though getting it from the diet is more effective in raising levels.&lt;span class="ql-inline-citation" data-cite="18"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_86-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_87-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Adults typically need 55 micrograms (mcg) daily, and requirements increase during pregnancy and lactation.&lt;span class="ql-inline-citation" data-cite="16"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_88-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_89-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Selenium is highly concentrated in the &lt;a href="https://www.verywellhealth.com/thyroid-gland-anatomy-4799991" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;thyroid gland&lt;/a&gt;. It's involved in the production and breakdown of thyroid hormones.&lt;span class="ql-inline-citation" data-cite="20"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_90-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_91-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Adequate levels of selenium in the body are needed for healthy thyroid function and to prevent thyroid disorders.&lt;span class="ql-inline-citation" data-cite="18"&gt;&lt;/span&gt; If your fatigue is associated with a thyroid condition, selenium could be a helpful add-on.
&lt;/p&gt;
&lt;p id="mntl-sc-block_92-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_93-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Remember that high amounts of selenium (above 400 mcg a day) can cause toxicity. Some symptoms of toxicity include the following:&lt;span class="ql-inline-citation" data-cite="18"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_94-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_96-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-8-tea"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_97-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 8. Tea &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_98-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Ingredients commonly found in tea, like amino acid &lt;a href="https://www.verywellhealth.com/l-theanine-everything-you-need-to-know-7503944" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;L-theanine&lt;/a&gt; and stimulant &lt;a href="https://www.verywellhealth.com/natural-caffeine-8673811" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;caffeine&lt;/a&gt;, may help combat fatigue.
&lt;/p&gt;
&lt;p id="mntl-sc-block_99-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_100-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A small study of 44 young adults showed that tea containing caffeine and L-theanine can improve symptoms associated with low energy levels, such as the following:&lt;span class="ql-inline-citation" data-cite="21"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_101-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_102-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;li&gt;Alertness&lt;/li&gt;&lt;li&gt;Fatigue&lt;/li&gt;&lt;li&gt;Accuracy performing tasks&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_103-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_104-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Caffeine's effects are increased by taking it in combination with L-theanine.&lt;span class="ql-inline-citation" data-cite="22"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_105-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-9-coq10"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_106-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 9. CoQ10 &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_107-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/coenzyme-q10-88388" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Coenzyme Q10&lt;/a&gt; (CoQ10) is an &lt;a href="https://www.verywellhealth.com/antioxidants-health-benefits-nutrition-and-food-5202325" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;antioxidant&lt;/a&gt; that protects the brain and reduces inflammation.&lt;span class="ql-inline-citation" data-cite="6"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_108-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_109-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The jury is mixed on CoQ10's effects on energy levels, and benefits may vary.
&lt;/p&gt;
&lt;p id="mntl-sc-block_110-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_111-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Trials show that taking at least 300 mg daily may help people with &lt;a href="https://www.verywellhealth.com/understanding-fibromyalgia-4014067" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;fibromyalgia&lt;/a&gt;. It's also been studied for chronic fatigue syndrome, but with mixed results. While one study reported improved energy levels for those who took CoQ10, another did not.&lt;span class="ql-inline-citation" data-cite="6"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_112-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_113-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; For those without underlying conditions, CoQ10 may or may not increase energy. More research is needed to know for sure.
&lt;/p&gt;
&lt;p id="mntl-sc-block_114-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-10-ashwagandha"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_115-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 10. Ashwagandha &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_116-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellmind.com/what-to-know-about-ashwagandha-for-stress-6374003" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1" rel="nofollow"&gt;&lt;span data-tts="true"&gt;&lt;br&gt;&lt;/span&gt;Ashwagandha&lt;/a&gt; is an herb that's been used for its medicinal purposes for thousands of years. Some research suggests that one of its benefits may be improved energy.
&lt;/p&gt;
&lt;p id="mntl-sc-block_117-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_118-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; One study looked at a group of college students who took ashwagandha supplements two times each day for a month. The findings suggested that the supplements left the students feeling mental clarity and sustained energy, and led to more restful sleep.&lt;span class="ql-inline-citation" data-cite="31"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_119-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_120-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Ashwagandha can affect thyroid hormone levels, as well as testosterone levels, so those with prostate cancer that's hormone-sensitive should probably avoid the herb.&lt;span class="ql-inline-citation" data-cite="32"&gt;&lt;/span&gt;&lt;span class="ql-inline-citation" data-cite="33"&gt;&lt;/span&gt;&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_121-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-11-melatonin"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_122-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 11. Melatonin &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_123-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellmind.com/what-is-melatonin-5114942" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1" rel="nofollow"&gt;Melatonin&lt;/a&gt; is a hormone that occurs naturally, which is responsible for the timing of the circadian rhythm, or your sleep cycle. It is also commonly taken in supplement form as a sleep aid. In addition to helping you sleep, though, melatonin also helps regulate your energy metabolism.&lt;span class="ql-inline-citation" data-cite="34"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_124-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_125-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Those who struggle with regular sleep cycles may benefit from taking a melatonin supplement to help their body get back on track and see improved energy as a result.
&lt;/p&gt;
&lt;p id="mntl-sc-block_126-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_127-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; People who are breastfeeding or have an autoimmune disorder should consult with a medical professional before taking the supplement.
&lt;/p&gt;
&lt;p id="mntl-sc-block_128-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-12-rhodiola-rosea"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_129-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 12. Rhodiola Rosea &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_130-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellmind.com/how-is-rhodiola-rosea-used-to-treat-anxiety-3024972" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1" rel="nofollow"&gt;&lt;span data-tts="true"&gt;Rhodiola rosea&lt;/span&gt;&lt;/a&gt; is a plant often used in Chinese medicine to treat everything from stress and fatigue to anxiety disorders and Alzheimer's.&lt;span class="ql-inline-citation" data-cite="37"&gt;&lt;/span&gt;&lt;span class="ql-inline-citation" data-cite="36"&gt;&lt;/span&gt; Some also use it to increase energy, strength, and overall athletic performance, although more research is needed to say for sure.
&lt;/p&gt;
&lt;p id="mntl-sc-block_131-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-13-magnesium"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_132-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 13. Magnesium &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_133-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a href="https://www.verywellhealth.com/magnesium-for-constipation-and-ibsc-1944780" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Magnesium&lt;/a&gt;, a supplement usually used to relax muscles and nerves, is also promoted as an energy booster. Magnesium regulates biochemical reactions in the body, including energy production, so an imbalance may lead to a lack of energy.&lt;span class="ql-inline-citation" data-cite="39"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_134-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_135-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Magnesium supplements are generally considered safe for healthy people, but consuming too much could have side effects, like nausea and diarrhea.
&lt;/p&gt;
&lt;p id="mntl-sc-block_136-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;div id="health-sc-block-callout--explainer_1-0" class="comp health-sc-block-callout--explainer health-sc-block-callout-base mntl-sc-block-callout mntl-block theme-explainer theme-explainer" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;&lt;h3 id="mntl-sc-block-callout-heading_2-0" class="comp mntl-sc-block-callout-heading mntl-text-block"&gt;Warning for Energy Suppements&lt;/h3&gt;
&lt;div id="mntl-sc-block-callout-body_2-0" class="comp mntl-sc-block-callout-body mntl-text-block expert-content"&gt;&lt;p&gt;Researchers completed a study of adverse events due to supplements.&lt;span class="ql-inline-citation" data-cite="29"&gt;&lt;/span&gt; The reports documented the following in some individuals 25 years and younger:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Hospitalization&lt;/li&gt;&lt;li&gt;Disability&lt;/li&gt;&lt;li&gt;Death&lt;span class="ql-inline-citation" data-cite="30"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Moreover, the following supplement categories had a three-fold increase in the risk for severe medical events compared to vitamins:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Muscle building&lt;/li&gt;&lt;li&gt;Energy&lt;/li&gt;&lt;li&gt;Weight loss&lt;span class="ql-inline-citation" data-cite="30"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;In general, their use is not advisable.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;
&lt;span class="heading-toc" id="toc-14-zinc"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_138-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text text-title-300"&gt; 14. Zinc &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_139-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Zinc plays a role in cellular energy, specifically the energy for the metabolism, so it is sometimes used to combat fatigue.&lt;span class="ql-inline-citation" data-cite="40"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_140-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_141-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; One study found that zinc significantly reduced fatigue in elderly people, but more research is needed to track zinc's effect on the energy levels of people of all ages.
&lt;/p&gt;
&lt;p id="mntl-sc-block_142-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;div id="health-sc-block-callout--explainer_2-0" class="comp health-sc-block-callout--explainer health-sc-block-callout-base mntl-sc-block-callout mntl-block theme-explainer theme-explainer" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;&lt;h3 id="mntl-sc-block-callout-heading_3-0" class="comp mntl-sc-block-callout-heading mntl-text-block"&gt;A Word About Supplements&lt;/h3&gt;
&lt;div id="mntl-sc-block-callout-body_3-0" class="comp mntl-sc-block-callout-body mntl-text-block expert-content"&gt;&lt;p&gt;In the United States, the Food and Drug Administration (FDA) does not regulate dietary supplements the way it regulates prescription medications. As a result, some supplement products may not contain the ingredients listed on the label. When &lt;a href="https://www.verywellhealth.com/how-do-i-choose-a-supplement-8379560" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;choosing a supplement&lt;/a&gt;, look for products independently tested or certified by organizations such as the National Sanitation Foundation (NSF), United States Pharmacopeia (USP), or ConsumerLab. For personalized guidance, consult your healthcare provider, registered dietitian nutritionist (RD or RDN), or pharmacist.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Verywell Health</author><pubDate>Wed, 28 Jan 2026 15:18:25 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMib0FVX3lxTE9wc1NiTWxhVXZGXzBHVnlpWVNhOGJfald6b1JkX3paeUJaX3IwYU5vMmJQeHJncDRic05ZM1AycUI0OFNLWGluRVNoVU9jTzl1NTI5YUpQQnFDQnNMOFYzbUNoZkVkT3E2OVhfT2VLNA</guid></item><item><title>忘记牙膏：这种粉末美白和修复- Newser</title><link>https://www.newser.com/story/382715/scientists-invent-tooth-powder-that-whitens-and-repairs.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="divStoryBodyAbove"&gt;
                                
                                    &lt;span id="StoryTextTop"&gt;&lt;/span&gt;
                                
                                
                                
                                    &lt;p class="storyParagraph"&gt;
                                        The problem with popular teeth-whitening agents, like peroxide-based gels, is that they risk damaging tooth enamel while they bleach. Now, Chinese scientists say they've developed a better option: one that instead repairs tooth enamel while it whitens. The prototype whitening powder activates when exposed to the vibrations of an electric toothbrush, per the &lt;a href="https://www.the-independent.com/news/science/teeth-whitening-repair-powder-toothbrush-b2908378.html"&gt;Independent&lt;/a&gt;. Unlike common peroxide-based whitening products, which generate reactive oxygen species (ROS) that can erode enamel while lifting stains, this powder is designed to limit ROS production to brushing time and to strengthen teeth in the process.
                                    &lt;/p&gt;
                                    
                                
                                
                            &lt;/div&gt;

                            
                            
                            
                            
                            

                            &lt;div id="divStoryBodyBelow"&gt;
                                
                                    &lt;p class="storyParagraph"&gt;
                                        The material, called BSCT, is made from charged particles of strontium and calcium combined with barium titanate, then heated into a ceramic powder. When the powder is put under stress through vibration, it produces a tiny electric field—similar to how quartz crystals power watches—which in turn triggers ROS-generating reactions that break down stain molecules. In lab tests on human teeth stained with tea and coffee, four hours of brushing with BSCT and an electric toothbrush produced visible whitening; after 12 hours, the treated teeth were nearly 50% brighter than those brushed with saline alone.
                                    &lt;/p&gt;
                                

                                
                                    &lt;p class="storyParagraph"&gt;
                                        Researchers say the ions in the powder also helped rebuild damaged enamel and dentin by forming mineral deposits on tooth surfaces, per &lt;a href="https://newatlas.com/health-wellbeing/whitening-tooth-powder/"&gt;New Atlas&lt;/a&gt;. In a separate experiment, rats on a high-sugar diet brushed for one minute daily over four weeks showed a healthier oral microbiome, with reductions in harmful bacteria linked to gum disease. The team, whose study appears in the journal &lt;a href="https://pubs.acs.org/doi/10.1021/acsnano.5c16997"&gt;&lt;em&gt;ACS Nano&lt;/em&gt;&lt;/a&gt;, describes the approach as a potential at-home option that combines whitening, enamel repair, cavity prevention, and support for beneficial mouth bacteria, though further testing will be needed before any consumer product hits the market.
                                    &lt;/p&gt;
                                

                                
                                
                                
                                

                                

                                



                            &lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Newser</author><pubDate>Wed, 28 Jan 2026 15:16:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinAFBVV95cUxOVzEtbDlmRm5oc2x4RnBnQTJVSG11alZGRHppeUJPbjBqRENfc25nYzJqQlBtZDI4dnktUVc2ODVRWkRMcC1wMm9aR28xMkM2ZW1HQzhEX0ZaVTR6dXdQaWRnSFR6R3FvSGFBNXNpZVdEbmdVVDZuYTJSamNOQXVla19aUmpTdUI5a2Z1eTBFMldWU2U1Qk9FY3VpQlo</guid></item><item><title>年轻的英国人不再喝酒了，那么对于后代来说，周六晚上会是什么样子？ | Emma Brockes -《卫报》</title><link>https://www.theguardian.com/commentisfree/2026/jan/28/young-british-people-alcohol-drinking</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body-commercial-selector article-body-viewer-selector dcr-hdpgoq"&gt;&lt;p class="dcr-130mj7b"&gt;&lt;span class="dcr-15rw6c2"&gt;I&lt;/span&gt;t’s November 2024 and my puritanical American children are attending their first autumn fair at their new English primary school. There’s a laser show and hotdogs and a raffle. There’s also a bar for the parents, which makes my two pull up short. Newcomers to this country experience many cultural differences but perhaps none as striking as this: “Is that alcohol?” says my child, scowling up at me like a tiny member of the Taliban. “At a school thing?” I’m two Baileys hot chocolates in at this point and give her a smile 10% broader than necessary. Yes, my darlings; welcome to Britain.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Or at least, welcome, possibly, to the last vestiges of how Britain once was. For a while now we’ve known anecdotally that people in this country are drinking less than they were. My own generation X is deep into middle age and many of us – save for the odd life-saver at a school event and the biggest occasions – have given it up. Where the anomalies fall more glaringly is in the generations below us, among young people whose behaviour differs from our own at their age. This week, official confirmation came in the form of a survey of 10,000 people commissioned by the NHS that found almost a quarter (24%) of adults in England had &lt;a href="https://www.theguardian.com/society/2026/jan/27/one-in-four-adults-in-england-do-not-drink-alcohol" data-link-name="in body link"&gt;not drunk alcohol&lt;/a&gt; in 2024, an increase from just under a fifth (19%) in 2022.&lt;/p&gt;&lt;p id="sign-in-gate"&gt;&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The top line, of course, is that this is a good thing. Not for the drinks industry, obviously, but for the &lt;a href="https://www.theguardian.com/society/nhs" data-link-name="in body link" data-component="auto-linked-tag"&gt;NHS&lt;/a&gt;, and also for people trying to maximise their life expectancy, which is all of us. Rigorous self-optimisation via application to the data is how we spend our leisure time these days, on the strength of which, after reading a piece about cancer-reducing foods this morning, I bought a “wheatberry, lentil and green vegetable salad” that I’m almost certainly not going to eat. What even is a wheatberry? Nobody knows. The point is we’re trying.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;If I sound sarcastic, I don’t mean to. I love not drinking. And it’s important not to join the ranks of those people in the generation above mine who, in the 1990s, when &lt;a href="https://www.theguardian.com/society/2017/jul/01/it-has-had-a-real-social-impact-readers-on-the-smoking-ban-ten-years-on" data-link-name="in body link"&gt;smoking bans&lt;/a&gt; took hold across the US, wrote long pieces arguing that cigarettes represented the buccaneer spirit of the country and, as a result, smokers were more interesting than people who drank “green juice”. These were, objectively, the worst people in the world and, while no one likes a teetotaller, it’s important to resist turning into them.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;My interest is more in what youth culture will look like without alcohol. The new survey results, which were commissioned as part of the Health Survey for England, found that women are slightly less likely to drink than men and that across the age groups young people are the most abstemious. In the &lt;a href="https://www.bmj.com/content/390/bmj.r1247" data-link-name="in body link"&gt;2022 NHS survey&lt;/a&gt;, gen Z reportedly contained the lowest proportion of people who drank frequently (10%), compared with 34% among 55 to 64-year-olds and 37% of 65 to 74-year-olds. Some of this is cost-of-living related, but most of it is likely to be cultural. It’s just not cool to be wasted.&lt;/p&gt;&lt;figure data-spacefinder-role="inline" data-spacefinder-type="model.dotcomrendering.pageElements.NewsletterSignupBlockElement" class="dcr-173mewl"&gt;&lt;gu-island name="EmailSignUpWrapper" priority="feature" deferuntil="visible" props='{"index":5,"listId":6056,"identityName":"matters-of-opinion","description":"Guardian columnists and writers on what they’ve been debating, thinking about, reading, and more","name":"Matters of Opinion","frequency":"Weekly","successDescription":"Subscription confirmed.","theme":"opinion","idApiUrl":"https://idapi.theguardian.com","hideNewsletterSignupComponentForSubscribers":true}'&gt;&lt;/gu-island&gt;&lt;/figure&gt;&lt;figure id="16d56077-98bd-49d8-b5ea-3ed7a93f3845" data-spacefinder-role="richLink" data-spacefinder-type="model.dotcomrendering.pageElements.RichLinkBlockElement" class="dcr-47fhrn"&gt;&lt;gu-island name="RichLinkComponent" priority="feature" deferuntil="idle" props='{"richLinkIndex":6,"element":{"_type":"model.dotcomrendering.pageElements.RichLinkBlockElement","prefix":"Related: ","text":"Why are saunas suddenly everywhere? I think it’s to do with booze | Zoe Williams","elementId":"16d56077-98bd-49d8-b5ea-3ed7a93f3845","role":"richLink","url":"https://www.theguardian.com/commentisfree/2026/jan/20/why-are-saunas-suddenly-everywhere-i-think-its-to-do-with-booze"},"ajaxUrl":"https://api.nextgen.guardianapps.co.uk","format":{"design":8,"display":0,"theme":1},"isInStarRatingVariant":false}'&gt;&lt;/gu-island&gt;&lt;/figure&gt;&lt;p class="dcr-130mj7b"&gt;In my own case, the calculation to cut back had less to do with cultural trends and more to do with the sudden, sad collapse of my metabolism, plus the fact I changed primary-care physicians. During the intake interview a few years ago, my new doctor made a note of what everyone in my family going back three generations had died of, before giving me a very stern look. “If I were you I wouldn’t drink,” she said. “At all.” This was harsh, but she was right.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;And yet, still my imagination falters. I look at my two and wonder what, when they’re 25, a Saturday night out will look like if it doesn’t terminate in them lying half off the sofa crying to Elaine Paige doing the big ballad from Chess. Where will their war stories come from? (Actual war, probably, but let’s not think about that.) What will they reminisce about when they are my age?&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;There’s nothing funny about my friend who threw up into a heating vent and, for the rest of her tenancy, couldn’t expunge the smell of sick from her flat. Standing, swaying gently, in the middle of a busy A-road trying to work out a strategy for getting to the other side that didn’t involve putting one foot in front of the other isn’t funny, either. I told my children this story and they were horrified. “You could’ve DIED,” they said, which was precisely the teachable moment I was after.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Meanwhile, the new findings aren’t anything to grow complacent about, since, even with these reduced numbers, we’re still sufficiently a nation of alcoholics to cost the NHS in England &lt;a href="https://www.theguardian.com/society/article/2024/may/17/27bn-a-year-spent-in-england-on-harm-done-by-alcohol-study-finds" data-link-name="in body link"&gt;£4.9bn a year&lt;/a&gt; in alcohol-related illness. In the spirit of which: I’m actually quite looking forward to eating my salad. I’m going to put an egg in it because, while not drinking is extremely good for you, as everyone knows it’s actually protein that will save us.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Guardian</author><pubDate>Wed, 28 Jan 2026 15:08:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilgFBVV95cUxPeEN5Uk5RalNva3lUSEh1VElVZUJveW1mY0xHZmpXYmdHTk9mdktVMGlsTll6cEc1SGdWQUFPYUlDUGpPV01JQmc0cE1VNi03dHFNVzBjV3dwU2owYndyZUNLX290alhTNmlKZThKbjZBNV9nQXh4bEZxc1hvby1YYnJ6c3Q3OVNHQWFsMjdVYS1XVFpQcHc</guid></item><item><title>西班牙科学家在重大医学突破中找到治愈胰腺癌的方法-印度时报</title><link>https://timesofindia.indiatimes.com/science/spanish-scientist-finds-cure-for-pancreatic-cancer-in-major-medical-breakthrough/articleshow/127714543.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="_s30J clearfix  "&gt;&lt;p&gt;A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of pancreatic cancer in laboratory mice, raising fresh hopes against one of the deadliest cancers. The study, led by Mariano Barbacid at Spain’s Spanish National Cancer Research Centre, found that a newly designed triple-drug therapy wiped out pancreatic tumours with no relapse seen after treatment. After six years of work, researchers reported that the animals showed minimal side effects and no tumour recurrence, results that mark one of the most promising advances yet in pancreatic cancer research.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="3"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="4"&gt;&lt;h2&gt;Pancreatic cancer and the therapy behind the breakthrough&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="5"&gt;&lt;/span&gt;&lt;p&gt;Pancreatic cancer, particularly pancreatic ductal adenocarcinoma, is among the deadliest malignancies due to its resistance to treatment, dense tumour microenvironment, and late diagnosis. Standard therapies often fail because tumours rapidly adapt, bypassing single-target drugs.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="10"&gt;&lt;/span&gt;&lt;p&gt;The CNIO therapy takes a different approach. Instead of attacking one pathway, it combines three drugs to shut down multiple tumour survival mechanisms simultaneously. According to the researchers, this strategy prevents cancer cells from rewiring themselves, a common cause of treatment failure.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="12"&gt;&lt;/span&gt;&lt;p&gt;Barbacid has previously argued that pancreatic cancer cannot be defeated with a single-drug strategy. &lt;/p&gt;&lt;p&gt;This tumour, he has said in earlier research discussions, is extraordinarily adaptable, and only coordinated inhibition of multiple pathways can produce lasting responses.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="16"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="17"&gt;&lt;h2&gt;What the study found in laboratory models&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="18"&gt;&lt;/span&gt;&lt;p&gt;In controlled laboratory experiments, mice with advanced pancreatic tumours experienced complete tumour elimination after receiving the triple-drug therapy. Even more notable was what happened afterwards. During extended follow-up, researchers observed no tumour regrowth, suggesting that the therapy may suppress the biological mechanisms that typically drive relapse.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="21"&gt;&lt;/span&gt;&lt;p&gt;The findings were published in Proceedings of the National Academy of Sciences (PNAS), where reviewers highlighted both the durability of the response and the unusually low toxicity seen in treated animals, a critical factor for any therapy aimed at human use.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="23"&gt;&lt;/span&gt;&lt;p&gt;Independent cancer researchers not involved in the study have noted that durable responses without relapse are exceptionally rare in pancreatic cancer models, making the results particularly significant within the field.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="26"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="27"&gt;&lt;h2&gt;&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p class="cdatainfo   id-r-component " data-pos="28"&gt;&lt;h2&gt;Who is Mariano Barbacid?&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="29"&gt;&lt;/span&gt;&lt;p&gt;Barbacid is one of Europe’s most influential cancer researchers. In the early 1980s, he helped identify the first human oncogene, a discovery that fundamentally reshaped modern cancer biology and established the genetic basis of cancer.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="31"&gt;&lt;/span&gt;&lt;p&gt;Over the past four decades, his work has repeatedly focused on KRAS-driven tumours, long considered among the hardest cancers to treat. Because KRAS mutations are present in roughly 90 per cent of pancreatic cancers, Barbacid’s sustained focus on this pathway gives the current breakthrough added weight within the scientific community.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="34"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="35"&gt;&lt;h2&gt;&lt;br&gt;Funding, institutions, and credibility&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="36"&gt;&lt;/span&gt;&lt;p&gt;The research was conducted at CNIO, one of Europe’s leading cancer research institutions, with support from Fundación CRIS Contra el Cáncer, which funds high-risk, high-impact cancer research projects.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="38"&gt;&lt;/span&gt;&lt;p&gt;The study followed established experimental protocols and underwent independent peer review before publication. There is no evidence the findings were rushed or bypassed scientific safeguards, a point emphasised by CNIO officials amid online speculation.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="41"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="42"&gt;&lt;h2&gt;Public reaction and online controversy&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="43"&gt;&lt;/span&gt;&lt;p&gt;News of the breakthrough spread rapidly across social media, generating both excitement and scepticism. Many users hailed the findings as a cure, while others questioned whether pharmaceutical or regulatory barriers could delay progress.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="45"&gt;&lt;/span&gt;&lt;p&gt;Such reactions reflect a broader tension in cancer research communication, namely the gap between legitimate scientific caution and public desperation for definitive cures, particularly for diseases with historically grim outcomes.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="48"&gt;&lt;/span&gt;&lt;p class="cdatainfo   id-r-component " data-pos="49"&gt;&lt;h2&gt;What happens next&lt;/h2&gt;&lt;/p&gt;&lt;span class="id-r-component br" data-pos="50"&gt;&lt;/span&gt;&lt;p&gt;The next phase involves further validation studies and safety testing, followed, if funding and regulatory approvals allow, by early-stage human trials. While a confirmed cure for pancreatic cancer in people remains years away, experts agree that this research provides one of the strongest indications yet that the disease may finally be vulnerable to targeted combination therapies rather than incremental treatment gains.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="52"&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Times of India</author><pubDate>Wed, 28 Jan 2026 15:07:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi5AFBVV95cUxPbFA4S1Y1Qk1aWlFkVHV4MktmcFJjdWwxSENaR3JLdWpvZjB4Qm8zNUpWaGRPUTBySFh2aTNjSG4tanBsQi1xaFg1T1B5MUgxOWx4NFJFQjVyLUdKcmw0MDVWY2hzVF9VZUhQcXlCaDE4RTFNMWFPZG9MV3RRUlpIcUhRVTktWkt0dzdiQjA4N2ZPMG85M2U0RTlWM0phdVJMVXVkYTNja3NzNFJYX3NEN3VSQWgxbmQ4UG43aTRlZU5OczdSZ2hCcmJjNTlMcDJKVHhZRVBKblVrY09BX2IxUnUwd2vSAeoBQVVfeXFMTUJ6dUdSQWd0MDV6aUw3UTBJYWRnWVVWeHFkZWdyQTlCRWV1VTM5ZEZ1SjN4eWtRQWQ4bGZfQ18xWlJpdlJaYm5yWXpLMDRIYjZUVW1TNW0tYzQtd1NiMTQwRC0tMXp3MXFSbWQ0NUVYcXpOMGdQRF9rX0Q5MmJ0em51RnFGRW1WbzFhWlg1NXNiZHZLaDh0NjFPWFpzTGk1NkgtUWVwS2NqdW4yME9aQ1JkRmhPRkkxU2c5aldoc1lrUWowbjlQODM1LXpOa3lqaUxRZjV5QnBGMGZGQ3BJLVdQOW10TUxKNWxn</guid></item><item><title>梅毒的起源故事比我们想象的要长得多- Ars Technica</title><link>https://arstechnica.com/science/2026/01/the-origin-story-of-syphilis-goes-back-far-longer-than-we-thought/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content post-content-double"&gt;
          
          
&lt;p&gt;13,700 years ago was roughly when humans first started populating South America and rapidly spread around the continent. And, based on this discovery, the bacteria of the &lt;i&gt;Treponema pallidum&lt;/i&gt; lineage were already diverse and capable of infecting people by then. This Late Pleistocene divergence, the authors note in their study, hints at the ancient pan-human distribution. Various &lt;i&gt;Treponema pallidum&lt;/i&gt; subspecies were probably our fellow travelers spreading globally with the first humans that migrated out of Africa.&lt;/p&gt;
&lt;p&gt;But there’s much more we need to learn before the “Columbian” syphilis origin debate is settled.&lt;/p&gt;

&lt;h2 class="p2"&gt;Beyond the Columbian story&lt;/h2&gt;
&lt;p&gt;While the 1495 siege of Naples remains the moment syphilis etched itself into the European psyche as a new and terrifying plague, it was likely just one violent flare-up in a relationship between humans and &lt;em&gt;Treponema&lt;/em&gt; pathogens that spans continents and millennia. What we don’t know is when and where the important turning points in this relationship took place.&lt;/p&gt;
&lt;p&gt;It’s unclear when and why &lt;i&gt;Treponema pallidum&lt;/i&gt; evolved its sexual transmission, so evidently present in the subspecies that caused the outbreak in Naples. It’s also unclear whether the 1495 pandemic was triggered by a newly imported strain or a mutation of a lineage already present in Europe. The team hopes analyzing other ancient pathogen genomes hosted by people from different places on the globe and different social contexts—hunter-gatherers, farmers, city dwellers—will answer at least some of these questions.&lt;/p&gt;
&lt;p&gt;The problem is, it’s hard to infer a specific pathogen’s features from ancient genomes. “With the data we have today, we can’t say anything about the virulence of this ancient &lt;i&gt;Treponema pallidum&lt;/i&gt; subspecies, about how the symptoms of the disease it caused looked like, or about its mode of transmission,” Bozzi says.&lt;/p&gt;
&lt;p&gt;What we do know, however, is that thousands of years ago, the &lt;i&gt;Treponema pallidum&lt;/i&gt; lineage was likely way more diverse than it is today. “In the future we’d love to look at broader ecological interactions between humans, animals, the environment, and the pathogens,” says Nelson. “We’d love to explore this diversity further.”&lt;/p&gt;
&lt;p&gt;Science, 2026. DOI: &lt;a href="http://dx.doi.org/10.1126/science.adw3020"&gt;10.1126/science.adw3020&lt;/a&gt;&lt;/p&gt;


          
                  &lt;/div&gt;

                  
          &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Ars Technica</author><pubDate>Wed, 28 Jan 2026 14:55:58 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqgFBVV95cUxPWm5WT3dSenAyNEh3QktlWjdkNlRQMGV1ZDg0Q3VvazB6aEJKWHJkNjk1WmpSSFdoWGtla19pZDdHVHZ6SlJaR3QxbkNMVUtrMzZXQlFaMFB1bWxLX3RnS2FILVY4UGNlOEY0TU5WM05lQVY3WFhKaGdINzBTVUJ4Ny1FbEpqTTh1ZUFhR3RWelkwdWpDTkpvY0wzS3BQb2NlT1dIbnp5RGFVUQ</guid></item><item><title>癌症免疫疗法经常失败的隐藏原因- ScienceDaily</title><link>https://www.sciencedaily.com/releases/2026/01/260128075323.htm</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p id="first" class="lead"&gt;Cancer immunotherapy has reshaped cancer treatment by training the body's immune system to recognize and attack tumors. Drugs known as immune checkpoint inhibitors, which target the PD-1/PD-L1 pathway, have led to long-lasting responses in some patients and fueled optimism about durable cancer control. Yet for most people, these therapies do not deliver the same benefit. Tumors can adapt and develop ways to escape immune detection, limiting the effectiveness of treatment.&lt;/p&gt;

						&lt;div id="text"&gt;
&lt;p&gt;This challenge has pushed researchers to look beyond the tumor itself and examine broader mechanisms of immune resistance. Scientists are increasingly focused on how cancers suppress immune activity throughout the body, not just at the tumor site. One emerging area of interest involves small extracellular vesicles (sEVs), tiny particles released by cancer cells that can carry immunosuppressive molecules and weaken the immune response in ways that are still not fully understood.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Investigating How PD-L1 Is Packaged and Released&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;To better understand this process, a research team from Fujita Health University in Japan, led by Professor Kunihiro Tsuchida, worked with collaborators from Tokyo Medical University Hospital and Tokyo Medical University. Their goal was to uncover how PD-L1, a key immune checkpoint protein, is selectively loaded into sEVs and to determine whether this pathway could be targeted therapeutically.&lt;/p&gt;
&lt;p&gt;The study, published in &lt;em&gt;Scientific Reports&lt;/em&gt;, was built around a central unanswered question. "Cancer cells release small extracellular vesicles containing PD-L1, which are thought to reduce the effectiveness of cancer immunotherapy. However, how PD-L1 is sorted into these vesicles has remained unclear." Addressing this mystery became the foundation of the research.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A New Molecular Player in Immune Resistance&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Using a wide range of techniques, including molecular and cell biology, biochemical and pharmacological tests, patient-derived samples, and bioinformatics, the researchers identified ubiquitin-like 3 (UBL3) as a key factor controlling how PD-L1 is directed into sEVs.&lt;/p&gt;

&lt;p id="insertion_middle"&gt;&lt;/p&gt;
&lt;p&gt;They found that PD-L1 undergoes a previously unknown post-translational modification involving UBL3. This modification occurs through a disulfide bond and differs from the classical process of ubiquitination. Further experiments showed that a specific amino acid, cysteine 272 in the cytoplasmic region of PD-L1, is essential for this modification.&lt;/p&gt;
&lt;p&gt;When UBL3 levels were increased in cancer cells, the amount of PD-L1 packaged into sEVs rose sharply, even though total PD-L1 inside the cells remained unchanged. In contrast, reducing UBL3 levels led to a clear drop in PD-L1 being loaded into vesicles and released outside the cell. Together, these results confirmed that UBL3 plays a central role in directing PD-L1 into sEVs.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Statins Interfere With a Key Immune Escape Pathway&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;One of the most striking findings came when the team examined drugs that might interfere with this process. They discovered that statins, which are widely prescribed to lower cholesterol, strongly block UBL3 modification. All clinically used statins tested in the study reduced UBL3 activity, lowered PD-L1 modification, and sharply decreased the amount of PD-L1 sorted into sEVs.&lt;/p&gt;
&lt;p&gt;These effects occurred at very low drug concentrations that are achievable in patients and were not linked to toxic effects on cells. Importantly, blood samples from people with non-small cell lung cancer showed a similar pattern. Among patients with high tumor PD-L1 expression, those taking statins had significantly lower levels of PD-L1-containing sEVs in their blood compared with patients not using statins.&lt;/p&gt;
&lt;p&gt;Further bioinformatic analysis revealed that the combined expression of UBL3 and PD-L1 was associated with survival outcomes in lung cancer patients. This finding highlights the potential clinical importance of this newly identified regulatory pathway.&lt;/p&gt;

&lt;p id="insertion_bottom"&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;What This Means for Cancer Treatment&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Taken together, these results help explain why immune checkpoint inhibitors often fail and point to a practical way to improve their performance. The study uncovers a hidden mechanism by which cancer cells spread immunosuppressive PD-L1 through extracellular vesicles, allowing tumors to weaken immune responses far beyond their immediate environment.&lt;/p&gt;
&lt;p&gt;Linking this pathway to statins is especially important because these drugs are widely used, inexpensive, and generally safe. This raises the possibility that the findings could be translated into clinical practice relatively quickly. As the researchers note, "In the long term, this research may lead to more effective and accessible cancer immunotherapies. It could help more patients benefit from immune checkpoint treatments, improving survival and quality of life in real-world settings."&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A New Target for Overcoming Immunotherapy Resistance&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In summary, the study shows that UBL3-driven modification promotes the packaging of PD-L1 into sEVs and that statins can disrupt this process, reducing levels of circulating immunosuppressive PD-L1. By identifying vesicle-associated PD-L1 trafficking as a modifiable driver of immune escape, the research opens a promising new path for tackling resistance to cancer immunotherapy. Adding statins to combination treatment strategies could offer a simple, scalable way to improve outcomes for patients receiving immune checkpoint inhibitors.&lt;/p&gt;&lt;/div&gt;

					&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceDaily</author><pubDate>Wed, 28 Jan 2026 14:12:12 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMib0FVX3lxTE1temxiZWpUaS1iNHQwN0hrSnZ6cGI5YXlVa0JoSjQ4SHdYYVJ6NDE0bUpjU0JyVzZkclF6LTdEc191OGI5b3lPVlhIWUs0WmJYekFzcjFXUVJSN0MzRHJkZ0NvV1IydHFCdWozbHVScw</guid></item><item><title>胆固醇药物后可怕的头发颜色变化-《西雅图时报》</title><link>https://www.seattletimes.com/life/wellness/hideous-hair-color-change-following-cholesterol-drug/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="article-content" class="article-content entry-content"&gt;
    &lt;h2 class="wp-block-heading"&gt;The People’s Pharmacy&lt;/h2&gt;&lt;p&gt;&lt;strong&gt;Q:&lt;/strong&gt; I stopped dyeing my hair in 2018 and got new photos for my passport and driver’s license once my hair turned white. Now my hair is turning dark brown while I’m on rosuvastatin. I started this prescription to lower my cholesterol in September 2024, and my hair started changing color within six months. Now it is hideous.&lt;/p&gt;&lt;p&gt;I saw articles about this possibility on your website. Is there an alternative cholesterol medicine that won’t affect hair color? I’m seriously considering stopping this medication to see if my hair will go back to white, which I now prefer. Help!&lt;/p&gt;&lt;p&gt;&lt;strong&gt;A:&lt;/strong&gt; It has been quite a while since a reader has reported hair darkening while taking a cholesterol-lowering medication. We received more complaints about ezetimibe (Zetia), but a few people also reported an experience like yours associated with simvastatin (Zocor) and rosuvastatin (Crestor). Drug-induced hair color changes are uncommon (European Journal of Dermatology, Dec. 1, 2016).&lt;/p&gt;&lt;p&gt;There are other medications that could help you control your cholesterol. You should discuss this with your health care provider. To prepare for that conversation, you might want to read our “eGuide to Cholesterol Control and Heart Health.” It is located under the Health eGuides tab at peoplespharmacy.com. In it, you’ll find discussions of the most common pros and cons of the various cholesterol-lowering medications.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Q: &lt;/strong&gt;In the early 1970s, my doctor prescribed Afrin for nasal congestion. I used it so often that eventually I had to carry it everywhere because I couldn’t breathe without it!&lt;/p&gt;&lt;p&gt;To get off it, I used the spray in only one nostril. That let the other one clear and open up. It took a lot of patience, but it worked. Then I never used it again. I still use Neo-Synephrine, children’s strength, when I’m congested but very sparingly. I never want to be like that again!&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A:&lt;/strong&gt; Once upon a time, Afrin (oxymetazoline) was available only by prescription. That changed in 1975 when the Food and Drug Administration allowed over-the-counter sales.&lt;/p&gt;&lt;p&gt;Many people have reported rebound congestion after using oxymetazoline nasal spray for more than several days. This topical decongestant is the active ingredient in Afrin No Drip, for example. Your tactic of using the spray in just one nostril can be effective for getting past rebound congestion.&lt;/p&gt;&lt;p&gt;When shopping for a nasal spray, be careful to read the ingredients. In addition to the oxymetazoline version, Afrin also has a drug-free saline nasal mist and an extra-strength “Saline Burst” product with seawater.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Q:&lt;/strong&gt; I have practiced medicine for decades. I learned long ago that many men begin to experience lower testosterone levels in their thirties and forties. Some older men end up with very low levels of this hormone.&lt;/p&gt;&lt;p&gt;I have found that testosterone replacement therapy can help these guys maintain both bone and muscle strength. I believe the best benefit is mental clarity and warding off depression. I am glad that the FDA has eased off its cardiovascular warnings, which had no scientific basis.&lt;/p&gt;&lt;p&gt;I think it is absurd, though, that doctors are required to have a DEA license to prescribe testosterone. That’s because it is considered a “controlled” substance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;A: &lt;/strong&gt;The FDA has indeed withdrawn its boxed warning about heart attacks and strokes from testosterone products. This hormone is still classified as a “Schedule III” controlled substance. That means the Drug Enforcement Administration believes it has a modest potential to create physical or psychological dependence.&lt;/p&gt;    &lt;p id="userMessagingIn-story"&gt;&lt;/p&gt;
        &lt;div class="extended-byline"&gt;&lt;p class="single-byline"&gt;In their column, Joe and Teresa Graedon answer letters from readers. Write to them in care of King Features, 300 W. 57th Street, 41st Floor, New York, NY 10019, or email them via their website: peoplespharmacy.com. Their newest book is “Top Screwups Doctors Make and How to Avoid Them.”&lt;/p&gt;&lt;/div&gt;  &lt;/div&gt;
        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Seattle Times</author><pubDate>Wed, 28 Jan 2026 14:00:05 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinAFBVV95cUxNWnA0ZEMyTVdIRF9SbkhlZmttdlJIRU90R29kbjNGRDB2dTBldnJwVmhvNkkyTTdjS3BLN3NTelVLcFhrSnhMMVZrSGxNY3RzZUJEbGw2aFJSVnctdUhZcmd4cFRzRUI0bnk3Y1JxckYwdEhGZ0JCN1JsdlFJb2J3NW5INlVmZTRaakhsalFHT08ydUg0MS1PRjFCMFM</guid></item><item><title>“我是一名63岁的私人教练：这是我为客户提供的5项简单的体重锻炼，它们比步行锻炼更快地锻炼肌肉。'-汤姆的指南</title><link>https://www.tomsguide.com/wellness/workouts/im-a-63-year-old-personal-trainer-5-simple-bodyweight-exercises-i-give-to-my-clients-that-build-muscle-faster-than-walking-workouts</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="article-body" class="text-copy bodyCopy auto"&gt;

&lt;p id="53572eac-2d4d-4a0a-967a-9567d18dadde"&gt;Keeping fit as we get older is one of the best ways to stay independent for longer, but if you’re a complete beginner or returning to exercise after an extended break, it can be hard to know where to start. The good news is, it’s never too late, and one woman who truly believes in this is Portia Page, a 63-year old personal trainer, Pilates instructor, and &lt;a data-analytics-id="inline-link" href="https://www.pilates.com/" target="_blank" rel="nofollow" data-url="https://www.pilates.com/" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none" data-mrf-recirculation="inline-link"&gt;&lt;u&gt;Balanced Body&lt;/u&gt;&lt;/a&gt; educator.&lt;/p&gt;&lt;p id="ad-unit-1" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;Below, she shares the five bodyweight exercises she recommends to seniors to improve their strength and mobility, as well as the advice she shares with her clients who are returning to the gym or just getting started.&lt;/p&gt;&lt;a id="elk-seasonal"&gt;&lt;/a&gt;&lt;p id="53572eac-2d4d-4a0a-967a-9567d18dadde-2"&gt;As a reminder, if you’re recovering from a specific injury, it’s always a good idea to seek personalized advice from a qualified professional.&lt;/p&gt;&lt;p id="mid-article-leaderboard" class="ad-unit sm:hidden block"&gt;&lt;/p&gt;&lt;div id="slice-container-person-p4CCLkvD8xpi6FVFjRZ3pj-6K9vERv5gC09d2QYgiem1JPqllbkK9QJ" class="slice-container person-wrapper person-p4CCLkvD8xpi6FVFjRZ3pj-6K9vERv5gC09d2QYgiem1JPqllbkK9QJ slice-container-person"&gt;&lt;div class="person person--separator"&gt;&lt;div class="person__bio"&gt;&lt;p&gt;Portia Page has been in the fitness industry for over 25 years as a teacher, competitor, program director, instructor trainer, international presenter and video co-star, fitness director and creator. She is a Gold Certified Pilates Teacher through Pilates Method Alliance, and a Master Instructor of Balanced Body® for Pilates, AI3D, Barre, Bodhi™, MOTR™, and CoreAlign®, holding current certifications with ACE, AFAA and PMA, with BS in Cognitive Science from University of California at San Diego.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;a id="elk-bddb2d35-3b0e-4577-990a-ce469b4de032" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h2 id="what-are-the-5-bodyweight-exercises-you-recommend-to-seniors-3"&gt;What are the 5 bodyweight exercises you recommend to seniors? &lt;/h2&gt;&lt;p id="baf30482-45e8-4a25-a5dc-1d684f305b62"&gt;“I’ve never ‘stopped’ working out — for me, it’s always been a part of my life," Page tells Tom’s Guide. "When I do go for a period of inactivity, I remember: working out feels hard at the beginning, yet within a few minutes, it’s already better, and long-term? No question — it works!”&lt;/p&gt;&lt;p id="ad-unit-2" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;“The good news? Your muscles don’t care how old you are — they respond to training at ANY age. I’ve seen people in their 70s and 80s gain strength in weeks. Biology is generous like that.”&lt;/p&gt;&lt;p&gt;Page’s simple routine involves “no fancy circus tricks”, just these 5 bodyweight exercises:&lt;/p&gt;&lt;a id="elk-1-sit-to-stand-chair-squats" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-1-sit-to-stand-chair-squats"&gt;&lt;span&gt;1. Sit-to-stand (chair squats) &lt;/span&gt;&lt;/h3&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="f398cc53-8c8f-4367-a34a-77e4cc6ddee2"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="e11e51a1-dd7f-4704-95af-32e60182f3bc"&gt;This exercise builds leg strength and mimics everyday activities like getting up from a chair or toilet. It’s one way doctors test leg strength in seniors — here’s how many &lt;a data-analytics-id="inline-link" href="https://www.tomsguide.com/wellness/workouts/if-you-can-do-this-many-sit-to-stands-after-60-your-leg-strength-is-considered-above-average" data-url="https://www.tomsguide.com/wellness/workouts/if-you-can-do-this-many-sit-to-stands-after-60-your-leg-strength-is-considered-above-average" data-hl-processed="none" data-mrf-recirculation="inline-link" data-before-rewrite-localise="https://www.tomsguide.com/wellness/workouts/if-you-can-do-this-many-sit-to-stands-after-60-your-leg-strength-is-considered-above-average"&gt;&lt;u&gt;reps you need to be able to complete after 60 to be considered ‘above average’&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;&lt;div id="slice-container-newsletterForm-articleInbodyContent-p4CCLkvD8xpi6FVFjRZ3pj" class="slice-container newsletter-inbodyContent-slice newsletterForm-articleInbodyContent-p4CCLkvD8xpi6FVFjRZ3pj slice-container-newsletterForm"&gt;&lt;div data-hydrate="true" class="newsletter-form__wrapper newsletter-form__wrapper--inbodyContent"&gt;&lt;div class="newsletter-form__container"&gt;&lt;section class="newsletter-form__main-section"&gt;&lt;p class="newsletter-form__strapline"&gt;Get instant access to breaking news, the hottest reviews, great deals and helpful tips.&lt;/p&gt;&lt;/section&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;ul id="2c2a9a53-8722-43da-b8f0-79c11ba0efb8"&gt;&lt;li&gt;Sit with your feet hip-width apart on the front of a chair. You should have a 90-degree bend in your knees, and your feet should be flat on the floor.&lt;/li&gt;&lt;li&gt;Place your hands on your thighs, at the side of the chair, or across your body (this is the hardest variation).&lt;/li&gt;&lt;li&gt;Lean forward slightly, shifting your weight into your feet, and engage your core as you push through your feet to stand up.&lt;/li&gt;&lt;li&gt;Slowly lower yourself back down to the chair, controlling the movement. Gently tap the chair before standing again.&lt;/li&gt;&lt;/ul&gt;&lt;a id="elk-2-wall-push-ups" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-2-wall-push-ups"&gt;&lt;span&gt;2. Wall push-ups&lt;/span&gt;&lt;/h3&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="aa57c125-ab29-479c-9bbc-dddff5dd71e3"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="59744848-4706-452d-a6ea-6383b4379a89"&gt;“These work on your upper body strength, are safer than floor push-ups, and are great for your shoulders and posture,” says Page. “I do mine against my kitchen counter while waiting for that first cup of coffee.”&lt;/p&gt;&lt;ul id="37ec960e-751f-4cc6-a180-cebd94331ec2"&gt;&lt;li&gt;Start by standing in front of a wall and take a couple of steps back. You should be able to stand with both hands flat against the wall.&lt;/li&gt;&lt;li&gt;Bend your elbows and move your torso towards the wall, keeping your back straight and your core engaged.&lt;/li&gt;&lt;li&gt;Push the wall away to straighten your arms and return to your starting position.&lt;/li&gt;&lt;/ul&gt;&lt;a id="elk-3-backward-lunges" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-3-backward-lunges"&gt;&lt;span&gt;3. Backward lunges &lt;/span&gt;&lt;/h3&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="4d1d2725-83ad-4433-a497-aa6ae61a51be"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="d298f2e2-11dd-4797-be3b-c098aeb26884"&gt;“These are great for hip strength, balance training, and building the muscles you need for walking,” says Page.&lt;/p&gt;&lt;ul id="1310b8c3-be10-4fb1-9669-c0240ad8b6e6"&gt;&lt;li&gt;Start standing tall, feet hip-width apart. If you’re holding dumbbells, hold one in each hand, arms down by your side.&lt;/li&gt;&lt;li&gt;Step one leg back, then bend both knees so your back knee just touches the floor and your front knee is stacked over your ankle or foot.&lt;/li&gt;&lt;li&gt;Keep your chest upright, then push up through your front heel to stand upright.&lt;/li&gt;&lt;li&gt;If you want to get into a deeper reverse lunge, try placing your front foot on a step.&lt;/li&gt;&lt;/ul&gt;&lt;a id="elk-4-standing-heel-raises" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-4-standing-heel-raises"&gt;&lt;span&gt;4. Standing heel raises &lt;/span&gt;&lt;/h3&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="ad319809-5355-43c8-8c35-ce9f177e24da"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="1c431ca9-8b19-4fb0-8eff-64e5ad0c9f66"&gt;“Heel raises strengthen the calves, feet, and ankles, improve balance, and reduce your risk of falls,” Page says. Here's how to do them.&lt;/p&gt;&lt;ul id="199c3398-30be-463f-8e8f-92442f42f5ee"&gt;&lt;li&gt;Start by standing tall, with your feet hip-width apart. To increase the intensity, hold a dumbbell in each hand.&lt;/li&gt;&lt;li&gt;Raise onto your tiptoes, pausing for a few seconds at the top of the movement and feeling the stretch through your calves.&lt;/li&gt;&lt;li&gt;Lower your heels back to the ground slowly and with control.&lt;/li&gt;&lt;/ul&gt;&lt;a id="elk-5-bird-dog" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-5-bird-dog"&gt;&lt;span&gt;5. Bird dog &lt;/span&gt;&lt;/h3&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="23d5cfda-5000-4585-a43d-fc4c43ca18a0"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="9fa4c39f-dbae-40a2-b509-b7e3716c6ea6"&gt;If you can, get down onto the ground, using a yoga mat to reduce the impact on your joints. This exercise works on your core stability, spine support, and coordination.&lt;/p&gt;&lt;ul id="74f30ddf-137e-44d2-8788-f60352e95089"&gt;&lt;li&gt;Begin on your hands and knees, in what is known as the tabletop position — wrists directly in line with your shoulders and knees in line with your hips&lt;/li&gt;&lt;li&gt;From here, extend your left arm straight ahead and your right leg behind you. Engage your core and concentrate on maintaining a flat back. You should be looking down at the floor.&lt;/li&gt;&lt;li&gt;Hold the position briefly, then return to the starting position. This is one rep.&lt;/li&gt;&lt;/ul&gt;&lt;p id="fa28478c-7955-49e8-8fdd-43a148ae05f0"&gt;Page recommends doing a 5-8 minute warm-up, then doing 6-8 reps of each move, and repeating the circuit 2-3 times, resting when needed. This workout will target your legs, core, upper body, and balance. Try to do the bodyweight circuit two to three times per week.&lt;/p&gt;&lt;p&gt;While walking workouts help your cardiovascular fitness, they won’t strengthen your muscles and bones in the same way as strength training, even when using just your bodyweight. Strength training can help increase bone density, which may prevent osteoporosis and minimize your risk of injuries from falls.&lt;/p&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="6eb7d678-a175-4b8b-b4da-0ccea9f3a17a"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Shutterstock)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;a id="elk-76bad126-1caf-4018-ac19-e0f77d238beb" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h2 id="what-advice-would-you-give-to-a-total-beginner-3"&gt;What advice would you give to a total beginner? &lt;/h2&gt;&lt;p id="814c54c2-dabf-4d20-a951-bfab3178ebf1"&gt;“First: You are not behind. You’re right on time,” says Page. She recommends starting by adding simple exercises like the ones above into your daily routine, using walls and counters for support, as well as walking daily to improve your fitness slowly.&lt;/p&gt;&lt;p&gt;“The only rules: No comparing, no need to rush, progress slowly, celebrate everything — the small wins are WINS and a reminder to ask — what is next? Do it again the next day!” she says. “And remember: you don’t train to look younger, you train to live better. The overall benefits are stronger bones, better balance, more confidence, and less fear.”&lt;/p&gt;&lt;hr id="f49e8b93-5aa7-49e8-adb6-e9e621092012"&gt;&lt;a href="https://news.google.com/publications/CAAqKAgKIiJDQklTRXdnTWFnOEtEWFJ2YlhObmRXbGtaUzVqYjIwb0FBUAE" rel="nofollow" id="6fe46253-f403-4550-b180-34f95947a1b0" data-url="https://news.google.com/publications/CAAqKAgKIiJDQklTRXdnTWFnOEtEWFJ2YlhObmRXbGtaUzVqYjIwb0FBUAE" target="_blank" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;figure class="van-image-figure pull-right inline-layout" data-bordeaux-image-check=""&gt;&lt;/figure&gt;&lt;/a&gt;&lt;p id="87da8b77-7ba5-4c61-8fb7-c05d85e2462a"&gt;&lt;em&gt;Follow &lt;/em&gt;&lt;a data-analytics-id="inline-link" href="https://news.google.com/publications/CAAqKAgKIiJDQklTRXdnTWFnOEtEWFJ2YlhObmRXbGtaUzVqYjIwb0FBUAE" target="_blank" data-url="https://news.google.com/publications/CAAqKAgKIiJDQklTRXdnTWFnOEtEWFJ2YlhObmRXbGtaUzVqYjIwb0FBUAE" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none" data-mrf-recirculation="inline-link"&gt;&lt;em&gt;Tom's Guide on Google News&lt;/em&gt;&lt;/a&gt; and&lt;em&gt; &lt;/em&gt;&lt;a data-analytics-id="inline-link" href="https://google.com/preferences/source?q=tomsguide.com" target="_blank" data-url="https://google.com/preferences/source?q=tomsguide.com" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none" data-mrf-recirculation="inline-link"&gt;&lt;em&gt;add us as a preferred source&lt;/em&gt;&lt;/a&gt;&lt;em&gt; to get our up-to-date news, analysis, and reviews in your feeds. &lt;/em&gt;&lt;/p&gt;&lt;hr id="7e752081-3d43-4491-91cd-2af6bf87b938"&gt;&lt;a id="elk-more-from-tom-s-guide" class="paywall" aria-hidden="true"&gt;&lt;/a&gt;&lt;h3 class="article-body__section" id="section-more-from-tom-s-guide"&gt;&lt;span&gt;More from Tom's Guide&lt;/span&gt;&lt;/h3&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Tom's Guide</author><pubDate>Wed, 28 Jan 2026 13:03:31 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMihgJBVV95cUxOVUI2TkdtdnpkQlhnZ1JWdzJ1aGk1cDhoZmR6dExlQmlJdlBjT2JZdms4Y2lRSTJuQ3hCVW9BWHpPNEdib2hvVFEwSXNIeDFsRVVIbGZXWVU0NHNXRVJVaG15RElUUXJLUG1Fd0ptOUZ4dEtQTzREbm9RVXhQZ1JOZ2FDaFY2THpCMVJWa214dndzTDNRM0RmWnhLODFveXFQdG5VZzBuTFFWQ0UzcU8waktydkpnV0hHOUU5RWdkQ3l4REg1LTVxSUVZZ0JMMzVNLXdGbnAwUGZvZHdWdDJfRFlMWHBZVEEzdHZNVGFMZVJ1Mm84QnoyekZJdWRqX3cxcVV0VWln</guid></item><item><title>一个陌生人开玩笑地问我是否有双胞胎。他不知道他的评论有多深。- HuffPost</title><link>https://www.huffpost.com/entry/pregnancy-loss-twin-death-belly_n_697229e7e4b0e15d54cc2015</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Hey, you got twins in there or what?” The bus driver shouted to me with a friendly wave as he waited for the school around the corner from our house to get out. He’d seen my round 9-month pregnant belly and made a lighthearted joke. But a shock to my chest stopped my breath where I stood.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;It was late November in 2024, but my body was transported to our pregnancy four years ago when our son’s identical twin brother died inside of me, and I was forced to carry both of them, one dead, one still alive, until their birthday.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I pretended not to hear him and continued my daily walk with our dog, acting like her reactivity was the reason I was trying to scurry away.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;He called out again. “I said, ‘You got twins in there?’ I swear you got some twins!!” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I restrained myself from responding back, “I did have twins, but one of them is dead!”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;em&gt;&lt;span&gt;Don’t make him uncomfortable.&lt;/span&gt;&lt;/em&gt;&lt;span&gt; I scolded myself before the words left my mouth. “No…” I weakly replied with my own friendly wave as I waddled down the sidewalk. “Just a week past my due date!” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I rounded the corner and heard my heart pounding in my ears. I ignored my you’ll-be-giving-birth-any-day pelvic pain, praying the tears that rushed to my eyes would wait until I got back home to fall.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;As time passes, grief becomes easier to carry. I no longer have panic attacks several times a day, and I can finally fall asleep without crying. But there are still moments when the loss rattles me to my core, as if it just happened last week.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;When I got home, my husband was in the kitchen. I walked straight into his arms and sobbed as if it were the day we had lost our sweet Killian. He held me with a familiar knowing that this was about our son.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In 2020, we bounced with joy when we found out we were pregnant with two healthy identical twin boys, after battling our way through three consecutive miscarriages. We had always talked about wanting twins.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;The doctors called the boys Baby A and Baby B. We had always said if we had twin boys we would name them Seamus and Killian ― two strong Irish names! Sitting silently in the car looking at our ultrasounds, my joy slowly evaporated.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“John…I know it sounds morbid, but I want to name which baby is Seamus and which baby is Killian. In case we lose one of them…I don’t want us needing to decide which name we keep.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Halfway through the pregnancy we indeed received an alarming diagnosis; Killian had become terminally ill. He had no chance of survival. Since he and his brother, Seamus, shared a placenta, the doctors would have to cauterize Killian’s umbilical cord, removing his life support ― and removing his connection to me ― in order to save Seamus’ life. We would lose both boys if we did nothing.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I carried both of them inside of me for the remainder of the pregnancy. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Each appointment we would check in on Seamus. We’d see him wiggling, posing, tossing and turning. We’d make jokes about him becoming a dancer or gymnast or soccer player.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Then, with our permission, we’d scan over to Killian’s lifeless body. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;He still matched his brother in size and shape, initially. But as the pregnancy progressed, he grew smaller and smaller. Eventually Seamus’ full-term size shoved Killian into a pocket under my right ribs. Every ultrasound we would see their distinct differences and be reminded of what would never be.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;The author during pregnancy.&lt;/figcaption&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Photo Courtesy Of Jayme Serbell"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Photo Courtesy Of Jayme Serbell&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Growing up, I was always taught that pregnancy was a blissful time. New life is beautiful. A person’s expanding belly, a miracle; something to celebrate out loud.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I wasn’t taught how common miscarriage and pregnancy loss was.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I didn’t know that you could be pregnant and miscarry without even knowing it. That you could suddenly have the most painful period of your life and never even know the blood coming out of you were the early stages of organs, fingers and toes, a child. 2017 taught me this.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I didn’t know that doctors could blandly tell you that your pregnancy wasn’t viable. I didn’t know that you could be asked if you wanted to scrape out the dying tissue inside of your uterus now or to pass the unsuccessful pregnancy naturally at home, as casually as a grocer would ask you if you want paper or plastic. Spring of 2019 taught me this.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I didn’t know that asking, “Why does this keep happening??” could land you in an over-the-top fancy office, with floor-to-ceiling glass windows, and a doctor decked out in a gaudy watch and designer suit explaining that a simple house downpayment could secure the possibility of maybe having kids someday. Fall of 2019 taught me this.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Early on in our twin pregnancy, when they both seemed healthy, I still felt the sting of well-intentioned comments from strangers.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Oh, is this your first child?” &lt;/span&gt;&lt;em&gt;&lt;span&gt;Well, no, but hopefully they will be our first living ones&lt;/span&gt;&lt;/em&gt;&lt;span&gt;. Something I never said, but always wanted to.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;The author with her son.&lt;/figcaption&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Photo Courtesy Of Jayme Serbell"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Photo Courtesy Of Jayme Serbell&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;After we lost Killian, we lived in two stark realities. In public, we were excitedly met with, “Is it a boy or a girl??” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;What do I say without it turning into a trauma dump on a person who just wanted to bask in the presence of new life? In private, we’d hold each other tight as we removed the doubles of everything off of our baby registry.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Pregnancy turns a body into a conversation starter. A pregnant belly seems to act as an invitation for questioning, guessing, commenting and touching. Most of those questions only make sense if pregnancy is joyful, safe and inevitably headed toward a happy ending.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;People ask, speculate and joke because pregnancy is often treated as a collective experience with a predictable outcome, not a private one filled with uncertainty. It’s easier to engage with the version of pregnancy we expect than the one that actually exists. I can’t recall a single stranger asking me how it was really going, or whether it felt manageable.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;What was missing from those interactions was any acknowledgment that pregnancy can be complicated, heavy or fragile. The assumption of hope and health didn’t uplift me. Our reality didn’t emotionally align with the comments we received, and that disconnect created distance instead of connection.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Near the end of our twin pregnancy, I was waddling around a Walmart when a stranger struck up a conversation with me about a book I was holding. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I was excited to connect with someone new since we lived in a remote place, and it was simultaneously the height of COVID-19. I missed other people. I was about to ask them another question about themselves when suddenly…&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“You sure you don’t have two in there?” they playfully asked, pointing.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Like the bus driver who asked me if I was pregnant with twins, they were being playful and silly. Their voices didn’t carry any cruelty. I can understand the warmth they extended my way, but my chest still hollowed out like a cold underground cave, and left me shivering with the remembrance of what I had lost.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;The author holding a positive pregnancy test.&lt;/figcaption&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Photo Courtesy Of Jayme Surbell"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Photo Courtesy Of Jayme Surbell&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Even when a pregnancy is going smoothly, it can still hold immense physical, emotional and psychological weight. Invisible grief can be deeply isolating, and I’ve come to understand how common it actually is. People are often carrying more than they show. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Our experiences have changed how I interact with people who are pregnant. I’m more careful with my words now. When I can, I ask about their heart: H&lt;/span&gt;&lt;span&gt;&lt;em&gt;ow are you &lt;/em&gt;feeling&lt;/span&gt;&lt;em&gt;&lt;span&gt;?&lt;/span&gt;&lt;/em&gt;&lt;span&gt; I’m careful to avoid saying anything about their bodies. &lt;/span&gt;&lt;span&gt;I’ve learned firsthand that the way a body looks rarely tells the whole story.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt; And sometimes the most meaningful thing we can offer is space for whatever might live inside that unknown.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;em&gt;Do you have a compelling personal story you’d like to see published on HuffPost? Find out what we’re looking for &lt;a href="https://www.huffpost.com/static/how-to-pitch-huffpost" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="here" data-vars-item-type="text" data-vars-unit-name="697229e7e4b0e15d54cc2015" data-vars-unit-type="buzz_body" data-vars-target-content-id="/static/how-to-pitch-huffpost" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;here&lt;/a&gt; and &lt;a href="mailto:pitch@huffpost.com" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="send us a pitch at pitch@huffpost.com." data-vars-item-type="text" data-vars-unit-name="697229e7e4b0e15d54cc2015" data-vars-unit-type="buzz_body" data-vars-target-content-id="mailto:pitch@huffpost.com" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt;send us a pitch at pitch@huffpost.com.&lt;/a&gt;&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Wed, 28 Jan 2026 12:33:05 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikwFBVV95cUxPclYyOURnUElWdjRsSWQxNm50emR2UzFac3l5d0dFNGN5emZJRHQ4UEFya1cwVzlYMjkyWkp5SHZ3R1BJdE1nTmZKUjN1U0xNQ093bU5QZ01VUjkwb3JxU0I0NkMtUHZDSXFicmwxUHhBcWNJTEpyLWFDdkRQQjVxOWpzVTFGSGp2X0d1TE9yZXRndHfSAZgBQVVfeXFMTXRqbm1NWEg1MFBIUTNyYWlTN25sX3dhWFB1ZDE4bHk1UUZWLUVtTTVkU2NwUDRjelJ0aUFxaFVUdnJOQ2hkNlVYNWZON3BzS0YyY3N0RENGNzV5VVRlbm9ydWE5OUtoZGNvNm9pN1l0WTNyNUdyNExFU1ZwVEc2Q2Z0VjA5V2Y2TjZPUkNSd2hoRWp2WTF3LWI</guid></item><item><title>4在确诊前几十年可能出现的帕金森病症状-《华盛顿邮报》</title><link>https://www.washingtonpost.com/wellness/2026/01/28/parkinsons-early-symptoms-smell-constipation-dreams/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="3MVQOQNXIVAARGKESTQ7PN6QBM" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;Many people think of a tremor as the quintessential warning sign of Parkinson’s disease. But other symptoms — many of them not involving changes in movement — can appear much earlier than what’s known as a resting tremor.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Wed, 28 Jan 2026 12:32:02 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipgFBVV95cUxOSk8xVXRwX2ctLUNnUzdJRTV0LVFocFFoRl9PRlYxX0tpc01MTzhMVEhYRFRWeGFEaDlGR0VIdm9oMGpBeFRJQllpQ2RvYU9tQkkyaFRXTHVTU2x0c3Zpaktzd3FnOGRMV2VWYzJ6Vmx3QUEtMFRqSnc0NDNONEFlWnlMRktrY3dGOWsweUE5OUFKV052cE9FNGVGeU8wbE4ycC00R1N3</guid></item><item><title>后视图：臀部形状如何预测糖尿病风险- Medscape</title><link>https://www.medscape.com/viewarticle/rear-view-how-glute-shape-predicts-diabetes-risk-2026a10002pk</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p&gt;Thanks to imaging data, researchers may have a new perspective on &lt;a href="https://emedicine.medscape.com/article/117853-overview" class="cl_ref_article"&gt;type 2 diabetes&lt;/a&gt; (T2D) risk — from the backside.&lt;/p&gt;&lt;p&gt;Researchers in the UK used three-dimensional MRI to study how age-related changes in the shape of a person’s gluteus maximus (GM) muscle were associated with an increase in T2D risk over time, and the results differed by sex.&lt;/p&gt;&lt;p&gt;“There is growing interest in the central role of muscle in lifelong health, from age-related conditions, such as sarcopenia and frailty, to metabolic diseases, especially at a time when many people are concerned about potential muscle loss associated with weight-loss drugs,” Louise Thomas, PhD, professor of metabolic imaging at the University of Westminster, London, England, told &lt;em&gt;Medscape Medical News&lt;/em&gt;.&lt;/p&gt;&lt;p&gt;“We wanted to understand whether muscle shape also carries important information, beyond the traditional measures of muscle volume and quality,” she said, adding that muscle quality is defined as the amount of fat infiltration.&lt;/p&gt;&lt;h2&gt;Assessing GM Morphology&lt;/h2&gt;&lt;p&gt;In a study presented at the &lt;a href="https://www.rsna.org/" rel="nofollow" target="_blank"&gt;Radiological Society of North America&lt;/a&gt; 2025 Annual Meeting, Thomas and colleagues reviewed data from 61,290 MRI exams in the UK Biobank database. They combined the imaging with data on physical measurements, demographics, disease biomarkers, medical history, and lifestyle factors to explore how sex-specific GM morphology related to body measures and T2D.&lt;/p&gt;&lt;p&gt;GM shape was defined in terms of surface-to-surface (S2S) imaging, a technique often used in assessment of internal organs that compares the differences between a patient’s anatomical surface and reference model templates for adult men and adult women. Positive values define muscle expansion, and negative values define muscle shrinkage or atrophy.&lt;/p&gt;&lt;p&gt;Overall, a rounder GM was significantly associated with higher BMI, greater alcohol intake, more physical activity, and increased grip strength, while those with flatter GMs were more likely to be older and frailer and more likely to have &lt;a href="https://emedicine.medscape.com/article/330598-overview" class="cl_ref_article"&gt;osteoporosis&lt;/a&gt; and spend more time sitting (&lt;em&gt;P&lt;/em&gt; &amp;lt; .05 for both).&lt;/p&gt;&lt;p&gt;However, in men, T2D was significantly associated with a flatter bottom, while the opposite was true for women (&lt;em&gt;P&lt;/em&gt; &amp;lt; .05 for both). The negative median difference in S2S from the template was -0.41 mm and -0.39 mm on the right and left GM muscles, respectively, for men with T2D, suggesting atrophy. For women, the positive median differences of 0.45 mm and 0.49 mm for the right and left GM muscles, respectively, suggested fatty hypertrophy, according to the researchers.&lt;/p&gt;&lt;h2&gt;Sex Differences Surprising&lt;/h2&gt;&lt;p&gt;“We were surprised not just by the scale of the differences, but by how sharply the muscle shape patterns linked to type 2 diabetes diverged between men and women,” Thomas told &lt;em&gt;Medscape Medical News&lt;/em&gt;. “Men showed clear regions of localized thinning consistent with muscle atrophy, whereas women showed outward bulging that likely reflects increased fat deposition,” she explained.&lt;/p&gt;&lt;p&gt;“We also found that people with a larger gluteus maximus at baseline had a substantially lower future risk of developing type 2 diabetes, even after accounting for age, BMI, waist-to-hip ratio, physical activity, and other lifestyle factors,” she said.&lt;/p&gt;&lt;p&gt;The results suggest different biological responses to the same disease, she noted. Not surprisingly, individuals with higher fitness, as measured by vigorous physical activity and hand grip strength, also had a rounder GM shape, while aging, frailty, and long sitting times were linked to muscle thinning, Thomas said.&lt;/p&gt;&lt;p&gt;The findings were limited by providing only a single snapshot measure, but the large study population makes the results valuable for understanding muscle structure at scale, said Thomas.&lt;/p&gt;&lt;p&gt;“Crucially, UK Biobank is now conducting repeat scans in another 60,000 participants, due to complete by 2030, and this follow-up will give us the opportunity to track how muscle shape changes as people age or modify their lifestyle,” she added. Sex-specific GM shape changes in T2D may reflect local differences in response to &lt;a href="https://emedicine.medscape.com/article/2089224-overview" class="cl_ref_article"&gt;insulin&lt;/a&gt; tolerance that merit additional investigation, she said.&lt;/p&gt;&lt;h2&gt;Spatial Specificity Unexpected&lt;/h2&gt;&lt;p&gt;The new study addresses a key limitation in how muscle health is assessed in metabolic disease, said Ricardo Rosero-Revelo, MD, endocrinologist at the Cleveland Clinic, Cleveland, and lead author of a study describing a &lt;a href="https://www.clinicalnutritionespen.com/article/S2405-4577(25)02968-7/fulltext" rel="nofollow" target="_blank"&gt;predictive model&lt;/a&gt; for muscle mass loss in &lt;a href="https://emedicine.medscape.com/article/123702-overview" class="cl_ref_article"&gt;obesity&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;“Traditional metrics such as muscle volume or total fat measures miss regional, sex-specific muscle adaptations that may be clinically meaningful,” said Rosero-Revelo, who was not involved in the UK study. “The availability of large biobank MRI datasets combined with automated segmentation and shape modeling allow for population-scale mapping of subtle morphological changes,” he said. The researchers leveraged these tools to refine muscle phenotyping in T2D in a way that was not previously feasible, he added.&lt;/p&gt;&lt;p&gt;While the findings were biologically plausible, the spatial specificity was surprising, Rosero-Revelo told &lt;em&gt;Medscape Medical News&lt;/em&gt;.&lt;/p&gt;&lt;p&gt;“Sex differences in fat distribution and muscle aging are well described, which makes divergent patterns between men and women in type 2 diabetes reasonable; however, it was unexpected to see clearly localized regions of inward versus outward deformation rather than a uniform change in muscle size,” he said.&lt;/p&gt;&lt;p&gt;“This highlights that metabolic disease affects skeletal muscle heterogeneously and supports the idea that muscle phenotype, not just muscle quantity, matters,” he explained.&lt;/p&gt;&lt;h2&gt;Consider Muscle Mass in Clinical Care&lt;/h2&gt;&lt;p&gt;The key implication for clinical practice is that relying on BMI, body weight, or even muscle quantity alone is insufficient to understand muscle health in people with T2D, Rosero-Revelo said. “While MRI-based shape analysis is not feasible for routine care, the study reinforces a practical direction for clinicians to incorporate scalable tools, such as body composition assessment together with strength and functional testing, to better approximate muscle quality and detect ‘hidden’ muscle vulnerability,” he said.&lt;/p&gt;&lt;p&gt;“Much of the clinical messaging around health focuses on weight loss and body fat, and while that matters, maintaining healthy muscle mass is just as essential for long-term well-being,” Thomas added.&lt;/p&gt;&lt;p&gt;“We should be encouraging people to engage in simple resistance exercises that help strengthen, build, and preserve muscle; this message deserves far more prominence in public health conversations,” she said.&lt;/p&gt;&lt;p&gt;Limitations of the study include reliance on MRI-based shape analysis, which is resource-intensive and not readily scalable, as well as potential selection bias, because only participants with high-quality imaging and valid segmentations can be included, Rosero-Revelo said. The study’s cross-sectional design prevents conclusions of causality, and the results may not generalize to all populations, he added.&lt;/p&gt;&lt;p&gt;“Future research should include longitudinal and multiethnic validation, calibration against reference measures of muscle composition and function, and development of simpler surrogate markers that can capture similar phenotypes in routine clinical practice,” said Rosero-Revelo.&lt;/p&gt;&lt;p&gt;“In the longer term, improved assessment of muscle health could inform treatment personalization, including selecting and monitoring therapies with attention to preserving lean tissue during weight loss,” he said.&lt;/p&gt;&lt;p&gt;&lt;em&gt;The study reported receiving no outside funding. The researchers and Rosero-Revelo reported having no financial conflicts to disclose.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Medscape</author><pubDate>Wed, 28 Jan 2026 12:27:04 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinwFBVV95cUxOWjNmYmxKajZJV3plTmpqdVRKQV9oaTZNYjRPZ0dqMWF5UWxxT1NVSG5Gdlp6aUxpbHFOWXpPZXRIcWpTanpQNkZHQlZhWExVYmRRaWFaekFBWm5vc0JZUklNSkhDZVVETTRSZk5PVHM5cVFFSWI0SGx0UWJPQ0lmdDQwZm50SVg4ZWRJYktOVUM2cGF1WHYyYTRKWnpDUjg</guid></item><item><title>尼帕病毒：印度出现病例后须知-路透社</title><link>https://www.reuters.com/business/healthcare-pharmaceuticals/what-know-about-nipah-virus-after-cases-emerge-india-2026-01-28/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Reuters</author><pubDate>Wed, 28 Jan 2026 12:17:32 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwgFBVV95cUxPOU05TnFSQS1DaDMyR09yOXVCVFEwczFxTEdaNlZGZDY1TjlYcmd5MTdoRUhTS19wSU1UY1FDejNLRm5TQWs5LVNxS1AxRk5BSkRqNTlKTVRiVmxXaXlFN3VEcEltQ2NuU0hiMEtfWkh6NS11ZU5RdkJ2cG16Z0x2M09LTUtCekVVTG03QlJ6MWRabEE3MHR0MEEzVEtPY3B5XzNzS2hPODRQVzJua3NPem1pN2dlZ2pzRllwTW9mY3g4UQ</guid></item><item><title>我们可能误解了红葡萄酒与长寿的关系- HuffPost</title><link>https://www.huffpost.com/entry/red-wine-longevity_l_69603102e4b0120ab25c86df</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Dry January is a time when the “evils” of alcohol hover over us. &lt;/span&gt;&lt;span&gt;The warnings about alcohol feel endless: it might &lt;a href="https://www.huffpost.com/entry/dementia-alcohol-study-safe_l_68f12994e4b0ab08d3195a9b" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="increase your risk of dementia" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="68f12994e4b0ab08d3195a9b" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;increase your risk of dementia&lt;/a&gt;, it might &lt;a href="https://www.huffpost.com/entry/alcohol-link-serious-illnesses_l_68c1c7ace4b0656225ce8563" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="cause cancer" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="68c1c7ace4b0656225ce8563" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt;cause cancer&lt;/a&gt;, it might kill you.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;But if that’s all true, why do so many &lt;a href="https://www.huffpost.com/entry/blue-zones-longer-life-tips_l_651af7dfe4b00421f662db6a" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="“Blue Zone”" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="651af7dfe4b00421f662db6a" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="2"&gt;“Blue Zone”&lt;/a&gt; centenarians drink red wine? Why does the American Heart Association say a small amount might&lt;/span&gt;&lt;span&gt; reduce your risk of heart attacks? And if it’s that bad, why does the research seem conflicted?&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;We asked experts to break down what we know about red wine — and alcohol in general — and its impact on lifespan. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Why We Connect Red Wine With Longevity&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In the popular Netflix documentary “Live To 100,” longevity researcher Dan Buettner showed the habits and environment of centenarians who live in the “Blue Zones.” These are places where people tend to live longer than the rest of the world. In two of those communities, Sardinia, Italy, and Ikaria, Greece, drinking red wine is an important daily ritual.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“The majority of people in the Mediterranean Blue Zones — who live up to 10 years longer than Americans do — are drinking a glass or two of local red wine daily, usually with a meal, family and friends. We don’t know if they are living longer because of the wine, the fellowship or the combination of both,” Buettner said in an email to HuffPost.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Yana Iskayeva via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Yana Iskayeva via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;There may not be enough polyphenols in a glass of wine to make a difference, and cardiovascular impact has also been observed when people drink other types of alcohol.&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;While this population tends to drink wine as they eat and socialize, they follow other healthy habits, too. Their diet is high in &lt;/span&gt;&lt;span&gt;fruits and vegetables, they are close with family and friends, and they get regular exercise. It’s possible that these other practices outweigh the moderate indulgences. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“It remains unknown whether drinking can be part of a healthy lifestyle,” &lt;/span&gt;&lt;span&gt;said&lt;/span&gt;&lt;a href="https://news.vanderbilt.edu/experts/expertprofile/?expert_username=mariann.piano" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Mariann Piano" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://news.vanderbilt.edu/experts/expertprofile/?expert_username=mariann.piano" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="3"&gt; &lt;span&gt;Dr. Mariann Piano&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, professor emeritus of nursing at Vanderbilt Universit&lt;/span&gt;&lt;span&gt;y. “Clearly, drinking too much — and that includes more than two drinks a day — is associated with many adverse cardiovascular effects. … I think the controversy is more around the low to moderate levels.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Here’s The Controversy&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Research clearly shows that excessive alcohol consumption and binge drinking can lead to medical issues, but the impact of lower quantities is more complicated.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Studies have shown that light drinkers may have lower mortality than both abstainers and heavy drinkers. Some researchers contest the finding, but &lt;/span&gt;&lt;a href="https://hsph.harvard.edu/profile/eric-b-rimm/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Eric Rimm" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://hsph.harvard.edu/profile/eric-b-rimm/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="4"&gt;&lt;span&gt;Dr. Eric Rimm&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, a professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health, attributes it to a reduced risk of cardiovascular disease.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“It does look like people who drink half a drink to one drink a day, which means three to seven drinks a week, live the longest,” Rimm said&lt;/span&gt;&lt;span&gt;. “Most of that is explained by the fact that they have lower rates of heart attacks — and heart attacks cause death.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In fact, heart disease is the &lt;/span&gt;&lt;a href="https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm#:~:text=Heart%20disease:%20680%2C981,COVID%2D19:%2049%2C932" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="No. 1" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm#:~:text=Heart%20disease:%20680%2C981,COVID%2D19:%2049%2C932" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="5"&gt;No. 1&lt;/a&gt;&lt;span&gt; cause of death in the developed world. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In June, the American Heart Association released a &lt;/span&gt;&lt;a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001341" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="review" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001341" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="6"&gt;&lt;span&gt;review&lt;/span&gt;&lt;/a&gt;&lt;span&gt; showing that low levels of alcohol showed no risk, or potentially lowered risk, of cardiovascular conditions. In small amounts, it can raise good cholesterol, have a blood-thinning effect and lower blood pressure. This was not specific to red wine, though.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;You may have heard that the polyphenols, or antioxidants, in red wine are what cause this, but this is unproven. There may not be enough polyphenols in a glass of wine to make a difference, and the cardiovascular impact has also been observed when people drink other types of alcohol.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Your heart isn’t the only area of focus when it comes to your body’s reaction to alcohol. Small quantities may also reduce the risk of developing Type 2 diabetes. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Moderate alcohol, 5 to 10 ounces a day, has been shown to potentially reduce the risk of developing Type 2 diabetes. Interestingly, some of the studies showed patients even losing a few pounds over time. … And even in our diabetic patients, we’re seeing improvements in blood sugars with moderate alcohol use, in particular with red wine,” said &lt;/span&gt;&lt;a href="https://crousemed.com/physicians-providers-directory/steven-zygmont-md/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Steven Zygmont" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://crousemed.com/physicians-providers-directory/steven-zygmont-md/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;&lt;span&gt;Dr. Steven Zygmont&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, diabetes and metabolism endocrinologist with Crouse Health. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;It’s possible that the polyphenols cause red wine to have a slightly better effect than other drinks, or it may be a result of the way that people typically consume red wine. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Health practitioners have major concerns about communicating these findings, which can easily be misunderstood. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“It’s a really tricky public health message because of all of the dangers of alcohol,” Rimm said. “It’s unlike other things in public health, because if you tell people, ‘you should have more fruits and vegetables,’ they’re not likely to binge on fruits and vegetables on Friday and Saturday. But alcohol has the problem that the pattern is probably equally as important as the amount,” Rimm said.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Tatiana Maksimova via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Tatiana Maksimova via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;All alcohol, no matter the type, is a known carcinogen.&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Given the addictive nature of alcohol, one glass of wine can easily become two or more. It’s a fine line: Drinking a little has a low risk, but increasing the amount can dramatically raise your risk.&lt;/span&gt; &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Plus, regardless of the other health implications, alcohol — including wine — is a known carcinogen. So, while heart disease remains the leading cause of death, cancer follows closely in second place. When it comes to cancer risk, there’s no safe amount of alcohol. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Risks related to cancer should not be ignored, and considered on an individual basis,” Piano said. “Some advice we give to people is, ’If you have a really strong family history of cancer, then you may want to have less or no alcohol. Everybody can choose to drink nothing; however, there are many lifestyle behaviors we can engage in to reduce our risk of chronic disease.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;How To Make Informed Choices&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;So, what does wine actually look like in the longevity picture? &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Keeping the science in mind while looking at the Blue Zones of Sardinia and Ikaria, we see a tradition of drinking wine with meals as part of an overall healthy lifestyle. Wine tends to be shared in social settings over food, which can limit amounts and slow the pace, easing the load as the body works to metabolize toxins. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“I think [red wine] is more linked to other positive eating and physical activity behaviors,” Piano said, pointing to a &lt;/span&gt;&lt;a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822215" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="study" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822215" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="8"&gt;&lt;span&gt;study&lt;/span&gt;&lt;/a&gt;&lt;span&gt; that found a small protective association with preferences for wine and consuming alcohol with meals. This could be due to slower alcohol absorption, and it might reflect the lifestyle choices of people who prefer red wine as their drink of choice. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“There are just too many unknowns at this time, except that drinking too much (and that includes more than two drinks a day) is associated with a lot of adverse cardiovascular effects,” Piano said.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Even if there is a protective effect associated with wine, it has serious limits. While light drinkers may have reduced cardiovascular risk, heavier drinkers have a significantly increased risk of heart attack, high blood pressure or stroke. Light drinkers tend to have &lt;/span&gt;&lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7324954/#:~:text=Compared%20with%20never%20drinkers%2C%20low,to%2014%20drinks%20per%20week." role="link" class=" js-entry-link cet-external-link" data-vars-item-name="lower rates" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7324954/#:~:text=Compared%20with%20never%20drinkers%2C%20low,to%2014%20drinks%20per%20week." data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="9"&gt;&lt;span&gt;lower rates&lt;/span&gt;&lt;/a&gt;&lt;span&gt; of cognitive decline, but heavier drinkers are more likely to develop &lt;/span&gt;&lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5086415/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="dementia" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5086415/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="10"&gt;&lt;span&gt;dementia&lt;/span&gt;&lt;/a&gt;&lt;span&gt;. Light drinkers are &lt;/span&gt;&lt;a href="https://pubmed.ncbi.nlm.nih.gov/26458258/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="less likely" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://pubmed.ncbi.nlm.nih.gov/26458258/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="11"&gt;&lt;span&gt;less likely&lt;/span&gt;&lt;/a&gt;&lt;span&gt; to develop diabetes, but excess drinking is a significant risk factor for &lt;/span&gt;&lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2768203/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Type 2 diabetes" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2768203/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="12"&gt;&lt;span&gt;Type 2 diabetes&lt;/span&gt;&lt;/a&gt;&lt;span&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In 2023, the Canadian Centre on Substance Use and Addiction tried to organize this risk into charts to help people understand the continuum, &lt;a href="https://www.ccsa.ca/sites/default/files/2024-05/Canadas-Guidance-on-Alcohol-and-Health-poster-2023-en.pdf" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="which you can see here" data-vars-item-type="text" data-vars-unit-name="69603102e4b0120ab25c86df" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.ccsa.ca/sites/default/files/2024-05/Canadas-Guidance-on-Alcohol-and-Health-poster-2023-en.pdf" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="13"&gt;which you can see here&lt;/a&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Alcohol use cannot be addressed with a blanket statement, which I know is what the public wants,” Piano said. “Nonetheless, from a public health perspective, it is important to highlight the risk of cancer and chronic diseases, with higher consumption linked to greater harm. Be more intentional and mindful about what you’re drinking. … People need to understand what their risk is, and then it’s going to be up to them.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;So, if you are going to drink, is red wine the best choice? It’s possible that wine may have a slight edge over other types of alcohol due to its composition, but its main advantage probably lies in the traditions that surround it. Although there’s no definitive answer, one thing is clear: If you’re going to indulge in red wine, keep portions small, because healthy food and good company seem to be far more important for longevity than wine alone. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Wed, 28 Jan 2026 12:00:17 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxOYWUyNXQwWGNuYnk3enNFX254d0xoNTlDelo2dFhfS0swLTRaR0JGc2VodzJUZEpsZFVEQnc3eDByaHdFZVhnVWtMUUxpRmRfV0xJWmJSOExFUllWWFM5Q0tGcklXcE0zYlRaRTZ3SXVONlpmVWk4YmdhMFYwemxtZWxR0gGHAUFVX3lxTE14akppZ0dmekJEc09QMHZSa2NKeE5nZVZwN2lZb0k0c1RoOFRZWFVCbzcxSHRJWmxSRWRzSGN0QnR3anNiQkhCNkJIQU9zeWxXek1Rb0lhVmp5ZDVNQUwxUVhIYUNqQmxuSl9oSGV4T2g3RGh6Rk16cFlhNlBmVC00Y2lSa19KWQ</guid></item><item><title>成千上万的新泽西州儿童正在逃避接种疫苗。看看您所在的县如何比较。- nj.com</title><link>https://www.nj.com/healthfit/2026/01/thousands-more-nj-kids-are-skipping-vaccines-see-how-your-county-compares.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content   "&gt;&lt;p class="article__paragraph article__paragraph--left" id="ZNFXKOEOJVEO5F7N72WPHFECAM"&gt;Vaccination rates among New Jersey children continue to fall as religious exemptions rise, a trend that public health experts say may contribute to the resurgence of vaccine-preventable diseases. &lt;/p&gt;&lt;p id="inarticle-1" data-gaid="inarticle-1"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="EZV47YHO3VHYBFBA4MAJGKXCEA"&gt;Data from the state Department of Health shows 24,962 kids skipped vaccines for religious reasons during the 2024-25 school year, a nearly 25% increase from the previous year. The number represents just 5% of all pre-K, kindergarten, first grade, sixth grade and transfer students in the state. However, it’s nearly triple what it was a decade ago.&lt;/p&gt;&lt;p id="inarticle-2" data-gaid="inarticle-2"&gt;&lt;/p&gt;&lt;p id="fusion-static-enter:GMG3XYU4QFBEPJCON56V4PJPAY" data-fusion-component="GMG3XYU4QFBEPJCON56V4PJPAY"&gt;&lt;/p&gt;&lt;p class="rawhtml"&gt;&lt;/p&gt;&lt;p id="fusion-static-exit:GMG3XYU4QFBEPJCON56V4PJPAY" data-fusion-component="GMG3XYU4QFBEPJCON56V4PJPAY"&gt;&lt;/p&gt;&lt;p id="inarticle-3" data-gaid="inarticle-3"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="AKTCG2WSJRFBFPCWBUO3CW7LWM"&gt;&lt;a href="https://www.datawrapper.de/_/xWJto/" target="_blank" rel="" title="https://www.datawrapper.de/_/xWJto/"&gt;If the chart above is not showing, you can see it here.&lt;/a&gt;&lt;/p&gt;&lt;p id="inarticle-4" data-gaid="inarticle-4"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="L3KUBRHKF5EAVMTVUYN4SVLRLA"&gt;New Jersey’s religious exemption rate among kindergartners of 4.6% is even higher than the U.S. median of 4%. &lt;/p&gt;&lt;p id="inarticle-5" data-gaid="inarticle-5"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="7Y475ZMMSVH2BPMLZTTWWC2VLE"&gt;New Jersey is one of 29 states that allow exemptions for religious reasons, according to the &lt;a href="https://www.ncsl.org/health/state-non-medical-exemptions-from-school-immunization-requirements" target="_blank" rel="" title="https://www.ncsl.org/health/state-non-medical-exemptions-from-school-immunization-requirements"&gt;National Conference of State Legislatures&lt;/a&gt;. Four states — California, Connecticut, Maine and New York — do not allow any type of non-medical exemption.&lt;/p&gt;&lt;p id="inarticle-6" data-gaid="inarticle-6"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="H5CRMWWUJRG4BC7MVREP2UJKEU"&gt;Under &lt;a href="https://www.nj.gov/health/cd/documents/imm_requirements/religious_exemption.pdf" target="_blank" rel="" title="https://www.nj.gov/health/cd/documents/imm_requirements/religious_exemption.pdf"&gt;New Jersey law&lt;/a&gt;, a parent or guardian can submit a written, signed request for exemption from mandatory immunization due to religious beliefs. They don’t need any other documentation, such as proof of membership in a religious organization. &lt;/p&gt;&lt;p id="inarticle-7" data-gaid="inarticle-7"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6KEE42GGEZCQDGCEZNFS7XNF3E"&gt;The state also allows exemptions for medical reasons, but that makes up a smaller portion of unvaccinated school children — .2% during the 2024-25 school year. &lt;/p&gt;&lt;p id="inarticle-8" data-gaid="inarticle-8"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="HF4Z2UYU3JFPTMOLU32EKLZT2U"&gt;Medical and religious reasons are the only acceptable grounds for skipping mandatory immunization requirements in New Jersey schools and daycares. The law states that requests “based on philosophical, moral, secular, or more general reasons” are not permitted. &lt;/p&gt;&lt;p id="inarticle-9" data-gaid="inarticle-9"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="KL6JN4ZJ65FM5LQDY3YWR7OY6U"&gt;The trend toward increasing vaccine exemptions could put New Jersey at increased risk for outbreaks. &lt;/p&gt;&lt;p id="inarticle-10" class="middleParagraph" data-gaid="inarticle-10"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="RQGLM5XWOZHZJAGHS6XRDAYDAY"&gt;A &lt;a href="https://pubmed.ncbi.nlm.nih.gov/41533386/" target="_blank" rel="noreferrer" title="https://pubmed.ncbi.nlm.nih.gov/41533386/"&gt;recent study&lt;/a&gt; published by the JAMA Network found an increase in non-medical exemptions to childhood vaccination requirements from 2010 to 2024, which may contribute to resurgence of vaccine-preventable diseases. &lt;/p&gt;&lt;p id="inarticle-11" data-gaid="inarticle-11"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="ECLEFN3PVBANHKZT3AOQXTPHRY"&gt;Measles, for example, is highly preventable but has made a resurgence. In 2025 the United States reported a total of 2,255 measles cases, the most since 1991, according to the Centers for Disease Control and Prevention. About 93% of cases were among people who were unvaccinated or whose vaccination status was unknown.&lt;/p&gt;&lt;p id="inarticle-12" data-gaid="inarticle-12"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="ABMDEDEVFFGPTER647PGAMG32Y"&gt;New Jersey has already lost its herd immunity to measles, putting unvaccinated people, especially children, more at risk. The CDC says more than 95% of people in a community need to be vaccinated for most people to be protected through herd immunity. &lt;/p&gt;&lt;p id="inarticle-13" data-gaid="inarticle-13"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="C2OWN357UVB2RG5D6KVMIJUEKY"&gt;In New Jersey, just 92.8% of kindergarteners received the MMR vaccine for the 2024-25 school year, down from 93% the previous year. &lt;/p&gt;&lt;p id="inarticle-14" data-gaid="inarticle-14"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="LA2QCKP3U5BKBFAEEF3IHCBQBE"&gt;The state reported a total of 11 measles cases in 2025, up from seven cases the previous year. &lt;/p&gt;&lt;p id="inarticle-15" data-gaid="inarticle-15"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="VEMZF72ZMJHIZMYZY4SWVPSPAI"&gt;Here is a county-by-county breakdown of how many school children have been granted exemptions from vaccines:&lt;/p&gt;&lt;p id="inarticle-16" data-gaid="inarticle-16"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="N7P35WZALNBS3KVQVZULG7KJKQ"&gt;&lt;a href="https://www.datawrapper.de/_/1mWXn/" target="_blank" rel="" title="https://www.datawrapper.de/_/1mWXn/"&gt;If the chart below is not showing, you can see it here. &lt;/a&gt;&lt;/p&gt;&lt;p id="inarticle-17" data-gaid="inarticle-17"&gt;&lt;/p&gt;&lt;p id="fusion-static-enter:O3RLDB7XUFFNJHXAEOVIROXOBM" data-fusion-component="O3RLDB7XUFFNJHXAEOVIROXOBM"&gt;&lt;/p&gt;&lt;p class="rawhtml"&gt;&lt;/p&gt;&lt;p id="fusion-static-exit:O3RLDB7XUFFNJHXAEOVIROXOBM" data-fusion-component="O3RLDB7XUFFNJHXAEOVIROXOBM"&gt;&lt;/p&gt;&lt;p id="inarticle-18" data-gaid="inarticle-18"&gt;&lt;/p&gt;&lt;p id="fusion-static-enter:LYSKX65CG5AGLMKETNVXUUTCRA" data-fusion-component="LYSKX65CG5AGLMKETNVXUUTCRA"&gt;&lt;/p&gt;&lt;p id="fusion-static-exit:LYSKX65CG5AGLMKETNVXUUTCRA" data-fusion-component="LYSKX65CG5AGLMKETNVXUUTCRA"&gt;&lt;/p&gt;&lt;p id="inarticle-19" data-gaid="inarticle-19"&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>nj.com</author><pubDate>Wed, 28 Jan 2026 12:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMitgFBVV95cUxPSFZtZFhYMnZwUzVISE9GcVBpeXpUcHZ6SmVTQmZjU1NQMDN3R2lDb1hCaFhfaEY2QmIxOW5HMjBJRHZKZU1rZ0pfbHJCbkNBRXhlNXJwQjZkVTBDeTlpM2VnclVmY3BUYTJiQVo4Wi0xdnBiVGdIYlNIUFY4a08zcF9UM1Q0aUd4OFhwdWJsZnU0UV9zNUtIbmVuVTFmSUtXeWh5MUdwTDVSZnVFcWNORWJDeWI5Zw</guid></item><item><title>12分钟的早晨锻炼，比50小时后的锻炼更快地恢复肌肉-吃这个不是那个</title><link>https://www.eatthis.com/12-minute-morning-routine-after-50/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="content single-post-content"&gt;
																			&lt;p class="tagline"&gt;Get stronger after 50 in 12 minutes, try this CPT-guided morning routine today.&lt;/p&gt;
												
																			
																		
						
						
						&lt;p&gt;For many people over 50, there’s a common misconception that you need to workout longer and harder to see results. But the reality is that 60-minute or longer training sessions can feel draining, hard to recover from, and difficult to sustain long term. &lt;a rel="noopener noreferrer external" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10854791/" target="_blank" data-citation="true" data-citation-type="ScholarlyArticle"&gt;Research&lt;/a&gt; shows that as you age, your exercise recovery capacity changes. Muscle protein synthesis slows down, your joints become less tolerant of repeated high loads, and fatigue lingers longer than it did when you were younger.&lt;/p&gt;
&lt;p&gt;The good news is that doing shorter bouts of resistance-based exercises on a regular basis can &lt;a rel="noopener noreferrer external" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3790587/" target="_blank" data-citation="true" data-citation-type="ScholarlyArticle"&gt;increase muscle protein synthesis&lt;/a&gt;, &lt;a rel="noopener noreferrer external" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12149312/" target="_blank" data-citation="true" data-citation-type="ScholarlyArticle"&gt;boost neuromuscular coordination&lt;/a&gt;, and &lt;a rel="noopener noreferrer external" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10403822/" target="_blank" data-citation="true" data-citation-type="ScholarlyArticle"&gt;maintain strength&lt;/a&gt; in adults 50 and beyond. To learn more, we chatted with &lt;b&gt;James Bickerstaff, CPT&lt;/b&gt;, a personal trainer at &lt;a rel="noopener noreferrer external" href="https://www.origym.co.uk/blog/author/jbickerstaff/" target="_blank"&gt;OriGym&lt;/a&gt;, who shares a stellar 12-minute morning routine designed specifically for older adults to restore muscle faster than any hour-long gym session.&lt;/p&gt;
&lt;p&gt;“Short morning routines that prioritize consistency, muscle activation, and recovery often outperform long workouts,” says Bickerstaff. “They stimulate muscle protein synthesis, improve joint lubrication, and boost circulation first thing in the morning, helping muscles recover and stay strong without unnecessary fatigue. This approach shifts the goal from exhaustion to activation, therefore preparing the body to move well throughout the day rather than draining it first thing.”&lt;/p&gt;
&lt;p&gt;The following 12-minute routine is built around simple, compound movements that activate large muscle groups and support joint health. Read on for the exercises and detailed step-by-step instructions. And when you’re finished, don’t miss these &lt;a rel="noopener noreferrer" href="https://www.eatthis.com/morning-exercises-for-men-over-50/" target="_blank"&gt;5 Exercises Men Over 50 Should Do Every Morning to Rebuild Lost Muscle&lt;/a&gt;.&lt;/p&gt;
	&lt;h2 id="sit-to-stand-squats-chair-squats" class="o-slide-title" data-num="1"&gt;&lt;span&gt;Sit-to-Stand Squats (Chair Squats)&lt;/span&gt;&lt;/h2&gt;
	
&lt;p&gt;&lt;iframe src="https://www.youtube.com/embed/ATYX9LAbpdY" frameborder="0" allowfullscreen="allowfullscreen"&gt;VIDEO&lt;/iframe&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Sit-to-stand squats are top shelf squat variation for adults over 50 because they directly support a common daily task: getting up and down from a chair. They target the quads, glutes, and core while boosting balance and joint control.&lt;/p&gt;&lt;p class="karma_unit karma_unit--distinct inline karma_unit--mobile hide-desktop karma_unit--sliding htlad-lazy-mob-square-fixed karma_unit--halfpage"&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;How to do it:&lt;/b&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Sit upright on a sturdy chair with your feet shoulder-width apart and flat on the floor.&lt;/li&gt;
&lt;li&gt;Scoot slightly forward so your weight is evenly distributed through your feet.&lt;/li&gt;
&lt;li&gt;Flex your core while keeping your chest lifted and your spine neutral.&lt;/li&gt;
&lt;li&gt;Drive through your heels to stand up while squeezing your glutes at the top.&lt;/li&gt;
&lt;li&gt;Pause for one to two seconds in the standing position to maintain balance.&lt;/li&gt;
&lt;li&gt;Slowly lower yourself back down to the chair over three to four seconds.&lt;/li&gt;
&lt;li&gt;Lightly touch the chair before repeating the next rep.&lt;/li&gt;
&lt;li&gt;Perform two sets of 12 to 15 reps, resting for 30 to 45 seconds between sets.&lt;/li&gt;
&lt;/ol&gt;

	&lt;h2 id="incline-push-ups-hands-on-wall-or-counter" class="o-slide-title" data-num="2"&gt;&lt;span&gt;Incline Push-Ups (Hands on Wall or Counter)&lt;/span&gt;&lt;/h2&gt;
	
&lt;p&gt;&lt;iframe title="YouTube video player" src="https://www.youtube.com/embed/yAbg3_pJKvw?si=WAU1hO-nM7bmVJpn" frameborder="0" allowfullscreen="allowfullscreen"&gt;VIDEO&lt;/iframe&gt;&lt;/p&gt;
&lt;p&gt;Incline push-ups can help build and maintain upper-body strength while being far more joint-friendly than traditional push-ups. This push-up variation strengthens your chest, shoulders, triceps, and core while helping improve posture.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;How to do it:&lt;/b&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Place your hands on a wall, countertop, or sturdy surface at chest height.&lt;/li&gt;
&lt;li&gt;Step your feet back slightly so your body forms a straight line from head to toe.&lt;/li&gt;
&lt;li&gt;Engage your core and glutes to prevent sagging through your lower back.&lt;/li&gt;
&lt;li&gt;Slowly bend your elbows and lower your chest toward your hands over two to three seconds.&lt;/li&gt;
&lt;li&gt;Keep your elbows angled slightly away from your sides.&lt;/li&gt;
&lt;li&gt;Press through your hands to return to the starting position in one controlled motion.&lt;/li&gt;
&lt;li&gt;Reset your posture before beginning the next rep.&lt;/li&gt;
&lt;li&gt;Complete two sets of 10 to 12 reps. Rest for 30 for 45 seconds between sets.&lt;/li&gt;
&lt;/ol&gt;
	&lt;h2 id="bodyweight-rows" class="o-slide-title" data-num="3"&gt;&lt;span&gt;Bodyweight Rows&lt;/span&gt;&lt;/h2&gt;
	
&lt;p&gt;&lt;iframe title="YouTube video player" src="https://www.youtube.com/embed/EIFEKZe4Wm8?si=UziQl2LJDab9pf5m" frameborder="0" allowfullscreen="allowfullscreen"&gt;VIDEO&lt;/iframe&gt;&lt;/p&gt;
&lt;p&gt;Bodyweight rows can help counteract the forward-rounded posture that often develops with age. They also strengthen your upper back, shoulders, and arms while boosting shoulder stability.&lt;/p&gt;&lt;p class="karma_unit karma_unit--distinct inline karma_unit--mobile hide-desktop karma_unit--sliding htlad-lazy-mob-square-fixed"&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;How to do it:&lt;/b&gt;&lt;span aria-hidden="true"&gt;6254a4d1642c605c54bf1cab17d50f1e&lt;/span&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Stand facing a sturdy table or surface and grip the edge.&lt;/li&gt;
&lt;li&gt;Walk your feet forward and lean your body back with your arms fully extended.&lt;/li&gt;
&lt;li&gt;Keep your chest upright and your shoulders relaxed away from your ears.&lt;/li&gt;
&lt;li&gt;Brace your core and pull your chest toward your hands by driving your elbows back.&lt;/li&gt;
&lt;li&gt;Squeeze your shoulder blades together at the top of the movement.&lt;/li&gt;
&lt;li&gt;Pause for one to two seconds then slowly lower your body back to the starting position.&lt;/li&gt;
&lt;li&gt;Maintain control throughout the entire range of motion.&lt;/li&gt;
&lt;li&gt;Aim for two sets of 10 to 12 reps, resting for 30\ to 45 seconds between sets.&lt;/li&gt;
&lt;/ol&gt;

	&lt;h2 id="standing-march-with-core-brace" class="o-slide-title" data-num="4"&gt;&lt;span&gt;Standing March With Core Brace&lt;/span&gt;&lt;/h2&gt;
	
&lt;p&gt;&lt;iframe title="YouTube video player" src="https://www.youtube.com/embed/shdbEBpDUTk?si=8lfsb2k3b9qBsois" frameborder="0" allowfullscreen="allowfullscreen"&gt;VIDEO&lt;/iframe&gt;&lt;/p&gt;
&lt;p&gt;This marching exercise variation will activate your hip flexors, glutes, and deep core muscles that support walking and daily movement while improving balance and coordination.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;How to do it:&lt;/b&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Stand tall with your feet hip-width apart and your arms relaxed at your sides.&lt;/li&gt;
&lt;li&gt;Flex your core by tightening your ab muscles.&lt;/li&gt;
&lt;li&gt;Lift one knee slowly toward hip height while keeping your torso upright.&lt;/li&gt;
&lt;li&gt;Pause for one to two seconds at the top to maintain balance and control.&lt;/li&gt;
&lt;li&gt;Lower your foot back to the floor with control.&lt;/li&gt;
&lt;li&gt;Alternate legs and repeat on the opposite side.&lt;/li&gt;
&lt;li&gt;Avoid leaning back or rushing the movement.&lt;/li&gt;
&lt;li&gt;Perform two sets of 30 to 40 second holds, resting for 20 to 30 seconds between sets.&lt;/li&gt;
&lt;/ol&gt;

	&lt;h2 id="standing-hip-hinge-with-arm-reach" class="o-slide-title" data-num="5"&gt;&lt;span&gt;Standing Hip Hinge With Arm Reach&lt;/span&gt;&lt;/h2&gt;
	
&lt;p&gt;&lt;iframe src="https://www.youtube.com/embed/EzE6olH5n0E" frameborder="0" allowfullscreen="allowfullscreen"&gt;VIDEO&lt;/iframe&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;This final movement incorporates your lower body, upper body, and core, helping to enhance coordination and mobility.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;How to do it:&lt;/b&gt;&lt;/p&gt;&lt;p class="karma_unit karma_unit--distinct inline karma_unit--mobile hide-desktop karma_unit--sliding htlad-lazy-mob-square-fixed"&gt;&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Stand with your feet shoulder-width apart and your knees slightly bent.&lt;/li&gt;
&lt;li&gt;Hold your arms straight in front of you at shoulder height.&lt;/li&gt;
&lt;li&gt;Hinge at your hips by pushing them back while keeping your spine neutral.&lt;/li&gt;
&lt;li&gt;Lower your torso slightly as your arms reach forward.&lt;/li&gt;
&lt;li&gt;Keep your weight balanced through your heels.&lt;/li&gt;
&lt;li&gt;Squeeze your glutes to return to an upright standing position.&lt;/li&gt;
&lt;li&gt;Reset your posture before repeating.&lt;/li&gt;
&lt;li&gt;Complete two sets of 10 to 12 reps. Rest for 30 to 45 seconds between sets.&lt;/li&gt;
&lt;/ol&gt;

																		
																	&lt;/div&gt;
										&lt;div class="c-article-short-bio"&gt;
	&lt;p class="c-article-short-bio__name"&gt;Adam Meyer, RHN&lt;/p&gt;
	&lt;div class="c-article-short-bio__bio"&gt;&lt;p&gt;
		Adam is a health writer, certified holistic nutritionist, and 100% plant-based athlete.					&lt;/p&gt;&lt;a class="c-article-short-bio__more" href="https://www.eatthis.com/author/adam-meyer/"&gt;Read more about Adam &lt;/a&gt;
			&lt;/div&gt;
&lt;/div&gt;
					&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Eat This Not That</author><pubDate>Wed, 28 Jan 2026 11:01:56 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMia0FVX3lxTE5DUjNENnFTakJfakZ5N0dkOGt6dmJpR3RueHNnYldWR2NTcEk3Vnh4Y1pBOGVvSjNXVzgtY1lia0JRVElLcVp3anpGR29WZnNYR0dKRXdjdmhhbjdaM1dRZjQ2RnhzR3B5T2dR</guid></item><item><title>10,000次脑部扫描揭示了为什么您的记忆力会随着年龄的增长而变差- ScienceAlert</title><link>https://www.sciencealert.com/10000-brain-scans-reveal-why-your-memory-gets-worse-with-age</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;Our &lt;a href="https://en.wikipedia.org/wiki/Episodic_memory"&gt;episodic memory&lt;/a&gt; – the ability to recall past events and experiences – is known to decline as we age. Exactly how and why has remained something of a mystery, and a recent study goes some way towards solving it.&lt;/p&gt;&lt;p&gt;Researchers led by a team from the University of Oslo in Norway wanted to see whether this memory loss affects everyone equally, or if it might be driven by individual risk factors, such as the &lt;em&gt;APOE&lt;/em&gt; ε4 gene &lt;a href="https://www.sciencealert.com/just-one-gene-may-be-responsible-for-over-90-of-alzheimers-cases"&gt;linked to&lt;/a&gt; &lt;a href="https://www.sciencealert.com/alzheimer-s-disease"&gt;Alzheimer's disease&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The scale of their analysis is impressive. The scientists combined data from 3,737 cognitively healthy participants, tracked over several years, including 10,343  &lt;a href="https://www.sciencealert.com/magnetic-resonance-imaging" class="lar_link lar_link_outgoing" data-linkid="73063" data-postid="189827" rel="nofollow" target="_self"&gt;MRI&lt;/a&gt; scans and 13,460 &lt;a href="https://www.sciencealert.com/scientists-name-new-type-of-memory-loss-often-mistaken-for-alzheimers" target="_blank" rel="noopener"&gt;memory assessments&lt;/a&gt;, from multiple long-running studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/we-may-now-know-why-alzheimers-erases-memories-of-our-loved-ones"&gt;We May Now Know Why Alzheimer's Erases Memories of Our Loved Ones&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;"By integrating data across dozens of research cohorts, we now have the most detailed picture yet of how structural changes in the brain unfold with age and how they relate to memory," &lt;a href="https://www.hebrewseniorlife.org/news/new-mega-analysis-reveals-why-memory-declines-age"&gt;says&lt;/a&gt; neurologist Alvaro Pascual-Leone, from the Marcus Institute for Aging Research at Harvard Medical School.&lt;/p&gt;&lt;figure id="attachment_189830" aria-describedby="caption-attachment-189830" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2026/01/BrainScans-1.jpg" alt="Brain scans" class="wp-image-189830 size-full" srcset="https://www.sciencealert.com/images/2026/01/BrainScans-1.jpg 642w, https://www.sciencealert.com/images/2026/01/BrainScans-1-600x281.jpg 600w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-189830" class="wp-caption-text"&gt;The researchers looked for links between brain structural changes and memory decline. (Vidal-Piñeiro et al., &lt;em&gt;Nat. Commun.&lt;/em&gt;, 2025)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;The results showed a complex picture. While the hippocampus – a brain region central to memory and learning – was most significant here, &lt;a href="https://doi.org/10.1002/dad2.12110" target="_blank" rel="noopener"&gt;as expected&lt;/a&gt;, memory decline was not linked to changes in a single area alone.&lt;/p&gt;&lt;p&gt;Reductions in brain tissue volume were linked to poorer episodic memory, which was not surprising, but the association was far from uniform. It became much clearer with age, especially in those older than 60, and was strongest in participants &lt;a href="https://www.sciencealert.com/male-brains-shrink-faster-than-female-brains-study-finds"&gt;whose brains were shrinking&lt;/a&gt; faster than average.&lt;/p&gt;&lt;p&gt;Among those carrying &lt;a href="https://www.sciencealert.com/just-one-gene-may-be-responsible-for-over-90-of-alzheimers-cases" target="_blank" rel="noopener"&gt;the &lt;/a&gt;&lt;a href="https://www.sciencealert.com/just-one-gene-may-be-responsible-for-over-90-of-alzheimers-cases" target="_blank" rel="noopener"&gt;&lt;em&gt;APOE&lt;/em&gt;&lt;/a&gt;&lt;a href="https://www.sciencealert.com/just-one-gene-may-be-responsible-for-over-90-of-alzheimers-cases" target="_blank" rel="noopener"&gt; ε4 gene&lt;/a&gt;, the researchers observed a more rapid loss of brain tissue volume and decline in memory compared to other participants, but the general trajectory was the same.&lt;/p&gt;&lt;p&gt;"Cognitive decline and memory loss are not simply the consequence of aging, but manifestations of individual predispositions and age-related processes enabling neurodegenerative processes and diseases," &lt;a href="https://www.hebrewseniorlife.org/news/new-mega-analysis-reveals-why-memory-declines-age"&gt;says&lt;/a&gt; Alvaro Pascual-Leone.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.sciencealert.com/castingcall?utm_source=SA_website&amp;amp;utm_medium=article&amp;amp;utm_campaign=casting_call"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-642x272.jpg" alt="Audition now for ScienceAlert's Casting Call" class="alignnone wp-image-189354 size-medium" srcset="https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-642x272.jpg 642w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-1200x509.jpg 1200w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-768x326.jpg 768w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1-600x255.jpg 600w, https://www.sciencealert.com/images/2026/01/Mid-Article-Promos-Casting-Call-1.jpg 1266w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;The findings raise plenty of questions and offer some answers, but overall they suggest that memory loss isn't necessarily a separate process from aging – and that the older we get, the more &lt;a href="https://www.sciencealert.com/sitting-could-be-shrinking-your-brain-and-exercise-may-not-help" target="_blank" rel="noopener"&gt;brain changes&lt;/a&gt; matter for memory.&lt;/p&gt;&lt;p&gt;There are also implications for treatments to slow or prevent memory loss: They'll need to target multiple brain areas, and may be most effective if started as early as possible. The good news is that the same therapies are likely to work for those with or without the &lt;em&gt;APOE&lt;/em&gt; ε4 gene, as the underlying mechanisms appear to be shared.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/scientists-found-an-early-signal-of-dementia-hidden-in-terry-pratchetts-novels"&gt;Scientists Found an Early Signal of Dementia Hidden in Terry Pratchett's Novels&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;It's becoming clear that a variety of different factors can influence memory loss in later life, as part of a broader set of &lt;a href="https://www.sciencealert.com/memory-problems-are-surging-in-adults-under-40-large-us-study-finds"&gt;cognitive capabilities&lt;/a&gt;. The more we learn about those factors, the better our chances of managing them.&lt;/p&gt;&lt;p&gt;"These results suggest that memory decline in aging is not just about one region or one gene – it reflects a broad biological vulnerability in brain structure that accumulates over decades," &lt;a href="https://www.hebrewseniorlife.org/news/new-mega-analysis-reveals-why-memory-declines-age"&gt;says&lt;/a&gt; Alvaro Pascual-Leone.&lt;/p&gt;&lt;p&gt;"Understanding this can help researchers identify individuals at risk early, and develop more precise and personalized interventions that support cognitive health across the lifespan and prevent cognitive disability."&lt;/p&gt;&lt;p&gt;The research has been published in &lt;a href="https://doi.org/10.1038/s41467-025-66354-y"&gt;&lt;em&gt;Nature Communications&lt;/em&gt;&lt;/a&gt;.&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Wed, 28 Jan 2026 11:01:24 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikwFBVV95cUxQcVdJRDdVSlpWQjVJSFU3R2haOFN1dUZ2WFg3OUFmX042dW5HdzY0NjVMemxqM2FnV0xndFZGWTdicE5Tb0JwbEdEMm9Yb0JSdEcwS3BnRGFfbTdsQkNDZmlZUHU0QktjZ245OVhaTXRvblJlaWNEdXhVTnZkV1hzOVVjTlJkZ2xuVVk4NVhxelUwaGs</guid></item><item><title>粪便微生物群移植加免疫治疗非小细胞肺癌和黑色素瘤： 2期FMT-LUMINate试验-自然</title><link>https://www.nature.com/articles/s41591-025-04186-5</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec10-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec11"&gt;Study participants and clinical trial design&lt;/h3&gt;&lt;p&gt;The FMT-LUMINate trial (&lt;a href="https://clinicaltrials.gov/ct2/show/NCT04951583"&gt;NCT04951583&lt;/a&gt;) is a multicenter, open-label, phase 2 trial that included patients with advanced NSCLC, cutaneous melanoma and uveal melanoma who were being treated with first-line ICI therapy. Biological sex was considered in the study based on self-report. Gender was not considered in the study. Patients were 18 years of age or older with histologically confirmed diagnosis of NSCLC, cutaneous melanoma or uveal melanoma and measurable disease as per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1). An Eastern Cooperative Oncology Group (ECOG) score of 0–2 was required. Previous treatment with palliative surgery or radiation was allowed. For the melanoma cohort, previous adjuvant anti-PD-1 was allowed provided the last dose occurred more than 6 months prior to enrollment. For the melanoma cohort, previous treatment with BRAF/MEK inhibitors was allowed. Major exclusion criteria included previous treatment with anti-PD-1 in the NSCLC cohort, a history of autoimmune diseases, active bowel disease, the use of daily corticosteroids &amp;gt;10 mg of prednisone or equivalent, symptomatic brain metastases or leptomeningeal disease. Patients were enrolled and treated at five academic centers in Canada: the Centre hopitalier de l’Université de Montréal (CHUM; Québec), the London Regional Cancer Program (LRCP; Ontario), the Centre hospitalier de l’Université de Québec (CHUQ; Québec), McGill University Health Centre (MUHC; Québec) and Lakeridge Health (Oshawa, Ontario). The research ethics board at each institution approved the conduct of the trial in accordance with current federal regulations, including the Canadian Food and Drug Regulations (C.05.001); the US Code of Federal Regulations (21 CFR Part 56); International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practice Guidelines; and the Declaration of Helsinki. The Unité d’Innovations Thérapeutiques at the CHUM was responsible for administrative functions, including the establishment of a DSMB, which provided safety oversight for the trial. Trial monitoring of the conduct of the trial and data management were performed by Ozmosis, Inc. All patients provided written informed consent and were able to withdraw consent at any time without compromising their cancer treatment. Patients were not financially compensated for their participation in this study.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec12"&gt;Ethics approvals&lt;/h3&gt;&lt;p&gt;The clinical trial and correlative analyses were approved by the CHUM Ethics Review Board and each participating center (ethics number MP-02-2022-10121/21.173). For culturomics analysis, this was conducted under project number 2025-12377 through biobank numbers MP-02-2018-7132/17.035 and 16.161.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec13"&gt;Patient inclusion and exclusion criteria for enrollment&lt;/h3&gt;&lt;p&gt;Inclusion criteria are summarized below:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;1.&lt;/span&gt;
                  
                    &lt;p&gt;Age 18 years of age or older&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;2.&lt;/span&gt;
                  
                    &lt;p&gt;Confirmed histological diagnosis of advanced cutaneous melanoma, unresectable or advanced uveal melanoma or advanced NSCLC&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;3.&lt;/span&gt;
                  
                    &lt;p&gt;Stage IV or unresectable disease&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;4.&lt;/span&gt;
                  
                    &lt;p&gt;No prior anti-PD1 treatment with the exception of those who received adjuvant therapy (see point 5)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;5.&lt;/span&gt;
                  
                    &lt;p&gt;For patients with newly diagnosed advance melanoma who relapsed after adjuvant immunotherapy, patients can be included in this study if they relapsed more than 6 months after their last dose of immunotherapy given in the adjuvant setting.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;6.&lt;/span&gt;
                  
                    &lt;p&gt;For patients with NSCLC, tumor PD-L1 expression level ≥50%&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;7.&lt;/span&gt;
                  
                    &lt;p&gt;Evaluable disease as per immune-related RECIST (iRECIST) or RECIST&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;8.&lt;/span&gt;
                  
                    &lt;p&gt;ECOG performance status of 0−2&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;9.&lt;/span&gt;
                  
                    &lt;p&gt;Ability to ingest capsules&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;10.&lt;/span&gt;
                  
                    &lt;p&gt;Patients receiving systemic steroids at physiologic doses are permitted to enroll provided the dose does not exceed 10 mg prednisone daily or equivalent.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;11.&lt;/span&gt;
                  
                    &lt;p&gt;Negative pregnancy test for women of childbearing potential&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;12.&lt;/span&gt;
                  
                    &lt;p&gt;Highly effective contraception (any method above 97% success rate) for both male and female patients throughout the study and for at least 60 days after last treatment administration if the risk of conception exists&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;p&gt;Exclusion criteria are summarized below:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;1.&lt;/span&gt;
                  
                    &lt;p&gt;Pregnant or breastfeeding or expecting to conceive or father children within the projected duration of the trial, starting with the prescreening or screening visit through 120 days after the last dose of trial treatment&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;2.&lt;/span&gt;
                  
                    &lt;p&gt;Current or recent (in the last 90 days) long-term exposure to high-dose oral or intravenous corticosteroids&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                        
                          &lt;p&gt;Patients who require intermittent use of bronchodilators, local steroid injections or short-term corticosteroids for any reason including, but not limited to, brain metastases treatment/prophylaxis are permitted to enroll at the discretion of the sponsor.&lt;/p&gt;
                        
                      &lt;/li&gt;
                    &lt;/ol&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;3.&lt;/span&gt;
                  
                    &lt;p&gt;Has a diagnosis of immunodeficiency (for example, HIV and transplantation) or receiving systemic steroid therapy (&amp;gt;10 mg prednisone daily or equivalent) or any other form of active immunosuppressive therapy&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;4.&lt;/span&gt;
                  
                    &lt;p&gt;Presence of a chronic debilitating intestinal disease (for example, malabsorption and colonic tumor)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;5.&lt;/span&gt;
                  
                    &lt;p&gt;Use of probiotics during FMT. Probiotics must be discontinued a minimum of 24 hours before FMT administration, and patients are not permitted to take probiotics during the course of immunotherapy treatment.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;6.&lt;/span&gt;
                  
                    &lt;p&gt;Use of antibiotics within 2 weeks of enrollment in the study&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;7.&lt;/span&gt;
                  
                    &lt;p&gt;Presence of absolute contraindications to FMT administration&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                        
                          &lt;p&gt;Toxic megacolon&lt;/p&gt;
                        
                      &lt;/li&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;b.&lt;/span&gt;
                        
                          &lt;p&gt;Severe dietary allergies (for example, shellfish, nuts and seafood)&lt;/p&gt;
                        
                      &lt;/li&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;c.&lt;/span&gt;
                        
                          &lt;p&gt;Active inflammatory bowel disease&lt;/p&gt;
                        
                      &lt;/li&gt;
                    &lt;/ol&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;8.&lt;/span&gt;
                  
                    &lt;p&gt;Expected to require any other form of systemic or localized anti-neoplastic therapy while on study. Palliative radiation therapy is permitted at the discretion of the sponsor.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;9.&lt;/span&gt;
                  
                    &lt;p&gt;In the last year, has a known history of a malignancy requiring anti-neoplastic treatment:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                        
                          &lt;p&gt;This time requirement does not apply to patients who underwent successful definitive resection of basal or squamous cell carcinoma of the skin, superficial bladder cancer and in situ cancers, including cervical cancer, breast cancer, melanoma or other in situ cancers.&lt;/p&gt;
                        
                      &lt;/li&gt;
                    &lt;/ol&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;10.&lt;/span&gt;
                  
                    &lt;p&gt;Symptomatic central nervous system metastases&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;11.&lt;/span&gt;
                  
                    &lt;p&gt;Leptomeningeal involvement (leptomeningeal enhancement on magnetic resonance imaging/computed tomography and/or positive cerebrospinal fluid cytology)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;12.&lt;/span&gt;
                  
                    &lt;p&gt;Has an uncontrolled autoimmune disease that requires active immunosuppressive agents:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                        
                          &lt;p&gt;Patients with vitiligo, type I diabetes, well-controlled hypothyroidism due to Hashimoto disease or resolved childhood asthma/atopy are not excluded.&lt;/p&gt;
                        
                      &lt;/li&gt;
                    &lt;/ol&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;13.&lt;/span&gt;
                  
                    &lt;p&gt;A history of (non-infectious) pneumonitis that required steroids or current pneumonitis&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;14.&lt;/span&gt;
                  
                    &lt;p&gt;Has serious concomitant illnesses, such as impaired cardiovascular function or clinically significant cardiovascular disease (uncontrolled congestive heart failure requiring treatment (New York Heart Association grade ≥3), uncontrolled hypertension, acute myocardial cardiac ischemia or unstable angina ≤2 months prior to study entry and severe cardiac arrhythmia) and active inflammatory bowel disorders&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;15.&lt;/span&gt;
                  
                    &lt;p&gt;Has an active infection requiring systemic therapy&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;16.&lt;/span&gt;
                  
                    &lt;p&gt;Patient has received a live vaccine within 4 weeks prior to the first dose of treatment:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                      &lt;li&gt;
                        &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                        
                          &lt;p&gt;Seasonal influenza vaccines for injection are generally inactivated flu vaccines and are allowed; however, intranasal influenza vaccines (for example, Flu-Mist) are live attenuated vaccines and are not allowed.&lt;/p&gt;
                        
                      &lt;/li&gt;
                    &lt;/ol&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;17.&lt;/span&gt;
                  
                    &lt;p&gt;Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;h3 class="c-article__sub-heading" id="Sec14"&gt;FMT&lt;/h3&gt;&lt;p&gt;Patients underwent a standard bowel preparation with 4,000 ml of PEG3350 liquid solution the evening before a single FMT using oral capsules. FMT capsules (now developed as LND-101) are produced using 80−100 g of feces per dose from screened healthy donors under the supervision of the Division of Infectious Diseases at St. Joseph’s Hospital in London, Ontario, Canada. Each dose of capsules contained the feces from a single donor. Major exclusion criteria for healthy donors included any known transmissible pathogen, history of medical illness, any history of major infection, such as COVID-19, monkeypox and hepatitis, and recent travel. A full list of inclusion and exclusion criteria was previously published&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023)." href="/articles/s41591-025-04186-5#ref-CR23" id="ref-link-section-d36557086e4617"&gt;23&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Craven, L. J. et al. Extended screening costs associated with selecting donors for fecal microbiota transplantation for treatment of metabolic syndrome-associated diseases. Open Forum Infect. Dis. 4, ofx243 (2017)." href="/articles/s41591-025-04186-5#ref-CR51" id="ref-link-section-d36557086e4620"&gt;51&lt;/a&gt;&lt;/sup&gt;. Donor assignment was performed according to donor availability, without particular selection other than the screening requirements. Patients were required to consume 36–40 capsules under supervision and within 2 hours of defrosting the capsules, followed by a 30-minute period of observation. If a patient required antibiotics for an active infection throughout the study protocol, a ‘salvage’ FMT was performed within 14 days of the last dose of antibiotics&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Elkrief, A. et al. Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation. Cancer Immunol. Res. 12, 308–321 (2024)." href="/articles/s41591-025-04186-5#ref-CR52" id="ref-link-section-d36557086e4624"&gt;52&lt;/a&gt;&lt;/sup&gt;. Salvage FMT was not performed if the treating investigator deemed that the procedure would interfere with patient safety (that is, antibiotics administered during a severe adverse event (SAE) period). Patients were not required to undergo a second bowel preparation in the event of salvage FMT. In the event of &lt;i&gt;Pneumocystis jirovecii&lt;/i&gt; prophylaxis, salvage FMT was not required.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec15"&gt;Donor screening&lt;/h3&gt;&lt;p&gt;Donor screening procedures are listed in Appendix 4 of the protocol and as previously published&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023)." href="/articles/s41591-025-04186-5#ref-CR23" id="ref-link-section-d36557086e4640"&gt;23&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec16"&gt;Capsule preparation&lt;/h3&gt;&lt;p&gt;FMT capsules were prepared according to an established protocol as described in our previous study&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023)." href="/articles/s41591-025-04186-5#ref-CR23" id="ref-link-section-d36557086e4652"&gt;23&lt;/a&gt;&lt;/sup&gt;. In brief, feces donations (80–100 g) were processed separately without pooling by mixing in 0.9% normal saline and glycerol and were filtered using a stomacher bag. The filtrate was centrifuged, and the final sediment was mixed to incorporate residual liquid to allow pipetting into capsules as previously published&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023)." href="/articles/s41591-025-04186-5#ref-CR23" id="ref-link-section-d36557086e4656"&gt;23&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec17"&gt;ICI therapy and assessments&lt;/h3&gt;&lt;p&gt;ICI therapy was publicly funded. For the NSCLC cohort, patients received pembrolizumab at 2 mg kg&lt;sup&gt;−1&lt;/sup&gt; every 3 weeks, as per the standard of care. For the melanoma cohort, patients received ipilimumab 3 mgkg&lt;sup&gt;−1&lt;/sup&gt; intravenously plus nivolumab 1 mg kg&lt;sup&gt;−1&lt;/sup&gt; intravenously every 3 weeks for four cycles, followed by maintenance nivolumab 3 mg kg&lt;sup&gt;−1&lt;/sup&gt; every 2 weeks or nivolumab 6 mg kg&lt;sup&gt;−1&lt;/sup&gt; intravenously every 4 weeks. The first cycle of ICI was initiated within 7 days after FMT (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-025-04186-5#Fig6"&gt;1b&lt;/a&gt;). Therapy continued at the discretion of the treating oncologist until unacceptable toxicity, completion of 2 years, progression or death. Routine imaging was completed every 3 months for the first 2 years. Acceptable imaging included computed tomography or magnetic resonance imaging at the discretion of the treating oncologist who was encouraged to use the same modality of imaging throughout whenever possible. The assessment of treatment response was conducted as per RECIST v1.1 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228–247 (2009)." href="/articles/s41591-025-04186-5#ref-CR53" id="ref-link-section-d36557086e4682"&gt;53&lt;/a&gt;&lt;/sup&gt;) and iRECIST&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Seymour, L. et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 18, e143–e152 (2017)." href="/articles/s41591-025-04186-5#ref-CR54" id="ref-link-section-d36557086e4686"&gt;54&lt;/a&gt;&lt;/sup&gt; when applicable at 3 months, 6 months and 12 months. Assessment of treatment response at all other timepoints was done by investigator-assessed RECIST. The ORR was defined as the proportion of patients with a complete response or a partial response and designated as ‘R’ for the translational studies. All other patients (the proportion with stable disease or progressive disease as best response), were designated as ‘NR’.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec18"&gt;Data and sample collection&lt;/h3&gt;&lt;p&gt;At each clinic visit, patient data, to include demographics, clinical and imaging assessments and adverse event recording, were collected per protocol using a secure, password-protected, electronic data capture web-based tool (Medidata Rave Unified Life Science Platform). Patient fecal and blood samples were collected at the following timepoints: before FMT (baseline), the first cycle of ICI therapy (1 week) and the second cycle of ICI therapy (1 month), 2 months, 3 months, 6 months, 9 months and 1 year. A complete clinical assessment was conducted at each visit with routine lab work per standard of care. Patients were permitted to withdraw consent at any time with no impact on treatment, although analysis of previously obtained samples was retained.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec19"&gt;Assessment and management of AEs&lt;/h3&gt;&lt;p&gt;FMT and ICI-related toxicities were evaluated using the Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v5.0) grading scale&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Freites-Martinez, A., Santana, N., Arias-Santiago, S. &amp;amp; Viera, A. Using the Common Terminology Criteria for Adverse Events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr. 112, 90–92 (2021)." href="/articles/s41591-025-04186-5#ref-CR55" id="ref-link-section-d36557086e4706"&gt;55&lt;/a&gt;&lt;/sup&gt;. Toxicities were attributed to FMT only if the investigator deemed the AE to be related to FMT and if the AE occurred before the first cycle of ICI. AEs were managed by the treating investigator in accordance with routine clinical practice guidelines. Any patient who experienced an SAE had ICI therapy suspended until resolved or discontinued at the discretion of the treating investigator. All AEs were reviewed by the trial sponsor to ensure consistency in attribution and grading.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec20"&gt;Outcomes and sample size&lt;/h3&gt;&lt;p&gt;The primary outcome of the study was the ORR in the NSCLC cohort, defined as the proportion of patients whose best objective response was either a complete response or a partial response. Best objective response was determined as the best response recorded from the first dose of study treatment until the last tumor assessment prior to initiation of subsequent therapy.&lt;/p&gt;&lt;p&gt;Secondary outcomes included DCR, defined as the proportion of patients achieving complete response, partial response or stable disease lasting more than 6 months; ORR in the melanoma cohort; and safety of FMT in combination with ICI. Additional secondary outcomes to be reported subsequently include PFS and OS at 12 months in both the NSCLC and cutaneous melanoma cohorts. Microbiome engraftment was evaluated by acquired donor–host similarity using the Bray–Curtis dissimilarity index.&lt;/p&gt;&lt;p&gt;Each cohort was analyzed independently, as outlined in the study protocol, given their differing disease biology and treatment context.&lt;/p&gt;&lt;p&gt;Sample size was determined as follows: for the NSCLC cohort, assuming that the ORR rate is 39% (null hypothesis)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Mok, T. S. K. et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet 393, 1819–1830 (2019)." href="/articles/s41591-025-04186-5#ref-CR3" id="ref-link-section-d36557086e4727"&gt;3&lt;/a&gt;&lt;/sup&gt;, a sample size of 18 patients has 80% power to detect an ORR of 64% (alternative hypothesis) using a one-sided binomial test with 0.10 level of significance. Because the prespecified primary endpoint of the study was ORR in the NSCLC cohort, there was no prespecified sample size calculation for the cutaneous melanoma cohort.&lt;/p&gt;&lt;p&gt;The present paper focuses on the NSCLC and cutaneous melanoma cohorts given prespecified primary and secondary endpoints in these groups outlined in the study protocol. Given that the uveal melanoma cohort was explicitly defined to be an exploratory cohort, the uveal melanoma cohort results will be reported separately.&lt;/p&gt;&lt;p&gt;Due to the COVID-19 pandemic and widespread disruptions to clinical trial operations&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Prindiville, S. A. et al. Patterns of enrollment in cancer treatment trials during the COVID-19 pandemic at National Cancer Institute-Designated Cancer Centers. Cancer J. 28, 111–117 (2022)." href="#ref-CR56" id="ref-link-section-d36557086e4738"&gt;56&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Waterhouse, D. M. et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. JCO Oncol. Pract. 16, 417–421 (2020)." href="#ref-CR57" id="ref-link-section-d36557086e4738_1"&gt;57&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Upadhaya, S. et al. Impact of COVID-19 on oncology clinical trials. Nat. Rev. Drug Discov. 19, 376–377 (2020)." href="/articles/s41591-025-04186-5#ref-CR58" id="ref-link-section-d36557086e4741"&gt;58&lt;/a&gt;&lt;/sup&gt;—including delayed site activations and reductions in outpatient oncology services—accrual to the trial was slower than anticipated. The protocol was amended to a total target of 20 patients, enabling evaluation of the primary and key secondary endpoints while maintaining feasibility under pandemic-related constraints.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec21"&gt;Metagenomics analysis&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec22"&gt;Sequencing and processing&lt;/h4&gt;&lt;p&gt;A total of 199 fecal samples collected from 39 patients enrolled underwent whole-genome shotgun sequencing. Stool aliquots were preserved at –80 °C in DNA/RNA Shield Buffer (Zymo Research) until processing. DNA extraction was performed using the DNeasy PowerSoil Pro Kit (Qiagen), following the manufacturer’s protocol. Sequencing libraries were prepared using the Illumina DNA Prep (M) Tagmentation Kit (Illumina), following the manufacturer’s instructions, and purified with a 0.7× ratio of Agencourt AMPure XP beads. Sequencing was conducted on a NovaSeq 6000 S4 flow cell (Illumina) at the University of Trento’s in-house sequencing facility (Trento, Italy). Raw reads were processed through a quality control pipeline available at &lt;a href="https://github.com/SegataLab/preprocessing"&gt;https://github.com/SegataLab/preprocessing&lt;/a&gt;. In brief, reads were filtered out if they had low quality (&lt;i&gt;Q&lt;/i&gt; &amp;lt; 20), were shorter than 75 bp or contained two or more ambiguous bases. Host-derived reads (human genome hg19 and Illumina spike-in phiX174) were also removed. On average, each sample yielded approximately 48 million high-quality reads. Five samples failed internal quality control and were excluded from downstream analyses. Taxonomic profiling was carried out using MetaPhlAn 4 (database version vJun23_CHOCOPhlAnSGB_202307). Of the 194 samples that passed quality control, 12 were excluded from the downstream analysis: 10 of excluded samples occurred during unscheduled visits, and two excluded samples were collected after salvage FMT. Because the salvage FMT typically involved a different donor, all samples occurring after the patient received salvage FMT were excluded.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec23"&gt;Statistical analysis for shotgun metagenomics sequencing&lt;/h4&gt;&lt;p&gt;Microbiome sequencing data were processed and analyzed using the phyloseq package (version 1.50.0). Taxonomic assignments and abundance tables were imported into a phyloseq object, including corresponding sample metadata. &lt;i&gt;α&lt;/i&gt;-Diversity analysis was performed using the vegan package (version 2.7.1), calculating richness and Shannon index. Principal component analysis was done with the packages prcomp (version 4.4.2) and factoextra (version 1.0.7), visualizing the variance explained by the principal components and the top contributing taxa. For the donor clusters unsupervised analysis, one sample from cluster A was removed from the visualization but included in the cluster calculation. PERMANOVA analysis was performed with 999 permutations using the ‘adonis’ function from the vegan package. Strain sharing between the patients and donors was calculated using StrainPhlAn4 with an in-house database for strain identification as previously published. Bray−Curtis dissimilarity was calculated between the samples and their corresponding donor samples using the ‘distance’ function from phyloseq. These distances were then adjusted to their corresponding baseline sample to observe the fold change over time. Linear discriminant analysis (LDA) effect size (LEfSe) was performed to identify microbial taxa that differentiate between subject groups according to their response, cohort or toxicity development using the package yingtools2 (version 0.0.1.184). We filtered taxa to be in at least 10% of the samples (prevalence cutoff of 5%). Features with LDA scores greater than 2 and &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05 were retained. Taxonomic abundance patterns between groups were visualized via heatmaps generated by the ComplexHeatmap package (version 2.22.0). The analysis was based on differentially abundant taxa between conditions using a Wilcoxon rank-sum test.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec24"&gt;Strain-level analysis&lt;/h4&gt;&lt;p&gt;The strain-level analysis to assess strain engraftment was performed following the procedure previously published&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023)." href="/articles/s41591-025-04186-5#ref-CR23" id="ref-link-section-d36557086e4790"&gt;23&lt;/a&gt;&lt;/sup&gt;. Phylogenetic trees were generated for each SGB with StrainPhlAn4. The thresholds on normalized phylogenetic distances to define same-strain pairs were determined for each SGB separately by comparing the distances between pairs of longitudinal samples to the pairs of unrelated samples in the corresponding phylogenetic tree, and their separation was maximized with Youden’s index. Strain engraftment of an SGB was detected if the donor sample had the same strain of the SGB as the post-FMT sample.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec25"&gt;Calculation of SGB categories&lt;/h4&gt;&lt;p&gt;For all patients with available corresponding donor shotgun metagenomic sequencing data, SGBs in each sample were categorized as follows: ‘Baseline’ for the SGBs unique only to the patient at their baseline sample; ‘Donor’ for the SGBs present in the sample that matched unique SGBs from the respective donor sample but were not found in the baseline sample; ‘Both’ for unique SGBs that were found in both the baseline sample and the matching donor sample; ‘New’ for SGBs not present in either the ‘Donor’ or the ‘Baseline’; and ‘Lost’ when SGBs that were identified at baseline were no longer present in the sample. To calculate the proportion of lost SGBs, we divided the ‘Lost’ SGBs by the total amount of SGBs present at baseline.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec26"&gt;Pathway analysis from shotgun metagenomics sequencing&lt;/h4&gt;&lt;p&gt;Shotgun metagenomic samples were also processed with the HMP Unified Metabolic Analysis Network (HUMAnN3) pipeline (version 3.8). We evaluated the stratified pathway abundances from the MetaCyc database. Pathways with zero total abundance across all samples were filtered out. Differential abundance analysis between baseline and post-FMT was performed using DESeq2 (version 1.46.0).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec27"&gt;BiomScope pipeline&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec28"&gt;Pipeline description&lt;/h4&gt;&lt;p&gt;Gene abundance profiling was performed using both the 10.1 million-gene integrated catalog of the human gut microbiome&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Plaza Onate, F. et al. Updated Metagenomic Species Pan-genomes (MSPs) of the human gastrointestinal microbiot. Zenodo 
                https://zenodo.org/records/12820832
                
               (2024)." href="/articles/s41591-025-04186-5#ref-CR59" id="ref-link-section-d36557086e4824"&gt;59&lt;/a&gt;&lt;/sup&gt; and the 8.4 million-gene integrated reference catalog of the human oral microbiome&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Le Chatelier, E. et al. A catalog of genes and species of the human oral microbiota. Data INRAE 
                https://doi.org/10.15454/WQ4UTV
                
               (2021)." href="/articles/s41591-025-04186-5#ref-CR60" id="ref-link-section-d36557086e4828"&gt;60&lt;/a&gt;&lt;/sup&gt;. Filtered high-quality reads were rarefied to 20 million by seqtk and then mapped with an identity threshold of 95% of each catalog using Bowtie (version 2.4.4). A gene abundance table was generated with BiomScope software&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Puller, V., Plaza Oñate, F., Prifti, E. &amp;amp; de Lahondès, R. Impact of simulation and reference catalogues on the evaluation of taxonomic profiling pipelines. Microb. Genom. 11, 001330 (2025)." href="/articles/s41591-025-04186-5#ref-CR61" id="ref-link-section-d36557086e4832"&gt;61&lt;/a&gt;&lt;/sup&gt; through a two-step procedure. First, the uniquely mapped reads (reads mapping to a single gene in the catalog) were attributed to their corresponding genes. Second, shared reads (reads that mapped with the same alignment score to multiple genes) were attributed according to the ratio of their unique mapping counts. For quantification of species, gene abundance was normalized using the fragments per kilobase of transcript per million mapped reads strategy (normalization by the gene size and the number of total mapped reads reported in frequency), and species abundance was determined from the average abundance of the first 100 core genes of each species provided in the annotation of the each million-gene catalog. Species with fewer than 10 core genes detected were counted with an abundance equal to zero. Species are reported as Metagenomic Species Pan-genomes (MSPs) that were defined and described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Plaza Oñate, F. et al. MSPminer: abundance-based reconstitution of microbial pan-genomes from shotgun metagenomic data. Bioinformatics 35, 1544–1552 (2018)." href="/articles/s41591-025-04186-5#ref-CR62" id="ref-link-section-d36557086e4836"&gt;62&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec29"&gt;Species retention&lt;/h4&gt;&lt;p&gt;Species were first categorized for each patient according to their presence status in baseline timepoint of patient and donor, defining the following categories: both, only patient, only donor and new categories. Species never seen at any timepoint were discarded. Species were then grouped by category and filtered for at least 10 observations—for example, seen in one of the categories for at least 10 patients. The proportion of patients with the species present at a given timepoint is called the species retention. The curve displaying species retention was obtained as the median of all retention values of the different species in a specific category, with 95% confidence intervals for median. &lt;i&gt;P&lt;/i&gt; values were calculated using the Mann−Whitney−Wilcoxon test.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec30"&gt;High-throughput culturomics&lt;/h3&gt;&lt;p&gt;High-throughput culturomics was done as previously performed&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Diop, K. et al. Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors. Gut Pathog. 17, 21 (2025)." href="/articles/s41591-025-04186-5#ref-CR63" id="ref-link-section-d36557086e4860"&gt;63&lt;/a&gt;&lt;/sup&gt;. A total of 0.3 g of stool from enrolled patients was resuspended in 1 ml of sterile 1× PBS. From this suspension, seven serial dilutions were prepared, and 50 µl of each dilution was plated onto 5% Columbia agar supplemented with sheep blood (COS; Thermo Fisher Scientific). Plates were incubated aerobically and anaerobically in an anaerobic chamber (5% H&lt;sub&gt;2&lt;/sub&gt;, 5% CO&lt;sub&gt;2&lt;/sub&gt; and 90% N&lt;sub&gt;2&lt;/sub&gt;) at 37 °C for up to 72 hours. Anaerobic conditions were achieved using sealed Zip bags (Becton Dickinson) containing GasPak anaerobic generators (Becton Dickinson). In parallel, enrichment cultures were performed by inoculating 200 µl of stool suspension into BD BACTEC Lytic/10 Aerobic (Becton Dickinson) for aerobic conditions. For anaerobic conditions, BD BACTEC Lytic/10 Anaerobic/F (Becton Dickinson) and Yeast Casitone Fatty Acids Broth with Carbohydrates (YCFAC) were used. All broth cultures were supplemented with 5% defibrinated sheep blood and 5% filtered rumen fluid (0.22 µm). At multiple timepoints (24 hours, 3 days, 7 days, 10 days, 15 days, 21 days and 30 days), serial dilutions from enrichment broths were plated on COS agar and incubated under the same aerobic and anaerobic conditions. After incubation, isolated colonies were subcultured onto fresh COS agar and incubated at 37 °C for an additional 72 hours. Colonies were then purified and subjected to identification. Bacterial identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). For each isolate, a double spot was deposited onto a 96-spot MSP target plate, overlaid with 1 µl of a saturated α-cyano-4-hydroxycinnamic acid matrix solution (prepared in 50% acetonitrile and 2.5% trifluoroacetic acid) and allowed to dry. Spectra were acquired using a MicroFlex LT/SH mass spectrometer (Bruker) and analyzed via FlexControl version 3.4 and MALDI Biotyper Compass version 4 software. Identification was achieved by comparison to the Bruker MBT Compass BDAL reference library and an in-house spectral database. Colonies yielding identification scores higher than 1.9 were considered reliably identified at the species level. Isolates with scores lower than 1.9 were further analyzed by whole-genome sequencing for taxonomic assignment. Bacterial species detected in patient samples at baseline were compared to those identified 1 month after FMT. Due to lack of donor samples available for culturomics, we used the corresponding donor shotgun metagenomics sequencing sample. Species detected at baseline but absent at the 1-month post-FMT timepoint were classified as lost. Conversely, bacterial species present in both the donor sample and the recipient 1 month after FMT—but not detected in the patient at baseline—were defined as engrafted from the donor. Engraftment from the donor versus lost from baseline was compared using the non-parametric Mann–Whitney &lt;i&gt;U&lt;/i&gt;-test using GraphPad Prism (version 10.4.2) software.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec31"&gt;Metabolomic analysis&lt;/h3&gt;&lt;p&gt;Fifty microliters of plasma was mixed with 500 μl of ice-cold extraction solution (methanol:water, 9:1, v/v, at −20 °C) containing isotopically labeled internal standards. The mixture was vortexed for 5 minutes at 2,500 rpm to ensure thorough homogenization and efficient extraction of endogenous metabolites. Samples were then centrifuged at 15,000&lt;i&gt;g&lt;/i&gt; for 10 minutes at 4 °C. The resulting supernatants were collected and aliquoted into multiple fractions to be analyzed by different liquid chromatography coupled with mass spectrometry (LC−MS)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Grajeda-Iglesias, C. et al. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites. Aging (Albany NY) 13, 6375–6405 (2021)." href="/articles/s41591-025-04186-5#ref-CR64" id="ref-link-section-d36557086e4884"&gt;64&lt;/a&gt;&lt;/sup&gt;. Targeted detection of polyamines and bile acids was performed by LC−MS/MS using a 1290 Ultra-High-Performance Liquid Chromatography (UHPLC) system (Agilent Technologies) coupled to a 6470 triple quadrupole mass spectrometer (QQQ 6470) (Agilent Technologies). For polyamine quantification, 10 μl of extract was injected into a Kinetex C18 analytical column (150 mm × 2.1 mm, 2.6-μm particle size; Phenomenex), equipped with a C18 guard column (5 mm × 2.1 mm). The column was maintained at 40 °C using a Peltier oven. Chromatographic separation was achieved using a binary mobile phase consisting of (A) water with 0.1% heptafluorobutyric acid (HFBA) and (B) acetonitrile with 0.1% HFBA, both freshly prepared. The initial mobile phase composition was 95% A and 5% B, followed by a linear gradient to 30% B over 7 minutes. The column was washed with 90% B for 2.25 minutes and then re-equilibrated with 5% B for 4 minutes. The autosampler was maintained at 4 °C. Mass spectrometry parameters included gas temperature of 350 °C, gas flow rate of 12 l min&lt;sup&gt;−1&lt;/sup&gt; and capillary voltage of 2.5 kV. For bile acid analysis, 10 μl of sample was injected onto a Column Poroshell 120 EC-C8 1,200 bars (100 mm × 2.1 mm, 1.9-μm particle size; Agilent Technologies), protected by an XDB-C18 guard column (5 mm × 2.1 mm, 1.8 μm). The column was also maintained at 40 °C. The mobile phase consisted of (A) water with 0.2% formic acid and (B) acetonitrile:isopropanol (1:1, v/v), both freshly prepared. Initial conditions were 70% A and 30% B, followed by a shift to 38% B over 2 minutes, maintained for an additional 2 minutes. A rapid gradient from 38% to 60% B was applied over 30 seconds. The column was washed with 98% B for 2 minutes and re-equilibrated at 30% B for 1.5 minutes. Autosampler temperature was kept at 4 °C. Instrument parameters were set with gas temperature of 310 °C, gas flow rate of 9 l min&lt;sup&gt;−1&lt;/sup&gt; and capillary voltage of 4.5 kV. In addition, pseudo-targeted metabolomic profiling was performed using ultra-high-performance liquid chromatography coupled with high-resolution accurate mass spectrometry (UHPLC−HRAM) on a Dionex U3000 UHPLC system coupled to a Q-Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific), as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Durand, S. et al. The intracellular metabolome of starving cells. Methods Cell Biol. 164, 137–156 (2021)." href="/articles/s41591-025-04186-5#ref-CR65" id="ref-link-section-d36557086e4892"&gt;65&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Abdellatif, M. et al. Nicotinamide for the treatment of heart failure with preserved ejection fraction. Sci. Transl. Med. 13,eabd7064 (2021)." href="/articles/s41591-025-04186-5#ref-CR66" id="ref-link-section-d36557086e4895"&gt;66&lt;/a&gt;&lt;/sup&gt;. All targeted treated data were merged and cleaned with a dedicated R package (@Github/Kroemerlab/GRMeta). We applied the ComBat function from the sva R package (sva version 3.52.0) to correct for inter-batch effect. Batches were divided into two groups. The batch correction model included a design matrix preserving the biological signal from key clinical covariates. Clinical features associated with samples included age, gender, body mass index (BMI), tumor type and time of first dose of ICI. ComBat was applied on log&lt;sub&gt;10&lt;/sub&gt;-transformed AreaQCCorr values.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec32"&gt;Statistical analysis for metabolites&lt;/h4&gt;&lt;p&gt;Metabolite longitudinal data were analyzed using generalized additive models (GAMs) with the mgcv R package (version 1.9-3) using the ‘gam’ function. Each metabolite was fitted with a GAM model that included the two groups (R and NR) present in the study. Before applying any model, data were cleaned by removing individuals with only one timepoint of analysis and duplicated samples. After cleaning the dataset, this metabolite analysis comprised 100 samples from 35 patients, each having at least two timepoints sampled (from two to four). Data normalization was performed before model fitting. Metabolite intensities were transformed using square root normalization with the ‘sqrt’ function from R base (version 4.5). Individual GAMs were fitted for each metabolite with the following model structure:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                  &lt;li&gt;
                    &lt;span class="u-custom-list-number"&gt;a.&lt;/span&gt;
                    
                      &lt;p&gt;Smooth terms for time with group-specific evolution over time using factor smooth interactions&lt;/p&gt;
                    
                  &lt;/li&gt;
                  &lt;li&gt;
                    &lt;span class="u-custom-list-number"&gt;b.&lt;/span&gt;
                    
                      &lt;p&gt;Random effects for individual patients&lt;/p&gt;
                    
                  &lt;/li&gt;
                  &lt;li&gt;
                    &lt;span class="u-custom-list-number"&gt;c.&lt;/span&gt;
                    
                      &lt;p&gt;Tweedie distribution to account for the data distribution characteristics&lt;/p&gt;
                    
                  &lt;/li&gt;
                  &lt;li&gt;
                    &lt;span class="u-custom-list-number"&gt;d.&lt;/span&gt;
                    
                      &lt;p&gt;Restricted maximum likelihood (REML) estimation method&lt;/p&gt;
                    
                  &lt;/li&gt;
                &lt;/ol&gt;&lt;p&gt;Time was modeled with penalized splines. The effective degree of freedom (edf) indicates the complexity of the time curve. In the fitted models, edf values excedeed 1, which is consistent with a nonlinear pattern. Model performance was assessed by calculating root mean squared error to evaluate model accuracy deviance explained and &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; to assess how much the model explained the signal variance, along with residual analysis and concurvity assessment. Temporal evolution was evaluated from the fitted group-specific time smooth across the entire observation window. Reported &lt;i&gt;P&lt;/i&gt; values are the significance tests for these time smooths, assessing the null hypothesis of no within-group time effect (flat curve). Temporal evolution was evaluated through model outputs and &lt;i&gt;P&lt;/i&gt; value. Between-group differences were calculated using the ‘difference_smooths’ function from the gratia package (version 0.10.0) to compute differences between R and NR smooth curves with 95% confidence intervals. Figures displaying temporal evolution were created using smooth estimates calculated with the ‘smooth_estimates’ function from the gratia package. Both trajectory and difference plots were generated using the ‘ggplot’ function from the ggplot2 package (version 3.5.2) and combined using the ‘plot_grid’ function from the cowplot package (version 1.1.3). &lt;i&gt;P&lt;/i&gt; values were displayed using the ‘ggsignif’ function from the ggsignif package (version 0.6.4). Data manipulation was performed using the dplyr package (version 1.1.4) and tidyverse (version 2.0.0). All analyses were conducted in R (version 4.5).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec33"&gt;Bio-Me qPCR assay&lt;/h3&gt;&lt;p&gt;We used Precision Microbiome Profiling (PMPTM) (Bio-Me), which is a validated qPCR method for analyzing the gut microbiome composition, based on TaqMan technology on the OpenArray format (Thermo Fisher Scientific). This assay targets 108 bacterial species and subspecies (107 bacteria and one fungal species). Standard curves for the assays were created using reference materials quantified by fluorescence (Thermo Fisher Scientific, Quant-iT PicoGreen dsDNA Reagent). The reference materials were acquired from the Leibniz Institute DSMZ or the American Type Culture Collection. Standard curves for each qPCR assay were used to convert the quantification cycle (Cq) value into number of genomic copies per microliter of sample; this number was transformed into normalized absolute quantification. qPCR was performed on 220 samples in total (&lt;i&gt;n&lt;/i&gt; = 181 patients and &lt;i&gt;n&lt;/i&gt; = 39 donors), and only patient samples with corresponding SGB category information were included in the final analysis (&lt;i&gt;n&lt;/i&gt; = 104 samples). Quantitative PCR and metagenomics relative abundance were visualized using the ComplexHeatmap package in R, and a Kendall score Kendall’s &lt;i&gt;τ&lt;/i&gt; was computed using the ‘cor.test’ function in the ‘stat’ package using pairwise complete observations. Spearman′s &lt;i&gt;r&lt;/i&gt; correlations were performed using GraphPad Prism.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec34"&gt;Olink proteomics&lt;/h3&gt;&lt;p&gt;Multiplex high-throughput proteomics was performed using the Immuno-Oncology Panel (Olink) and analyzed per the manufacturer’s instructions. All Olink data are reported as linearized normalized protein expression (NPX), per the manufacturer’s instructions. Olink data were visualized in R using the OlinkAnalyze package using ‘olink_umap_plot’ using manyfold approximations and projections using uniform manifold approximation and projection (UMAP) and ‘olink_volcano_plot’. For volcano plots, Benjamini−Hochberg-corrected &lt;i&gt;P&lt;/i&gt; values less than 0.05 were considered statistically significant.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec35"&gt;Quantification of 16S PCR&lt;/h3&gt;&lt;p&gt;Quantitative real-time PCR was performed to assess the relative abundance of total bacterial DNA in stool samples by targeting the V6 region of the 16S rRNA gene. The primer pair used was 891F (5′-TGGAGCATGTGGTTTAATTCGA-3′) and 1033R (5′-TGCGGGACTTAACCCAACA-3′)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Anhê, F. F. et al. Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice. Gut 68, 453–464 (2019)." href="/articles/s41591-025-04186-5#ref-CR67" id="ref-link-section-d36557086e5015"&gt;67&lt;/a&gt;&lt;/sup&gt;. For each reaction, 400 ng of extracted DNA was combined with 500 nM of each primer and 1× qPCRBIO SyGreen Blue Mix Hi-ROX (PCR Biosystems). Amplification was carried out using a real-time PCR system, and threshold cycle (Ct) values were obtained. Bacterial load was estimated by comparing sample Ct values to a standard curve generated using serial dilutions of &lt;i&gt;Escherichia coli&lt;/i&gt; genomic DNA, allowing for the approximation of bacterial DNA concentration in ng μl&lt;sup&gt;−1&lt;/sup&gt;. Non-parametric Mann−Whitney−Wilcoxon test to compare SGB loss groups and two-way ANOVA were performed in GraphPad Prism.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec36"&gt;Peripheral blood mononuclear cell immuno-phenotyping&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec37"&gt;Spectral flow cytometry staining and acquisition&lt;/h4&gt;&lt;p&gt;Aliquots of cryopreserved peripheral blood mononuclear cells (PBMCs), each containing 5 × 10&lt;sup&gt;6&lt;/sup&gt; cells preserved in fetal calf serum (FCS) with DMSO, were quickly thawed, gently washed and resuspended in FACS buffer consisting of 1× PBS supplemented with 5% FCS and 2 mM EDTA. To exclude non-viable cells, samples were incubated with the LIVE/DEAD Fixable Blue Dead Cell Stain Kit (Invitrogen) according to the manufacturer’s protocol. Surface staining was performed using fluorochrome-conjugated antibodies sourced from BD Biosciences, R&amp;amp;D Systems, MBL, BioLegend, Miltenyi Biotec and Cytek (see reagent list for detailed panel composition; Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-025-04186-5#MOESM1"&gt;3&lt;/a&gt;). Data were acquired with a Cytek Aurora 5-laser spectral analyzer, and data analysis was performed using FlowJo version 10.8.1 software.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec38"&gt;Manual gating and high-dimensional flow cytometry analysis&lt;/h4&gt;&lt;p&gt;Flow cytometry analysis of PBMCs followed a sequential gating strategy that excluded debris, cell doublets and non-viable cells, ultimately selecting for viable CD45&lt;sup&gt;+&lt;/sup&gt; immune cells. The resulting CD45&lt;sup&gt;+&lt;/sup&gt; live-cell populations were exported as new .fcs files using FlowJo version 10.8.1, and these curated datasets served as input for UMAP and Single-cell Cytometry Annotation Network (Scyan) analyses.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec39"&gt;Algorithms for dimensionality reduction: UMAP analysis&lt;/h4&gt;&lt;p&gt;The UMAPs were computed and displayed using the Scanpy package&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Wolf, F. A., Angerer, P. &amp;amp; Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018)." href="/articles/s41591-025-04186-5#ref-CR68" id="ref-link-section-d36557086e5061"&gt;68&lt;/a&gt;&lt;/sup&gt; on alive CD45&lt;sup&gt;+&lt;/sup&gt; cells.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec40"&gt;Scyan automatic annotation&lt;/h4&gt;&lt;p&gt;Cell type annotations were automatically performed using Scyan&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Blampey, Q. et al. A biology-driven deep generative model for cell-type annotation in cytometry. Brief. Bioinform. 24,bbad260 (2023)." href="/articles/s41591-025-04186-5#ref-CR69" id="ref-link-section-d36557086e5075"&gt;69&lt;/a&gt;&lt;/sup&gt; a biology-driven model that leverages prior knowledge of cell types. This approach allowed us to identify nine main populations: basophils, natural killer cells, B cells, monocytes, dendritic cells, CD4&lt;sup&gt;+&lt;/sup&gt; T cells, CD8&lt;sup&gt;+&lt;/sup&gt; T cells, double-positive T cells and double-negative T cells. Subsequently, for each patient, separate .fcs files were generated for each of these nine populations. The percentages of all subpopulations were then determined through manual gating using FlowJo version 10.8.1.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec41"&gt;Murine experiments&lt;/h3&gt;&lt;p&gt;All animal studies were approved by the Institutional Animal Care Committee at the Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) and carried out in compliance with Canadian Council on Animal Care guidelines (ethical protocol C22017Br). Murine experiments were conducted using 7-week-old female wild-type C57BL/6 SPF-reared mice obtained from Charles River Laboratories. Mice received 3 days of antibiotics solution containing ampicillin (1 mg ml&lt;sup&gt;−1&lt;/sup&gt;), streptomycin (5 mg ml&lt;sup&gt;−1&lt;/sup&gt;) and colistin (1 mg ml&lt;sup&gt;−1&lt;/sup&gt;) (Sigma-Aldrich), which was added to the sterile drinking water of mice before FMT. Three consecutive FMTs, using patient feces (ethics approval was obtained (MP-02-2022-10121/21.173, MP-02-2018-7132/17.035 and 16.161)), were performed at day −15, day −14 and day −13 (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-025-04186-5#Fig4"&gt;4i&lt;/a&gt;). FMT was performed by thawing fecal material, and 200 µl of the suspension (100 mg ml&lt;sup&gt;−1&lt;/sup&gt;) was then transferred by oral gavage. An additional 100 µl was applied on the fur of each animal.&lt;/p&gt;&lt;p&gt;Two weeks after the first FMT, mice were implanted subcutaneously with 0.8 × 10&lt;sup&gt;6&lt;/sup&gt; MCA-205 cells. When tumors reached 25−35 mm&lt;sup&gt;2&lt;/sup&gt; in size or 35−45 mm&lt;sup&gt;2&lt;/sup&gt; in size for anti-PD-1 monotherapy and anti-PD-1 plus anti-CTLA-4 experiments, respectively, mice were treated four times intraperitoneally every 3 days with anti-PD-1 monoclonal antibody (250 μg per mouse; Bio X Cell, clone RMP1-14) or anti-PD-1 monoclonal antibody plus anti-CTLA-4 monoclonal antibody (100 µg per mouse; Bio X Cell, clone 9D9). Additionally, the mice received a 200-µl gavage of NaCl or bacterial cocktail group starting 3 days after the tumor implantation and at each treatment. Tumor sizes were measured with manual calipers. The mice were euthanized 2 days after the last treatment. Experimental groups were compared using the Mann−Whitney−Wilcoxon test in GraphPad Prism.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec42"&gt;Bacterial cocktail group preparation&lt;/h3&gt;&lt;p&gt;For murine experiments, bacterial cocktails were prepared as follows. Bacterial strains used in the murine experiments were isolated from patients at baseline enrolled in the FMT-LUMINate clinical trial and stored at –80 °C. Bacteria were cultured from frozen stocks on fastidious anaerobe agar plates (Thermo Fisher Scientific, PB0225A) for 48 hours at 37 °C under anaerobic conditions. Prior to cocktail formulation, the identity of each isolate was confirmed by MALDI-TOF MS. After identification, bacterial colonies were collected, resuspended in sterile NaCl and adjusted to an optical density of 1.0, corresponding to approximately 1 × 10&lt;sup&gt;9&lt;/sup&gt; colony-forming units (CFU) per milliliter.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec43"&gt;Cell culture, reagents and tumor cell lines&lt;/h3&gt;&lt;p&gt;MCA-205 fibrosarcoma cells, class I MHC H-2b syngeneic cell lines for C57BL/6 mice, were used for this study and obtained from Jonathan Stagg’s laboratory. The cells were cultured at 37 °C in the presence of 5% CO&lt;sub&gt;2&lt;/sub&gt; in RPMI 1640 containing 10% FCS, 2 mM L-glutamine and 100 UI ml&lt;sup&gt;−1&lt;/sup&gt; penicillin−streptomycin. All reagents were purchased from Gibco-Invitrogen. Cell lines were checked for mycoplasma using PlasmoTest Mycoplasma Detection Kit (InvivoGen).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec44"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;All statistical analysis and visualization were done in R or GraphPad Prism (version 10.4.2). &lt;i&gt;P&lt;/i&gt; values were considered statistically significant if &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05, and all &lt;i&gt;P&lt;/i&gt; values were two-sided.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec45"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-025-04186-5#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 10:39:19 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE1zVkRTZjNuYmtTODlhazkxcFVCSW1lV3ZjcVI4Yl9EYVptVW1aaWVYQjExcDJRWElsZ0xHM0JPWVptQmtCQTBfSUQ3Q3hwNUlOd2l1Y2cxYkR0VnlDWkg4</guid></item><item><title>视频展示了金毛猎犬在没有皮带的情况下行走时的动作- AOL.com</title><link>https://www.aol.com/articles/video-shows-golden-retriever-does-102625901.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="caas-body"&gt;&lt;figure class="caas-figure align-caption-with-image"&gt;&lt;div class="no-margin"&gt;&lt;div&gt;&lt;p class="caption-wrapper"&gt;&lt;figcaption class="caption-collapse"&gt;Photo Credit: @hudsonstaysgolden/Instagram&lt;/figcaption&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;p&gt;It is absolutely understandable to be nervous about unhooking your dog’s lead in the middle of a snowy field. But Maria, who posts her &lt;a href="https://dogtime.com/dog-breeds/golden-retriever" rel="nofollow noopener" target="_blank" data-ylk="slk:Golden Retriever’s;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Golden Retriever’s&lt;/a&gt; life on @hudsonstaysgolden, clearly has way more faith in her pup than most people. Hudson is usually busy being a school therapy dog in the NJ area with his teacher mom. So he’s basically a professional at keeping his cool even when the world is a giant marshmallow. In this video, she decides to ditch the leash entirely to see what happens. Spoiler alert: Hudson emerges as the goodest boy.&lt;/p&gt;&lt;h2&gt;Golden Retriever listens to owner even while walking without a leash&lt;/h2&gt;&lt;p&gt;When the clip opens, we see Hudson in his full winter gear: boots, coat, the whole nine yards, and he is just beaming. Like, the dog cannot stop smiling. On-screen text says, “I took off my dog’s leash…” and your brain immediately prepares for chaos. But then she stops walking. And Hudson stops too. He just halts right next to her like that was always the plan.&lt;/p&gt;&lt;p&gt;Then, Mom asks him to smile. And he actually does it. He makes his face even wider. It’s the cutest thing ever, and it’s no wonder the post has over 5.2k likes already because the sheer focus he has on his mom is just… wow. One person in the comments was literally like, “ma’am I think I’m in love with your dog,” and yeah, join the club.&lt;/p&gt;&lt;p&gt;Next, the text flashes, “He did run off…” which feels like a fake-out until it finishes with “…when I asked him to like this.” Hudson zooms to a nearby tree, loops around it perfectly, and comes straight back.&lt;/p&gt;&lt;p&gt;He tries doing a “bridge” on command, too. But there isn’t enough space. And then he gets a treat for doing all of it, obviously. That’s when we see the best part about this video and the Golden Retriever without a leash. Hudson runs around happily in the snow, carrying a massive stick. One person in the comments from the UK said he literally cures their gloomy weather blues. And that’s a big compliment for this boy who loves to leave people happier.&lt;/p&gt;&lt;p&gt;The post &lt;a href="https://dogtime.com/news/204588-golden-retriever-walking-without-leash-video" rel="nofollow noopener" target="_blank" data-ylk="slk:Video Shows What Golden Retriever Does While Walking Without His Leash;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Video Shows What Golden Retriever Does While Walking Without His Leash&lt;/a&gt; appeared first on &lt;a href="https://dogtime.com" rel="nofollow noopener" target="_blank" data-ylk="slk:DogTime;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;DogTime&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>AOL.com</author><pubDate>Wed, 28 Jan 2026 10:38:40 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMigwFBVV95cUxOT3N4WF9aVUJkdENJZTZmaEQwYWVKVE95VTY1QW4xLW5YbEhQWVU5RnNrVGgwYWV2YS00cWthcHJhdndEd1NLNEhTWUlhLUdYR1M1bjJMR0dnaVFHam84VWEtWnl0endLLUdCc2lWTFdKYjFiLTBMejQzeHo0Y2JVbVIzaw</guid></item><item><title>视频展示了金毛猎犬在没有皮带的情况下行走时的动作- DogTime</title><link>https://dogtime.com/news/204588-golden-retriever-walking-without-leash-video</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content wp-block-post-content is-layout-flow wp-block-post-content-is-layout-flow"&gt;
&lt;p&gt;It is absolutely understandable to be nervous about unhooking your dog’s lead in the middle of a snowy field. But Maria, who posts her &lt;a href="https://dogtime.com/dog-breeds/golden-retriever"&gt;Golden Retriever’s&lt;/a&gt; life on @hudsonstaysgolden, clearly has way more faith in her pup than most people. Hudson is usually busy being a school therapy dog in the NJ area with his teacher mom. So he’s basically a professional at keeping his cool even when the world is a giant marshmallow. In this video, she decides to ditch the leash entirely to see what happens. Spoiler alert: Hudson emerges as the goodest boy.&lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-golden-retriever-listens-to-owner-even-while-walking-without-a-leash"&gt;Golden Retriever listens to owner even while walking without a leash&lt;/h2&gt;



&lt;figure class="wp-block-embed is-type-rich is-provider-instagram wp-block-embed-instagram"&gt;&lt;/figure&gt;



&lt;p&gt;When the clip opens, we see Hudson in his full winter gear: boots, coat, the whole nine yards, and he is just beaming. Like, the dog cannot stop smiling. On-screen text says, “I took off my dog’s leash…” and your brain immediately prepares for chaos. But then she stops walking. And Hudson stops too. He just halts right next to her like that was always the plan.&lt;/p&gt;



&lt;p&gt;Then, Mom asks him to smile. And he actually does it. He makes his face even wider. It’s the cutest thing ever, and it’s no wonder the post has over 5.2k likes already because the sheer focus he has on his mom is just… wow. One person in the comments was literally like, “ma’am I think I’m in love with your dog,” and yeah, join the club.&lt;/p&gt;



&lt;p&gt;Next, the text flashes, “He did run off…” which feels like a fake-out until it finishes with “…when I asked him to like this.” Hudson zooms to a nearby tree, loops around it perfectly, and comes straight back.&lt;/p&gt;&lt;p class="pb-in-article-content test-1"&gt;&lt;/p&gt;



&lt;p&gt;He tries doing a “bridge” on command, too. But there isn’t enough space. And then he gets a treat for doing all of it, obviously. That’s when we see the best part about this video and the Golden Retriever without a leash. Hudson runs around happily in the snow, carrying a massive stick. One person in the comments from the UK said he literally cures their gloomy weather blues. And that’s a big compliment for this boy who loves to leave people happier.&lt;/p&gt;
&lt;/div&gt;



&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>DogTime</author><pubDate>Wed, 28 Jan 2026 10:26:25 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxONzlqRjA3c2c0c3JYWkktZjctUEh4UDJfQUZDdjh0bTB1M3ZTaU9zMG96Q2NURUl6Yk5oRmxUeUtpNTBnRzNpMWdzSXBMdVJyVlNJS1ZQQ2YyZVE1ZWNnWGMwSkpqU1pUWWFVNTk2d00yNVdaN25NekZOSFQ1S3JkaVNR0gGHAUFVX3lxTE02SXRiSGlCbm9oNV9YN1VxeHlrVXg2UVhYdkVpMC0zZ3BSRjlTNW5CNDJPbEYtWjVveG82Z05JV1BPZjQwVWNweHZvdWFrMDRCQ1QyZzJMS016aWYxOW9kTmw1bnJVWURlYlJJZGxreGZHa1NPeXpEZWlkRWlFdnNBMjh2UnRmTQ</guid></item><item><title>少量锻炼带来的惊人健康益处-大自然</title><link>https://www.nature.com/articles/d41586-026-00237-0</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__teaser" data-test="access-teaser"&gt; &lt;p&gt;January is peak gym time — the month when fitness seekers commit to New Year’s resolutions. By February, however, those goals are often forgotten. That busting of best intentions begs the question: &lt;a href="https://www.nature.com/articles/d41586-024-01200-7" data-track="click" data-label="https://www.nature.com/articles/d41586-024-01200-7" data-track-category="body text link"&gt;how much exercise&lt;/a&gt; do people really need, and what’s the ideal way to get it? Recent research fortunately has some welcome advice for the time-stressed in 2026.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-024-01200-7" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_27075652.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;Why is exercise good for you? Scientists are finding answers in our cells&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;Existing guidelines from most national and global health organizations call for at least 150–300 minutes of moderate physical activity each week, or 75–150 minutes of vigorous activity, for healthy adults, sometimes alongside activities to strengthen muscle and bone. Although those guidelines remain good goals to aim for, newer studies suggest that meaningful health benefits emerge with much less exercise.&lt;/p&gt;&lt;p&gt;Researchers are getting a clearer understanding of the bare minimum amount of exercise needed for health gains thanks to data from wearable devices. These can provide more-reliable measurements than do self-reported data, which form much of the basis for current guidelines. By incorporating wearables into study design, researchers can collect accurate data on physical activity minute by minute, says I-Min Lee, an epidemiologist at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts. “And this is when we start to see that even low levels of physical activity are helpful,” she says.&lt;/p&gt;&lt;p&gt;These data are redefining what counts as physical activity and could push future recommendations towards lower targets. But a potential shift in guidelines needs to be considered carefully in terms of the message it might send, says Emmanuel Stamatakis, a researcher specializing in physical activity and population health at the University of Sydney, Australia. No one wants to suggest that people shouldn’t strive to move more, especially when an estimated 31% of people worldwide don’t meet existing recommendations&lt;sup&gt;&lt;a href="#ref-CR1" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;1&lt;/a&gt;&lt;/sup&gt;, and physical inactivity contributes to &lt;a href="https://www.nature.com/articles/d41586-023-03143-x" data-track="click" data-label="https://www.nature.com/articles/d41586-023-03143-x" data-track-category="body text link"&gt;health problems such as obesity&lt;/a&gt; and heart disease.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;“We’re in a bit of an awkward situation because if we are to take the wearable-based evidence at face value, we will have to release guidelines that will be recommending lower amounts” of minimum physical activity, says Stamatakis.&lt;/p&gt;&lt;p&gt;Another way in which wearables are changing thinking is by helping to quantify daily inactivity, which might be just as important as how much a person exercises. Some guidelines are already incorporating caps on sedentary time. “Especially if you work from home, you can do very little exercise in a day. It’s quite scary,” says Carol Maher, an exercise researcher at the University of South Australia in Adelaide.&lt;/p&gt;&lt;h2&gt;The more, the better — up to a point&lt;/h2&gt;&lt;p&gt;Today’s exercise recommendations are born from large epidemiological studies that compare disease and death rates between those who are more and less physically active. Whereas previous guidelines had focused on enhancing athletic performance and relied mostly on studies in young and fit male medical students, studies beginning in the 1980s followed larger groups of people over many years and included women and older people.&lt;/p&gt;&lt;p&gt;Such studies have consistently shown that physical activity offers strong protection against cardiovascular disease, &lt;a href="https://www.nature.com/articles/d41586-024-00720-6" data-track="click" data-label="https://www.nature.com/articles/d41586-024-00720-6" data-track-category="body text link"&gt;reduces the risk of several types of cancer&lt;/a&gt; and lowers the risk of death from any cause, as well as having &lt;a href="https://www.nature.com/articles/d41586-024-02225-8" data-track="click" data-label="https://www.nature.com/articles/d41586-024-02225-8" data-track-category="body text link"&gt;mental-health benefits&lt;/a&gt;. Although observational studies can be limited by potential bias — those who exercise might be healthier to start with — researchers go to great lengths to mitigate this problem. Studies tend to control for variables such as age, smoking status, alcohol consumption and body weight, and adjust for family history of cardiovascular disease and cancer, as well as &lt;a href="https://www.nature.com/articles/d41586-025-03687-0" data-track="click" data-label="https://www.nature.com/articles/d41586-025-03687-0" data-track-category="body text link"&gt;postmenopausal hormone use&lt;/a&gt;, &lt;a href="https://www.nature.com/articles/d41586-025-01402-7" data-track="click" data-label="https://www.nature.com/articles/d41586-025-01402-7" data-track-category="body text link"&gt;sleep duration&lt;/a&gt; and other factors. Some studies exclude participants diagnosed with cardiovascular disease or cancer and those who do not engage in any physical activity. Some also exclude the first years of observation, so that participants with as-yet-undiagnosed diseases can be identified over time. The biases alone cannot explain the findings, says Lee.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-025-03596-2" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_51687774.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;Alzheimer’s decline slows with just a few thousand steps a day&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;A 2011 meta-analysis found that people who met the recommendation of 150 minutes of moderate physical activity a week — defined as movement that raises heart and breathing rates — had a 14% lower risk of coronary heart disease than those who reported no physical activity in their leisure time&lt;sup&gt;&lt;a href="#ref-CR2" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;2&lt;/a&gt;&lt;/sup&gt;. Such moderate activity, during which the exerciser can still talk but would struggle to sing a song, includes brisk walking and light cycling. Those who exercised even more, about 300 minutes a week, had a 20% lower risk than those who didn’t exercise. Heart benefits continued to increase with more exercise, although gains tapered off at higher levels.&lt;/p&gt;&lt;p&gt;Notably, even people exercising for half the recommended 150 minutes a week showed heart-disease risk reductions that were almost the same as for those who met the guideline. The authors concluded that “the biggest bang for the buck for coronary-heart-disease risk reduction occurs at the lower end of the activity spectrum: very modest, achievable levels of physical activity”.&lt;/p&gt;&lt;p&gt;A similar pattern emerges for risk of death (see ‘Movement matters’). A 2022 study analysing 30 years of data from 116,221 adults found that those who did 150–300 minutes of moderate physical activity each week had a 20–21% lower risk of all-cause mortality during the study period than those with almost no moderate activity&lt;sup&gt;&lt;a href="#ref-CR3" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;3&lt;/a&gt;&lt;/sup&gt;. Smaller amounts were already beneficial: 20 to 74 minutes of moderate activity a week resulted in a 9% lower risk of death. People who exercised up to about 600 minutes a week — four times the recommended minimum — had an extra 10–11% reduction in risk. But going beyond that didn’t provide further benefits.&lt;/p&gt;&lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_51974440.png?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_51974440.png?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="MOVEMENT MATTERS. Graphic shows that mortality hazard ratio decreases significantly with moderate physical activity." loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_51974440.png"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span&gt;Source: Ref. 3&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;Lee and her colleagues have also reported, in a meta-analysis published this month that included data from more than 40,000 people, that only five extra minutes of moderate-to-vigorous activity a day could prevent 6% of all deaths among the 20% least active participants. Those participants spent, on average, 2.2 minutes a day in this type of activity&lt;sup&gt;&lt;a href="#ref-CR4" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;4&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;“A big part of the benefit comes from going from doing nothing to doing something,” says Leandro Rezende, an epidemiologist at the Federal University of São Paulo, Brazil, and a co-author of the 2022 study.&lt;/p&gt;&lt;p&gt;When it comes to vigorous physical activity — the type of movement that makes speaking difficult, such as cycling uphill or running — as little as 15 minutes each week can be enough to reduce the risk of death. A prospective study, reported in 2022, that followed participants for almost six years revealed that this modest effort resulted in an 18% lower mortality risk over the study period&lt;sup&gt;&lt;a href="#ref-CR5" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;5&lt;/a&gt;&lt;/sup&gt;. The analysis adjusted for how much light and moderate physical activity the participants did overall, as well as other underlying health conditions that could affect their capacity to do vigorous exercise.&lt;/p&gt;&lt;p&gt;Studies using different measures of physical activity come to similar conclusions about &lt;a href="https://www.nature.com/articles/d41586-025-03596-2" data-track="click" data-label="https://www.nature.com/articles/d41586-025-03596-2" data-track-category="body text link"&gt;the benefits of minimal exercise&lt;/a&gt;. A 2019 analysis — which adjusted for factors such as self-rated health and family history of diseases — concluded that, among older women, taking 4,400 steps a day (far below the 10,000 steps that many people aim for) is already associated with a lower mortality risk&lt;sup&gt;&lt;a href="#ref-CR6" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;6&lt;/a&gt;&lt;/sup&gt;. Benefits levelled after 7,500 steps a day. Although there isn’t an exact correspondence between number of steps and minutes of activity, another study using accelerometer data from around 3,500 people found that those who reached 150 minutes of moderate-to-vigorous physical activity in a week typically accumulated around 7,000 steps a day (including from intentional exercise and everyday activities)&lt;sup&gt;&lt;a href="#ref-CR7" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;7&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h2&gt;Exercise snacks&lt;/h2&gt;&lt;p&gt;The introduction of wearables opened the door to studying exercise sessions that are shorter than 10 minutes, as well as lighter physical activity. Stamatakis is among those who began investigating the effect of short bursts of vigorous activity in people’s daily routines.&lt;/p&gt;&lt;p&gt;He says that he has loved movement since his childhood in Greece, when he spent hours playing football after school. The idea of studying how people can enhance their health with everyday movement occurred to him around 2008. Living in Brighton, UK, he grew sick of the local traffic. “I sold my car, and I started walking everywhere and cycling everywhere,” Stamatakis recalls. “It felt so liberating. It felt so nice. I felt more connected with my community. From that point on, I started converting this into a scientific interest.”&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-025-03632-1" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-026-00237-0/d41586-026-00237-0_51939902.png"&gt;&lt;p class="recommended__title u-serif"&gt;How much protein do you really need? What the science says&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 28 Jan 2026 10:18:10 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5Ub0Jkcmo3ZWNKSWVGZDAzTlVCcktNekZkRWdoNjBGOEZCYUdwVGx4REFYX2tmM1ozQUFvejh1RHU5NGZCTjZzbVROR3VfVzlfLVVNUlRmVEFfLVdRUlRj</guid></item><item><title>茶可以改善您的健康和长寿，但您喝茶的方式很重要- ScienceDaily</title><link>https://www.sciencedaily.com/releases/2026/01/260127112132.htm</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p id="first" class="lead"&gt;A comprehensive review finds that tea, especially green tea, is strongly associated with a reduced risk of cardiovascular diseases (CVDs), obesity, diabetes, and several forms of cancer. Beyond these well known benefits, tea consumption is also linked to brain protection, reduced muscle loss in older adults, and anti-inflammatory and antimicrobial effects. Together, these findings point to tea as a beverage with broad potential to support long-term health. At the same time, the review highlights important concerns related to certain modern tea products, particularly bottled and bubble teas, which may include artificial sweeteners, preservatives, and other additives.&lt;/p&gt;

						&lt;div id="text"&gt;
&lt;p&gt;Tea is produced from the leaves of Camellia sinensis and has been consumed worldwide for centuries. It was first used mainly for medicinal purposes before becoming a widely enjoyed daily drink. Researchers have long been interested in tea because it contains high levels of polyphenols, especially catechins, which are believed to play a key role in its health effects. The review examines tea's influence on multiple health outcomes using evidence from laboratory research as well as human studies. While green tea has been studied extensively, much less is known about the health effects of other varieties, including black, oolong, and white tea, particularly when comparing their benefits. The review also considers potential risks tied to additives and contaminants found in some commercially produced tea beverages.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Study Highlights Gaps in Current Research&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The findings were published in &lt;em&gt;Beverage Plant Research&lt;/em&gt; by Mingchuan Yang &amp;amp; Li Zhou's team, Tea Research Institute, Chinese Academy of Agricultural Sciences. The authors emphasize that additional research is needed to more clearly define both the benefits and possible risks of tea consumption across different populations and tea types.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;How Tea Affects the Heart, Metabolism, and Weight&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;According to the review, green tea stands out for its protective effects on the cardiovascular system. Studies show it can help lower blood pressure and improve cholesterol levels. Large cohort studies also suggest that people who regularly drink tea have a lower risk of death from all causes, reduced rates of CVDs, and a decreased likelihood of developing certain cancers. Tea may also play a role in weight management and diabetes control. Evidence indicates that green tea catechins can support weight loss and improve metabolic markers in individuals with obesity.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Brain Health and Muscle Preservation in Aging&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Tea consumption is also associated with benefits beyond heart and metabolic health. Research suggests that regular tea drinkers, particularly older adults, show lower rates of cognitive decline and fewer biomarkers linked to Alzheimer's disease. In addition, tea catechins may help slow age-related muscle loss. This effect could support better muscle strength, physical function, and overall performance in seniors.&lt;/p&gt;

&lt;p id="insertion_middle"&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Potential Risks From Processed Tea Products&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Despite tea's many advantages, the review cautions that not all tea products offer the same health value. Bottled teas and bubble teas often contain added sugar, artificial sweeteners, and preservatives that may weaken or offset tea's natural benefits. The authors also note concerns about pesticide residues, heavy metals, and microplastics found in tea. While these contaminants are not considered a significant risk for most people at typical intake levels, they may be more relevant for individuals who consume large amounts of tea over long periods. The review also discusses how tea can interfere with the absorption of certain nutrients, including non-heme iron and calcium, which may be important for people following vegetarian diets or those with specific nutritional requirements.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Freshly Brewed Tea Offers the Most Benefit&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Overall, the review concludes that tea provides clear health benefits, especially when consumed in its traditional, freshly brewed form. Moderation is advised when it comes to processed options like bottled tea and bubble tea due to their added sugars and preservatives. The authors suggest that regular, moderate intake of brewed tea may help reduce the risk of cardiovascular diseases, diabetes, and cancer. They also note that future studies examining long-term consumption, differences among tea varieties, and the impact of contaminants will be essential for refining guidance on tea's health effects.&lt;/p&gt;&lt;/div&gt;

					&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceDaily</author><pubDate>Wed, 28 Jan 2026 10:09:52 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMib0FVX3lxTE5aUnNyU0ZpMl96VW5sQmg0NDZDaWwxXzlNeTUwcWpPdlIwR2NueTBLdmxvLWdfMEhMRUF0dFRmWmhva2swUlI0RG1XRnR0TjBsYm9GVVR6QjhabHlMOENZcHpQWEtTdFZNZDRldU1Vcw</guid></item><item><title>蛋白质真的是饱腹感的关键吗？ -《纽约时报》</title><link>https://www.nytimes.com/2026/01/28/well/eat/protein-weight-loss-benefits.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 28 Jan 2026 10:00:22 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMigwFBVV95cUxPWkdLbDY3RHVhMV9lQlpIU0VRalVrYlJjTmdPVHNxYUNqcVF1eUpkb0NoaGp3eXR5OGF6TFRkaUxzX0FlZi1Od3U2d3phNDJXbzc2MGNHNm1DaW1lRU5aeXpJNnMzNVJ2NFR5eVNWbDJXNllSZWtHREdyTEpBZElXZUVpTQ</guid></item><item><title>真正导致偏头痛的原因是什么？ - BBC</title><link>https://www.bbc.com/future/article/20260127-what-really-causes-migraines</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="sc-85f9acf9-0 kfxpiP"&gt;&lt;p class="sc-9a00e533-0 eZyhnA"&gt;"Well, that's a classic example, and the causal attribution is probably wrong," says Peter Goadsby, professor of neurology at King's College London, in the UK. "What if, instead, during the premonitory phase of an attack, you're sensitive to scent, you notice smells that you wouldn't normally." &lt;/p&gt;&lt;p class="sc-9a00e533-0 eZyhnA"&gt;Goadsby has analysed &lt;a target="_blank" href="https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.12451" class="sc-f9178328-0 iCaRzc"&gt;the brain scans of migraine patients&lt;/a&gt; who feel that light triggers their attack and compared them to patients who don't tend to blame light for the onset of their pain. Only the former had overactivity in the part of the brain responsible for vision right before their migraine, suggesting that, during that moment, they were biologically primed to be more sensitive to light than their counterparts. "Unquestionably, something is going on biologically," says Goadsby.&lt;/p&gt;&lt;p class="sc-9a00e533-0 eZyhnA"&gt;But the quest to discover what that underlying biological mechanism has been a long one.&lt;/p&gt;&lt;h2 class="sc-f98b1ad2-0 gXmhTb"&gt;&lt;span id="the-genetic-origin-of-migraine" class="sc-d16436d-0 gCPVhV"&gt;&lt;b id="the-genetic-origin-of-migraine" class="sc-d16436d-0 gnUCoQ"&gt;The genetic origin of migraine&lt;/b&gt;&lt;/span&gt;&lt;/h2&gt;&lt;p class="sc-9a00e533-0 eZyhnA"&gt;&lt;a target="_blank" href="https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/head.14789" class="sc-f9178328-0 iCaRzc"&gt;Studies on twins&lt;/a&gt; show that there is a strong genetic component and that if your &lt;a target="_blank" href="https://journals.sagepub.com/doi/full/10.1177/0333102419828989" class="sc-f9178328-0 iCaRzc"&gt;parents or grandparents had migraine&lt;/a&gt;, you're statistically likely to inherit the neurological condition too. Inherited genes appear to play a role in an &lt;a target="_blank" href="https://www.sciencedirect.com/science/article/abs/pii/S1474442224000267" class="sc-f9178328-0 iCaRzc"&gt;estimated 30-60%&lt;/a&gt; of people who suffer from migraine, with other cumulative external factors such as life history, environment and behaviour accounting for the rest, says Dale Nyholt, a geneticist at Queensland University of Technology in Australia. &lt;/p&gt;&lt;p class="sc-9a00e533-0 eZyhnA"&gt;Nyholt is screening thousands of people to find the exact genes running amok, but the quest has been "more complex than what we were ideally hoping for", he says. In 2022, he &lt;a target="_blank" href="https://www.nature.com/articles/s41588-021-00990-0" class="sc-f9178328-0 iCaRzc"&gt;trawled through the genes of 100,000 migraine patients&lt;/a&gt;, comparing them with those of 770,000 people who do not have migraines. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BBC</author><pubDate>Wed, 28 Jan 2026 10:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifEFVX3lxTE9rNHBMTmFXUEJwQUJuWGhEdE4zWm9KN3VjdWxnV0ZGREpHckNPNER5d2ppSDJvbl83T29scnhBOGtQMVhOaWFWOHVUcUpMSGtGd25kb0ZMT1dZR0xLQTg1YlBLelJjcXFqNkhENHJudVdacG5zMHZfS0VQWnM</guid></item><item><title>科学家在突破性研究中实现胰腺肿瘤消退- Euronews.com</title><link>https://www.euronews.com/health/2026/01/28/scientists-achieve-pancreatic-tumour-regression-in-breakthrough-study</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p&gt;[m3EU�GQR{�{������p��{� ��0�����p�����?�����-�z�T�����iٖM۲ڒ���X �H! Jf����}O{��yO��Kվr&amp;amp;�+�qz�~���)�hn8�F�zVh�� &amp;gt;�$��A|��Ad��[�mv������L�8)8��I�z�&amp;gt;p��X�7��������W�H7��D$ţ����W��J;%J�8�휗q�u�+���z�|@���v`�ybڥ���[��o��2�\T!����cU����;3:�����(H����H��8s'-�RȝC
]r[͛�^�t��}��G����D���cgU����7����g2���!Lbr��0��Z{e�p��chv���f���c���*`Cl~���ޗ(���twf˘��Z�w b"|�9_��k�a}�v�fô����v�	����|8Ò��5k��J���^�Ň�:�^�g��)��J����ݙh0��,cfƶ?�MĀ�8	��6�����3U|�&amp;amp;�?�~�/��[[�Pp@PA8��ż���7 s@�p�  ,�.�;X]��&lt;m&gt;&lt;/m&gt;&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Euronews.com</author><pubDate>Wed, 28 Jan 2026 09:25:20 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMisgFBVV95cUxQRklWQ2RxRmYwbHFjUEt1TWRMWC1hcE5zSC1zVmNfQ0lPNlRzZU1rS09PVzdaQnp1VUQyMmFIaDlEVDBJU19vQWFkSGs1bXJrSWNkTExsYUhsR1lCa0RKdXZpbGVMRlRyMEEyZWZuZi1PbnB1blNMMFhtN0tabjhTZEd4N1FQRVh4YXJhZTZCclZPRHptZXZxTmZfU0RhMk4zOTJkd1huaEpidk11b0R2QWdB</guid></item><item><title>男性的心脏病发作风险在30多岁时攀升，比女性早几年- Northwestern Now News</title><link>https://news.northwestern.edu/stories/2026/01/mens-heart-attack-risk-climbs-by-mid-30s-years-before-women</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;
                        &lt;p class="MsoNormal horizontal-quote"&gt;Why it matters: Earlier risk in men suggests factors beyond smoking, hypertension and diabetes alone.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Men begin developing coronary heart disease — which can lead to heart attacks — years earlier than women, with differences emerging as early as the mid-30s, according to a large, long-term study led by Northwestern Medicine.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The findings, based on more than three decades of patient follow-up, suggest that heart disease prevention and screening should start earlier in adulthood, particularly for men.&lt;/p&gt;
&lt;p&gt;“That timing may seem early, but heart disease develops over decades, with early markers detectable in young adulthood,” said study senior author &lt;a title="Alexa Freedman" href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=62239"&gt;Alexa Freedman&lt;/a&gt;, assistant professor of preventive medicine at Northwestern University Feinberg School of Medicine.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;“Screening at an earlier age can help identify risk factors sooner, enabling preventive strategies that reduce long-term risk.”&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Older studies have consistently shown that men tend to experience heart disease earlier than women. But over the past several decades, risk factors like smoking, high blood pressure and diabetes have become more similar between the sexes. So, it was surprising to find that the gap hasn’t narrowed, Freedman said.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;To better understand why sex differences in heart disease persist, Freedman and her colleagues say it’s important to look beyond standard measures such as cholesterol and blood pressure and consider a broader range of biological and social factors.&lt;/p&gt;
&lt;h2 class="MsoNormal"&gt;Tracking heart disease from young adulthood&lt;/h2&gt;
&lt;p class="MsoNormal"&gt;The study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, which enrolled more than 5,100 Black and white adults ages 18 to 30 in the mid-1980s and followed them through 2020.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Because participants were healthy young adults at enrollment, the scientists were able to pinpoint when cardiovascular disease risk first began to diverge between men and women. Men reached 5% incidence of cardiovascular disease (defined broadly to include heart attack, stroke and heart failure) about seven years earlier than women (50.5 versus 57.5 years).&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The difference was driven largely by coronary heart disease. Men reached a 2% incidence of coronary heart disease more than a decade earlier than women, while rates of stroke were similar and differences in heart failure emerged later in life. “This was still a relatively young sample — everyone was under 65 at last follow-up — and stroke and heart failure tend to develop later in life,” Freedman explained.&lt;/p&gt;
&lt;h2 class="MsoNormal"&gt;Beyond traditional risk factors&lt;/h2&gt;
&lt;p class="MsoNormal"&gt;The scientists examined whether differences in blood pressure, cholesterol, blood sugar, smoking, diet, physical activity and body weight could explain the earlier onset of heart disease in men. While some factors, particularly hypertension, explained part of the gap, overall cardiovascular health did not fully account for the difference, suggesting other biological or social factors may be involved.&lt;/p&gt;
&lt;h2 class="MsoNormal"&gt;A critical age: 35&lt;/h2&gt;
&lt;p class="MsoNormal"&gt;One of the most striking findings was when the risk gap opened. The scientists found that men and women had similar cardiovascular risk through their early 30s. Around age 35, however, men’s risk began to rise faster and stayed higher through midlife. Heart disease screening and prevention efforts often focus on adults over 40. The new findings suggest that approach may miss an important window.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The authors highlight the relatively new American Heart Association’s &lt;a href="https://professional.heart.org/en/guidelines-and-statements/prevent-calculator"&gt;PREVENT&lt;/a&gt; risk equations, which can predict &lt;a href="https://news.northwestern.edu/stories/2025/11/new-heart-percentile-calculator-helps-young-adults-grasp-their-long-term-risk"&gt;heart disease starting at age 30&lt;/a&gt;, as a promising tool for earlier intervention.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Still, one major challenge to close the sex gap is that preventive care rates among U.S. adults ages 18 to 44 are highly uneven. Women are more than four times as likely as men to attend routine checkups, largely due to gynecologic and obstetric visits.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;“Our findings suggest that encouraging preventive care visits among young men could be an important opportunity to improve heart health and lower cardiovascular disease risk,” Freedman said.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;She also emphasized that cardiovascular disease remains the leading cause of death for both men and women, and prevention is critical for everyone.&lt;/p&gt;
&lt;h2 class="MsoNormal"&gt;Notes&lt;/h2&gt;
&lt;p class="MsoNormal"&gt;The study, published in the &lt;a title="Journal of the AHA" href="https://www.ahajournals.org/doi/full/10.1161/JAHA.125.044922"&gt;Journal of The American Heart Association&lt;/a&gt;, is supported by the National Heart, Lung, and Blood Institute. CARDIA is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the University of Alabama at Birmingham, Northwestern University, University of Minnesota and Kaiser Foundation Research Institute.&lt;/p&gt;
                        
                    &lt;/div&gt;
                &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Northwestern Now News</author><pubDate>Wed, 28 Jan 2026 08:04:28 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqAFBVV95cUxOT1lBdFNMTEkxOWs0enFKLVlmX09FX2F5YVltV3dHVm4wY3pRckJ4VlAzbzJYVDRDM2ctaWloRVpGQTk0QTltc0hNVXJwZlVFbFBtbDNYN2dSQzVWOGZmTlltT0JQSVJQNWZpbVF0T3k2azFQd2p1TkN0SGk2bU41OGw1aDg1Zy1kc1pHSzcxeWtjN3lhNGwxVjJZSWwyZFJaamtCQ3VlbWM</guid></item></channel></rss>